The development and application of organocatalytic asymmetric epoxidation by Bartlett, Chris
 The Development and Application of 
Organocatalytic Asymmetric 
Epoxidation 
Christopher J. Bartlett 
 
A thesis submitted is partial fulfilment of the  
requirements for the degree of Doctor of Philosophy 
 
 
 
University of East Anglia 
 
School of Chemistry 
University of East Anglia 
Norwich, NR4 7TJ 
 
 i 
 
 
 
 
 
 
 
DECLARATION 
This thesis is submitted to the University of East Anglia for the Degree of Doctor of 
Philosophy and has not been previously submitted at this or any university for 
assessment or for any other degree. Except where stated, and reference and 
acknowledgment is given, this work is original and has been carried out by the 
author alone. 
 
 
CHRISTOPHER J. BARTLETT 
  
 
 
  
 ii 
 
ABSTRACT 
THE DEVELOPMENT AND APPLICATION OF ORGANOCATALYTIC ASYMMETRIC EPOXIDATION 
CHRISTOPHER J. BARTLETT 
Epoxides are widely encountered within organic and biological chemistry, being 
present in many secondary metabolites and pharmaceuticals. In addition, the 
unique functionality of the epoxide has been exploited to facilitate the synthesis of 
many organic molecules. A particularly attractive way to stereoselectively epoxidise 
a substrate is to employ an organocatalytic system. Our group has been actively 
pursuing research in this area for over a decade and we have developed several 
catalytic systems capable of excellent stereocontrol in the epoxidation of alkene 
substrates. In considering possible refinements to catalyst structure, we targeted 
two development paths: i) variation of the dihedral angle Φ within the atropos 
azepinium systems - shown by Lacour to strongly influence the levels of 
stereoinduction,1 and ii) introduction of a substituent α- to the iminium nitrogen, 
which we envisaged would also influence the stereochemical outcome of any 
process occurring at the catalytically active centre.  
 
The application of the combined optimisations to existing catalyst frameworks 
allowed us to create a second generation of catalyst that was capable of furnishing 
epoxides in ees of up to 97% for tri-substituted unfunctionalised alkenes. We 
observed a tangible improvement upon the previous generation, and, in 
explanation, we offer an in-depth discussion on the influence of α-substitution on 
the ratio of sp2N-sp3C rotamers, and the importance of that ratio on the improved 
enantiocontrol. As part of an extended research program within our group, we also 
report the emergence of atropisomerism of the traditionally tropos sp2C-sp2C axis 
contained within biphenyl systems, presumably caused by efficient stereochemical 
relays mediated by the α-substituent. 
Lastly, we were able to successfully apply our methodology in the 
enantioselective total synthesis of (+)-scuteflorin A.2,3 The key epoxidation step 
proceeded in 99% ee and 99% yield, as part of a 7-step sequence that was 
completed with a 14.3% overall yield. 
 
1. 
 R. Novikov, G. Bernardinelli, J. Lacour, Adv. Synth. Catal., 2009, 351, 596. 
2.  J. Li, Y. Ding, X. –C. Li, D. Ferreira, S. Khan, T. Smillie, I. A. Khan,  J. Nat. Prod., 2009, 72, 983  
3.  C. J. Bartlett, D. Day, Y. Chan, S. M. Allin, M. J. McKenzie, A. M. Z. Slawin, P. C. B. Page, J. Org. Chem., 2012, 77, 772. 
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1.0 Introduction 
1.1 Chirality 
Chirality exists in molecules which do not possess a plane of symmetry; such 
molecules cannot be superimposed on their mirror images and possess a different 
configuration in 3D space in every conformation. Molecules that are mirror images 
of each other are termed enantiomers and have identical physical properties, e.g.; 
m.p., reactivity, NMR spectra and molecular weight, etc, except that each 
enantiomer rotates the plane of plane polarized light by an equal magnitude but in 
the opposite direction with respect to the other.1 
Jean-Baptiste Biot discovered in 1815 that some natural isolates (natural 
products) rotated the plane of plane polarized light.2 The reason, unknown to Biot 
at the time, is that many natural products exist as only one of the two possible 
enantiomers.  
                          
Figure 1.1: The two enantiomers of tartaric acid.* 
Naturally occurring tartaric acid 1 was shown to be optically active by Biot 
(Figure 1.1). However, synthetic tartaric acid made at the time by chemists was not. 
Of course, the synthetic acid was a 1:1, or racemic, mixture of 1 and 2 causing the 
net rotation of light to be zero.3  This observation was rationalized when in 1849 by 
Louis Pasteur, who noticed that crystallization of the sodium ammonium salt of 
tartaric acid yielded two asymmetric crystals that were mirror images of each other 
(Figure 1.2). The two forms of the crystal were manually separated by Pasteur, and 
both were found to be optically active. Importantly, he correctly proposed this was 
due to the structure of tartaric acid being somehow asymmetric.4  
 
*Tartaric acid can also exist as its meso-(R,S) isomer; it possesses two chiral centres, but also a plane 
of symmetry within its structure. It is, therefore, not optically active.  
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Figure 1.1: Illustration of the two asymmetric crystals of the tartaric acid salts. 
Jacobus Henricus van’t Hoff was the first person to suggest that the 
tetrahedral arrangement of four different groups around a carbon atom could 
result in an asymmetric product and hence account for Pasteur’s observations. The 
theory put forward in his 1874 paper and subsequently in his book ‘‘La chimie dans 
l’espace’’ was at first ridiculed by many scientists, most famously by Kolbe who in 
an open letter wrote:5 
 
“A Dr. J. H. van ’t Hoff of the Veterinary School at Utrecht has no liking, 
apparently, for exact chemical investigation. He has considered it more 
comfortable to mount Pegasus (apparently borrowed from the 
Veterinary School) and to proclaim in his ‘La chimie dans l’espace’ how 
the atoms appear to him to be arranged in space, when he is on the 
chemical Mt. Parnassus which he has reached by bold flight’’ 
 
J. H. van’t Hoff’s theory was eventually accepted by the scientific community 
and he went on to become one of the greatest chemists of his generation 
contributing hugely to the fields of organic and physical chemistry. In 1901 van’t 
Hoff was awarded the first Nobel Prize in chemistry. 
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1.1.2 Chirality and Life 
All life on earth is chiral - the human body for example uses only the L-amino acids 
and D-hexoses (Figure 1.3). The D and L notation used here corresponds to the 
enantiomer of glyceraldehyde, which is isolated upon chemical degradation of 
molecules like 3 and 4 and stands for dextrorotatory and laevorotatory.1 
 
Figure 1.2: Generic structure of the L-amino acids and D-hexoses. 
As indicated above, enantiomers in isolation have the same physical 
properties and reactivity. In a chiral system such as the body, however, 
enantiomers behave differently and can have drastically different effects.6 The most 
infamous example of this disparity was observed with the use of the drug (±)-
thalidomide to treat morning sickness in pregnant women (Figure 1.4). 
 
Figure 1.3: The two enantiomers of thalidomide. 
Thalidomide was first available as a racemic mixture in 1957, and shortly 
after its release there was a large increase of miscarriages and many instances 
where babies with malformed limbs and other defects were born from mothers 
who were taking thalidomide.7 A substantial research effort was directed at 
investigating the side-effects of the drug and it was determined that while (R)-
thalidomide 5 did alleviate morning sickness and was non-toxic, (S)-thalidomide 6 
was a powerful teratogen and caused severe birth defects in the developing 
foetus.8 Administration of enantiomerically pure (R)-thalidomide was not an option 
in this instance as the drug was racemized in vivo.9 Many lessons were learned from 
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this terrible incident, leading to stricter regulation on drug development to ensure a 
recurrence was not possible.10  
As a result, many new drugs have to be produced as a single enantiomer, 
and, today, enantioselective synthetic strategies are a vital tool to achieve this. 
However, several decades ago there were few enantioselective techniques, and no 
doubt industry’s need for such methodology drove its development. Consider a 
new drug that has only three stereocentres - it could exist as 23 stereoisomers. If 
the reactions to make these stereocentres are not selective, then over the synthesis 
87.5% of the drug material is lost before the chemical yield of each step is taken 
into account. This would result in heavy financial strain for the pharmaceutical 
company, making it less probable that the drug will be financially viable. Evidently, 
if a drug needs to be made as one stereoisomer then the synthesis has to be 
stereoselective.  
 
1.2 Epoxides 
The epoxide, or oxirane, is a strained three-membered cyclic ether composed 
of two carbon atoms and a bridging oxygen (Figure 1.5). The internal bond angles of 
the epoxide are typically 60, which is a large deviation from the preferred sp3 
hybridized bond angle of 109, and this disparity loads the ring with substantial 
Baeyer strain.11 
 
Figure 1.4: The epoxide. 
Due to the Baeyer strain present in the ring and the + charge induced on 
the two carbon atoms by the electronegative oxygen, epoxides are reactive 
electrophiles. Either electrophilic carbon can be targeted with range of 
nucleophiles, the most common including: oxygen,12 nitrogen,13 carbon14 and 
sulfur15 species. This reactivity allows easy access to many 1,2-functionalized 
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products such as 7 and 8. An example of how either carbon can be targeted by acid 
or base catalysis is outlined below (Scheme 1.1).11 
 
 
Scheme 1.1: Acid- (or also Lewis acid) and base-catalysed ring opening of an 
epoxide. The nucleophile attacks the most substituted carbon in the acid catalysed 
reaction to give 7, while the least substituted carbon is attacked in the 
corresponding base catalysed reaction to give 8. As with all SN2 reactions, inversion 
is observed at the electrophilic centre. 
Chemical groups that act to reduce the symmetry of the epoxide can 
differentiate the reactivity between the electrophilic carbon sites. Properties such 
as the steric size of attached R groups will achieve this, and functional groups close 
to the epoxide that affect electron density on the carbon atoms can influence 
regioselectivity also.  
As well as the standard SN2 type reactions, epoxides are also known to 
undergo several synthetically powerful rearrangements. It is possible to generate 
great complexity from a relatively simple epoxide-bearing skeleton, and some 
interesting examples are outlined below. Perhaps the most well known example is 
the Payne rearrangement, which describes the epoxide migration of 2,3-
epoxyalcohols such as 9 in the presence of a strong base (Scheme 1.2).16 The 
arrangement in this example exists as an equilibrium in which the most substituted 
epoxide 10 is favoured, although electron-withdrawing groups (EWG) destabilize 
the epoxide moiety.17 
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Scheme 1.2: The Payne rearrangement. 
The related homo-Payne rearrangement of 3,4-epoxy alcohols is also well 
documented. The resulting oxetane is much more stable than the original epoxide 
and dominates the product constitution.18  
An elegant rearrangement of a trans-diamine epoxide species 12 was 
utilized in Fukuyama’s synthesis of haplophytine (Scheme 1.3).19 The alkene in 11 
was oxidized to the epoxide which spontaneously rearranged to furnish ketone 13. 
 
Scheme 1.3: The use of an epoxide in Fukuyama’s synthesis of haplohytine.19 
Many epoxide rearrangements are initiated by Lewis acids; by coordinating 
to the epoxide, Lewis acids activate the epoxide motif to nucleophilic attack or 
spontaneous ring opening.20 Yamamoto has reported the exploitation of the well 
known Lewis acid-catalysed rearrangements to synthesise chiral β-hydroxy ketones 
14 and β-siloxy aldehydes 15, which are important intermediates in some natural 
product syntheses.21 Route I has been effected by use of titanium tetrachloride,22 
while route II required the use of bulky aluminium species to facilitate a controlled 
and reliable reaction (Scheme 1.4).23 
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Scheme 1.4: Yamomoto’s early titanium mediated rearrangement and the more 
recent aluminium mediated rearrangement of 2,3-epoxysilols. 
Corey reported in 1997, while investigating potential syntheses of steroidal 
skeletons, a ‘complex and unpredictable’ rearrangement that was initiated by a 
Lewis acid-catalysed ring-opening of epoxide 16 to form benzylic cation 17, which 
subsequently underwent a two-step cyclization followed by numerous bond and 
group migrations to form the bicyclic skeleton of 18 (Scheme 1.5).24  
Scheme 1.5: The cascade rearrangement reported by Corey initiated by epoxide 
ring-opening. a) Cation formation and bond rotation; b) two-step cyclization; c) boat 
to chair flip; d) methyl shift; e) fusion bond shift; f, g) hydride shift; h) elimination. 
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Fukumoto took advantage of an epoxide rearrangement to synthesise chiral 
cyclobutanones 20,25 which are also key intermediates for the synthesis of natural 
products (Scheme 1.6).26 The chiral epoxy-cyclopropanes 19 were prepared by the 
Sharpless asymmetric epoxidation (discussed below) from an allylic alcohol 
precursor which was then treated with citric acid in a one-pot reaction to furnish a 
cyclobutanone species.  
 
Scheme 1.6: Fukumoto’s synthesis of chiral cyclobutanones. 
Jung has reported the utilization of a Lewis acid-accelerated epoxide 
rearrangement to enable the synthesis of aldehydes with an α-chiral quaternary 
centre.27 This rearrangement was discovered when attempting a Corey-Fuchs 
homologation of 2,3-epoxy aldehyde 21.28 Instead of the desired allylic epoxide 22, 
the main component of the isolated material was the allylic aldehyde 23 (Scheme 
1.7). Jung proposed that ZnBr2, formed as a by product of a successful 
homologation, was a potent enough Lewis acid to facilitate the rearrangement. 
 
Scheme 1.7: Jung’s Lewis acid-catalysed rearrangement. a) Zn, Ph3P, CBr4, 60%; b) 
HMPT, CBr4, CH2Cl2, 99%; c) BF3·Et2O, 89%.  
The rearrangement was more controllable in a two step sequence with the 
use of the Lewis acid BF3 on the allylic epoxide. This rearrangement has been 
successfully used by Jung to synthesise biologically relevant molecules.27 
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Suzuki and Tsuchihashi have demonstrated the use of the epoxy alcohol 
rearrangement to prepare aldol-type 1,3-disubstituted products featuring 
enantiopure quaternary carbon centres as in 24.29 This rearrangement is again 
Lewis acid-mediated, and the general scheme is shown below (Scheme 1.8). 
 
Scheme 1.8: The epoxy alcohol-aldol rearrangement used to construct chiral 
quaternary carbon centres. 
As well as being synthetically useful, epoxides themselves are widely 
encountered within organic and biological chemistry, being present in many 
secondary metabolites and pharmaceuticals (Figure 1.6).30 
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Figure 1.6: Natural products containing an epoxide functional group: dynemicin 
2531; hybridalactone 2632; azadirachtin 2733; and the pharmaceutical Ixempra 2834 
which is used in the treatment of metastatic breast cancers. 
The epoxide is believed to be used in nature in the synthesis of secondary 
metabolites, as highlighted in the proposed biomimetic sequence involved in the 
synthesis of brevitoxin-B 29.35 In this example, nucleophilic ring-opening of an 
epoxide in 30 by a free hydroxyl results in a reactive nucleophilic oxy-anion, which 
then ring-opens a second epoxide within the same molecule and so on –
propagating a cascade sequence. These cascade, or domino, reactions are thought 
to resemble closely how some natural products are constructed in living systems 
(Scheme 1.9).36 
 
Chapter 1 – Introduction 
 
11 
 
 
Scheme 1.9: A biomimetic cascade step in the synthesis of brevitoxin-B. 
In addition, the unique functionality of epoxides coupled with the many 
methods of introducing the moiety into a substrate, has resulted in the routine 
exploitation epoxides by chemists to facilitate the efficient synthesis of many 
complex organic molecules. For example, Paterson’s synthesis of etheromycin 
made excellent use of an epoxide cascade strategy to efficiently construct a 
polycyclic ether skeleton 31 (Scheme 1.10).37 
 
Scheme 1.10: A biomimetic cascade step in Paterson’s synthesis of etheromycin. 
 
It is clear that the epoxide is an extremely powerful and important 
functional group for the synthetic organic chemist, as such, it is one that used 
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routinely in the laboratory synthesis of natural products and pharmaceutics. If one 
can exert stereocontrol over the insertion of an epoxide into a compound then 
resolution steps will be avoided and one would not have to dispose of unwanted 
stereoisomers (Figure 1.7).  
 
 
Figure 1.7: Enantiomeric and diastereoisomeric epoxides. 
As such, over the past few decades there has been a drive to develop 
stereoselective processes for the introduction of epoxides into alkene substrates. 
There are two main classes of methodology; the first is metal-based catalysis and 
the second is the relatively new field of organocatalysis. Both methodologies are 
explored in detail below preceded by a brief overview of other epoxidation 
techniques. 
  
Chapter 1 – Introduction 
 
13 
 
1.3 Epoxidation Methodologies 
Epoxides can be synthesised using many different and varied methodologies, and, 
as mentioned above, this wide range of techniques available to the synthetic 
chemist helps make the epoxides a particularly useful functional group.   
1.3.1 Williamson Ether Synthesis 
One of the simplest reactions used to form an epoxide is a type of Williamson ether 
synthesis. Mechanistically, a nucleophilic oxygen attacks a carbon at the β-position 
bearing a good leaving group such as a tosylate 32.38 This 3-exo-tet cyclization 
typically furnishes the epoxide in good yields. This procedure was used by Kim to 
install the epoxide in 33 late on in a synthesis of (–)-fumagillol in 88% yield (Scheme 
1.11).39 
 
Scheme 1.11: Williamson ether synthesis as a key step in Kim’s synthesis of (–)-
fumagillol. 
1.3.2 Darzens Condensation 
The Darzens condensation is commonly used to synthesise α,β-epoxy esters; 
traditionally α-halo esters and ketones or aldehydes were used as the coupling 
partners.40 However, many variations of this reaction have recently been 
investigated, and one can now use α-halo sulfones,41 ketones,42 nitriles43 and 
amides,43,44 for example, to effect a similar reaction.     
  This reaction is illustrated in Schwartz’s synthesis of the calcium 
channel blocker dilatazem 37 (Scheme 1.12).45 This proceeds similarly to the aldol 
reaction initially – the α-halo ester 34 is deprotonated to form an enolate, which 
then reacts through the C-terminus with aldehyde 35 forming a halohydrin 
Chapter 1 – Introduction 
 
14 
 
intermediate 36. The oxy-anion of the halohydrin rapidly attacks the electrophilic 
carbon centre, furnishing the α,β-epoxy ester in good yield. 
 
Scheme 1.12: The application of the Darzens condensation in Schwartz’s dilatazem 
synthesis. 
1.3.3 Corey-Chaykovsky Epoxidation 
Johnson first described in 1961 the unexpected formation of an epoxide when he 
attempted a Wittig reaction between 9-dimethylsulfonium fluorenylide and a 
benzaldehyde.46 But in what became known as the Corey-Chaykovsky epoxidation, 
sulfonium or sulfoxonium ylides are employed to transfer, in the simplest case, a 
methylene unit to ketones or aldehydes.47 Ylides such as 38 are typically prepared 
in situ from either sulfoxonium or sulfonium salts. Mechanistically, a nucleophilic 
ylide attacks a carbonyl species 39 to form a betaine intermediate 40, which 
collapses to the epoxide 41.48 Wickberg used the Corey-Chaykovsky epoxidation in 
his very short syntheses of both (+)-aphanamol I and II (Scheme 1.13).49  
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Scheme 1.13: Use of the Corey-Chaykovsky epoxidation in Wickberg’s synthesis of 
(+)-aphanamol I and II. 
1.4 Non-Stereoselective Epoxidation of Alkenes and Enones 
The most commonly seen class of epoxidation reaction involves the transfer of an 
oxygen to a C=C bond. As well as the reactions below, many other oxidants may be 
used, including: peroxoselenic acid, peroxycarboximidic acids, O2 + hν, magnesium 
monoperoxypthalate and alkyl hydroperoxides in conjunction with transition 
metals.50,51 
 1.4.1 Prilezhaev Epoxidation 
The ability of peracids to oxidize isolated carbon-carbon double bonds was first 
discovered in 1909 by Prilezhaev.52 The reaction is completely stereospecific, 
meaning the substrate will always carry its double bond E- or Z- geometry through 
to the final product. The reaction is believed to proceed through a concerted 
‘butterfly’ transition state, which explains the observed stereospecificity.53 The 
reaction can be envisaged to begin with a nucleophilic interaction of the alkene’s -
orbital with the σ* orbital of the peracid’s O-O bond, but it is a concerted process 
(Scheme 1.14). 
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Scheme 1.14: The concerted ‘butterfly’ transition state believed to operate in the 
Prilezhaev oxidation. 
The oxidant can attack either the top or bottom face of the planar olefin 42, 
resulting in a racemic mixture if the substrate contains no chiral centres. However, 
if the substrate is optically active then selectivity for one face will be observed as 
the two transition states will be diastereoisomeric, thus their activation energies 
and therefore their rates of formation will be different. This facial selectivity is 
particularly pronounced if there is a group such as a hydroxyl close to the alkene 
that can coordinate to the peracid and direct it to one face.54 
The Prilezhaev reaction is also chemoselective. The epoxidation proceeds 
faster with increasing electron density on the alkene. Because aliphatic groups are 
mildly electron-donating, a trisubstituted alkene will be epoxidized in preference of 
a styrene in the same molecule, for example. The reactivity is lessened when the 
alkene is substituted by electron-withdrawing groups. Some electron-poor olefins 
can be oxidized using this system, but the limit is found at ,-unsaturated ketones, 
which are unreactive.51 
 
1.4.2 Weitz-Scheffer Epoxidation 
The electron-deficient nature of the ,-unsaturated ketone moiety 43 does lend 
itself to nucleophilic attack by an alkaline hydrogen peroxide system. This 
methodology, developed in 1921 by Weitz and Scheffer, provides a route to ,-
epoxyketones 44 (Scheme 1.15).55  
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Scheme 1.15: Weitz-Scheffer epoxidation of electron deficient alkene substrates. 
 
1.4.3 Dioxirane-Mediated Epoxidation 
Dioxiranes are a very important class of oxidants. Their existence had been 
postulated since the early 1900s,56 however, it was not until 1977 that substantial 
evidence was obtained in a microwave spectroscopy study that conclusively 
supported their existence.57 A few years later, chemists were able to readily 
synthesise dioxiranes, and, with that development, their use in synthetic chemistry 
began to accelerate.58,59  
 For simple achiral systems, dioxiranes are typically synthesised by oxidation 
of simple ketones such as acetone. The ketones can be oxidized by the triple salt 
Oxone® (2KHSO5.KHSO4.K2SO4) 45, and the resulting dioxiranes can then be isolated 
by distillation of the reaction mixture.59 A more practical method, which was 
developed by Curci and Edwards in 1984,60 is to form the dioxirane 46 in situ, which 
gives the opportunity to create a system catalytic in the ketone (Scheme 1.16). 
Chiral ketones are one of the most investigated classes of organocatalyst for 
asymmetric epoxidation, and while, perhaps, a catalytic system is not important if 
one is using acetone, it was a crucial development that later made the use of chiral 
ketones practical. This catalytic procedure involved the use of a biphasic CH2Cl2/H2O 
solvent system, Oxone®, and a phase-transfer catalyst to allow the solvation of the 
water-soluble oxidant in the organic phase. Organic molecules that behave as 
phase-transfer agents are an important class of organocatalysts, and phase transfer 
catalysis will be discussed in more detail later. 
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Scheme 1.16: Dioxirane-mediated catalytic cycle to oxidize alkenes. 
Dioxiranes have been put to good use in natural product synthesis. In 2000, 
Yang was able to produce methyl(trifluoromethyl)dioxirane 46 in situ to epoxidize a 
precursor of (–)-triptolide in 70% yield and, owing to the stereochemistry already 
present in the precursor 47, 48 was isolated as a single diastereoisomer (Scheme 
1.17). Notably, Yang used a homogenous MeCN/H2O system to achieve good 
reactivity. The modification greatly improved on the previous biphasic system, 
developed by Curci and Edwards, which relied on phase-transfer agents to facilitate 
the formation of the dioxirane.61 
 
Scheme 1.17: Oxidative step in Yang’s synthesis of (–)-triptolide. 
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1.5 Metal-Mediated Stereoselective Olefin Epoxidation Methodology 
1.5.1 Sharpless Asymmetric Epoxidation 
The Sharpless epoxidation is a method to transform allylic alcohols into their 
respective epoxyalcohols, using the transition metal titanium (Scheme 1.18).62 It is 
considered one of the most important methodologies developed within organic 
chemistry in the past 30 years, and consequently, Sharpless shared the Nobel Prize 
in 2001 for his work on this and other asymmetric transformations.63,64 
The Sharpless catalytic system is capable of imparting great stereocontrol to 
a range of substrates that contain the necessary allylic alcohol moiety 49. The 
reaction usually furnishes the epoxide product 50 in a high yield and very high 
enantiomeric excess (>95 %).65 The authors found that a relatively simple mixture of 
Ti(IV)(OiPr)4, 
tBuOOH as the stoichiometric oxidant, together with a chiral 
diethyltartrate ligand (DET) is all that was needed to achieve high conversion and 
enantioselectivity.  
 
 
Scheme 1.18: a) Ti(OiPr)4, (+) or (–)-DET,  
tBuOOH, 3-5 Å molecular sieve, CH2Cl2,          
–20 C. 
The complex that is believed to be the active catalyst is somewhat more 
complicated (Scheme 1.19).66 When carrying out this reaction, the Ti(IV) complex 
and the desired DET are added together first, typically in CH2Cl2 at –20 C, to form 
complex 51. The oxidant tBuOOH is then added to the solution, which undergoes 
ligand exchange with 51, displacing one of the DET’s carbonyl groups as well as an 
iPrO– ligand, the solution is allowed to stir for 20-30 min to mature, allowing the 
formation of active complex 52. Lastly, the allylic-alcohol substrate is introduced; 
this is believed to displace an axial iPrO– ligand to form the transitional complex 53. 
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Scheme 1.19: a) tBuOOH, b) allylic alcohol substrate. (+)-DET is shown in this 
example. 
Either enantiomer of the desired epoxyalcohol can be synthesised by changing the 
enantiomer of DET used and, importantly, both isomers are available cheaply 
(Scheme 1.20). L-(+)-DET, the more commonly found form of tartrate, is extracted 
from grapes. The ‘non-natural’ form of D-(–)-DET is rare, and is more expensive.  
 
Scheme 1.20: The mnemonic for predicting the major product depending on the 
enantiomer of tartrate used.  
Molecular sieve is required to remove water from the system, as water is 
detrimental to the activity of the complex. Without molecular sieve, one equivalent 
of the active Ti complex is required. However, with them, only 5-10% of the 
complex is required; rendering the process catalytic.67 
The Sharpless epoxidation is capable of extremely high ees (>99%), and, as 
such, many natural product syntheses have made use of this powerful methodology 
to date. Morimoto used the Sharpless epoxidation to introduce key stereochemistry 
and functionality in the first asymmetric total synthesis of the marine triterpene 
polyether (+)-intricatetraol (Scheme 1.21).68 
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Scheme 1.21: The Sharpless epoxidation as a key step in Morimoto’s total synthesis 
of (+)-intricatetraol. 
The epoxidation proceeded in almost quantitative yield with complete 
stereocontrol. Using this powerful methodology, Morimoto was able to install the 
first of two epoxides which are then set-up to undergo an intricate cascade 
reaction, forming several of the key structural moieties present in (+)-intricatetraol. 
 
1.5.2 Yamamoto 
Over the past decade, Yamamoto has reported several powerful metal-based 
catalytic systems for the epoxidation of allylic alcohols.69 These systems are 
designed similarly to Sharpless’, and as a consequence the substrate scope is also 
limited to alkenes bearing a pendent alcohol group.  
The transition metal centre in Yamamoto’s initial systems was vanadium, 
introduced as V(v)O(OiPr)3, and monohydroxamic acid ligands 54 and 55 were 
employed as the source of stereochemical information (Figure 1.8).69  
 
Figure 1.8: Monohydroxamic ligands designed by Yamamoto. 
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 Early results were promising, attaining some good ees particularly for 
homoallylic alcohols (Scheme 1.22). Furthermore, the vanadium-based systems do 
not require the use of molecular sieve, as the water-induced attenuation of 
catalytic activity was not observed.  
 
Scheme 1.22: Epoxidation of homoallylic alcohols with Yamamoto’s vanadium 
catalytic system. 
In his drive to further improve the facial selectivity of the vanadium-based 
system, Yamamoto increased the steric bulk of the ligand; however, he reported 
reaching the limit of reactivity before achieving the ees he desired.70 Having 
seemingly reached a dead end, Yamamoto has recently detailed the exploration of 
the ability of other metals to epoxidize homoallylic and bis(homoallylic) alcohols 
(Figure 1.9). Several group 4 and 5 metals such as titanium, zirconium, hafnium and 
niobium were trialled. It was found that hafnium and zirconium, in conjunction with 
a bis(hydroxamic acid), provided the best results in terms of both reactivity and 
enantioselectivity.70 
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Figure 1.9: Illustration of several transition metal intermediates, showing a bound 
homoallylic alcohol. Yamamoto the larger size of the metal centres of the later 
group 4 elements would alleviate some of the reactivity problems experienced with 
the relatively crowded vanadium analogue.  
During the optimization of the reaction parameters, it was observed that the 
hafnium system benefited from the addition of 4 Å molecular sieve to remove any 
contaminating water, while the analogous zirconium system did not. Yamamoto 
also discovered that the sub-stoichiometric addition of DMPU, a polar aprotic 
solvent, caused a large increase in yield. He noted that this was likely due for two 
reasons: a) the vacant coordination sites present on the zirconium and hafnium 
metal centres in 57 and 58 respectively could facilitate a slow oligomerisation of the 
catalyst species, potentially leading to a drop in activity. He suggested that DMPU 
occupies these sites, thus stabilizing the monomeric form; b) DMPU may accelerate 
the completion of the catalytic cycle by allowing the facile release of the 
coordinated product from the metal centre. 
After optimization, it was apparent that the hafnium-based system was far 
superior to the analogous zirconium-based system. Yamamoto achieved some 
impressive ees for the isolated β- and γ-hydroxy epoxides, although yields were 
only moderate to good (Scheme 1.23). The bis(homoallylic) alcohols still present 
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themselves as difficult substrates, requiring a 5-fold increase in catalytic loading to 
approach the yields achieved for the homoallylic alcohols.70 
Scheme 1.23: Yamamoto’s reported results for homoallylic alcohols (blue) and 
bis(homoallylic) alcohols (red). 
 
1.5.3. Jacobsen-Katsuki 
In 1990, a stereoselective modification of a procedure to oxidize olefins originally 
developed by Kochi71 was reported by Jacobsen and Katsuki.72,73 This is another 
example of a transition metal-mediated epoxidation. In this instance, the metal 
species is manganese(III). Surrounding the metal centre is a tetradentate ‘salen’2–
ligand, and either a chlorate anion in Jacobsen’s catalysts 59, or an acetate anion in 
Katsuki’s analogous catalysts 60 (Figure 1.10). Unlike the Sharpless and Yamamoto 
epoxidations above, this method does not require the substrate to contain a 
hydroxyl group for high enantioselectivities to be attained. The advantage is that 
these systems are effective for a less specific range of substrates, but the 
compromise is that the enantioselectivity must be controlled through purely steric 
interactions with no coordinating functionality present. 
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Figure 1.10: Jacobsen’s and Katsuki’s general catalyst structure, 59 and 60 
respectively. 
The above catalysts, although similar, demonstrate differing preference over 
substrate geometry; i.e. 59 and 60 each impart their greatest stereocontrol over 
different alkene classes. Jacobsen’s catalysts 59 demonstrated enhanced 
enantioselectivity when Z-alkenes were used as substrates, while Katsuki’s catalysts 
60 were more selective with E-alkene substrates; though both require the alkene 
bond to be in conjugation with an aryl moiety for high ees.  Both can be used at 
very low catalyst loadings; it is not uncommon for 1 mol% loadings to be used, and 
ees in the isolated epoxides can be >99%.74  
The transition metal centre is compatible with a variety of stoichiometric 
oxidants: NaOCl, H2O2 or m-CPBA are effective, although other less common species 
such as iodosobenzene (PhIO) and magnesium monoperoxypthalate (MMPP) can 
also be used (Scheme 1.24).75 It is widely accepted that the active form of the 
catalyst is a Mn(V) 62 species produced upon oxidation of the Mn(III) complex 61.76  
 
Scheme 1.24: The suspected catalytically active species. L = Cl, OAc. 
There are two rationales for the observed enantioselectivity in the 
epoxidation process, the difference between them being the approach of the 
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substrate to the active catalyst. Jacobsen has proposed a ‘top-on’ approach to the 
axial oxygen, whereas Katsuki has suggested a ‘side-on’ approach (Figure 1.11).77 
 
Figure 1.11: The two discussed approaches from Katsuki and Jacobsen. 
The mechanism has not yet been fully elucidated,78 and there exist three 
different mechanistic explanations for how the reaction propagates (Figure 1.12).79 
The first pathway I is concerted, much like the oxidation with m-CPBA, the reaction 
is predicted to be stereospecific as again there is no opportunity for bonds to 
rotate. The second pathway II is also stereospecific, although unlike the first an 
intermediate exists – a metalla-oxetane species, which then collapses to give the 
epoxide with the same stereochemistry as the substrate. The third III, however, is 
the only one that can explain the observed loss of stereospecifity when some 
conjugated alkenes, are used. It is the only one of the three pathways that 
propagates along a radical pathway. The radical intermediate, produced through 
either a single electron transfer from the catalyst or a homolytic splitting of the Mn-
C bond of the metalla-oxetane species, is stabilized in conjugated alkenes and so 
allows time for the stereochemistry to switch.80  
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Figure 1.12: Summary of proposed pathways.  
While the radical pathway is the only one that accounts for the observed 
loss of stereospecificity in conjugated systems, it is entirely possible that more than 
one of the pathways operate.  
The Jacobsen-Katsuki and Sharpless-type transition metal-catalysed 
asymmetric epoxidation systems are among the most widely employed epoxidation 
protocols in organic synthesis. Many other transition metal based systems have 
been reported, including cobalt, ruthenium, samarium, gadolinium and ytterbium in 
conjunction with chiral ligands such as porphyrins and BINOL,81 but an in depth 
discussion on this field is beyond the scope of this review. 
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1.6 Organocatalysis 
Organocatalysis is an important concept in chemistry that, over the past decade, 
has began to mature despite a slow beginning.82 By the middle of the 20th century, 
there were only a handful of manuscripts published on the area, and, at the time, 
they were only seen as intriguing individual reactions, with next to no research 
following up on the early promise.  
The first reported ‘asymmetric organocatalytic’ reaction was published 
almost 100 years ago by Fiske and Bredig – they observed that the addition of HCN 
to benzaldehyde was catalysed by quinine, and that the resulting cyanohydrin 65 
was optically active (Scheme 1.25).83  
 
Scheme 1.25: The formation of optically active cyanohydrins like 65 by Fiske and 
Bredig using quinine. 
Hajos and Parrish, and Wiechert, Sauer and Eder, independently discovered 
in the early 1970s that the asymmetric intramolecular aldol reaction could be 
catalysed by chiral amines such as L-proline – a natural amino acid.84,85 The 
Wieland-Miescher ketone 66, an important intermediate in many terpene 
syntheses, was synthesised with a 74% ee by Hajos and Parrish while working at 
Hoffmann LaRoche, illustrating the utility of this methodology (Scheme 1.26).85  
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Scheme 1.26: The L-proline catalysed Hajos-Parrish aldol reaction – formation of the 
Wieland-Miescher ketone. 
During the same period, metal-based catalysis was enjoying its golden era, 
ever more powerful reactions were being discovered, and the rate of development 
was rapid. The importance of the methodologies developed at that time cannot be 
over-stated; the Nobel Prize committee saw fit to award the prize in 2001 to 
Sharpless, Noyori and Knowles, and most recently to Heck, Suzuki and Negishi in 
2010 for their work on transition-metal catalysis. 
The breadth of reactivity and structural properties across different metal-
centres, coupled with the ability of coordinating ligands to harness and tune the 
behaviour of a metal centre have ensured that transition-metal catalysis is applied 
to many processes. These processes can then be optimized by altering the metal’s 
ligands – a characteristic that is very important for industrial uses. But metal-
catalysis also has several disadvantages: the metals are often toxic, which 
potentially leads to pollution; product contamination; and the need for waste 
management. Also, some of the transition-metals used are exotic and are therefore 
expensive.82 Considering these disadvantages, several groups in the late 90’s 
became curious as to whether small organic molecules could achieve the same 
transformations.86 In theory, these systems would have many advantages over the 
metal-based counterparts; namely, they would be cheaper and cleaner. Though 
non-chiral processes have also been addressed, only the asymmetric processes will 
be discussed below. The successful asymmetric work carried out by the groups of 
MacMillan, Barbas III, List, Lusinchi, Denmark, Corey, Page and Jørgensen, to name 
a few, inspired many others and created a surge in research (Figure 1.13).87 Of 
course, ‘organocatalysis’ has been around for many years depending on one’s 
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definition, but the graph below gives an indication of the growth of interest in the 
area. 
 
Figure 1.13: Graph indicating the growth in the number of papers published per 
year on the subject of ‘organocatalysis’.86 
Today, organocatalysis, together with enzyme and metal-based catalysis, 
forms an integral part of the techniques available to the modern synthetic 
chemist.88,89 For example, cinchona alkaloid-mediated catalysis, first described by 
Fiske and Bredig, is almost a whole field unto itself with a plethora of procedures, 
such as the Baylis-Hillman reaction, Michael addition and Diels-Alder reaction – all 
of which are accelerated and rendered enantioselective with their use.90 The rest of 
the chapter concerns the development of organocatalytic epoxidation 
methodology. 
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1.6.1 Asymmetric Epoxidation of Aldehydes by Sulfonium Ylides 
The synthesis of chiral epoxides by the reaction of chiral sulfonium ylides with 
carbonyl moieties is fundamentally different from the other asymmetric 
organocatalytic procedures in which an unsaturated bond is oxidized. Here, the 
reaction between a carbonyl group and a nucleophilic carbon atom furnishes the 
epoxide (Scheme 1.27). While other carbon nucleophiles such as carbenes may be 
used,91 the most commonly used species are sulfonium ylides.87 
 
Scheme 1.27:. Retrosynthetic disconnection of the epoxide. 
Johnson was the first to demonstrate that the asymmetric synthesis of 
epoxides from sulfonium ylide species and carbonyl groups was possible (Scheme 
1.28). He reported that the enantiopure aminosulfoxonium ylide 67, when used 
stoichiometrically, yielded the enantiomerically-enriched styrene oxide in a 20% 
ee.92 
  
Scheme 1.28: Johnson’s enantioenriched synthesis of styrene oxide employing an 
aminosulfoxonium ylide. 
Following Johnson’s preliminary research, Trost also investigated the utility 
of chiral sulfonium ylides for asymmetric epoxidation. The enantiopure adamantane 
sulfonium salt 68 was prepared and isolated; the sulfonium ylide 69 was 
subsequently formed in situ by deprotonation with nBuLi. The nucleophilic ylide 
generated then transferred its methylene group to benzaldehyde derivatives.93 
Curiously, the resulting styrene oxides displayed no optical activity. The 
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racemization of sulfonium species by inversion is known,94 but this possibility was 
ultimately ruled out by Trost and 69 was demonstrated to be configurationally 
stable (Scheme 1.29).93 However, it turned out that had Trost investigated the 
reaction of the sulfonium benzylides, he would likely had observed reasonable 
enantiocontrol.91  
 
Scheme 1.29: Attempts by Trost to enantioselectively transfer a methylene group to 
benzaldehydes were unsuccessful. 
Furukawa, however, did investigate sulfonium benzylides.95 The ylides were 
formed in situ from sulfides derived from (+)-camphorsulfonic acid and benzyl 
bromides in the presence of powdered KOH. Using the procedure illustrated below, 
the authors were able to observe some catalytic turnover, although it was minimal 
(Scheme 1.30). 
 
Scheme 1.30: Furukawa’s catalytic cycle. MeCN, KOH, RT. 
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Dai’s employment of closely related sulfides derived from (+)-camphor 
offered an improvement, and highlighted the importance of a hydroxyl group 
vicinal to the active centre (Figure 1.14). The exo-trans-sulfide 70 was prepared as 
well as the endo-cis-sulfide 71 and the exo-cis-sulfides 72 and 73.96 
 
Figure 1.14: (+)-Camphor derived sulfides prepared for this study. The hydroxyl 
group was found to have an accelerating and directing influence over the reaction 
pathway.  
It was found that if the hydroxyl was methylated as in 73, reactivity and 
enantioselectivity were heavily compromized. Thus, Dai proposed that the hydroxyl 
group was needed to form a hydrogen bond with the ketone substrate. It was 
believed that such an interaction stabilized the reactive conformation, which 
exposed the re-face of the ketone to nucleophilic attack from the ylide; π-stacking 
was also suggested to favour the conformation 74 (Scheme 1.31).96 Dai also 
reported that the products were isolated as single diastereoisomers – only the 
trans-epoxides such as 75 were observed. 
Scheme 1.31: Transition state is stabilized by co-operative H-bonding and π-stacking 
between the ylide and ketone substrate. In this example, 72 was used at a 20 mol% 
catalyst loading. 
Although Dai isolated single diastereoisomers of the epoxides, it was an 
exception for this transformation; the general complication of this methodology is 
the potential for the formation of diastereoisomeric ylide intermediates. This was 
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addressed by Durst with the synthesis and use of C2-symmetric sulfides; the 
benzylide can only be formed as one diastereoisomer, and thus the complication 
was addressed (Figure 1.15).97 
 
Figure 1.15: Durst’s C2 symmetric ylides for asymmetric epoxide formation; ees of up 
to 83% were attained for the synthesis of 4-nitrostilbene when employing the above 
salts. 
In 2001, Metzner reported some exceptional results from the 
implementation of C2 symmetric chiral sulfides 76 and 77 in his catalytic 
epoxidation procedure. Structurally and synthetically, they were the simplest 
sulfide catalysts to date (Figure 1.16).98 
 
Figure 1.16: Metzner’s simple C2 symmetric sulfides.  
Metzner also explored the substrate scope, and expanded it to include: 
furan, thiophene and naphthyl aldehydes as the electrophile. However, for this 
system, benzylides were still the only class of carbon nucleophiles that exhibited 
enantioselectivity – the analogous methylides only furnished the epoxides in a 
negligible ee. Initially, it was not uncommon for reactions to take up to one month, 
but through careful analysis of the reaction pathway, Metzner and co-workers 
identified two slow rate-determining steps: formation of the sulfonium salt and 
nucleophilic attack of the aldehyde to form the betaine intermediate. Since the 
second is the step in which enantioselectivity is determined, the authors reasoned 
that the first could be accelerated without any loss in epoxide ee.99 To achieve the 
desired rate acceleration, iodide salts were used to effect a Finkelstein-type 
reaction of the benzyl bromide; the resulting benzyl iodide reacted much faster 
Chapter 1 – Introduction 
 
35 
 
with the sulfide.98 The concentration of the aldehyde was also important: too low 
(0.25M) led to long reaction times whereas an elevated concentration (1M) caused 
the yield to drop off substantially, probably due to the competing Cannizzaro side 
reaction. With the optimized conditions, only 10 mol% of the catalysts were needed 
to obtain the epoxides in good yield, and in excellent ee and de, but reaction times 
were still up to several days in duration (Figure 1.17).98  
 
Figure 1.17: Epoxides prepared by Metzner. NaOH, tBuOH/H2O, 
nBu4NI or NaI, 4-6 
days, RT. 
Other notable contributions to this area of research have come from the 
groups of Aggarwal and Goodman (Scheme 1.32).. Aggarwal developed a one-pot 
asymmetric catalytic process in which the sulfonium ylides were generated in situ 
by the reaction of a chiral sulfide 78 with phenyldiazomethane in the presence of 
Rh2(OAc)4.
100 The epoxides were isolated in good yield, in up to 93% ee and 96% de. 
Goodman has succeeded in designing a procedure capable of methylene transfer in 
good ees of up to 70%. Although the chiral sulfide 79, which was derived from D-
mannitol, had to be used stoichiometrically, it was easily recovered.101 No attempt 
is made here to go into detail about either of these studies as it is beyond the scope 
of this review.  
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Scheme 1.32: Chiral sulfide-mediated epoxidation by Aggarwal and Goodman. 
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1.6.2 Organocatalytic Enone Epoxidation 
1.6.2.1 Juliá-Colonna  
One of the first organocatalytic epoxidations of enones was reported by Juliá in 
1980.102 Juliá employed poly-L-alanine to epoxidize enone containing substrates, 
such as chalcone, with excellent enantiocontrol under heterogeneous triphasic 
conditions with H2O2 as the oxidant (Scheme 1.33).  
 
Scheme 1.33: Epoxidation of chalcone by Juliá using poly-L-alanine 
While the insolubility of the poly-peptide was advantageous in that it 
allowed the recovery and subsequent re-use of the catalyst, the triphasic nature of 
the initial reaction conditions unfortunately led to long reaction times of up to 
several days.103 Further, the strong basicity of the aqueous phase used not only 
degraded the peptide in some instances, but also limited the possible substrate 
scope; as it did not allow enolizable enones to be successfully oxidized (Scheme 
1.34).104  
 
 
Chapter 1 – Introduction 
 
38 
 
 
Scheme 1.34: Poor reactivity was observed with the poly-L-leucine catalyst due to its 
insolubility. 
Despite its drawbacks, but probably due to the perceived potential, the 
Juliá-Colonna procedure attracted considerable interest. Roberts first outlined his 
optimized biphasic non-aqueous conditions for the Juliá-Colonna epoxidation in 
1997.105 His modified conditions use urea-hydrogen peroxide as the oxidant, the 
strong organic base – DBU, and poly-L-leucine as the catalyst. The problems 
imposed by the triphasic conditions were remedied with the use of the new 
biphasic conditions; reaction times were reduced dramatically, and enolizable 
substrates were no longer problematic.106 Roberts demonstrated the use of his 
modified conditions in his synthesis of the drug dilatazem, and also in his synthesis 
of the side chain of Taxol® 80 (Scheme 1.35).105 
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Scheme 1.35: The use of the Juliá-Colonna epoxidation in the synthesis of the side 
chain of Taxol®. 
Through systematic studies, including the use of NMR and IR spectroscopy, 
it has been determined that the N-terminus of the poly-peptide catalysts is the 
probable active site.107,108 Crucially, for the catalyst to be active, it must adopt a 
helical conformation. Berkessel recently proposed a mechanistic model to explain 
the stereocontrol observed in the Juliá-Colonna epoxidation.108 Berkessel 
synthesised the oligomers of L-leucine from n = 1  20 and attached those 
oligomers to solid phase supports. Each of the supported oligomers was then used 
as a catalyst for the epoxidation of chalcone to study its activity. It was discovered 
that only five residues was needed for full stereoinduction, but the activity of the 
oligomer increases with n. Berkessel concluded that the stereoinduction is achieved 
by hydrogen bonding of non-intra-helical N–H groups of the oligomer to both the 
oxidant and substrate (Figure 1.18). 
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Figure 1.18: Berkessel’s proposed model of the H-bonding between the substrate 
and peptide responsible for the stereoinduction (yellow). It is believed by Berkessel 
that the peroxide H-bonds to the N–H at the (n – 1) position and is thus directed to 
one face of the chalcone substrate. The intra-helical H-bonding responsible for 
maintaining the helical structure is also shown (black).108 
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1.6.2.2. Epoxidation of α,β-unsaturated Carbonyls by Iminium Activation 
During the past decade, several groups have described their efforts to create 
efficient techniques to epoxidize α,β-unsaturated carbonyls by temporarily 
condensing primary or secondary amines to the carbonyl moiety.88 The resulting 
electron deficient iminium salt 81 activates the double bond to nucleophilic attack, 
and the covalently bonded catalyst is able to direct nucleophilic oxidants such as 
H2O2 with excellent facial selectivity, leading to high ees in the isolated epoxides 
(Scheme 1.36).109,110 
 
Scheme 1.36: General catalytic cycle of the epoxidation of enones by iminium 
activiation. 
Jørgensen and co-workers reported the synthesis and use of the L-proline-
derived catalyst 83 in 2005, and presented an investigation into its efficacy as an 
enantioselective organocatalyst for epoxidation (Scheme 1.37).109 
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Scheme 1.37: Highly enantioselective epoxidation of enones with Jørgensen‘s L-
proline-derived amine catalyst. 
Initially, the screening of a series of conditions, covering a range of different 
oxidants and solvents, was performed to determine the optimum conditions for the 
use of 83. Jørgensen observed that conditions that employed aprotic solvents and 
peroxides provided the best results in terms of ee, yield and diastereomeric ratio 
(dr). When protic solvents were employed the dr was adversely affected. This was 
probably due, as suggested by Jørgensen, to the stabilization of intermediate 82 in 
the catalytic cycle; this stabilization increases the lifespan of 82 and creates an 
increased potential for bond rotation. 
MacMillan and Lee reported their efforts to create an improved and 
completely diastereoselective modification of Jørgensen’s work in 2006.111 
MacMillan had already synthesised a range of chiral imidazolidinone catalysts that 
were developed for the related stereoselective 1,4-addition of other nucleophiles, 
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and it was envisaged they would enjoy similar success with epoxidation.112 
MacMillan reasoned that by using a nucleophilic source of oxygen that was coupled 
to an excellent leaving group, the resulting fast ring-closure of intermediate 82 
would improve enantioselectivity and diastereoselectivity by preventing unwanted 
bond rotation. MacMillan found that hypervalent λ3-iodanes, such as 
iodosobenzene, exhibited the desired behaviour (Figure 1.19). Iodosobenzene, 
upon reaction with the electron deficient substrate, unveils the phenyliodonio 
moiety. Incredibly, the phenyliodonio moiety has a leaving group ability of roughly 
six orders of magnitude greater than that of the triflate group.113 The excellent 
leaving group-ability of the phenyliodonio moiety facilitates the desired rapid ring-
closure of intermediate 82.  
 
Figure 1.19: The structure of MacMillan’s imidazolidinone catalyst and 
iodosobenzene.  
Having identified a suitable oxidant and catalyst, and using crotonaldehyde 
as a test substrate, MacMillan sought to investigate other variables, such as the 
solvent, the acid co-catalyst and temperature. Similarly to Jørgensen, MacMillan 
found that the use of CH2Cl2 and CHCl3 offer the best results with regards to epoxide 
ee, but only led to moderate yields. Notably, employing wet DMF (10% H2O) as the 
reaction solvent elicited the best conversion at 87%, but the ee was the lowest 
reported at 25%. An investigation into the acid co-catalyst revealed both the 
isolated epoxide ees and yield to be strongly dependent on the pKa of the acid 
(Table 1.1). MacMillan suspected this particular trend was due to the increased 
equilibrium concentration of the substrate-catalyst complex, similar to 81, with 
stronger acids – this increased the observed epoxide ees because it ensured the 
catalytic pathway could ‘out-compete’ the racemic non-catalysed pathway.111 
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Entry HX pKa Conv. (%) ee (%) 
1 TfOH –14 74 87 
2 HClO4 –10 68 88 
3 p-TSA –2.6 50 76 
4 TFA –0.3 42 72 
5 DCA 1.3 27 72 
6 CNA 2.5 27 69 
Table 1.1: Effect of the pKa of the acid co-catalyst. 
Lowering the temperature had the expected effect of increasing the epoxide 
ees in accordance with the Boltzmann distribution. It also, somewhat unexpectedly, 
increased the conversion and reactivity dramatically. MacMillan discovered through 
NMR studies that if the reaction was run at temperatures exceeding about –40 °C, 
the rate of decomposition of the catalyst and substrate through competing 
oxidative pathways became significant, and was detrimental to the efficiency of the 
reaction (Table 1.2).111 
 
Entry T (°C)  Time (h) Conv. (%) ee (%) 
1 –20 18 49 83 
2 –30 20 74 87 
3 –40 15 98 89 
4 –50 15 100 93 
Table 1.2: Effect of temperature. 
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The substrate scope of the reaction was also investigated; it was observed 
that the epoxide ees rapidly fell off with the increasing stability of an intermediate 
iminium species similar to 81. It is the addition to this species which is believed to 
be the rate determining step of the process. MacMillian theorized that if this 
species becomes less reactive, the competing and degrading nucleophilic attack of 
the catalyst by hypervalent λ3-iodanes correspondingly becomes more favoured 
(Scheme 1.38). Thus over time, the efficiency of the process is lessened.  
Scheme 1.38: Mode of catalyst degradation. 
 In an attempt to negate the degradation of the imidazolidinone 84, p-Me 
iodosobenzene was trialled for its increased nucleophilicity, as it was believed it 
would react with iminium species much faster. However, it turned out that the rate 
of degradation was actually much higher; yields of only 20% of the α,β-epoxy 
aldehyde products were achieved. This, in comparison with the > 90% yields 
achieved when employing iodosobenzene as the oxidant. Macmillan discovered 
that this was due to the increased solubility and over-availability of the p-Me 
iodosobenzene oxidant. The oxidant was introduced as its polymeric form but p-Me 
iodosobenzene was readily solvated as the monomer, whereas iodosobenzene was 
not. The presence of a large concentration of the oxidant increased the rate of 
catalyst decomposition.111 MacMillan focused on alternative sources of 
iodosobenzene that could be employed to release the reactive monomer at a much 
reduced rate – conceptually functioning as an ‘internal syringe pump’. He 
discovered that [(nosylimino)iodo]benzene hydrolysed in situ in the presence of 1 
M acetic acid, releasing iodobenzene at a rate that maintained a low but productive 
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concentration in the reaction mixture, and crucially, did not result in the 
degradation of the catalyst (Figure 1.20).  
 
Figure 1.20: The [(nosylimino)iodo]benzene polymer used to achieve the ‘‘internal 
syringe pump’’ effect. 
The employment of [(nosylimino)iodo]benzene resulted in a large improvement in 
the isolated epoxide ees for the substrates which formed more stable, less 
electrophilic iminium intermediates. With this development, MacMillan was able to 
oxidize a broad range of α,β-unsaturated aldehydes with excellent stereocontrol 
and in excellent yield (Scheme 1.39).111 
 
Scheme 1.39: Substrate scope with MacMillan’s oxazolidinone 84 employing 
[(nosylimino)iodo]benzene as the oxidant. 
Recently, List has reported the use of bifunctional diamines 86-88 to 
facilitate the highly stereoselective epoxidation of cyclic α,β-unsaturated ketones. 
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The work is an elegant variation on the previously developed iminium-activated 
epoxidation. List’s methodology also requires the formation of a conjugated 
iminium species, from the condensation of a primary amine with the α,β-
unsaturated carbonyl group. The catalysts employed feature a tertiary amine that 
can form hydrogen bonds with H2O2 and actively guide the oxidant preferentially to 
one face of the now-activated double bond (Figure 1.21).114 
 
Figure 1.21: Bifunctional catalysts used by List and their mode of action. 
Using this novel methodology, List was able to isolate epoxides in good 
yields and demonstrate excellent facial control over the attack of the oxidant. List 
observed the greatest levels of stereoinduction with β-substituted substrates, 
particularly for the cyclohexenone and cycloheptenone families (Scheme 1.40). 
Substrates that featured any α-substitution were not active under the reaction 
conditions.  
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Scheme 1.40: Results of a substrate screen carried out by List employing his most 
stereoselective catalyst. 
List has recently explored a procedure for asymmetric epoxidation 
employing an achiral ammonium salt paired with a chiral counter-anion, which he 
terms ‘asymmetric counter-ion-directed catalysis’ (ACDC) (Figure 1.22). In a recent 
report, he detailed his efforts in utilizing the anion 3,3’-bis(2,4,6-triisopropyl-
phenyl)-1,1’-binaphthyl-2,2’-diyl phosphate (TRIP) 88– coupled with dibenzyl 
ammonium salt 88+ to effect the highly stereoselective epoxidation of β,β-
substituted α,β-unsaturated enals – a class of substrate that had only been oxidized 
with moderate to good enantiocontrol until this work.  
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Figure 1.22: The most enantioselective ion-pair designed by List. 
Furthermore, ion-pair 88 is also capable of oxidizing enals that are 
symmetrically substituted at the β-position. Because the initial addition at the β- 
position of the iminium moiety would not create a chiral centre, List proposes that 
the chiral anion must therefore be inducing the chirality by influencing the ring 
closing step (Scheme 1.41). 
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Scheme 1.41: Proposed mode of action of List’s ion-pair catalyst and origin of the 
stereocontrol. 
ACDC has proven to be a powerful technique to access enantioenriched β,β-
substituted α,β-unsaturated enals (Scheme 1.42). Its success in oxidizing this 
difficult class of substrate stems from its novel mode of action.115  
Scheme 1.42: Various β,β-substituted α,β-epoxy ketones synthesised by List, 
including the sex pheromone of the acarid mite 89. 
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1.6.2.3 Phase Transfer Catalysis 
‘Phase transfer catalysis’ is a term that was first coined by Starks in 1971 to explain 
the role lipophilic salts played in facilitating a reaction between two reagents in 
different immiscible solvents; today, phase transfer catalysis is an extremely 
important and useful tool for the synthetic organic chemist (Figure 1.23).116 There 
are now many types of organocatalytic reactions that phase transfer catalysts 
(PTCs) have been successfully applied to, such as alkylation, Michael addition, the 
Horner-Wadsworth-Emmons reaction and, of course, epoxidation.117 Quaternary 
ammonium salts (QUATs) are the biggest class of PTC as they are stable, easy to 
synthesise, and chiral diversity is easy to achieve – these features are crucial for 
their use in asymmetric organocatalysis. 
            
Figure 1.23: A generalised oxidative phase transfer reaction. The hydrophilic oxidant 
can only transfer into the organic phase to perform a reaction once it has ion 
exchanged with the PTC to form a lipophilic ion pair.  
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Wynberg was the first to develop a catalytic procedure to oxidize enones by 
employing cinchona alkaloid-derived QUATs 90 and 91, and he achieved ees of up 
to 54% in the isolated epoxides with their use (Figure 1.24). 118,119 
 
Figure 1.24: Quinine and quinidine derived quaternary ammonium salts developed 
by Wynberg. 
The groups of Oda,120 Onda121 and Adam,122 amongst others, followed up on 
this pioneering research with their own PTCs, which were also derived from 
cinchona alkaloids (Scheme 1.43). Impressive epoxide ees were achieved by these 
groups, particularly for the chromone derivatives 93. 
 
Scheme 1.43: An example of a PTC synthesised by Adam and its use in the 
epoxidation of an isoflavone.122 
Lygo123 and Corey124 independently created (9-anthracenyl)methyl-
containing cinchonidine-derived quaternary ammonium salts 94 and 95, and both 
observed excellent ees for a range of enone substrates (Figure 1.25).  
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Figure 1.25: Catalysts developed by Lygo and Corey. 
Maruoka has described the synthesis and use of binaphthalene-derived 
ammonium salts such as 96, and reported high levels of enantiocontrol for the 
epoxidation of enone substrates with their use (Scheme 1.44).125 
 
Scheme 1.44: The spiro ammonium catalyst synthesised by Maruoka. 
Bakó created a family of monoaza-[15]-crown-5 ethers derived from cheap 
and readily available D-monosaccharides such as D-mannose 97 and D-galactose 98. 
Using tBuOOH as the oxidant and a chiral crown ether, he reported ees in the 
isolated epoxides of up to 94% (Figure 1.26).126 
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Figure 1.26: Aza-crown ethers prepared by Bakó 97 and 98, derived from D-mannose 
and D-galactose respectively. 
A family of C2-symmetric salts containing the guanidinium motif were 
designed by Murphy and co-workers from (S)-malic acid, such as 99. Guanidinium 
salt 99 was used for the epoxidation of chalcone derivatives, and Murphy reported 
achieving ees in excess of 90% (Figure 1.27). Impressively, 99 has also found utility 
in asymmetric alkylation.127 
 
Figure 1.27: Guanidinium salt PTC prepared by Murphy. 
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1.6.3. Chiral Dioxirane-Mediated Epoxidation 
A logical development of Curci’s initial work with the dioxirane/ketone cyclewas to 
explore the possibility of asymmetric epoxidation by using chiral ketone 
catalysts.58,60  Curci first investigated (+)-isopinocamphone 100 and (S)-(+)-3-
phenylbutan-2-one 101 as potential asymmetric organocatalysts (Figure 1.28).128 
Unfortunately, these two ketones demonstrated poor enantiocontrol for 
unfunctionalised alkenes; the epoxides were isolated in ees of up to 12%. 
Furthermore, high catalyst loadings of 20-300 mol% had to be employed. Curci also 
published the use of two other chiral ketones 102 and 103 as catalysts for 
asymmetric epoxidation; both were poor at transferring their chiral information to 
the substrate, and ees of up to only 20% were measured in the isolated epoxides.129 
 
Figure 1.28: The chiral ketone catalysts developed by Curci between 1984 and 1995. 
Even though Curci’s investigation did not provide the high ees that metal-
based systems at the time were capable of, it was a proof of concept that helped 
inspire further research into the use of chiral ketones as organocatalysts by other 
groups.  
 
 
1.6.3.1 C2 Symmetric Ketones 
In 1996, Yang was one of the first to try to improve upon the results 
achieved by Curci. He approached the problem by considering why Curci’s catalysts 
were poor at asymmetric induction. She reasoned that the dioxirane, formed on 
oxidation of the ketone, possesses two oxygen atoms – each capable of being 
transferred to an alkene substrate. In theory, as the chiral environment around 
each oxygen atom was different in Curci’s previous species, the transfer of one of 
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the dioxirane’s oxygens could result in differing levels of stereoinduction, or even 
opposing stereoinduction, with respect to the other oxygen.130   
Yang considered two solutions to the problem: 1) to block the approach of 
the alkene to one of the oxygens; 2) to design C2 symmetry into the catalyst 
structure which necessarily implies both approaches of the alkene would be 
identical (Figure 1.29).  
 
Figure 1.29: Potential paths of attack on a non-C2 symmetric dioxirane 104, and on 
a C2 symmetric dioxirane 105.
35 
Yang initially compared simple ketones to investigate which structural and 
chemical properties led to good reactivity. She discovered that electron-
withdrawing groups close to the ketone increased its reactivity, while introducing 
substituents in the α-position was detrimental to reaction rate.131  
The influence of the size of the ring bearing the ketone was also investigated 
and it was determined that an 11-membered ring 106 offered the best reactivity – 
oxidizing trans-stilbene to 100% conversion in only 7 min, which was over four 
times faster than 1,1,1-trifluroacetone (Scheme 1.45). 
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Scheme 1.45: Yang’s investigation into the size of the ketone bearing ring. 
To introduce chirality into the 11-membered ring system, Yang used the 
chiral and C2 symmetric binaphthalene motif 107. Yang found that she was able to 
induce ees in the isolated epoxides of up to 87% when employing 107 at a loading 
of only 10 mol% – a marked improvement over Curci’s previous ketone catalysts 
(Figure 1.30).130 
 
Figure 1.30: Some of Yang’s promising results with his first C2 symmetric 
binaphthalene derived catalyst. 
From X-ray analysis of 107, Yang suspected that H-3 and H-3’ atoms act as 
the steric sensors, making them important for the transferral of the chiral 
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information of the catalyst to the alkene substrate. By increasing the size of the 
group at the 3 and 3’ positions Yang believed she could further improve the facial 
selectivity of her catalyst.132 
Yang introduced a range of groups at the 3 and 3’ positions, and she found 
that as the size of the group increased, the epoxide ees only increased up to a 
point; after which, any further increase in the steric bulk led to diminished 
stereocontrol (Table 1.3). In a model study, which employed trans-stilbene as the 
test substrate, chloro groups were found to have the optimal steric influence. The 
chloro-substituted catalyst 108 oxidized trans-stilbene with good enantiocontrol 
(76% ee), which, in comparison to 107 (44% ee), was a marked improvement.  
 
 
X = ee (%) X = ee (%) 
H 44 Me 56 
Cl 76 CH2OCH3 66 
 
Br 
 
75 
 
 
71 
I 32 SiMe3 44 
 
Table 1.3: Effect of the size of the steric sensor at the 3 and 3’ positions on the ee of 
trans-stilbene oxide. 
Yang’s epoxidation methodology is used industrially to synthesise Diltiazem 
hydrochloride by the Tenabe Seikayu company. Using the chloro-substituted 
catalyst, they oxidize methyl p-methoxycinnamate, which is isolated initially in an 
87% yield with an ee of 78%. The epoxide is then recrystallized to obtain it in an 
enantiopure form (Figure 1.46).133 
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Scheme 1.46: Tenabe Seikayu’s synthesis of Diltiazem hydrochloride. 
Song134 and Adam135 also investigated the synthesis and use of C2-symmetric 
ketones 110 and 111, and 112 and 113 respectively. However, these catalysts were 
not as reactive, nor able to induce ees as high as Yang’s binaphthalene ketones 
(Figure 1.31).  
 
Figure 1.31: C2-symmetric catalysts developed by Song and Adam. 
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1.6.3.2. Shi’s Ketones Derived from Monosaccharides 
In 1996, Shi published his first paper on his research directed at developing 
sugar-derived ketones for asymmetric epoxidation. Over the past decade it has 
become one of the most powerful and versatile methodologies for organocatalytic 
asymmetric epoxidation.136 Shi initially set out a few guidelines for his catalyst 
development: 1) The element that transfers chiral information should be located in 
proximity to the reacting dioxirane to maximise the stereoinduction; 2) A fused ring 
should be present α to the carbonyl group to minimise epimerization at this 
position; 3) The approach of the substrate to the dioxirane should be controlled by 
blocking one face, or, by a C2 or pseudo C2 symmetric element; 4) Electron-
withdrawing functionality should be present to activate the catalytic centre.137 
 Shi’s first published attempt at a catalyst was the D-fructose-derived catalyst 
114 (Scheme 1.47). As well as satisfying the four guidelines above, it also fulfils 
another equally important criterion – low cost and ease of synthesis. It is accessible 
in only two high-yielding and straightforward steps. This attribute is key to any 
catalyst being used by other groups and industry. 
 
Scheme 1.47: Synthesis of Shi’s D-fructose derived ketone. 
Initially, however, it was required to use 114 in excess to achieve complete 
conversion of the alkene to its respective epoxide.136 Shi undertook a short 
investigation to understand why an excess of this ‘catalyst’ was required. Careful 
analysis of the reaction cycle suggested that 114 is decomposed under the reaction 
conditions through a Baeyer-Villiger pathway (Scheme 1.48).138 
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Scheme 1.48: Catalytic cycle of the Shi asymmetric epoxidation showing the Baeyer-
Villiger decomposition pathway. 
This understanding of the catalytic cycle provided insight into how to 
suppress the decomposition pathway. These epoxidation reactions, mediated by 
ketones such as 114, were initially performed at pH 7-8. This pH was believed by Shi 
to favour the existence of the intermediate 115, and it is this intermediate which is 
susceptible to the Baeyer-Villiger decomposition. Increasing the pH to around 10 
favours the Criegee intermediate 116, which collapses rapidly to the catalytically 
active dioxirane 117. Therefore, performing the reaction at higher pH heavily 
favours the formation of the dioxirane over the esters. The improved efficiency of 
the catalytic cycle allows a sub-stoichiometric amount of ketone 114 to be used and 
also a 30% reduction of the amount of Oxone® required.137 
With a truly catalytic system, Shi studied the substrate scope of the catalyst 
and found that 114 was extremely versatile with regards to the substrates it could 
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efficiently oxidize in high yield and ee. Many functional groups were tolerated and 
the observed enantiocontrol was excellent for trans di-substituted and tri-
substituted alkenes.138 Later studies demonstrated that hydroxyl-alkenes,139 enol 
esters,140 2,2-disubstituted vinylsilanes,141 enynes142 and dienes143 were also 
suitable substrates. Contrastingly, 114 provided poor ees for the enantioselective 
epoxidation of cis-alkenes or terminal alkenes (Figure 1.32). 
 
Figure 1.32: Yields and ees for several classes of alkenes with catalyst 114. 
Clearly, ketone 114 is an excellent catalyst in terms of stereoinduction, cost, 
the ease of its preparation and extent of its reactivity. It is not surprising then, that 
114 has found widespread use outside of Shi’s own lab. Several natural product 
syntheses have utilized Shi’s methodology to access key intermediates.36 
Morimoto used Shi’s ketone to install the second epoxide, in a 6:1 dr and 
87% yield, into a key intermediate in his synthesis of (+)-intracatetraol (Scheme 
1.49). The first epoxide was introduced into the molecule using the Sharpless 
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epoxidation, and installation of the second preceded the base-induced 
rearrangement which formed some of the important structural features present in 
(+)-intracatetraol.68 
 
Scheme 1.49: Installation of the second epoxide into a synthetic precursor to (+)-
intracatetraol. 
With the aim of making the methodology applicable to many other 
substrates, Shi investigated other co-oxidants. The most successful stoichiometric 
oxidant of those screened was H2O2. Oxone® has good selectivity for the catalyst, 
causing little to no background epoxidation; however, its active oxygen content is 
extremely low, and requires a large mass to be used.144 In contrast, H2O2 has a high 
oxygen content and is far more atom economical. Shi was able to develop milder 
and cleaner reaction conditions, and decrease catalyst loading with its use. It was 
found that to successfully use H2O2 as the stoichiometric oxidant use of a nitrile 
containing solvent, such as MeCN or EtCN was essential. Shi suggests that H2O2 is 
activated by the nitrile functionality, forming a peroxyimidic acid, such as 118 in the 
case of MeCN, in situ which then oxidizes the ketone (Figure 1.33).145 
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Figure 1.33: Formation of the peroxyimidic acid 118, the active co-oxidant in Shi’s 
H2O2 system. Epoxide ees achieved using 0.1-0.3 equiv. 114. 
In order to intelligently design future catalysts, it was important to 
understand the interaction between the substrate and catalyst in the transition 
state (TS). Baumstark and co-workers published experimental and computational 
results to suggest that a spiro TS is favoured for dioxirane-mediated epoxidation of 
alkenes over the planar TS.146 Through analysis of the stereochemistry of the 
isolated epoxides and modelling, Shi rationalized that the epoxidations involving 
catalyst 114 do preferentially proceed via a spiro transition state (Figure 1.34).141 It 
is suspected that the preference for the spiro TS is due to the existence of 
stabilizing interactions between the non-bonding orbitals on the oxygen atom and 
the empty π* orbital of the alkene. The same stabilizing orbital overlap is not 
geometrically possible for the planar TS, thus the spiro TS is lower in energy, and 
favoured over the planar TS.147 
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Figure 1.34: The most favoured conformation of both the spiro and planar transition 
states. 
While analysis of the transition states illustrates why ketone 114 furnishes 
trans and tri-substituted epoxides in good ee, the study of the TS also suggests why 
cis- and terminal alkenes are poor substrates. In both of the spiro transition states, 
both groups on the alkene face away from the steric bulk of the catalyst, hence the 
catalyst cannot differentiate between the two faces of the alkene to a reasonable 
degree,  which results in low ees (Figure 1.35).148 
 
Figure 1.35: Competing transition states for terminal (RS=H) and cis-alkenes. 
With an understanding of why cis and terminal alkenes were very poor 
substrates, Shi was able to design and synthesise the oxazolidinone-containing 
alkene 119. Interestingly, this new species may not differentiate between the two 
spiro TSs by steric interactions, instead, Shi suggests that the oxazolidinone 
interacts favourably with R groups that contain π density, and that this interaction 
is essential for high ees (Figure 1.36). 148 
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Figure 1.36: Competing spiro transition states for the oxazolidinone catalyst.  
This interaction manifests itself with transition states analogous to I being 
favoured over II. It is through this mechanism that 119 imparts greater ees for cis 
and terminal alkenes than catalyst 114 (Figure 1.37). The new mode of facial 
selectivity does, however, lessen the difference in energy between the transition 
states for both trans and tri-substitued alkenes, which resulted in low ees for these 
classes of substrate when catalyst 119 was employed. 
 
Figure 1.37: Isolated epoxide ees when employing catalyst 119. 
Shi has developed several chiral ketones capable of high stereoselectivities 
across most classes of alkene substrates. A disadvantage to Shi’s systems is the 
requirement for relatively high catalyst loadings in some instances, due to the 
instability of the ketone to Baeyer-Villiger oxidation despite the optimized 
conditions.137 
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1.6.3.3 Denmark’s Oxoammonium Salts and Ketones. 
Denmark has made considerable contributions to the field of 
organocatalysis, and he has focused considerable research into asymmetric 
epoxidation. He has reported the synthesis and utilization of several 
organocatalysts which fall into two main classes; oxoammonium salts149 and α-
fluorinated ketones150.  
Denmark’s initial research was directed at a systematic study of 
aqueous/organic biphasic reaction parameters that are used in the dioxirane-
mediated epoxidations. Denmark hoped the information would provide an insight 
in how to design an efficient catalytic system. He explored the effects of 
temperature, pH and the addition rate of Oxone®.150,151    
 Temperature variation was rather limited, to 0-20 °C, since the aqueous 
phase freezes if the temperature is any lower, and, at higher temperatures, the rate 
of the decomposition of Oxone® becomes significant. Likewise, it was found that 
the optimal pH was also limited to a small range of 7.5-8. At low pH, Denmark 
observed that decomposition of the ketone catalyst, through a Baeyer-Villiger 
pathway, was rapid.150 It was the decomposition of Oxone® that determined the 
upper limit of pH. Furthermore, epoxides can be ring opened by both acid and base 
catalysed pathways, further highlighting the importance of the need for pH control. 
It was found to be advantageous to add Oxone® slowly over a period of time to 
limit its decomposition. Oxone® decomposes by a bimolecular mechanism, thus, if 
the concentration of Oxone® in solution was kept low, the rate of decomposition 
was attenuated.151  
The study of basic ketones demonstrated that efficiency significantly 
decreased with increasing linear chain length and that efficiency is strongly linked 
to ring size, agreeing with Yang’s investigation (Table 1.4).  
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Entry Ketone Alkene / Epoxide ratio 
1 acetone 13 / 87 
2 2-butanone 60 / 40 
3 3-pentanone 95 / 5 
4 cyclobutanone 98 / 2 
5 cyclopentanone 97 / 3 
6 cyclohexanone 33 / 67 
7 1,1-dimethyl-4-oxopiperidinium nitrate 98 / 2 
 
Table 1.4: Screening of ketone structure using Denmark’s optimized conditions. 
Curiously, 1,1-dimethyl-4-oxopiperidinium nitrate did not show the activity 
expected (Entry 7). Denmark believed that this was due to it being strongly solvated 
in the aqueous layer, and therefore not available in the organic layer to epoxidize 
the alkene. By altering the N-alkyl chain length and counter-ion, Denmark was able 
to tune the solubility profile of the oxopiperidinium salts, such that it was readily 
solvated by CH2Cl2 and create a catalyst that was more efficient than acetone.
151 
Once the most efficient catalyst structure had been determined, chiral 
variants of it were investigated to try to also to exert enantiocontrol in the 
epoxidation process. The chiral keto-ammonium salts 120 and 121, however, were 
very poor catalysts in terms of conversion. Denmark suggested that the poor 
reactivity may be due to congestion at the α-position.151 In an attempt to increase 
the reactivity of the chiral catalysts, Denmark investigated the aromatic 
bis(immonium) ketone 122 (Scheme 1.50). It was hoped that the removal of the α-
functionality, and having two immonium moieties in the catalyst, would help 
improve the reactivity. Unfortunately the aromatic bis(immonium) catalyst 122 was 
completely unreactive. This lack of turnover was suspected to be due to the 
oxidative instability of the aromatic immonium moiety, i.e. the catalyst was 
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destroyed by some oxidative degradation pathway faster than it could epoxidize 
the substrate.151 
 
Scheme 1.50: Comparison of mono and bis(ammonium) ketones and bis(immonium) 
ketones.151 
To solve the problem of oxidative instability, Denmark synthesised a range 
of aliphatic bis(ammonium) ketones 123-125. These were much more reactive than 
their keto-ammonium salt counterparts; reactions typically ran to completion in 
under 6 h. The bis(ammonium) moiety was also very resilient to the Baeyer-Villager 
degradation pathway.152  
Previous studies of α-fluoro ketones by Curci had shown them to be 
superior than their unsubstituted analogues for dioxirane-mediated epoxidation.153 
As such, they became an attractive target for Denmark, and he first synthesised a 
range of α-fluorinated 4-tBu-cyclohexanones to probe the effect of the fluoro 
substitution in order to gain an insight in how to design an effective catalyst (Figure 
1.38).154 
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Figure 1.38: The range of α-fluorinated 4-tBu-cyclohexanones synthesised to 
investigate the stereo-electronic effect of fluorine. 
Denmark found that the orientation of the fluoro substituent was critical for 
the activity of the catalyst, i.e. it had to be equatorial to observe the increase in 
reactivity for the mono-substituted cyclohexanones. Moreover, when the fluoro 
substituent was axial, as in 126, the catalyst was extremely susceptible to Baeyer-
Villager decomposition. Placing the second fluoro substituent axially, in either the 
geminal or trans-2,6 position relative to the first, decreased reactivity. Ketone 127, 
with the cis-2,6 configuration of the fluorine atoms, was the most active of this 
series.154 
The insight gained from the investigation into the effects of the pattern of α-
fluoro substitution led to the design and synthesis of 128, which proved to be 
Denmark’s most successful catalyst (Table 1.5). Under modified monophasic 
conditions, a 94% ee was obtained for trans-stilbene, and good stereoselectivity 
was observed across a range of other trans-di-substituted alkenes.154 
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Entry Alkene Time (h) Yield (%) ee (%) 
1 (E)-2-methylstyrene 10 80 88 
2 trans-stilbene 72 46 94 
3 (E)-cinnamyl alcohol 7 93 89 
5 1-phenylcyclohexene 4 78 59 
6 4-chlorostyrene 30 55 43 
 
Table 1.5: Asymmetric epoxidation of a range of alkenes with 128. 
A closely related system, based on the C2-symmetric binaphthyl moiety, was 
developed by Behar.155 Several fluorinated ketones were synthesised and screened 
for their reactivity and enantioselectivity against the model alkene substrate trans-
β-styrene. In concurrence with Denmark’s own investigations, the trans-pseudo-
equatorial fluorine substitution pattern of 129 exhibited the best reactivity and 
enantioselectivity in the epoxidation process, furnishing trans-β-styrene oxide in an 
86% ee (Scheme 1.51). Other substitution patterns, similar to those reported by 
Denmark, reportedly performed well, with ees also around 80%. However, when all 
four α-positions were fluorinated, the resulting catalyst demonstrated poor 
reactivity and enantiocontrol. Catalyst 130 existed almost exclusively as the 
hydrate; Behar speculated that the rate of formation of the reactive dioxirane 
would therefore be reduced, so explaining the decrease in reactivity and 
enantioselectivity. 
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Scheme 1.51: Asymmetric epoxidation of trans-β-methyl styrene with ketones 
developed by Behar.  
These novel ketones were more reactive than Denmark’s 6,6’-
dimethylbiphenyl analogues, but the enantioselectivity observed was, in fact, 
slightly lower.  
 
1.6.3.4 Armstrong’s Ketones 
Armstrong has been at the forefront of research on organocatalytic epoxidation, 
having contributed intellectually to the development of both iminium-salt and 
ketone-mediated catalytic procedures. The utility of oxabicyclo[3.2.1]octanones 
and tropinone derivatives for the asymmetric epoxidation of alkenes was 
investigated by Armstrong and co-workers (Table 1.6).156 The initial motivation for 
studying these conformationally rigid catalysts was to address the susceptibility of 
Shi’s catalysts, in particular, to undergo oxidative decomposition, with the aim to 
reduce catalyst loadings.157 
 
 
Chapter 1 – Introduction 
 
73 
 
 
Entry Ketone Alkene Conv. (%) ee (%) 
1 131 trans-stilbene 100 76 
2 131 styrene 100 29 
3 132 trans-stilbene 85 93* 
4 132 styrene 100 48* 
5 133 trans-stilbene 46 81* 
6 133 styrene 100 40* 
 
Table 1.6: Example catalyst structures of the original bicycles employed by 
Armstrong for asymmetric epoxidation.* ee(max) = 100 x (product ee / ketone 
ee).156 
Early results were promising and highlighted the stability of the bicyclic 
structural motif; in some instances, it was only necessary to use a 10 mol% loading. 
Moreover, it was possible to isolate 131 from the reaction mixture for re-use. This 
stability inspired Sartori, in collaboration with Armstrong, to incorporate 131 onto a 
solid support, creating a heterogeneous catalytic system (Figure 1.39).158 Binding 
131 onto a mesoporous silica support created a re-useable solid-phase catalyst 
designated MCM-41-FT that provided the same levels of stereocontrol, and 
comparable reactivity to, the homogeneous catalyst. Other solid supports were 
trialled, including amorphous silica and Merrifield resins, but these solutions did not 
offer satisfactory results.  
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Figure 1.39: Structural schematic of the silica-bound ketone 131, designated MCM-
41-FT. 
Armstrong has also investigated bicyclic ketones featuring a second 
electron-withdrawing substituent at the α-position (Figure 1.40).159  
 
Figure 1.40: Di-substituted oxabicyclic ketones prepared by Armstrong. Results 
shown are reported as the ee(max) for the epoxidation of trans-stilbene. Using 20 
mol% catalyst. 
Disappointingly, each of these oxabicyclic ketones demonstrated lower 
enantiocontrol in the epoxidation process than the tropinone 131. In particular, 
ketone 134 displayed a marked drop in enantioselectivity for the epoxidation of 
trans-stilbene. Armstrong proposed that this large drop could have been due to the 
manifestation of an asymmetric spiro-TS. Previous computational studies indicated 
that an equatorial electron-withdrawing fluorine substituent caused the shortening 
of the forming C–O bond closest to the fluorine.160 Armstrong surmised that if the 
equatorial, and also electron-withdrawing, acetoxy group in 134 caused the same 
bond asymmetry then the alkene would be shifted away from the stereochemically 
controlling axial fluorine substituent - leading to, and explaining the decreased 
enantiocontrol.159 
Armstrong and co-workers have also investigated two other structural 
classes of enantiopure ketone catalysts for asymmetric epoxidation, namely: 
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tetrahydropyran-4-ones 135 and spirocyclic N-carbethoxy-
azabicyclo[3.2.1]octanones 136 (Figure 1.41).161  
 
Figure 1.41: Different structural classes of ketones synthesised by Armstrong, and a 
sample of the results from their employment in asymmetric epoxidation. The 
epoxysilylether was subjected to acidic work-up, to isolate the α-hydroxyketone. 
Oxone® (5 equiv.), catalyst (10-30 mol%), NaHCO3 (15.5 equiv), Na2EDTA (aq.), 
MeCN. 
Armstrong has been able to design several classes of ketones for dioxirane-
mediated epoxidation and has succeeded in achieving his original goals of creating 
oxidatively stable catalysts that allow catalyst loadings as low as 10 mol% to be 
used, which compares favourably to Shi’s hexose derived catalysts at about 30 
mol%. Armstrong has proposed to investigate analogues to 136 to further improve 
enantiocontrol in the epoxidation process.161 
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1.6.4 Iminium Salt Mediated Epoxidation 
1.6.4.1 Lusinchi and Bohé’s Initial Studies  
In the year preceding the confirmation of dioxiranes as reactive oxidative 
intermediates, Lusinchi reported the preparation of an oxaziridinium species from  
a steroidal iminium salt (Scheme 1.52).162 Lusinchi later demonstrated that 
oxaziridinium species can oxidize several functional groups: amines, sulfides, imines 
and alkenes.163 
 
Scheme 1.52: Synthesis of the first oxaziridinium salt. 
Crucially, Lusinchi and co-workers were subsequently able to develop a 
catalytic system based on an iminium/oxaziridinium cycle, employing Oxone® as the 
stoichiometric oxidant. A sub-stoichiometric catalyst loading makes the 
introduction of chirality into the catalyst a feasible option, and thus creates an 
organocatalytic asymmetric cycle (Scheme 1.53). The discovery of the catalytic cycle 
also implied that it would be possible to use the iminium salt as the pre-catalyst and 
oxidize it in situ, avoiding extra synthetic steps. 
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Scheme 1.53: The iminium/oxaziridinium oxidative catalytic cycle. 
Lusinchi and Bohé later reported the synthesis of the first optically active 
oxaziridinium salt in 1993, which was derived from (1R,2R)-(+)-norephedrine. 
Importantly, they were also able to determine the structure of the oxaziridinium 
salt by X-ray crystallography (Figure 1.42).164  
 
Figure 1.42: The chiral oxaziridinium salt synthesised by Lusinchi from (1R,2R)-(+)-
norephedrine 137 and the related iminium salt 138. 
Both the oxaziridinium salt and the iminium salt were tested in the 
epoxidation of a range of alkenes; using 137 stoichiometrically yielded the trans-
stilbene oxide in a 42% ee, whereas, employing 138 at a 5 mol% loading furnished 
the epoxide in a 35% ee. This disparity was suggested to result from the 
oxaziridinium species being formed as a diastereoisomeric mixture in situ.165  
A decomposition pathway exists for the oxaziridinium species derived from 
the parent 3,4-dihydroisoquinolinium salts developed by Lusinchi (Scheme 1.54).166 
It was proposed by Bohé that if the irreversible, base-induced rearrangement and 
subsequent dehydration of oxaziridinium salts, such as 137 and particularly those 
derived from 3,4-dihydroisoquinolinium species like 139 that contain protons α- 
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and β- to the iminium nitrogen, could be blocked, then a more efficient catalytic 
entity would result.167  
 
Scheme 1.54: The base-catalysed decomposition of an oxaziridinium species 
containing α- and β- protons. 
Bohé prepared the achiral 3,3-dimethyl-dihydroisoquinolinium salt 141 and 
employed the new catalyst to epoxidize a range of alkenes (Scheme 1.55). By 
replacing both protons at the α-position, the base induced isomerization side 
reaction was prevented, and, accordingly, Bohé observed an improvement in the 
reactivity and stability of 141 under epoxidation conditions over 140. The reactivity 
of the 3,3-disubstituted catalyst was augmented by incorporating an electron-
withdrawing nitro group at the 7-position of the dihydroisoquinolinium moiety, as 
in 142 and 143. The combined effects of blocking the decomposition pathway and 
the reducing the electron density on the electrophilic iminium motif as in 143, cut 
the reaction time down dramatically.167 
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Scheme 1.55: By incorporating an electron-withdrawing nitro group and blocking 
the base-induced decomposition pathway; Bohé was able to substantially increase 
the reactivity of the iminium species. The results shown for each catalyst are for the 
epoxidation of trans-stilbene. 
 
1.6.4.2 Armstrong’s Exocyclic Iminium Salts and Intramolecular Epoxidation 
In 1998, Armstrong reported the synthesis and use of a range of exocyclic iminium 
salt organocatalysts.168 The synthesis of the exocyclic iminium salt variants was 
inspired by the potential for the formation of a combinatorial library through the 
condensation of chiral amines with carbonyl compounds. It was hoped such an 
approach would expedite the creation of a diverse library and enable the rapid 
discovery of an efficient catalyst, capable of transferring its stereochemical 
information effectively to the alkene substrate. 
During his preliminary investigation Armstrong synthesised a range of 
benzylidinepyrrolidinium triflate salts to explore various substitution patterns on 
benzene (Scheme 1.56). After testing several different condensation 
methodologies, Armstrong found that coupling an N-silyl protected pyrrolidine to 
benzaldehydes with TMSOTf in ether generated the desired exocyclic iminium salts. 
In some instances, however, the catalysts were contaminated with pyrrolidinium 
triflate.168  
Chapter 1 – Introduction 
 
80 
 
 
Scheme 1.56: Benzylidinepyrrolidinium triflate salts synthesised by Armstrong and 
co-workers. 
The instability of the exocyclic iminium salts to hydrolysis was a primary 
concern. It was conceivable that the resulting carbonyl species would be oxidized to 
the dioxiranes in situ and this could have caused unwanted background 
epoxidation; potentially lowering the enantioselectivity in the epoxidation process. 
Fortunately, in control reactions no background epoxidation was observed, but it 
was evident the exocyclic iminium salts were hydrolysing under the reaction 
conditions, particularly the electron-rich species.  
It was found that the iminium salts bearing an electron-withdrawing group 
at the ortho position were superior catalysts (Table 1.7). This was postulated to be 
for two reasons: 1) the increased rate of attack of the iminium salt by the 
nucleophilic peroxide component of Oxone® or the faster electrophilic epoxidation 
of the alkene; 2) the ortho group disfavoured planarity between the iminium bond 
and aromatic ring, rendering it less stabilized and more reactive. 
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Entry Iminium mol% Conv. (%) 
1 144 100 25 
2 145 100 0 
3 146 100 63 
4 147 100 100 
5 147 25 100 
6 146 10 24 
7 147 10 82 
8 148 10 100 
9 149 10 28 
10 147 5 52 
11 148 5 52 
Table 1.7: Initial screening of the benzylidenepyrrolidinium salts. 
Armstrong investigated structural variance in the iminium moiety to 
establish which features were beneficial, to aid the design of improved chiral 
iminium salts. He synthesised catalysts analogous to 144 by employing morpholine, 
piperidine and diethylamine. However, all of these iminium species underwent 
rapid hydrolysis and were ineffective as catalysts. Noting that there had been no 
literature reports of acyclic catalysts prepared from ketone derivatives, Armstrong 
and co-workers investigated generating acyclic catalysts by coupling pyrrolidine to 
several ketone motifs.  
 
Figure 1.43: Iminium salts generated from ketones. 
The methyl analogue of 147, 149, was prepared and was shown to be less 
active, converting only 44% of the alkene to the epoxide at 100 mol% catalyst 
loading. Likewise, 150 was not as active as many of the benzylidenepyridinium salts, 
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though Armstrong noted that the presence of an electron-withdrawing acetoxy 
group at the α-position did have a positive effect. This observation led to the idea of 
using an existing ketone 131, developed for dioxirane mediated epoxidation. 
Unfortunately, the synthesis of iminium salt 151 was problematic and all attempts 
to isolate it were unsuccessful (Figure 1.43).  
Armstrong investigated two strategies to incorporate chirality into 
pyrrolidinium salt catalysts; to employ either chiral aldehydes or chiral pyrrolidines 
(Figure 1.44). Again, for both strategies, he encountered significant problems trying 
to isolate the pyrrolidinium salts cleanly, if at all. The best ee was only 22%, 
achieved when employing crude 152 to epoxidize 1-phenylcyclohexene at 100 
mol% loading. Clearly, these exocyclic iminium salts were not viable as 
enantioselective organocatalysts, and no further effort was directed towards their 
development.168 
 
Figure 1.44: Chiral pyrrolidinium catalysts synthesised by Armstrong. 
In 1999, Armstrong reported an extremely interesting intramolecular 
oxidation (Scheme 1.57). Oxidation of a chiral imine with Oxone®, synthesised by 
coupling an enantiopure amine to an unsaturated aldehyde, yielded a separable 
pair of diastereoisomeric oxaziridines. Methylation of the oxaziridine to generate 
the oxaziridinium salt, led to the concomitant transfer of the electrophilic oxygen to 
the pendent alkene. A basic work-up cleaved the imine and furnished the epoxy-
aldehyde, usually in excellent ee.169  
Chapter 1 – Introduction 
 
83 
 
 
Scheme 1.57: Preparation of the oxaziridine diastereoisomers in a 3:1 ratio. 
Oxidation of the oxaziridine motif and subsequent hydrolysis of the chiral auxiliary 
resulted in isolation of the epoxy aldehyde in excellent ee. 
This cunning procedure also provided much needed insight into the 
transition state of the epoxidation process (Scheme 1.58). Computational analysis 
of the epoxidation of a model substrate demonstrated that the epoxidation process 
prefers to proceed via the spiro TS in favour of the planar TS, analogously to the 
dioxirane systems. This hypothesis was consistent for all examples, with the major 
epoxide enantiomer observed suggesting the spiro TS. 
 
Scheme 1.58: Depiction of the possible spiro and planar transition states. Isolation 
of the 4R epoxide as the major enantiomer suggests that the epoxidation of alkene 
bonds by oxaziridinium salts favours the spiro TS. 
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Computer studies, later performed by Houk, provided further evidence in 
support of the proposal that the reaction proceeds via the spiro TS.170 
 
1.6.4.3 Komatsu’s Exocyclic Iminium Salts 
A short study into the synthesis and use of novel exocyclic iminium salts for 
asymmetric epoxidation was reported by Komatsu and co-workers in 2000. Initially, 
simple ring skeletons were screened for their effectiveness as epoxidation 
mediators (Figure 1.45).171  
 
Figure 1.45: Achiral, exocyclic iminium salts. Oxone® (1 equiv.), NaHCO3 (4 equiv.), 
H2O / MeCN, 10 mol% iminium salt, RT. 
Fortunately, unlike Armstrong’s examples, these exocyclic iminium salts 
were synthesised easily by condensing cyclic amines with cyclic ketones under 
Dean-Stark conditions, in the presence of HBF4. The most proficient catalyst 
skeleton proved to be 153. Subsequently, a chiral variant 154 was synthesised from 
L-prolinol and screened and demonstrated to have reasonable catalytic efficiency. 
Unfortunately, with regard to the ees observed in the isolated epoxides, Komatsu 
and co-workers were left wanting (Figure 1.46).  
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Figure 1.46: Enantioselective epoxidation of cinnamyl alcohol. Oxone® (1 equiv.), 
NaHCO3 (4 equiv.), H2O / MeCN, 154 10 mol%, RT. 
 
1.6.4.4 Aggarwal’s Studies 
In 1996, Aggarwal reported the preparation of a binaphthyl-based iminium 
salt 155, with which he was able to epoxidize 1-phenylcyclohexene with a 71% ee 
while employing only a 5 mol% catalyst loading (Figure 1.47).172  
 
Figure 1.47: Aggarwal’s chiral binaphthyl catalyst and the epoxide ees achieved. 
The idea of generating the iminium salt by condensing carbonyls with 
amines in situ was independently investigated by both Yang and Aggarwal.173 While 
both groups found it was possible in certain instances, thus negating some 
synthetic investment in the catalyst, the most interesting result came from routine 
control experiments. It was observed by Aggarwal that the pyrrolidine fragment 
alone was capable of catalyzing the epoxidation (Figure 1.59).174 
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Scheme 1.59:. Conditions under which Aggarwal and co-workers observed 
epoxidation using amines such as pyrrolidine. Pyridine is used to prevent the 
hydrolysis of the epoxide to the diol. 
To understand this process further, Aggarwal planned and executed a series 
of experiments to elucidate the role of the amine in the catalytic cycle. There is 
literature precedent for the oxidation of alkenes to occur via a radical cationic 
amine species.175 Initial results obtained by the group seemed to suggest that this 
was plausible, however, these results were irreproducible and later discounted.176 
It was theorized that an oxidized species of the amine - such as a nitrone - 
generated in situ, could catalyze the epoxidation. While the nitrone was found to be 
produced in the reaction mixture at RT, it was later proved not to be capable of 
oxidizing the alkene substrate (Scheme 1.60). Furthermore, when the reaction was 
performed at –10 °C, the amine could be recovered in good yield and the nitrone 
156 was not observed.  
 
Scheme 1.60: A control experiment ascertained that the nitrone species 156 could 
not epoxidize the alkene under the reaction conditions. 
One important experiment utilized the HCl salt 157 as the catalytic entity. 
Aggarwal and co-workers found this salt was far more active than the neutral amine 
itself. This observation led the group to prepare ammonium salts 158 and 159 
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(Figure 1.48). Contrastingly, a substantial drop in reactivity and enantioselectivity 
was observed when employing the tri-substituted salt 158, and the quaternary 
ammonium salt 159 was exceptionally poor, behaving almost identically to the 
quaternary ammonium salt 160. The authors note that these results suggested that 
the ammonium salt 157 was somehow activating Oxone® for nucleophilic attack, 
and that this behaviour was in addition to phase-transfer catalysis.176 
 
Figure 1.48: The series of ammonium salts synthesised by Aggarwal that suggested 
salt 157 was somehow activating Oxone®. 
Aggarwal proposed that the catalytic behaviour of ammonium salt 157 in 
the presence of Oxone® could be explained by the existence of an electrophilically 
activating hydrogen bonding mode between 157 and the monoperoxysulfate 
component of Oxone® (Figure 1.49). To support this theory, salt 161 was 
synthesised and used to epoxidize a range of test substrates directly. It was found 
to produce identical results to when the HCl salt 157 was employed catalytically 
with Oxone®.  
 
Figure 1.49: Different bonding modes proposed by Aggarwal that explain why 
Oxone® was electrophilically activated. 
Potentially, there are several analogous bonding modes, differing in the 
orientation of the monoperoxysulfate anion. The existence of several of these 
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species was believed to have a negative effect on enantioselectivity, since each 
orientation would be expected to exert varying enantiocontrol. 
 
1.6.4.5. Page’s Studies 
Page first reported his efforts towards designing iminium salts for organocatalytic 
asymmetric epoxidation in 1998; and since then, he has made significant 
contributions to this important area of research.177 There were two main ideas that 
formed the concept for his catalyst design: the first was that chirality should be 
present as close as possible to the site of oxygen transfer as possible to enable the 
efficient relay of stereochemical information; secondly, it was important for the 
synthetic route to allow the incorporation of primary amines from the vast chiral 
pool to enable the rapid creation of a library of iminium salts (Scheme 1.61). 
Because of the demonstrated superiority of cyclic iminium salts over the acyclic 
analogues, the first structural class investigated was based on the cyclic 
dihydroisoquinolinium motif 163. 
 
Scheme 1.61: Rapid synthesis of chiral dihydroisoquinolinium –BPh4 salts. 
The syntheses of the dihydroisoquinolinium salts were clean and rapid, 
requiring no column chromatography at any stage. The isolated yield of the salts 
were heavily dependent on the steric size of the amine; i.e. the larger amines 
produced lower yields probably due to their increased preference to act as bases, 
facilitating the decomposition of the bromaldehyde 162. Impressively, the synthesis 
of the iminium-tetraphenylborate (–BPh4) salts from scratch through to isolation of 
the epoxide could be completed in as little as 6 h. Furthermore, in epoxidation 
catalysis only 0.5 mol% of iminium salt was required to achieve full conversion in 1 
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h in some instances – outperforming those previously synthesised by all other 
groups (Scheme 1.62).177 
 
Scheme 1.62: Screening of dihydroisoquinolinium salts for the epoxidation of 1-
phenylcyclohexene. 
After screening the catalysts against a model, substrate 1-phenyl 
cyclohexene, catalyst 164 was singled out and used to epoxidize several other 
substrates. The best result was achieved when employing 164 at 10 mol% loading 
for the epoxidation of trans-stilbene in 73% ee. 
In order better to understand the epoxidation system, and perhaps to 
establish leads into possible optimization and development pathway, an 
exploratory study of the reaction parameters was undertaken.178 Some basic 
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mechanistic insight was provided by the investigation, and the proposed catalytic 
cycle is presented below (Scheme 1.63).179  
 
Scheme 1.63: Proposed catalytic cycle involving the nucleophilic attack of the 
iminium moiety by Oxone® and subsequent expulsion of sulfate to form the reactive 
oxaziridinium species. There is the complication of the potential formation of a 
diastereoisomeric oxaziridinium pair, which would be expected to lower epoxide ees. 
The iminium salt 163 can be attacked reversibly by persulfate from either its 
si or re face; theoretically forming diastereoisomeric adducts 165 a or b. Irreversible 
ring closure and expulsion of sulfate is believed to be the rate determining step and 
forms a diastereoisomeric pair of oxaziridinium species, which were expected to 
impart differing, if not opposing, levels of enantioselectivity. Transfer of the oxygen 
from the oxaziridinium species to the substrate regenerates the iminium salt, and is 
believed to be fast and non-rate determining. 
Effect of Counter-Ion: Several anion pairings of N-isopinocampheyl catalyst 
164 were prepared and assessed for their relative reactivity and enantiocontrol for 
the epoxidation of 1-phenylcyclohexene (Table 1.8). 
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Entry Counter-Ion ee (%) Conv. (%) 
1 –BPh4 (+)-40 100 
2 –BF4 (+)-28 100 
3 –PF6 (+)-28 100 
4 –lO4 (+)-35 100 
5 –ClO4 (+)-20 100 
Table 1.8: Effect of the counter-ion on epoxide ee. All reactions ran to completion in 
≤45 min, and all epoxide configurations were (R,R). 
Having established that perchlorate and periodate were not oxidizing 
catalyst 164, or the alkene, the results suggested that the catalytic species existed 
as ion pairs in solution and that the anion had a significant influence on ee in this 
system. It was suggested that the anion amplifies the intrinsic enantioselectivity of 
the iminium salt by further differentiating the activation energies for the 
diastereoisomeric transition states. It has been shown that the diastereoselectivity 
in the transfer of oxygen to the iminium species is partly controlled by the counter-
ion (Table 1.9). 
  
Chapter 1 – Introduction 
 
92 
 
 
Entry Counter-Ion         dr ee (%) 
1                 –BPh4 27 : 73 33 
2                 –BF4 34 : 66 32 
3                 –PF6 31 : 69 31 
4                 –ClO4 42 : 58 22 
 
Table 1.9: Determination of the oxaziridinium diastereoisomeric ratio by NMR 
spectroscopy. 
The same experiment also suggested that the subsequent transfer of oxygen 
to the substrate was sensitive to the counter-ion because the relationship between 
the diastereoisomeric ratio and the ee was not linear. For example, the –BF4 species 
had a ratio of 34:66 and an ee of 32% whereas the –PF6 species possessed a greater 
diastereoenrichment of 31:69 yet it gave a marginally lower ee of 31%. So it is 
probable that the counter-ion does influence the relative energies of the 
diastereoisomeric transition states of both oxygen transfer steps.180  
Effect of Solvent System: Several solvents were chosen, such that a range of 
dielectric constants were covered, (ε): CH2Cl2 (8.9), trifluoroethanol (26.7), MeCN 
(37.5), water (78.4), DMF (109.0), formamide (111.0), (Table 1.10).  
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Entry Organic 
Solvent 
Counter-
Ion 
Time 
(h) 
Conv. 
(%) 
ee (%) 
1 CH2Cl2 
–ClO4 3 50 33 
2 CF3CH2OH 
–ClO4 0.5 100 26 
3 MeCN –ClO4 0.5 100 20 
4 H2NCHO 
–ClO4 3 0 - 
5 CH2Cl2 
–BPh4 3 0 - 
6 CF3CH2OH 
–BPh4 0.5 100 26 
7 MeCN –BPh4 0.5 100 40 
8 H2NCHO 
–BPh4 3 0 - 
Table 1.10: Comparison between organic co-solvents used with water 1:1. 
Interestingly, no reaction occurred with formamide and it was suggested 
this was either due to irreversible attack of the iminium salt by formamide, or that 
the iminium salts are just too well solvated and therefore rendered unreactive. In 
contrast, the epoxidation does proceed in DMF (65% in 4 h) and its dielectric 
constant is equally high. 
Employing trifluoroethane as co-solvent provided an interesting result. 
When the iminium salts paired with the periodate anion were screened, the 
epoxide ees and reactivity were the same - suggesting that the generation of the 
trifluroroethoxide anion pair occurs and displaces the original anion. 
The solvent with the lowest dielectric constant, CH2Cl2, provided the poorest 
reactivity – believed to be due to the poor availability of Oxone® in the organic 
phase. Although, more recently, Lacour has enjoyed much success employing 
CH2Cl2 along with the phase-transfer catalyst 18-crown-6 ,which acts to increase the 
concentration of the oxidant in the presence of the catalyst.181 
The best organic co-solvent used, in terms of both enantioselectivity and 
reactivity, was MeCN. The ratio of MeCN to water was investigated, and it was 
found that increasing the proportion of water significantly increased the rate of 
reaction without affecting epoxide ees, this was particularly true for low catalyst 
loadings of 0.5 mol%. Higher catalyst loadings of 5 mol% outweighed the 
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accelerating effect of water - using any H2O / MeCN ratio from 1:9 to 9:1 led to full 
conversion in ≤20 min. The fact that the rate increase is observed alongside 
unchanged epoxide ees when increasing the ratio of water in the solvent system 
supports that the formation of adduct 165 is indeed the rate determining step It 
was proposed that the rate increase is due to increased Oxone® solubility and the 
increased solvation of the leaving sulfate group. 
 
Effect of Temperature: Page and co-workers investigated the effect of 
temperature on the system’s behaviour. It was a limited study as the characteristics 
of Oxone® only allowed for a narrow range of temperatures to be surveyed. The 
solubility of Oxone® at temperatures below 0 °C, when employing a 1:1 MeCN / H2O 
solvent system, drops off dramatically - its availability is therefore decreased and 
the reaction effectively stops. It is mentioned above that the rate of reaction 
increased significantly when a greater ratio of water in the solvent system was 
employed, and a 1:3 MeCN / H2O solvent system offset the decreased solubility and 
allowed the temperature to be decreased to –10 °C, although this made little 
difference to the ee of the isolated epoxide. 
Decomposition of Oxone® was rapid under the alkaline epoxidation 
conditions at much above RT and negligible conversion was observed at >25 °C. 
Across the functional temperature range studied the ees of the isolated epoxides 
remained consistent. 
Effect of Catalyst Loading: The trend in ee caused by the variation of catalyst 
loading suggested that it was an important parameter. Since it had been 
established that no background epoxidation occurs in the absence of an iminium 
salt catalyst, the pattern of ees supported the proposal that it was the breakdown 
of the ion-pairs at low concentration that caused the sharp drop-off (Figure 1.50).  
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Figure 1.50: Graph indicating the dependence of catalyst loading on the isolated ee 
of 1-phenylcyclohexene oxide. 
As mentioned above, the counter-ion was believed to play an important role 
in maintaining the integrity of the transferral of stereochemical information from 
the catalyst to the substrate. Thus, if the ion-pair is dissociated in solution, the 
enantioselectivity of the process decreases. 
By studying reaction parameters Page was able better to understand the 
iminium salt-mediated epoxidation system. Page noted that because the step in 
which enantioselectivity is imparted is non-rate determining, there was great 
potential to increase the enantioselectivity of the system without affecting the rate 
deleteriously.178 Also, a rather obvious problem for iminium salt catalysts was the 
formation of the diastereoisomeric oxaziridinium species. In order better to control 
the diastereoselectivity of oxaziridinium formation, Page believed it would be 
possible to direct the stoichiometric oxidant to one face of the iminium bond by 
incorporating polar, co-ordinating functionality into the pendent chiral amine 
(Figure 1.51). To this end, a small family of catalysts derived from 1,2-aminoalcohols 
were prepared and screened.179 
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Figure 1.51: Dihydroisoquinolinium catalysts prepared from chiral 1,2-
aminoalcohols by Page. 
It was immediately evident that these new catalysts were less active than 
previous iterations. It is believed that this behaviour was due to the equilibrium 
between the ring-open (active) and ring-closed (inactive) forms in the slightly basic 
epoxidation conditions (Scheme 1.64).  
 
Scheme 1.64: Equilibrium between the active and inactive forms of the iminium salt 
167 believed to operate under the alkaline reaction conditions. 
Catalysts bearing a primary hydroxyl group all imparted almost zero 
enantioselectivity on test alkene substrates. In contrast, those bearing a chiral 
secondary hydroxyl group did impart some enantioselectivity (12-33% ee), although 
they were even less active than the primary hydroxyl derivatives, requiring up to 
five times the catalyst loading to achieve the same conversion.  
To address this deactivating equilibrium process, Page prepared a range of 
ether derivatives, maintaining the coordinating ability of the oxygen, but, crucially, 
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rendering it much less nucleophilic (Figure 1.52). Unfortunately, the epoxide ees 
attained when using the catalysts were only in single figures, although they did 
demonstrate greater reactivity than the hydroxyl-bearing catalysts.179 
 
Figure 1.52: Ether-containing catalysts prepared by Page, and (S,S)-acetonamine 
168. 
While experimenting with the ether-containing chiral amines, Page and co-
workers investigated (S,S)-acetonamine 168, which was prepared from ketalization 
of (1S,2S)-2-amino-1-phenyl-1,3-propanediol. The synthesis of 169 was high yielding 
and it proved to be a far superior catalyst to 164. In fact, amine 168 and derivatives 
thereof, are now used exclusively in Page’s most recent and successful catalyst 
designs. 
Having identified a chiral amine that possessed significant potential, Page 
and co-workers sought to investigate other ‘backbone’ moieties to use in 
conjunction with 168 in the hope improving enantioselectivity and reactivity.182 A 
series of catalysts featuring the azepinium ring system, the type first employed by 
Aggarwal for asymmetric epoxidation, were prepared from 2,2’-
bis(hydroxymethyl)biphenyl in a similar manner to the dihydroisoquinolinium 
species and tested under Page’s standard epoxidation conditions (Figure 1.53).  
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Figure 1.53: Biphenyl-azepinium catalysts prepared by Page and co-workers. 
It was immediately apparent that these new tropos azepinium catalysts 
were very reactive; in some instances full conversion was observed within 3 min 
when using a 5 mol% loading. Catalyst 169 was particularly active and it also 
demonstrated good enantiocontrol in the epoxidation process (Figure 1.54). 
 
Figure 1.54: A sample of epoxidation results using a new azepinium salt catalyst. 
Catalyst 169 (5 mol%), Oxone® (2 equiv.), Na2CO3 (4 equiv.), MeCN / H2O (1:1), 0 °C. 
Having established that the (S,S)-acetonamine-containing azepinium motif 
was very reactive, and with the aim of improving the observed epoxide ees, Page 
incorporated the atropos binaphthylene backbone to introduce another source of 
chiral information to the catalyst structure in the hope that it would reinforce that 
already possessed by 168 (Figure 1.55).183 
 
Figure 1.55: The so-called ‘matched’ 171 and ‘mismatched’ 172 BINOL-derived 
catalysts. 
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Both diastereoisomers were synthesised, and, through screening, it was 
apparent that they possess startlingly different reactivity (Figure 1.56). The (Ra)-
binaphthylene azepinium 171 demonstrated excellent enantiocontrol in the 
epoxidation process and was very reactive indeed; whereas (Sa)-binaphthylene-
azepinium 172 was an inefficient catalyst, resulting in poor conversion (<5%) under 
the reaction conditions in most cases. Evidently, the constituent chiral amine and 
backbone of the ‘matched’ azepinium were acting synergistically, resulting in a 
catalyst that was the most enantioselective iminium salt catalyst to date (up to 95% 
ee). Of course, the opposite was true of the ‘mismatched’ diastereoisomers where 
the chiral elements combined to be destructive to catalytic behaviour. 
 
Figure 1.56: Substrate screen with ‘matched’ catalyst 171 (green), and 
‘mismatched’ catalyst 172 (red). Oxone® (2 equiv.), Na2CO3 (4 equiv.), MeCN / H2O 
(1:1), 0 °C. 
Remarkably, catalyst 171 was still potent at 0.1 mol%, with the epoxidation 
of 1-phenylcyclohexene running to full conversion in 88% ee after only 6 h. On 
average, therefore, the catalyst is performing 1000 turnovers, which for an 
organocatalyst was unprecedented.183  
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Following the success of catalysts containing 168, a whole series of amines 
varying in their stereochemistry and functionality were synthesised to determine 
why it was a successful pendent amine and also to try to improve upon it. The 
amines were condensed with bromaldehyde 162 to generate their respective 
catalysts (Figure 1.57).184 
 
Figure 1.57: An example of other chiral dihydroisoquinolinium salts investigated by 
Page to gain an insight into the importance of certain structural features. 
The isolated –BPh4 dihydroisoquinolinium salts were employed in the 
epoxidation of tri- and di-substituted alkenes under Page’s standard MeCN/H2O 
conditions. The para-substituted aryl catalysts 173 and 174 demonstrated slightly 
reduced asymmetric induction in comparison with 169, but the electron-rich para-
methoxy substituted catalyst 175 elicited superior enantiocontrol than 169 in some 
instances, but it was not as reactive. Interestingly, catalysts 176 and 177, although 
reactive, imparted almost no enantioselectivity (<5%) (Table 1.11).  
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                                                                      Catalyst 
Alkene 169 173 174 175 176 177 
 
100% conv.  
60% ee 
(–)-(1S,2S) 
48% conv.  
38% ee 
(–)-(1S,2S) 
47% conv. 
 56% ee 
(–)-(1S,2S) 
63% conv. 
50% ee 
(+)-(1R,2R) 
<5% ee <5% ee 
 
95% conv. 
37% ee 
(–)-(1S,2S)  
30% conv.  
17% ee 
(–)-(1S,2S) 
100 conv. 
21% ee 
(–)-(1S,2S) 
61% conv. 
50% ee 
(+)-(1S,2S) 
No 
Result 
No 
Result 
 
90% conv. 
59% ee 
(+)-S 
22% conv.  
11% ee 
(+)-S 
55% conv. 
10% ee 
(+)-S 
63% conv. 
26% ee 
(–)-R  
No 
Result 
No 
Result 
Table 1.11: Screening of new acetonamine-type catalysts. Iminium salt (10 mol%), 
Oxone® (2 equiv.), Na2CO3 (4 equiv.), MeCN / H2O (1:1), 2 h, 0 °C. 
Analysis of the results suggested that the presence of an aromatic group on 
the acetonamine derivatives was crucial to obtaining significant enantioselectivity 
in the epoxidation process.  
Water is required in the above systems to solubilize Oxone®, and without 
water the reaction does not proceed.185 A major disadvantage of the aqueous 
conditions described thus far, is that there is a strict lower limit to the temperatures 
that can be used owing to the freezing point of water. Lowering the temperature is 
advantageous, because according to the Boltzmann distribution, which describes 
the energies of molecules in a bulk substance, epoxide ees should improve with 
cooling; i.e., colder temperatures led to greater differentiation between the 
diastereoisomeric transition states. Thus, the development of the non-aqueous 
conditions required the employment of an oxidant that was readily solvated by 
organic solvents; ensuring its availability to participate in the catalytic cycle.  
Page investigated many stoichiometric oxidants for use under the new non-
aqueous conditions; some caused achiral background epoxidation (peracids, 
persulfates) while the rate of reaction was impractically low for others 
(perselenates, iodosobenzene diacetate, perborates). The best candidate turned 
out to be a modified Oxone® species – tetraphenylphosphonium 
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monoperoxysulfate (TPPP), first reported by Di Furia for oxidation of manganese 
porphyrin species.186 It exhibited excellent reactivity while causing no background 
epoxidation, andits employment led to the creation of an extremely efficient 
epoxidation system (Scheme 1.65).   
 
Scheme 1.65: Non-aqueous conditions developed by Page. 
Performing the epoxidations at much cooler temperatures was made 
practical by using the non-aqueous conditions. Another advantage of the non-
aqueous system was its simplicity; no form of base is needed and the work-up only 
required the dilution of the reaction mixture with Et2O to precipitate excess TPPP 
and its by-products, followed by a filtration. Also, if the reaction had run to 
completion, the epoxide was the only product and it could be isolated in excellent 
purity.187  
It was discovered that, under the non-aqueous conditions, catalyst 174 
displayed excellent enantioselectivity for cis-disubstituted alkenes.13 Page was able 
to utilize this catalyst for the highly enantioselective total synthesis of several 
natural products, all featuring asymmetric epoxidation mediated by 174 as the key 
step: (–)-cromakalim 179,13 (+)-(3S,4R)-trans-khellactone 181,188 and (–)-(3S)-
lomatin 182 188 (Scheme 1.66). 
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Scheme 1.66: Total syntheses of (–)-cromakalim, (+)-(3S,4R)-trans-khellactone and 
(–)-(3S)-lomatin. a) Alkene (1 equiv.), 174 (10 mol%), TPPP (2 equiv.), CHCl3, –40 °C - 
(6-cyano-2,2-dimethylbenzopyran 178) or –30 °C - (seselin 180). b) Pyrrolidin-2-one, 
NaH, DMSO, RT, 52%. c) 1M H2SO4 (aq.), acetone, RT, 95%. d) NaBH3CN (1 equiv.), 
BF3·OEt2, THF, 0 °C, 92%. 
Recently, Page has also explored other variants of the aqueous systems, 
principally trialling other stoichiometric oxidants.189 Hydrogen peroxide was 
investigated as it is one of the most environmentally friendly oxidants; it has a high 
active oxygen content and its reduced product is water. Sodium hypochlorite has 
also been employed under the aqueous conditions, but the results were much 
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poorer than when employing Oxone®, and catalyst degradation was an important 
factor in contributing to this.190 Page has described an interesting oxidant system in 
which the stoichiometric oxidant was generated in situ electrochemically. The 
results were comparable to those achieved when employing Oxone®, and the 
technique is under further development.191 
 
1.6.4.6 Lacour’s Studies 
Preceeding their contributions to the field of iminium salt-mediated 
organocatalysis, Lacour and co-workers reported the preparation and resolution of 
the chiral anion tris(tetrachlorobenzenediolato)phosphate (V) or ‘TRISPHAT’ 183 
(Figure 1.58).192 It had been successfully used as an NMR chiral shift reagent, as well 
as a resolving agent for organometallic species and cationic organic salts.193 A 
TRISPHAT ion-pair is highly lipophilic, easily solvated by organic solvents and does 
not partition itself in an aqueous layer.194  
 
Figure 1.58: The Δ-TRISPHAT anion designed by Lacour. 
Following the evidence for a charged transition state for the oxygen 
transfer, Lacour envisaged that if one could engineer the epoxidation to occur only 
in the organic phase, the charged diastereoisomeric transition states would be less 
stabilized, which would hopefully facilitate improved differentiation between the 
two conformations of the transition states, and led to greater enantioenrichment of 
Chapter 1 – Introduction 
 
105 
 
the resulting epoxides.181 To investigate this idea, Lacour and co-workers prepared 
a range of iminium salts paired with enantiopure TRISPHAT. Taking the efficient 
iminium salt 169, described above, both diastereoisomers of the TRISPHAT ion pairs 
were synthesised and isolated 184. A non-chiral iminium salt was also prepared 185 
as a standard to determine if the chiral anion caused any stereoinduction (Figure 
1.59).181 
 
Figure 1.59: Example ion-pairs prepared by Lacour. TT = TRISPHAT. Both the Δ and Λ 
enantiomers were used separately to generate diastereoisomeric ion-pairs. 
A comparison was made with Page’s –BPh4 species under the polar MeCN / 
H2O conditions. Interestingly, a near identical result was attained – Lacour stated 
this was probably due to the ion-pairs being fully disassociated in the polar 
medium, (Table 1.12).195 Under the new biphasic conditions, however, a meaningful 
jump in epoxide ee was observed. It was evident that the chirality of the anion had 
no stereochemical influence on the epoxidation process as both diastereoisomeric 
ion pairs gave identical epoxide ees and also the achiral iminium salt that was 
paired with Δ-TRISPHAT imparted no stereoinduction. For the biphasic conditions, 
PTC 18-crown-6 was required to transfer the monoperoxysulfate component of 
Oxone® into the organic layer to allow the oxidation of the iminium salt.  
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Entry Iminium Anion Solvent System Conv. (%) ee (%) 
1 184 –BPh4 MeCN / H2O 1:1, 0 °C 100 (–)-60 
2 184 ΛTT– MeCN / H2O 1:1, 0 °C 100 (–)-61 
3 184 ΔTT– CH2Cl2 / H2O 3:2, 18-crown-6, 0 °C 100 (–)-69 
4 184 ΛTT– CH2Cl2 / H2O 3:2, 18-crown-6, 0 °C 100 (–)-69 
5 185 ΔTT– CH2Cl2 / H2O 3:2, 18-crown-6, 0 °C 100 0 
Table 1.12: Screening of the new the biphasic conditions and TRISPHAT counter-ion 
through the epoxidation of 1-phenylcyclohexene. 
Lacour has made significant advances in catalyst design in recent years and 
this began with the synthesis of doubly-bridged biphenyl species, such as 186 
(Figure 1.60).196  
 
Figure 1.60: A doubly-bridged biphenyl iminium salt.  
The DBB iminium salts led to an appreciation of the influence of the two 
dihedral angles within the aromatic backbones on the enantioselectivity of the 
epoxidation process. It has been reported that the dihedral angle is an important 
parameter in enantioselective catalytic transformations and Lacour took this into 
consideration for catalyst development (Figure 1.61). 
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Figure 1.61 Illustration of the internal and external dihedral angles – θ and Φ 
respectively.  
To probe this effect, three backbone moieties were selected that covered a 
range of dihedral angles: the 6,6’-dimethylbiphenyl, binaphthyl, and 
5,5’,6,6’,7,7’,8,8’-octahydrobinaphthyl (Figure 1.62).197 Lacour has incorporated 
several different chiral amines in his catalyst designs. In this study, designs 
containing 3,3-dimethyl-2-butylamine were the most proficient, and a comparison 
of the three iminium salts 187-189 which probes the effect of the dihedral angles is 
offered below (Table 1.13). The iminium salts in this study were prepared in situ; 
the precursor azepines were stirred for 5 min prior to their use and were the 
bromide salts. 
 
Figure 1.62: 6,6’-dimethylbipheny 187, binaphthyl 188, and 5,5’,6,6’,7,7’,8,8’-
octahydrobinaphthyl 189 derived iminium salts featuring (R)-3,3’dimethyl-2-
butylamine. The dihedral angles shown are from a related iminium salt series 
featuring (S)-1-phenyl-1-propylamine and are offered to provide a sense of scale. 
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Alkene 187  188  189 
 
 
(+)-57% ee 
 
< 
 
(+)-85% ee 
 
< 
 
(+)-92% ee 
 
 
 
(–)-67% ee 
 
< 
 
(–)-75% ee 
 
< 
 
(–)-83% ee 
 
 
(–)-44% ee 
 
< 
 
(–)-54% ee 
 
< 
 
(–)-67% ee 
 
Table 1.13: Substrate screen. Iminium salt (5 mol%), Oxone® (1 equiv.), NaHCO3 (4 
equiv.), 18-crown-6 (2.5 mol%), CH2Cl2 / H2O (3:2), 0 °C 
 
Clearly, increasing the dihedral angle has the effect of increasing the 
isolated epoxide ees over this range. The external dihedral angle Φ offers the best 
correlation with epoxide ee. A slight increase in ee was observed on employing the 
pre-isolated –BPh4 salts, concurring with Page’s results during his investigation of 
the effect of the counter-ion. 
Lacour and co-workers recently reported an interesting consequence of 
using the –BPh4 counter-ion – increasing the catalyst loading decreased the isolated 
epoxide ees. In searching for an explanation of this behaviour, large amounts of 
1,1’-biphenyl were observed in reaction mixture. It was proposed that 1,1’-biphenyl 
arose from the oxidative breakdown of the counter-ion; indeed, stirring NaBPh4 
with Oxone® led to the production of 1,1’-biphenyl.198 
The counter-ion was switched for an oxidatively-stable –SbF6 anion AND the 
resulting catalyst has since been used at low loadings (2.5 mol%) to oxidize two 
classes of substrates: tri-substituted unfunctionalized alkenes and tri-substituted 
allylic alcohols (Figure 1.63).199  
Chapter 1 – Introduction 
 
109 
 
 
Figure 1.63: Substrate screen. Iminium salt 189 –SbF6 (2.5 mol%), Oxone® (1.1 
equiv.), NaHCO3 (4 equiv.), 18-crown-6 (2.5 mol%), CH2Cl2 / H2O (3:2), 0 °C 
The extensive range of substrates screened by Lacour and co-workers has 
allowed them to propose a mnemonic for predicting the major enantiomer of the 
epoxidation process (Figure 1.64). 
 
Figure 1.64: Predictive mnemonic for 189 –SbF6 proposed by Lacour.  
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1.7. Conclusion 
In the preceding pages, a brief overview of chirality which emphasises the 
importance of enantioselective synthesis and a concise overview of the structure, 
behaviour and reactivity of epoxides has been offered. It is hoped that the 
versatility and utility of epoxides in modern day organic chemistry has been 
conveyed. Much attention has been paid to the preparation of chiral epoxides, in 
particular to methods which involve organocatalytic oxygen transfer to an alkene as 
it is this field on which the work presented herein is focused.  
  
Chapter 1 – Introduction 
 
111 
 
1.8. References for Chapter 1  
                                                     
1  P. Wothers, N. Greeves, S. Warren, J. Clayden, Organic Chemistry 5th Ed., Oxford 
University Press, 2005, 381.  
2  http://www.britannica.com/EBchecked/topic/66209/Jean-Baptiste-Biot 
accessed 21/08/10  
3  E. Hecht, in Optics 3rd Ed., Addison Wesley, 1998 
4  H. D. Flack, Acta. Cryst. Section A, 2009, 65, 371. 
5  E. W. Meijer, Angew. Chem. Int. Ed., 2001, 40, 3783. 
6  H. Caner, E. Goner, L. Levy, I. Agranat, DDT, 2004, 9, 105. 
7  W. B. McBride, Lancet, 1961, 1358. 
8  C. Therapontos, L. Erskine, E. R. Gardner, W. D. Figg, N. Vargesson, Proc. Natl. 
Acad. Sci., 2004, 106, 8573. 
9  T. Eriksson, S. Björkman, B. Roth, A. Fyge, P. Höglund, Chirality, 1995, 7, 44. 
10  D. C. Graham, Canad. Med. Ass. J., 1963, 88, 208. 
11  P. Wothers, N. Greeves, S. Warren, J. Clayden; in Organic Chemistry 5th Ed., 
Oxford University Press, 2005, 435. 
12   A. Murai, K. Fujiwara, H. Mishima, A. Amano, T. Tokiwano, Tetrahedron Lett., 
1998, 39, 393. 
13  P. C. B. Page, B. R. Buckley, H. Heaney, A. John Blacker, Org. Lett., 2005, 7, 375. 
14  D. A. Evans, B. W. Trotter, B. Côté, Tetrahedron Lett., 1998, 39, 1709. 
15  W. K. D. Brill, D. Tirefort, Tetrahedron Lett., 1998, 39, 787. 
16  G. B. Payne, J. Org. Chem., 1962, 27, 3819. 
17  R. M. Hanson, Org. React., 2002, 60, 1. 
18  S. Dua, M. S. Taylor, M. A. Buntine, J. H. Bowie, J. Chem. Soc., Perkin Trans. 2, 
1997, 1991. 
19  H. Ueda, H. Satoh, K. Matsumoto, K. Sugimoto, T. Fukuyama, H. Tokuyama, 
Angew. Chem. Int. Ed., 2009, 48, 7600. 
20  T. J. Snape, Chem. Soc. Rev, 2007, 36, 1823. 
Chapter 1 – Introduction 
 
112 
 
                                                                                                                                                      
21  (a) S. Masamune, W. Choy, S. J. Petersen, L. R. Sita, Angew. Chem, Int, Ed.,1985, 
24, 1. (b) S. J. Danishefsky, Aldrichimica Acta, 1986, 19, 59. 
22  K. Maruoka, M. Hasegawa, H. Yamamoto, K. Suzuki, M. Shimasaki, G. J. 
Tsuchihashi, J. Am. Chem. Soc., 1986, 108, 3827. 
23  K. Maruoka, T. Ooi, S. Nagahara, H. Yamamoto, Tetrahedron, 1991, 47, 6983. 
24  E. J. Corey, B. E. Roberts, Tetrahedron Lett., 1997, 38, 8921. 
25  H. Nemoto, H Ishibashi, M. Nagamochi, K. Fukumoto, J. Org. Chem., 1992, 57, 
1707. 
26  F. A. Thomas, Y. Bassiere, The Total Synthesis of Natural Products, J. W. ApSimon, 
Ed.; Wiley: New York, 1988, 7, 275. 
27  M. E. Jung, D. C. D’Amico, J. Am. Chem. Soc., 1995, 117, 7379. 
28  E. J. Corey, P. L. Fuchs, Tetrahedron Lett., 1972, 3769. 
29  M. Shimasaki, H. Hara, K. Suzuki, G. Tsuchihashi, Tetrahedron Lett., 1987, 47, 
5891. 
30  K. C. Nicolaou, D. Vourloumis, N. Winssinger, P. S. Baran, Angew. Chem. Int. Ed., 
2000, 39, 44. 
31  (a) M. Konishi, H. Ohkuma, T. Tsuno, T. Oki, G. D. Van Duyne, J. Clardy, J. Am. 
Chem. Soc., 1990, 1127, 3715. (b) A. G. Myers, M. E. Fraley, M. J. Tom, S. B. Cohen, 
D. J. Madar, Chem. Biol., 1995, 2, 33. 
32  E. J. Corey, B. De, J. W. Ponder, J. M. Berg, Tetrahedron Lett., 1983, 25, 1015. 
33  G. E. Veitch, E. Beckmann, B. J. Burke, A. Boyer, S. L. Maslen, S. V. Ley, Angew. 
Chem. Int. Ed., 2007, 46, 7929. 
34  I. Paterson, N. M. Gardner, E. Guzman, A. E. Wright, Bioorg. Med. Chem., 2009, 
17, 2282. 
35  D. Yang, Acc. Chem. Res., 2004, 37, 497. 
36  I. Vilotijevic, T. F. Jamison, Angew. Chem. Int. Ed., 2009, 48, 5250. 
37  I. Paterson, R. D. Tillyer, G. R. Ryan, Tet. Lett. 1993, 34, 4389.  
38  a) W. Williamson, J. Chem. Soc., 1852, 229. (b) M. Hill, A. Dronsfield, Educ. 
Chem., 2002, 39, 47. 
39  D. Kim, S. K. Ahn,, H. Bae, W. J. Choi, H. S. Kim, Tetrahedron Lett., 1997, 38, 4437. 
Chapter 1 – Introduction 
 
113 
 
                                                                                                                                                      
40  (a) G. Darzens, Compt. Rend., 1911, 883. (b) T. Rosen, in Comprehensive Organic 
Synthesis, (Ed: B. M. Trost, I. Fleming), 2, 409, (Pergamon: Oxford 1991). 
41 S. Arai, T. Shioiri, Tetrahedron, 2002, 58, 1407. 
42  I. Shibata, H. Yamasaki, A. Baba, H. Matsuda, Synlett, 1990, 490. 
43  S. Arai, Y. Suzuki, K. Tokumaru, T. Shioiri, Tetrahedron. Lett., 2002, 43, 833. 
44 V. K. Aggarwal, G. Hynd, W. Picoul, J. -L. Vasse, J. Am. Chem. Soc., 2002, 124, 
9964. 
45 A. Schwartz, P. B. Madan, E. Mohacsi, J. P. O’Brien, L. J. Todaro, D. L. Coffen, J. 
Oeg. Chem., 1992, 57, 851. 
46 A. W. Johnson, R. B. LaCount, J. Am. Chem. Soc., 1961, 83, 417. 
47  E. J. Corey, M. Chaykovsky, J. Am. Chem. Soc., 1965, 87, 1353. 
48  F. Volatron, O. Eisenstein, J. Am. Chem Soc., 1984, 106, 6117 
49  T. Hannson, B. Wickberg, J. Org. Chem., 1992, 57, 5370. 
50  S. A. Rao, in Comprehensive Organic Synthesis., (Ed: B. M. Trost, I. Fleming), 7, 
357, (Pergamon: Oxford 1991). 
51 L. Kürti, B. Czakó, in Strategic Applications of Named Reactions in Organic 
Synthesis, 1, 362, (Elsevier, 2005). 
52  N. Prilezhaev, Ber., 1909, 42, 4811. 
53  P. Beak, D. R. Anderson, S. G. Jarboe, M. L. Kurtzweil, K. W. Woods, Pure Appl. 
Chem., 2000, 36, 195. 
54  A. H. Hoveyda, D. A. Evans, G. C. Fu, Chem. Rev., 1993, 93, 1307. 
55 E. Weitz, A. Scheffer, Chem. Bor., 1921, 54, 2307. 
56  A. V. Bayer, V. Villiger, Ber., 1899, 32, 3625. 
57  F. J. Lovas, R. D. Suenram, Chem. Phys. Lett., 1977, 51, 453. 
58  (a) R. Curci, M. Fiorentino, L. Troisi, J. Org. Chem., 1980, 45, 4758. (b) R. W. 
Murray, J. Org. Chem., 1985, 50, 2847. (c) W. Adam, R. Curci, J. O. Edwards, Acc. 
Chem. Res., 1989, 22, 207. 
59  R. W. Murray, Chem. Rev., 1989, 89, 1187. 
60  O. J. Edwards, B. H. Bater, R. Curci, F. DiFuria, Photochem. Photobiol.,, 1979, 30, 
63.  
Chapter 1 – Introduction 
 
114 
 
                                                                                                                                                      
61  D. Yang, Y. X. Ye, M. Xu, J. Org. Chem., 2000, 65, 2208. 
62  T. Katsuki, K. B. Sharpless, J. Am. Chem. Soc., 1980, 102, 5974. 
63  G. Li, H. –T. Chang, K. B. Sharpless, Angew. Chem. Int. Ed., 1996, 35, 451. 
64  S. G. Hentges, K. B. Sharpless, J. Am. Chem. Soc, 1980, 102, 4263. 
65  K. B. Sharpless, Angew. Chem. Int. Ed, 2002, 41, 2024. 
66  I. D. Williams, S. F. Pederson, K. B. Sharpless, S. J. Lippard, J. Am. Chem. Soc., 
1984, 106, 6430. 
67  R. M. Hanson, K. B. Sharpless, J. Org. Chem., 1986, 51, 1922. 
68  Y. Morimoto, T. Okita, M. Takaishi, T. Tanaka, Angew. Chem. Int. Ed., 2006, 46, 
1132. 
69  (a) N. Makita, Y. Hoshino, H. Yamamoto, Angew. Chem., Int. Ed., 2003, 42, 941 
and Angew. Chem. 2003, 115, 971. (b) W. Zhang, A. Basak, Y. Kosugi, Y. Hoshino, H. 
Yamamoto, Angew. Chem., Int. Ed. 2005, 44, 4389; Angew. Chem., 2005, 117, 4463. 
(c) A. U. Barlan, W. Zhang, H. Yamamoto, Tetrahedron, 2007, 63, 6075. (d) W. 
Zhang, H. J. Yamamoto, Am. Chem. Soc., 2007, 129, 286. (e) Z. Li, W. Zhang, H. 
Yamamoto, Angew. Chem., Int. Ed., 2008, 47, 7520; Angew. Chem. 2008, 120, 7630. 
70  Z. Li, H. Yamamoto, J.Am. Chem. Soc., 2010, 132, 7878. 
71  K. Srinivasan, P. Michaud, J. K. Kochi, J. Am. Chem. Soc., 1986, 108, 2309.. 
72  W. Zhang, J. L. Loebach, S. R. Wilson, J. Am. Chem. Soc., 1990, 112, 2801 
73  R. Irie, K. Noda, Y. Ito, N. Matsumoto, T. Katsuki, Tetrahedron: Asymmetry, 1991, 
2, 481. 
74  R. Noyori, S. Hashihuchi, T. Yamano, Adv. Synth. Catal., 2002, 344, 131. 
75  E. N. Jacobsen, in Catalytic Asymmetric Synthesis, (Ed: I. Ojima), 159, (VCH: 
Weinheim, 1993). 
76  D. Feichtinger, D. A. Plattner, Angew. Chem. Int. Ed., 1997, 36, 1718. 
77  H. Jacobsen, L, Cavallo, Chem. Eur. J., 2001, 7, 800. 
78  L. Kürti, B. Czakó, in Strategic Applications of Named Reactions in Organic 
Synthesis, 1, 222, (Elsevier, 2005). 
79  L. Cavallo, H. Jacobsen, Angew. Chem. Int. Ed., 2000, 39, 589. 
Chapter 1 – Introduction 
 
115 
 
                                                                                                                                                      
80  W. Adam, K. J. Roschmann, C. R. Saha-Moeller, D. Seebach, J. Am. Chem. Soc., 
2002, 124, 5068. 
81 Q. –H. Xia, H. –Q. Ge, C. –P. Ye, Z. –M. Liu, K. –X. Su, Chem. Rev., 2005, 105, 1603. 
82  P. I. Dalko, L. Moisan, Angew. Chem. Int. Ed., 2001, 40, 3726. 
83  G. Bredig, W. S. Fiske, Biochem. Z., 1912, 7. 
84  U. Eder, G. Sauer, R. Wiechert, Angew. Chem. Int. Ed., 1971, 10, 496.  
85  Z. G. Hajos, D. R. Parrish, J.Org. Chem., 1974, 39, 1615. 
86  D. W. C. MacMillan, Nature, 2008, 455, 304. 
87  A. Berkessel, H Gröger, Asymmetric Organocatalysis, (Wiley-VCH, 2005) 
88  P. I. Dalko, L. Moisan, Angew. Chem. Int. Ed., 2004, 43, 5138. 
89  A. Dondoni, A. Massi, Angew. Chem. Int. Ed, 2008, 47, 4638. 
90  D. Seidel, J. Am. Chem. Soc, 2010, 132, 8224. 
91  A. –H. Li, L. –X. Dai, V. K. Aggarwal, Chem. Rev., 1997, 97, 2341. 
92  A. W. Johnson, R. B. LaCount, J. Am. Chem. Soc., 1961, 83, 417. 
93  B. M. Trost, R. F. Hammen, J. Am. Chem. Soc, 1973, 95, 962. 
94  D. Darwish, R. L. Tomlinson, J. Am. Chem. Soc, 1968, 90, 5938. 
95  N. Furukawa, Y. Sugihara, H. Fujihara, J. Org. Chem., 1989, 54, 4222. 
96  A. –H. Li, L. –X. Dai, X. –L. Hou, Y. –Z. Huang, F. –W. Li, J. Org. Chem., 1996, 61, 
489.  
97  L. Breau, W. W. Ogilvie, T. Durst, Tetrahedron Lett., 1990, 31, 35. 
98  J. Zinardi, C. Leriverend, D. Aubert, K. Julienne, P. Metzner, J. Org. Chem., 2001, 
66, 5620. 
99  K. Julienne, P. Metzner, V. Henryon, J. Chem. Soc., Perkin. Trans. 1, 1999, 731. 
100 (a) V. K. Aggarwal, Synlett, 1998, 329. (b) V. K. Aggarwal, I. Bae, H. –Y. Lee, 
Tetrahedron, 2004, 60, 9725. 
101 B. R. Bellenie, J. M. Goodman, Chem. Comm., 2004, 1076. 
102 S. Juliá, J. Masana, J. C. Vega, Angew. Chem. Int. Ed., 1980, 19, 929. 
103 S. Juliá, J. Guixer, J. Masana, J. Rocas, S. Colonna, R. Annuziata, H. Molinari, J. 
Chem.Soc., Perkin Trans. 1, 1982, 1317. 
Chapter 1 – Introduction 
 
116 
 
                                                                                                                                                      
104 S. Colonna, H. Molinari, S. Banfi, S. Juliá, J. Masana, A. Alvarez, Tetrahedron, 
1983, 39, 1635. 
105 B. M. Adger, J. V. Barkley, S. Bergeron, M. W. Cappi, B. E. Flowerdue, M. P. 
Jackson, R. McCague, T. C. Nugent, S. M. Roberts, J. Chem. Soc., Perkin Trans. 1, 
1997, 3501. 
106 (a) A. T. Gilmore, S. M. Roberts, M. B. Hursthouse, K. M. Abdul Malik, 
Tetrahedron Lett., 1998, 39, 3315. (b) J. V. Allen, S. Bergeron, M. J. Griffiths, S. 
Mukerjee, S. M. Roberts, N. M. Williamson, L. Eduardo Wu, J. Chem. Soc, Perkin 
Trans. 1, 1998, 3171. 
107 R. W. Flood, T. P. Geller, S. A. Petty, S. M. Roberts, J. Skidmore, M. Volk, Org. 
Lett., 2001, 3, 683. (b) R. Takagi, A. Shiraki, T. Manabe, S. Kojima, K. Ohkata., Chem. 
Lett., 2000, 366. 
108 A. Berkessel, N. Gasch, K. Glaubitz, C. Koch, J. Org. Lett., 2001, 3, 3839. 
109 M, -K. Wong, L. -M. Ho, Y. –S. Zheng, C. –Y. Ho, D. Yang, Org. Lett., 2001, 16, 
2587. 
110 M. Marigo, J. Franzén, T. B. Poulsen, W. Zhuang, K. A. Jørgensen, J. Am. Chem. 
Soc., 2005, 127, 6964. 
111 S. Lee, D. W. C MacMillan, Tetrahedron, 2006, 62, 11413. 
112 (a) N. A. Paras, D. W. C. MacMillan, J. Am. Chem. Soc., 2001, 123, 4370. (b) R. K. 
Kunz, D. W. C. MacMillan, J. Am. Chem. Soc., 2005, 127, 3240. 
113 P. Stang, Chem. Rev., 1996, 96, 1123. 
114 X. Wang, C. M. Reisinger, B. List, J. Am. Chem. Soc., 2008, 130, 6070. 
115 X. Wang, B. List, Angew. Chem. Int. Ed., 2008, 47, 1119.  
116 C. M. Starks, J. Am. Chem. Soc., 1971, 4621. 
117 T. Ooi, K. Maruoka, Angew. Chem. Int. Ed., 2007, 46, 4222. 
118 H. Wynberg, B. Greijdanus, J.  Chem. Soc., 1978, 427. 
119 R. Helder, J. C. Hummelen, R. W. P. M. Laane, J. S. Weiring, H. Wynberg, 
Tetrahedron Lett., 1976, 1831. 
120 N. Baba, J. Oda, M. Kawaguchi, Agric. Biol. Chemm, 1986, 50, 3113. 
121 Y. Hatigaya, H. Yamaguchi, M. Onda, Heterocycles, 1981, 15, 183. 
Chapter 1 – Introduction 
 
117 
 
                                                                                                                                                      
122 W. Adam, P. B. Rao, H. –G. Degen, C. R. Saha-Möller, Tetrahedron: Asymmetry, 
2001, 12, 121. 
123 (a) B. Lygo, P G. Wainwright, Tetrahedron Lett., 1998, 39, 1599. ; (b) B. Lygo, P G. 
Wainwright, Tetrahedron, 1999, 55, 6289.; (c) B. Lygo, D. C. M. To, Tetrahedron 
Lett., 2001, 42, 1343. 
124 E. J. Corey, F. –Y. Zhang, Org.Lett., 1999, 1, 1287. 
125 T. Ooi, D. Ohara, M. Tamura, K. Maruoka, J. Am. Chem. Soc., 2004, 126, 6844. 
126 (a) T. Báko, P. Báko, G. Keglevich, P. Bombicz, M. Kuninyi, K. Pál, S. Bodor, A. 
Máko, L. Tke, Tetrahedron: Asymmetry, 2004, 15, 1589. (b) P. Báko, T. Báko, A. 
Mézáros, G. Keglevich, A. Szöllõsy, S. Bodor, A Máko, L. Tke, Synlett, 2004, 643. 
127 M. T. Allingham, A Howard-Jones, P. J. Murphy, D. A. Thomas, P. W. R. Caulkett, 
Tetrahesron Lett., 2003, 44, 8677.  
128 R. Curci, M. Fiorentino, M. R. Serio, J. Chem. Soc., Chem. Commun., 1984, 155. 
129 R. Curci, L. D’Accolti, M. Fiorentino, A. Rosa, Tetrahedron Lett., 1995, 36, 5831. 
130 D. Yang, Y. C. Yip, M. W. Tang, M. K Wong, J. H. Zheng, K. K. Cheung, J. Am. 
Chem. Soc., 1996, 118, 491. 
131 D. Yang, Y. C. Yip, M. W. Tang, M. K. Wong, K. K. Cheung, J. Org. Chem., 1998, 63, 
9888. 
132 (a) D. Yang, X. C. Wang, M. K. Wong, Y. C. Yip, M. W. Tang, J. Am. Chem. Soc., 
1996, 118, 11311.; (b) D. Yang, Y. C. Yip, M. W. Tang, M. K. Wong, K. K. Cheung, J. 
Am. Chem. Soc., 1998, 120, 5943. 
133 (a) M. Seki, S. Yamada, T. Kuroda, R. Imashiro, T. A. Shimizu, Synthesis, 2000, 
1677.; (b) T. Furutani, R. Imashiro, M. Hatsuda, M. Seki, J. Org. Chem., 2002, 67, 
4599. 
134 (a) C. E. Song, Y. H. Kim, K. C. Lee, S. –G. Lee, B. W. Jin, Tetrahedron: Asymmetry, 
1997, 8, 2981.; (b) A. Berkessel, H Gröger, in Asymmetric Organocatalysis, 278, 
(Wiley-VCH, 2005) 
135 W. Adam, C. –G. Zhao, Tetrahedron: Asymmetry, 1997, 8, 3995. 
136 Y. Tu, Z. –X. Wang, Y. Shi, J. Am. Chem. Soc, 1996, 118, 9806. 
137 Y. Shi, Acc. Chem. Res., 2004, 37, 488. 
Chapter 1 – Introduction 
 
118 
 
                                                                                                                                                      
138 (a) Z. –X. Wang, Y. Tu, M. Frohn, Y. Shi, J. Org. Chem., 1997, 62, 2328. (b) Z. –X. 
Wang, Y. Tu, M. Frohn, J. –R. Zhang, Y. Shi, 1997, 119, 11224. 
139 Z. –X. Wang, Y. Shi, J. Org. Chem, 1998, 63, 3099. 
140 Y. Zhu, L. Shu, Y. Tu, Y. Shi, J. Org. Chem., 2001, 66, 1818. 
141 J. D. Warren, Y. Shi, J. Org. Chem., 1999, 64, 7676. 
142 G. –A. Cao, Z. -X.Wang, Y. Tu, Y. Shi, Tetrahedron Lett., 1998, 39, 4425. 
143 M. Frohn, M. Dalkiewicz, Y. Tu, Z. –X. Wang, Y. Shi, J. Org. Chem., 1998, 63, 2948. 
144 L. Shu, Y. Shi, Tetrahedron, 2001, 57, 5213. 
145 G. B. Payne, P. H. Denning, P. H. Denning, J. Org. Chem., 1961, 26, 659. 
146 A. L. Baumstark, C. J. McClosky, Tetrahedron Lett¸ 1987, 28, 3311. 
147 (a) K. N. Houk, J. Liu, N. C. FeMello, K. R. Condroski, J. Am. Chem. Soc., 1997, 119, 
10147.; (b) C. Jenson, J. Liu, K. N. Houk, W. L. Jorgensen, J. Am. Chem. Soc, 1997, 
119, 12982. 
148 H. Tian, X. She, L. Shu, H. Yu, Y. Shi, J. Am. Chem. Soc., 2000, 122, 11551. 
149 S. E. Denmark, D. C. Forbes, D. S. Hays, J. S. DePue, R. G. Wilde, J. Org. Chem., 
1995, 60, 1391. 
150 S. E. Denmark, H. Matsuhashi, J. Org. Chem., 2002, 67, 3479. 
151 S. E. Denmark, Z. Wu, Synlett, 1999, 847. 
152  A. Berkessel, H Gröger, in Asymmetric Organocatalysis, 286, (Wiley-VCH, 2005) 
153 R. Mello, M. Fiorentino, O. Sciaovelli, R. J. Curci, J. Org. Chem., 1989, 111, 6749. 
154 S. E. Denmark, Z. Wu, C. M. Crudden, H. Matsuhashi, J. Org. Chem., 1997, 62, 
8288. 
155 C. J. Stearman, V. Behar, Tetrahedron Lett., 2002, 43, 1943. 
156 A. Armstrong, W. O. Moss, J. R. Reeves, Tetrahedron: Asymmetry, 2001, 12, 
2779. 
157 (a) A. Armstrong, B. R. Hayter, Chem. Commun., 1998, 621.; (b) A. Armstrong, B. 
R. Hayter, W.O. Moss, J. R. Reeves, J. S. Wailes, Tetrahedron: Asymmetry, 2000, 11, 
2057. 
158 G. Sartori, A. Armstrong, R. Maggi, A. Mzzacani, R. Sartorio, F. Bigi, B. 
Dominguez-Fernandez, J. Org. Chem., 2003, 68, 3232. 
Chapter 1 – Introduction 
 
119 
 
                                                                                                                                                      
159 A. Armstrong, B. Dominguez-Fernandez, T. Tsuchiya, Tetrahedron, 2006, 62, 
6614. 
160 A. Armstrong, I. Washington, K. N. Houk, J. Am. Chem. Soc., 2000, 122, 6297. 
161 A. Armstrong, M. Bettati, A. J. P. White, Tetrahedron, 2010, 66, 6309. 
162 (a) A. Picot, P. Milliet, X. Lusinchi, Tetrahedron Lett., 1976, 19, 1573. (b) (a) A. 
Picot, P. Milliet, X. Lusinchi, Tetrahedron Lett., 1976, 19, 1577 
163 (a)G, Hanquet, X. Lusinchi, Tetrahedron Lett., 1993, 34, 5299.; (b) L. Bohé, M. 
Lusinchi, X. Lusinchi, Tetrahedron, 1994, 50, 12185. 
164 L. Bohé, G. Hanquet, M. Lusinchi, X. Lusinchi, Tetrahedron Lett., 1997, 34, 7271. 
165 L. Bohé, G. Hanquet, M. Lusinchi, X. Lusinchi, Tetrahedron, 1999, 55, 13727. 
166 L. Bohé, M. Kammoun, Tetrahedron Lett., 2002, 47, 803. 
167 L. Bohe, M. Kammoun, Tetrahedron Lett., 2004, 45, 747. 
168 A. Armstrong, G. Ahmed, I. Garnett, K. Goucolou, J. S. Wailes, Tetrahedron, 1999, 
55, 2341. 
169 A. Armstrong, A. G. Draffan, Tetrahedron Lett., 1999, 40, 4453. 
170 I Washington, K. N. Houk, J. Am. Chem. Soc., 2000, 122, 2948. 
171 S. Minikata, A. Takemiya, K. Nakamura, I. Ryu, M. Komatsu, Synlett, 2000, 12, 
1810. 
172 V. K. Aggarwal, M. F. Weng, J. Chem. Soc., Chem. Commun., 1996, 191. 
173 M. –K. Wong, L. –M. Ho, Y. –S Zheng, C. –Y. Ho, D. Yang, Org. Lett., 2001, 3, 2587. 
174 M. F. A. Adamo, V. K. Aggarwal, M. A. Sage, J. Am. Chem. Soc, 2000, 122, 8317. 
175 (a) C. Ferroud, P. Rool, J. Santamaria, Tetrahedron Lett., 1998, 39, 9423.; (b) D. F. 
Evans, M. W. J. Upton, J. Chem. Soc, Dalton Trans. 2, 1985, 6, 1151. 
176 V. K. Aggarwal, C. Lopin, F. Sandrinelli, J. Am. Chem. Soc., 2003, 125, 7596. 
177 P. C. B. Page, G. A. Rassias, D. Bethel, M. B. Schilling, J. Org. Chem., 1998, 63, 
2774. 
178 P. C. B. Page, G. A. Rassias, D. Barros, D. Bethel, M. B. Schilling, J. Chem. Soc., 
Perkin Trans.1, 2000, 3325. 
179 P. C. B Page, G. A. Rassias, D. Barros, A. Ardakani, B. Buckley, D. Bethel, T. A. D. 
Smith, A. M. Z. Slawin, J. Org. Chem., 2001, 66, 6926. 
Chapter 1 – Introduction 
 
120 
 
                                                                                                                                                      
180 P. C. B. Page, D. Barros, B. R. Buckley, B. A. Marples, Tetrahedron: Asymmetry, 
2005, 16, 3488. 
181 J. Lacour, D. Monchaud, C. Marsol, Tetrahedron Lett., 2002, 43, 8257. 
182 P. C. B. Page, G. A. Rassias, D. Barros, A. Ardakani, D. Bethel, E. Merrifield, 
Synlett, 2002, 4, 580.  
183 P. C. B. Page, B. R. Buckley, A. J. Blacker, Org. Lett., 2004, 6, 1543. 
184 P. C. B. Page, B. R. Buckley, g. A. Rassias, A. J. Blacker, Eur. J. Org. Chem., 2006, 
803. 
185 P. C. B. Page, D. Barros, B. R. Buckley, A. Ardakani, B. A. Marples, J. Org. Chem., 
2003, 69, 3595 
186 S. Campestrini, F. Di Furia, G. Labat, F. J. Novello, J. Chem Soc., Perkin Trans. 2, 
1994, 2175. 
187 (a) P. C. B. Page, B. R. Buckley, D. Barros, A. J. Blacker, H. Heaney, B. A. Marples, 
Tetrahedron, 2006, 62, 6607. (b) P. C. B. Page, B. R. Buckley, D. Barros, A. J. Blacker, 
B. A. Marples, M. R. J. Elsegood, Tetrahedron, 2007, 63, 5386. 
188 P. C. B. Page, L. F. Appleby, D. Day, Y.Chan, B. R. Buckley, S. M. Allen, M. J. 
McKenzie, Org. Lett., 2009, 11, 1991. 
189 P. C. B. Page, P. Parker, G. A. Rassias, B. R. Buckley, D. Bethell, Adv. Synth. Catal., 
2008, 350, 1867. 
190 P. C. B. Page, P. Parker, B. R. Buckley, G. A. Rassias, D. Bethel, Tetrahedron, 
2009,65, 2910. 
191 P. C. B Page, F. Marken, C. Williamson, Y. Chan, B. R. Buckley, D. Bethel, Adv. 
Synth. Catal., 2008, 350, 1149. 
192 (a) J. Lacour, C. Ginglinger, F. Favarger, Tetrahedron Lett., 1998, 35, 4825.; (b) J. 
Lacour, C. Ginglinger, C. Grivet, G. Bernardinelli, Angew. Chem., Int. Ed., 1997, 36, 
608–609. 
193 J. Lacour, J. J. Jodry, D. Monchaud, Chem. Commun., 2001, 2302. 
194 J. J. Jodry, J. Lacour, Chem. Eur. J., 2000, 6, 4297.  
195 C. Reichardt, in Solvents and Solvent Effects in Organic Chemistry, 2, (Ed: VCH: 
Weinheim 1988) 
Chapter 1 – Introduction 
 
121 
 
                                                                                                                                                      
196 J. Vachon, S. Rentsch, A. Martinez, C. Marsol, J. Lacour, Org. Biomol. Chem., 
2007, 5, 501. 
197 R. Novikov, G. Bernardinelli, J. Lacour, Adv. Synth. Catal., 2008, 350, 1113.  
198 R. Novikov, G. Bernardinelli, J. Lacour, Adv. Synth. Catal., 2009, 351, 596. 
199 R. Novikov, J. Lacour, Tetrahedron: Asymmetry, 2010, 21, 1611. 
 
Chapter 2 – Results and Discussion 
 
122 
 
  2.0 Results and Discussion 
2.1 Previous Work and Outline of Initial Direction 
Recent research within the Page group, some of which is discussed above, has been 
focused towards developing iminium salt-mediated organocatalytic systems for the 
asymmetric epoxidation of alkenes. The work described herein builds upon the 
discoveries and the developments reported previously by us, and also by others.   
 
Lacour has shown in a recent study that the enantiocontrol imparted by azepinium 
salt catalysts over the epoxidation of alkenes is heavily influenced by the dihedral 
angle Φ.1 We considered that incorporation of a substituent at the prochiral carbon 
α- to the nitrogen would allow us greater influence over any process occurring at 
the catalytically-active iminium functionality. We hoped to design new and 
improved iminium salts through the investigation of these two development paths 
(Figure 2.1). Initial work was towards the preparation and study of a family of 
iminium salts based on the 6,6’-dimethylbiphenyl backbone motif to perform a 
preliminary study. 
 
Figure 2.1: The two routes investigated herein to attempt the optimization of 
catalyst function: i) effect of the dihedral angle within the backbone structure;1 ii) 
effect of substitution α- to the iminium nitrogen. 
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2.2 Catalysts based on the 6,6’-Dimethylbiphenyl-Azepinium Motif 
Synthesis of the backbone motif followed a procedure used and reported by 
Denmark,2 and began with the copper-mediated coupling of 2-amino-3-methyl 
benzoic acid 190 (Scheme 2.1) The diazonium salt of 190 was first prepared by its 
exposure to solution of nitrous acid; the solution of the intermediate diazonium salt 
was then transferred into a vessel containing a reducing copper-containing solution. 
The yield of the racemic bis(benzoic acid) 191 was very sensitive to the rate at 
which the two are mixed: i.e. if the addition was too slow, the azo-containing 
compound 192 was isolated as the major product; to achieve 191 in good yields, 
the concentration of the diazonium salt in the reducing solution needed to be kept 
high as possible while maintaining the temperature below 5 °C, and the best yield 
achieved for the coupling reaction was 58%. The bis(hydroxymethyl) 193 was 
isolated in an essentially quantitative yield by the treatment of 191 with LiAlH4., 
subsequently, the bis(benzaldehyde) 194 required for the coupling of the amine 
was prepared in good yield by exposure to PCC.  
 
Scheme 2.1: a) HCl, NaNO2; then Cu2SO4, (NH4OH)2•H2SO4, NH4OH, 5 °C, 58%; b) 
LiAlH4 (3 equiv.),  Et2O, RT, 96%; c) PCC (3 equiv.), CH2Cl2, RT, 87%. 
(S,S)-Acetonamine 168 has been demonstrated by us to be one of the most 
effective chiral amine motifs for iminium salt-mediated asymmetric epoxidation.3 
Chapter 2 – Results and Discussion 
 
124 
 
Catalysts derived from 168 are generally the most reactive and also display the 
highest levels of enantiocontrol. On paper at least, 168 could conceivably be 
synthesized in one step by the ketalization of the 1,3-diol present in (1S,2S)-(+)-2-
amino-1-phenyl-1,3-propanediol 195; of course the more-nucleophilic primary 
amine functionality does not permit such a synthesis, and the amine must first be 
protected as its formamide prior to ketalization in a one-pot procedure to give 196 
(Scheme 2.2). Deprotection of the amine finishes the preparation of 168 in a 69% 
overall yield over 3 steps.3 
 
Scheme 2.2: Synthesis of (S,S)-acetonamine 168: a) Methyl formate (1.2 equiv.), 
MeOH, NaOMe (0.1 equiv.), RT; b) toluene, CSA (0.1 equiv.), 2,2-DMP (5 equiv.), 94% 
over two steps; c) hydrazine, reflux, 3 h, 73%. 
The coupling of 168 to 194 to prepare the 7-membered-ring azepine construct was 
achieved by a reductive amination procedure,1 creating a pair of diastereoisomers 
197 and 198, owing to the employment of (±)-194. Fortunately, we were able to 
separate the diastereoisomers by flash column chromatography (Scheme 2.3). 
 
Scheme 2.3: Synthesis of the (Ra) and (Sa)-6,6’-dimethylbiphenyl azepine: a) 
NaBH3CN (2.2 equiv.), MeOH, AcOH, RT, 24 h, 197-49%, 198-26%. 
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To determine the absolute stereochemistry of the two azepines, the spectral data 
and optical rotation of each were compared with an authentic sample of 198, itself 
prepared from (S)-191 which was isolated by resolution with quinine prior to the 
manipulation of its oxidation state.2  
The oxidation of 197 and 198 up to their respective iminium salt species 199 and 
200 was readily achieved on exposure to NBS and subsequent ion-exchange with 
NaBPh4 (Scheme 2.4). 
 
Scheme 2.4: Synthesis of the (Ra) and (Sa)-6,6’-dimethylbiphenyl azepinium salts: a) 
NBS (1.1 equiv.), CH2Cl2, 0 °C  reflux, 2; then NaBPh4 (1.1 equiv.), EtOH / MeCN, 
61% (199), 83% (200). 
 
A model study was conducted with catalyst 199 and 1-phenyl-3,4-
dihydronaphthylene as substrate under a range of previously reported conditions,  
to establish under which these new catalysts performed best (Table 2.1). 
 
Entry Conditions Time Conv. (%) ee (%) Config. 
1 MeCN / H2O 10:1, Oxone®, 
NaHCO3, 0 °C 
30 min. 99 89 (+)-(1R,2S) 
2 MeCN / H2O 1:1, Oxone®, 
NaHCO3, 0 °C 
20 min. 98 81 (+)-(1R,2S) 
3 CH2Cl2 3:2, Oxone®, NaHCO3, 
0 °C 
2 h 80 47 (+)-(1R,2S) 
4 CHCl3, TPPP, –30 °C 72 h 47 4 (–)-(1S,2R) 
5 MeCN, TPPP, –30 °C 2 h 99 77 (+)-(1R,2S) 
 
Table 2.1: Evaluation of the epoxidation conditions with catalyst 199 against 1-
phenyl-3,4-dihydronaphthylene. 
 
The aqueous MeCN systems out-performed the other systems in terms of both 
reactivity and enantioselectivity (Entries 1 and 2). Clearly, the ratio of water in the 
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system had a significant effect; a higher ratio of water in the solvent system 
augmented the reactivity, no doubt in part due to increased solubility and 
availability of Oxone® - which is involved in the proposed rate determining step. It is 
also reasonable to suggest that the water stabilizes the charged transition state 
involved in the formation of the oxaziridinium in the rate determining step - 
lowering the EA, which would have the effect of increasing the reaction rate. 
Moreover, an increased water ratio would be expected to stabilize both charged 
diastereoisomeric transition states involved in the enantioselective transfer of 
oxygen to the alkene, which in this instance has manifested itself as a decrease in 
the enantioselectivity of the process. We decided to employ the conditions which 
offered the highest levels of enantiocontrol to assess the new catalysts against a 
range of unfunctionalized alkene substrates (Table 2.2).  
 
Substrate Catalyst  
 
199 200 
 
0.8 h, 99, 87, 
(–)-(1S,2S) 
1.8 h, 99, 82, 
(+)-(1R,2R) 
 
0.5 h, 99, 89, 
(+)-(1R,2S) 
2 h, 99, 82, 
(–)-(1S,2R) 
 
 
 
 
 
 
3 h, 99, 67, 
(–)-(1S,2S) 
6 h, 99, 60, 
(+)-(1R,2R) 
 
 
 
 
 
 
 
 
4.3 h, 99, 15, 
(–)-(1S,2S) 
6 h, 99, 8, 
(+)-(1R,2R) 
 
Table 2.2. Epoxidation of unfunctionalized alkenes: In each case (time, conversion 
(%), ee%, config.). Conditions; Alkene (1 equiv., 0.4 mmol), Oxone® (2 equiv.), 
NaHCO3 (5 equiv.), catalyst (5 mol%), MeCN / H2O 10:1. Run to completion. 
 
It was the pairing of the Ra backbone with the (S,S)-acetonamine that produced the 
most reactive and enantioselective catalyst 199 – the so-called ‘matched’ catalyst. It 
was expected, due to the smaller dihedral angle within the chiral backbone, that 
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199 would be less able to differentiate between the enantiotopic faces of the alkene 
than the analogous binaphthyl-azepinium salt 171 described above in Chapter 1, 
and indeed, this was the case. Further, in comparing the results obtained with the 
6,6’-dimethylbiphenyl azepinium to the binaphthyl-azepinium, it was noted that the 
configuration of the major epoxides isolated were identical in all instances. This 
concurred with Lacour’s suggestion that it is the backbone that controls the 
absolute stereochemistry, while the amine and its relationship with the backbone 
(synergistic or otherwise) has a lesser effect.1 
 
We next wanted to investigate the influence that a substituent at the methylene 
unit adjacent to the iminium nitrogen had on the epoxidation process; we 
envisaged that we should be able to introduce such a substituent to the 6,6’-
dimethylbiphenyl-azepinium salts by the nucleophilic attack of a Grignard reagent 
at the C terminus of the iminium bond. We were uncertain with regards to the 
potential stereochemical outcome of such a reaction but, when the addition was 
performed at –78 °C with MeMgCl in THF, we observed the formation of the 
azepines 201 and 202 as single diastereoisomers (Scheme 2.5).  
 
Scheme 2.5: Diastereoselective introduction of a methyl substituent by Grignard 
addition: a) MeMgCl (10 equiv.), THF, –78 °C  RT, 94% (201), 99% (202). 
 
For both azepines, the methyl resonance was shifted far up-field of where we 
expected, δH = 0.21 ppm (201), 0.14 ppm (202). From the analysis of a model, and 
analysis of similar systems by Wallace,4 it is clear that if the methyl substituent is 
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pseudo-axial, it is held in close proximity to the face of the aromatic ring opposite it 
on the azepine ring. This arrangement subjects the methyl substituent to a ring-
current during the acquisition of the NMR, lowering the local magnetic field B0, thus 
causing the apparent up-field shift in the methyl substituent’s resonance. Crucially, 
exposure to a ring-current is not possible if the methyl substituent exists in the 
pseudo-equatorial configuration. Thus, the absolute configuration of the methyl 
substituent was inferred from the 1H and 13C NMR spectra - addition to 199 resulted 
in the R configuration at the α-position while addition to 200 resulted in the S 
configuration at the α-position. The fact that the absolute configuration of the 
methyl-bearing carbon changes with the backbone suggests that it is the backbone 
that controls the facial selectivity of the Grignard addition - not the chiral amine. 
 
Oxidation of the novel 6,6’-dimethylbiphenyl-methylazepines 201 and 202 with NBS 
to their respective methylazepinium salts, 203 and 204, was surprisingly low 
yielding, although both were formed as single regio- and diastereoisomers (Scheme 
2.6).  
 
Scheme 2.6: Synthesis of the novel 6,6’-dimethylbiphenyl methylazepinium salts: a) 
NBS (1.1 equiv.), CH2Cl2, 0 °C  reflux, 2 h, 30% (203), 32% (204). 
 
The reason for the low yield was that the reaction did not go to full completion with 
1.1 equivalents of NBS, and because crystallization to obtain 203 and 204 could only 
be performed once; subsequent crystallizations were contaminated by products 
which at the time were unidentified and never isolated. We have since obtained MS 
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evidence to suggest the presence of brominated salts, such as 205. The presence of 
205 explained why the conversion of the azepine was incomplete - NBS was being 
consumed in the by-reaction (Figure 2.2).  
 
 
Figure 2.2: Proposed representative structure of the brominated impurities. 
 
The iminium bond could potentially have formed as one of two regioisomers – 
depending on whether the new iminium bond formed from the least substituted 
carbon α- to nitrogen 207 or from the most substituted carbon 208. Interestingly, 
we only observed and isolated the former from the reaction mixture, which to a 
crude approximation, we would have expected to be the least thermodynamically 
favoured of the two as it is the least substituted. This result implied, and originally 
led us to believe, that the regioselectivity of the oxidation process was therefore 
kinetically controlled and not due to an equilibrium. The oxidation is believed to 
proceed through the initial bromination of the nitrogen 206. From the resulting 
positively charged intermediate, the iminium bond is then formed by abstraction of 
a proton and concomitant expulsion of bromide in an E2 mechanism. The E2 
mechanism requires the anti-periplanar relationship of the H to the Br to provide 
the necessary orbital overlap. Thus, as the methyl group occupies a pseudo-axial 
position, the proton on that same carbon is pseudo-equatorial (Heq) and is not in the 
correct alignment with the bromine to eliminate. The only proton that can attain 
the necessary anti-periplanar alignment is therefore the pseudo-axial proton (Hax), 
and so it is from the least substituted carbon that the iminium bond is formed 207 
(Figure 2.3).  
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Figure 2.3: The kinetically favoured abstraction of the pseudo-axial H is believed to 
be the sole reason for the exclusive formation of the regioisomer 207.  
 
For these 6,6’-dimethylbiphenyl methylazepinium systems, this kinetic model 
concisely explained the regioselectivity we observed. 
 
Methyl-substituted catalysts 203 and 204 were screened under the same conditions 
as their parent catalysts, against the unfunctionalized alkenes displayed below 
(Table 2.3). 
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Substrate Catalyst  
 
203 204 
 
1 h, 99, 92, 
(–)-(1S,2S) 
3 h, 99, 82, 
(+)-(1R,2R) 
 
1 h, 99, 85, 
(+)-(1R,2S) 
6 h, 77, 78, 
(–)-(1S,2R) 
 
3 h, 99, 73, 
(–)-(1S,2S) 
6 h, 99, 48, 
(+)-(1R,2R) 
 
 
 
 
 
 
 
 
6 h, 99, 39, 
(–)-(1S,2S) 
6 h, 99, 10, 
(+)-(1R,2R) 
 
Table 2.3 Epoxidation of unfunctionalized alkenes: In each case (time, conversion 
(%), ee%, config.). Conditions; Alkene (1 equiv., 0.4 mmol), Oxone® (2 equiv.), 
NaHCO3 (5 equiv.), catalyst (5 mol%), MeCN / H2O 10:1. Run to completion. 
 
It was clear that this new generation of methylated azepinium salt was less reactive 
than the previous (Fig 1.52). We tentatively considered this may have been due to a 
slight increase in the electron-density on the methylazepinium ring caused by the 
weakly electron donating methyl substituent, but the effect appeared too large; the 
reaction times increased by up to a factor of 2 in some instances.  
 
Interestingly, incorporation of the methyl substituent to give 203 had a positive 
effect on the enantioselectivity in comparison with 199, while its incorporation into 
the ‘mismatched’ catalyst 200 created a less enantioselective azepinium salt 204. 
We were unable to explain the influence that the methyl substituent had over the 
epoxidation process at this point, but buoyed by the jump in enantioselectivity 204 
exhibited, we decided to initiate a more thorough study and prepare a larger family 
of binaphthyl-azepinium salts to ascertain whether this effect was more general, 
and importantly – to develop a theoretical model to explain our observations.  
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2.3 Regioselective Iminium Bond Formation and Stereochemical Relays 
The biphenyl backbone contained in catalysts 169 and 170, does not possess stable 
atropisomers, as the absence of sterically demanding substituents at the 6 and 6’ 
positions allow the rapid rotation about the sp2C-sp2C bond at room temperature 
(Figure 2.4). 
 
Figure 2.4: Rotation about the biphenyl axis is rapid at RT. 
 
So, the isolation of a mixture of two isomers from the Grignard addition for each 
was not unexpected, but the exact nature of the isomers was surprising and also 
provided further evidence for our hypothesis that it is the backbone that ultimately 
controls the stereochemistry of the Grignard reagent addition (Scheme 2.7). The 
backbone could have this influence directly, i.e. it could physically hinder the Burgi-
Dunitz approach of the Grignard reagent required to achieve a reaction with the 
iminium bond. Or, it could be that it is the conformation of the azepinium ring itself 
- determined by the conformation of the backbone - that results in the facial 
selectivity. Axial attack on six membered iminium systems is favoured due to the 
reduction of 1,3-diaxial interactions.5 The resultant pseudo-axial configuration of 
the methyl substituent in our azepinium systems, could just be a result of the 
accepted kinetic rules for fixed-conformation ring attack. 
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Scheme 2.7: Grignard addition to 169 and 170 produced a mixture of two 
atropisomers. 
 
The methyl substituent in both isomers of 209 and 210 ((Ra, R) and (Sa, S)) displayed 
the characteristic up-field shift in their respective NMR spectra indicating the 
methyl group was axial in both, which implied that the two isomers had to 
therefore be atropisomers. That is to say - the methyl group, once inserted, 
significantly increases the barrier to rotation of the biaryl sp2C-sp2C bond, creating 
an atropisomeric centre at room temperature. The backbone’s configuration is 
much more stable to inversion because the sp2C-sp2C bond rotation movement 
required to do so, in the presence of a bulky pendent amine,4 causes the methyl to 
clash with the H atom at the 3’ position, giving the inversion a high energy barrier 
(Figure 2.5) 
 
Figure 2.5: Illustration of the high-energy bond rotation movement required for 
inversion at the atropisomeric centre. 
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To understand the origin of the atropisomeric ratio observed for the Grignard 
addition to 169 and 170, we probed the catalysts by conducting NOESY experiments 
at –80 °C – the same temperature at which the Grignard addition is performed. We 
observed the existence of distinct sp2C-sp2C rotamers in 169 and 170 at that 
temperature; interestingly, the ratio of the rotamers corresponded very closely to 
the atropisomeric ratio observed in the biphenyl methylazepines 209 and 210.  
 
For 169, sp3C-sp2N roatamers were also observed at –80 °C. This resulted in a total 
of 4 iminium peaks in the NMR spectra. Comparison to the NOESY data of the 
closely related binaphthyl analogue 171, described below, and correlation data 
obtained from the NOESY spectra of 170 allowed us to confidently assign which 
peak corresponded to which conformation, and therefore deduce the sp2C-sp2C 
ratio. Only two iminium peaks were present in the spectra of 170 at –80 °C, both of 
which were the syn rotamer, therefore the two conformations were deduced to be 
sp2C-sp2C roatamers (Figure 2.6).  
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Figure 2.6: NOESY spectra of 170 at the sp2C-sp2C at –80 °C, showing that both 
iminium signals (red) show correlations with the proton on the chiral amine (blue). 
 
Since the methyl substituent is axial in all cases and since the observed rotameric 
ratio is approximately equal to isolated atropisomeric ratio, it follows that the 
backbone somehow ultimately controls the insertion to be axial, and that the 
insertion stabilises the rotamer (Scheme 2.8).  
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Scheme 2.8: Relation of the sp2C-sp2C ratio of rotamers observed at –80 °C by nOe 
to the isolated atropisomeric ratio. 
 
Of course, it is the chirality of the pendent amine which determines the extent to 
which the two possible pseudo-diastereoisomeric rotamers are occupied at low 
temperature. So, in effect, we have observed a stereochemical relay of point  
axial  point chirality. The isopinocampheyl-derived group in 170 was not as 
capable of transferring its stereochemical information as 168, perhaps due to its 
less bulky substituent at the position indicated by the circle (Figure 2.7). 
 
Figure 2.7: Transfer of point  axial  point chirality. 
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2.4 Catalysts based on the Binaphthyl-Azepinium Motif 
The atropisomeric binaphthyl motif is one of the most widely exploited sources of 
chiral information today, finding utility in organocatalysis, metal mediated catalysis, 
resolving agents and chromatographic stationary phases.6 We,7 and others,1,8 have 
described the preparation of azepinium salt catalysts based on the binaphthyl motif 
previously and reported some of the highest enantioselectivities for the 
epoxidation of unfunctionalized tri-substituted alkenes with their use, some of 
which are highlighted above in Chapter 1. Given the already high levels of 
stereocontrol exhibited by these species, we were keen to investigate the potential 
gains we could achieve by modification at the α-position. Following on from the 
work performed on the 6,6’-dimethyl biphenyl-azepinium catalysts, we planned to 
probe the effect of other substituents, as well as other pendent amines, to better 
understand the underlying mechanism by which the introduced substituent exerts 
its influence on the epoxidation process (Figure 2.8). 
 
Figure 2.8: Schematic of the general structure of the binaphthyl-azepinium salts, 
highlighting the site of our modification. 
The synthesis of the unsubstituted binaphthyl-azepinium catalysts is rapid, 
requires no column chromatography, and begins from (R)-(+)- and (S)-(–)-BINOL 
211. Triflation of the phenolic hydroxyl groups was achieved with triflic anhydride 
212, which appropriately functionalized the 2 / 2’ positions for the subsequent 
Kumada coupling used to install the required carbons of 213.7 The activated 
benzylic positions were then brominated by the action of NBS and AIBN to furnish 
bis(bromomethyl) 214, needed for the coupling of the amine (Scheme 2.11).  
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Scheme 2.11:  Synthesis of (R) and (S)-2,2’-bis(bromomethyl)-binaphthylenyl: a)Tf2O 
(3 equiv.), DMAP (0.4 equiv.), 2,6-lutidine (3 equiv.), CH2Cl2, 16 h, –30 °C  RT, 
99%; b) MeMgBr (4 equiv.), Ni(II)Cl dppe, Et2O, 16 h, –30 °C  RT, 88%; c) NBS (2.2 
equiv.), AIBN (5 mol%), cyclohexane, reflux, 3 h, 58%.  
For this extended study, we employed (R) and (S)-3,3-dimethyl-2-butylamine 
215 and the non-chiral isopropylamine 216, alongside 168 to prepare the initial 
azepines (Scheme 2.12). The coupling was readily achieved by refluxing a 1:1 
mixture of 214 and the desired amine in MeCN overnight in the presence of K2CO3 
to furnish the azepines 217-221 in excellent yield and purity. 
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Scheme 2.12: Synthesis of binaphthyl azepines: a) RNH2 (1 equiv.), 214 (1 equiv.), 
K2CO3 (3 equiv.), MeCN, reflux, 16 h. 
The chiral amines 215 were chosen because they have been shown by 
Lacour to be excellent mediators of enantiocontrol when partnered with the 
binaphthyl- motif. The diastereoisomeric pair 218 and 219 also demonstrated 
‘matched’ and ‘mismatched’ behaviour that we wanted to assess further, 
particularly because for this pair, one diastereoisomer is more reactive, while the 
other is more enantioselective. That relationship contrasts with that between 171 
and 172, where 171 is both more reactive and more enantioselective.1 The non-
chiral amine 216 was selected as a ‘control’.9 We hoped the catalysts synthesized 
from its use would allow us to determine if the influence of the α-substituent 
manifested itself through an interaction with the pendent amine. 
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The formation of the tetraphenylborate binaphthyl-azepinium salts 
prepared below was effected by exposure to NBS and subsequent ion-exchange in 
varying yield (Scheme 2.13).  
 
Scheme 2.13: Synthesis of binaphthyl azepinium catalysts: a) NBS (1.1 equiv.), 
CH2Cl2, reflux, 1 h; then NaBPh4 (1.1 equiv.), EtOH / MeCN. 
With the five catalysts in hand, a preliminary substrate screen was 
performed. Catalysts 171, 172 and 224 were assessed under standard MeCN / H2O 
conditions. There was a much greater ‘matched’ and ‘mismatched’ disparity 
between 171 and 172 than there was for the 6,6’-dimethylbiphenyl-azepinium 
analogues 199 and 200. Presumably, the larger Φ angle contained within the 
binaphthyl backbone was the cause – exacerbating the conflicting chiral 
information contained within 172 while reinforcing the cooperant chiral 
information in 171. It was also interesting to observe that 171 was more reactive 
than 224 despite it containing a far bulkier amine (Table 2.4). Catalysts 222 and 223 
were used under Lacour’s CH2Cl2 / H2O conditions.
10 It was clear the difference 
between the two diastereoisomers was small, but nevertheless 222 demonstrated 
slightly more stereocontrol, while 223 was more reactive (Table 2.5). 
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Substrate 171 172 224 
 
0.2 h, 99, 91,  
(–)-(1S,2S) 
1.5 h, 99, 79,  
(+)-(1R,2R) 
0.5 h, 99, 75,  
(–)-(1S,2S) 
 
0.3 h, 99, 94,  
(+)-(1R,2S) 
2.2 h, 80, 57,  
(–)-(1S,2R) 
0.7 h, 99, 91,  
(+)-(1R,2S) 
 
0.3 h, 99, 49,  
(–)-(1S,2S) 
4.6 h, 40, 49,  
(+)-(1R,2R) 
2.5 h, 99, 53, 
(–)-(1S,2S) 
 
 
 
 
 
 
 
0.3 h, 99, 15,  
(–)-(1S,2S) 
4.6 h, 28, 11,  
(+)-(1R,2R) 
-- 
 
0.6 h, 99, 18,  
(+)-(1R,2S) 
1.5 h, 99, 21, 
(–)-(1S,2R) 
-- 
 
13 h, 81, 16,  
(+)-(S) 
13 h, 7, 3,  
(–)-(R) 
-- 
Table 2.4: Epoxidation of unfunctionalized alkenes: In each case: (time, conversion 
(%), ee%, config.). Conditions; Alkene (1 equiv., 0.4 mmol), Oxone® (2 equiv.), 
NaHCO3 (5 equiv.), catalyst (5 mol%), MeCN / H2O 1:1, 0 °C. 
 
Substrate 222 223 
 
99, 75,  
(–)-(1S,2S) 
99, 74,  
(–)-(1S,2S) 
 
80, 85,  
(+)-(1R,2S) 
99, 83,  
(+)-(1R,2S) 
 
18, 52,  
(–)-(1S,2S) 
56, 44,  
(–)-(1S,2S) 
Table 2.5: Epoxidation of unfunctionalized alkenes: In each case (conversion (%), 
ee%, config.). Conditions; Alkene (1 equiv., 0.3 mmol), Oxone® (1 equiv.), NaHCO3 (4 
equiv.), 18-crown-6 (2.5 mol%), catalyst (5 mol%), CH2Cl2 / H2O 3:2, 0 °C, 2 h. 
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After the preliminary screen of the non-substituted binaphthyl azepinium catalysts, 
we next investigated the incorporation of substituents into 222, to create a small 
range of α-substituted binaphthyl azepinium salts (Scheme 2.14).  
 
Scheme 2.14: Preparation of several α-substituted binaphthyl-azepinium salts: a) 
RMgBr (10 equiv.), THF, –78 °C  RT, 16 h; b) NBS (1.1 equiv.), CH2Cl2, RT, 10 min; 
then NaBPh4 (1.1 equiv.), EtOH / MeCN. 
Again, an up-field shift was witnessed of the methyl substituent in the NMR spectra 
for 225, and also of the iPr group in 226, which provided strong evidence that these 
substituents were pseudo-axially orientated; it was difficult to assess such a marked 
shift for the Ph group in 227, but we suspect, by analogy to all other results, it too 
was pseudo-axial.  
The catalysts were assessed under the biphasic CH2Cl2 / H2O conditions for the 
epoxidation of 1-phenyl-3,4-dihydronaphthylene – a substrate that the azepinium 
catalysts were typically able to epoxidize with excellent enantiocontrol. Catalyst 225 
was an improvement upon 222 in terms of enantiocontrol. Unfortunately, however, 
the reactivity was substantially compromised, if still practical (Table 2.6). We were 
pleased to observe that the incorporation of a methyl group improved upon the 
enantiocontrol demonstrated by 222, particularly because this showed that the 
modification was effective for other chiral amines as well as other backbone motifs. 
However, from this small study, and from other results previously obtained within 
the group,11 it was apparent that a methyl group was the only candidate which 
achieved the desired augmentation of the catalyst’s enantiocontrol. Bulkier 
substituents were extremely deleterious to both reactivity and enantioselectivity. 
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Substrate 225 226 227 
 
 
2 h, 40, 87, 
(+)-(1R,2S) 
 
5 h, 12,45, 
(+)-(1R,2S) 
 
16 h, 4,-, - 
Table 2.6: Epoxidation of unfunctionalized alkenes: In each case (conversion (%), 
ee%, config.). Conditions; Alkene (1 equiv., 0.3 mmol), Oxone® (1 equiv.), NaHCO3 (4 
equiv.), 18-crown-6 (2.5 mol%), catalyst (5 mol%), CH2Cl2 / H2O 3:2, 0 °C, 2 h. 
Having satisfied ourselves that a methyl substituent was likely to be the optimal 
alkyl substituent to incorporate at the α-position, we applied the modification to a 
range of binaphthyl-azepinium salts (Scheme 2.15). 
 
Scheme 2.15: Synthesis of the binaphthyl-methyl azepines: a) MeMgBr (10 equiv.), 
THF, –78 °C  RT, 16 h. 
All NMR spectra of the binaphthyl-methyl azepines prepared above displayed the 
same up-field shift of the methyl substituent, and the spectrum of 228 is shown 
below (Figure 2.9). We also obtained a crystal X-ray structure of 228, which 
confirmed the pseudo-axial configuration of the methyl substituent and is also 
shown below (Figure 2.10). 
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Figure 2.9: Large up-field shift of the methyl group in 228, δH = 0.12 ppm. 
 
 
Figure 2.10: Crystal X-ray structure of 228, clearly showing the configuration of the 
methyl substituent. 
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Oxidation of the binaphthyl-methylazepines and isolation of the binaphthyl-
methylazepinium –BPh4 salts were achieved in the usual way. As expected, the 
least-substituted iminium bond regioisomers were obtained, with complete 
retention of stereochemistry at the α-position in all instances (Scheme 2.16).  
 
Scheme 2.16: Synthesis of binaphthyl-methyl azepinium –BPh4 salts: a) NBS (1.1 
equiv.), CH2Cl2, RT, 10 min; then NaBPh4 (1.1 equiv.), EtOH / MeCN. 
The new generation of catalysts was then tested against a range of substrates to test 
their efficacy as enantioselective organocatalysts. The results are outlined below 
(Tables 2.7 and 2.8).   
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Substrate 232 235 234 
 
0.3 h, 99, 94, 
(–)-(1S,2S) 
2 h, 99, 44, 
(+)-(1R,2R) 
0.5 h, 99, 79, 
(–)-(1S,2S) 
 
0.5 h, 99, 94, 
(+)-(1R,2S) 
4 h, 93, 63, 
(–)-(1S,2R) 
0.6 h, 99, 85, 
(+)-(1R,2S) 
 
0.6 h, 99, 64, 
(–)-(1S,2S) 
4 h, 26, 30, 
(+)-(1R,2R) 
2.5 h, 99, 55, 
(–)-(1S,2S) 
 
 
 
 
 
 
 
1.2 h, 99, 36, 
(–)-(1S,2S) 
4 h, 14, 7, 
(+)-(1R,2R) 
-- 
 
0.6 h, 99, 15, 
(+)-(1R,2S) 
2 h, 99, 26, 
(–)-(1S,2R) 
-- 
 
13 h, 38, 28, 
(+)-(1S,2S) 
13 h, 6, 1, 
(–)-(1R,2R) 
-- 
Table 2.7: Epoxidation of unfunctionalized alkenes: In each case (time, conversion 
(%), ee (%), config.). Conditions; Alkene (1 equiv., 0.4 mmol), Oxone® (2 equiv.), 
NaHCO3 (5 equiv.), catalyst (5 mol%), MeCN / H2O 1:1, 0 °C. 
 
Substrate 225 233 
 
88, 92,  
(–)-(1S,2S) 
99, 88,  
(–)-(1S,2S) 
 
40, 87,  
(+)-(1R,2S) 
99, 90,  
(+)-(1R,2S) 
 
17, 55,  
(–)-(1S,2S) 
40, 50,  
(–)-(1S,2S) 
Table 2.8: Epoxidation of unfunctionalized alkenes: In each case (conversion (%), 
ee%, config.). Conditions; Alkene (1 equiv., 0.3 mmol), Oxone® (1 equiv.), NaHCO3 (4 
equiv.), 18-crown-6 (2.5 mol%), catalyst (5 mol%), CH2Cl2 / H2O 3:2, 0 °C, 2 h. 
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Again, incorporation of the methyl substituent into the catalyst structure had a 
profound effect on the levels of enantiocontrol imparted by the catalysts, with the 
exception the iPr-based 224 and 234. However, the reactivity of the ‘’second 
generation’’ binaphthyl-methylazepinium salts was generally lower than the ‘’first 
generation’’. Now that we had a larger body of results, which backed up those we 
obtained from the 6,6’-dimethyl biphenyl system, we wanted to understand how 
the methyl substituent’s presence influences the both the enantioselectivity and 
rate of the epoxidation process.  
 
 
2.5 The Influence of sp2N-sp3C Rotamers on Enantioselectivity 
We considered several models to explain our observations, and in order to 
strengthen the argument for that which we ultimately proposed, it was important 
to accumulate evidence to rule out other reasonable mechanisms.  
 
I.  The possibility of the formation of the oxidatively active oxaziridinium salts as a 
mixture of diastereoisomers from oxidation of the planar pro-chiral pre-catalytic 
iminium species is well documented.12 As is mentioned above in Chapter 1, when 
discussing a diastereoisomeric mixture of oxaziridinium salts during the catalytic 
cycle mediated by the dihydroisoquinolinium salts, each diastereoisomer would be 
expected to impart differing - if not opposing - levels of enantiocontrol. Our first 
consideration was that the oxidation of the iminium motif 236 would have been 
less favoured from the face on which methyl group was present because of the 
extra steric bulk (Scheme 2.17). Regardless, assuming the minor diastereoisomer 
237 did form, it was also a possibility that the methyl group instead blocked the 
substrate’s approach. Thus, the oxidation of the substrate by the minor 
oxaziridinium diastereoisomer would become much slower. In any case, Houk has 
shown with a model system (R = Me, R1 = H)13 that the intermediate of the 
oxidation of 236 by Oxone® leading to the formation of the minor diastereoisomer 
237, was “8.1 kcalmol–1 higher in energy than the intermediate leading to the major 
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diastereoisomer 238’’, noting that the difference was due to steric repulsion 
between the monoperoxysulfate and the arene H at the 3 position.  
 
Scheme 2.17:  Formation of oxaziridinium epimers. 
II. We considered the possibility that the added methyl substituent was able to 
influence the dihedral angle Φ; we conceived that in an attempt to reduce the 
unfavourable steric interaction between the methyl substituent and the H atom at 
the 3’ position of the backbone in the modified catalyst 249 might be encouraged 
to adopt a wider angle than its parent catalyst 250 (Figure 2.11).   
 
 
Figure 2.11: An increase in the dihedral angle Φ was postulated to result from the 
presence of the α-substituent, and perhaps affect enantioselectivity. 
 
We were able to rule this model out through the comparison of the CD spectra 
between generations. It has been shown by Sandstrom that the λMAX absorbance 
value of aromatic axially-chiral species is dependent on the dihedral angle.14 The 
λMAX values were almost identical for the species measured, suggesting that the 
dihedral angle is the same for both generations, and that a change in the dihedral 
angle was not responsible for our observations (Figure 2.12). 
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c 
Figure 2.12: The CD spectra of 224 and 234.Both had λMAX values in their UV spectra 
of 218 nm. 
 
The two theories detailed above in I and II attempt to explain the effect the methyl 
group has by its interaction with the backbone and ring system, i.e. they do not take 
into account the pendent amine and are independent of it. So, we would expect 
that if one of the above models were accurate, the same jump in the isolated 
epoxide ees would have been observed for 234, and that was not the case. This 
indicated to us that the methyl group’s influence is acting through an interaction 
with the pendent amine group. 
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III. It seemed reasonable to us that the methyl group could increase the energy for 
rotation around the sp2N-sp3C bond through steric interaction with the bulkier 
pendent amines. We conceived that this would have created a more rigid, well-
defined catalytic entity which would have been more efficient at transferring its 
stereochemical information to the substrate (Figure 2.13). 
 
 
Figure 2.13: The presence of the methyl group could conceivably have increased the 
energy barrier for sp2N-sp3C bond rotation. 
 
However, the energy for rotation remained unchanged – VT NMR experiments 
estimated the energy barrier for rotation of both generations of catalyst to be 11-
12 kcal mol–1 by inputting the coalescence temperature and the separation (Hz) of 
the two resulting signals into the mathematical relationship: 
ΔG+=RTc[22.96+ln(T/Δʋ)] (Figure 2.14). Of course, this is not surprising when one 
considers that the sp2N-sp3C bond rotation pathway is degenerate. That is to say, 
the amine has two different paths to rotate between any two positions (clockwise 
or anti-clockwise); one direction will bring the bulky pendent amine into close 
proximity with the methyl substituent and the other direction will avoid the 
unfavourable interaction. So even though the energy is raised for one of the given 
rotation pathways, the other is unchanged. The lowest energy pathway will be used, 
and therefore we observe no change in the energy barrier for rotation about the 
sp2N-sp3C bond.  
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Figure 2.14: Collated VT NMR data recorded for 171 and 232 respectively. 
 
Chapter 2 – Results and Discussion 
 
152 
 
IV. The addition of the methyl group did, however, affect the ratio of sp2N-sp3C 
rotamers (Figure 2.15).15 From NOESY experiments performed at –80 °C (Figure 
2.15), it was evident these systems heavily, if not entirely, favoured the syn-
periplanar rotamer 241 where R = H. Where R = Me, the proportion of the anti-
periplanar rotamer increased significantly 242 (Table 2.9).  
 
Figure 2.15: Illustration of the syn- and anti-periplanar rotamers. 
 
From the illustrations it is clear that in the syn-periplanar rotamer, the 
stereochemical information is held away from the ‘active site’ of the catalyst, while 
the same stereochemical information is positioned much closer to the active site in 
the anti-periplanar rotamer, facilitating its more efficient transfer to the substrate. 
The reactivity difference between the two generations can be explained by this 
model too, and Lacour has suggested that the anti-periplanar rotamer is less 
reactive. Indeed, the extra steric crowding near the active site would be expected to 
increase the energy barrier for transfer of the electrophilic oxygen to the alkene 
substrate. While the rotamers do not exist discretely at the temperature these salts 
are employed at (0 °C), the ratio does represent the time-averaged conformation of 
the catalyst, and provides an indication of the steric influence the pendent amine 
has. 
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 Syn-periplanar Anti-periplanar 
171 88 12 
232 (Me) 60 40 
172 72 28 
235 (Me) 61 39 
223 100 0 
233 (Me) 80 20 
224 100 0 
234 (Me) 100 0 
 
Table 2.9: Comparison between the sp2N-sp3C rotameric ratio of the two 
generations of catalyst. Determined by NOESY @ –80 °C. 
 
This model also explains why little difference in enantioselectivity was observed 
between the two isopropylamine-derived catalysts 224 and 234. In this case, there 
was no difference between the rotameric ratio, with both entirely favouring the syn-
periplanar rotamer.  
 
 
Figure 2.16: Sample NOESY spectra 233. 
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There is one caveat - we have already suggested that the formation of the 
oxaziridinium salt is completely diastereoselective for the first generation, and so 
we believe the oxygen transfer to the alkene must be the step in which the pendent 
amine influences the stereoselectivity. The rotameric ratios would be expected to 
be different for the oxaziridinium species, and we have not directly measured those 
values. However, we suspect that the substitution would increase the proportion of 
the anti-periplanar rotamer for the oxaziridinium species too, and this model thus 
remains valid. 
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2.6 Catalysts Based on the 5,5’,6,6’,7,7’,8,8’-Octahydrobinaphthyl Azepinium 
Motif 
The octahydrobinaphthyl-azepinium backbone motif has been demonstrated by 
Lacour to contain a larger dihedral angle Φ than the analogous binaphthyl species, 
when part of an azepinium system.1 We aimed to create a range of catalysts based 
on this motif and to incorporate the α-methyl substitution into their structure. We 
hoped that by marrying the larger dihedral angle with the now-understood 
modification at the α-position, we could create the most enantioselective iminium 
catalyst for the epoxidation of tri-substituted alkenes to date. 
 
The synthesis began with the reduction of (Ra)-211 to octahydro-BINOL 243 using 
Pd/C with H2 at a pressure of 3.5 bar.
16 From 243 it was conceivable that we could 
follow the same route used in the manipulation of the binaphthyl- motif to obtain 
the desired bis(bromomethyl) octahydrobinaphthyl- species 248. It has been 
reported in the literature that this route is unsuccessful – the required benzylic 
oxidation with NBS was problematic and a complex mixture of brominated products 
was isolated.17 The route taken by others and used by us avoided any process which 
required benzylic C-H functionalization (Scheme 2.18).1,18 The bis(triflate) 244 was 
obtained quantitatively from the treatment of 243 with Tf2O; this functionality 
allowed the subsequent transformation of 244 to the (bis)methyl ester 245 by a 
palladium-mediated carbonylation. The reduction of the ester functionality to the 
diol 246 was achieved with LiAlH4. From 246 two routes were investigated to 
prepare the desired azepines.  
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Scheme 2.18: Synthesis of the bis-alcohol: a) Pd/C, H2 (3.5 bar), AcOH, 80C,10 d., 
45%; b) Tf2O (3 equiv.), DMAP (0.4 equiv.), 2,6-lutidine (3 equiv.), –30 °C  RT, 16 h, 
99%; c) Pd(OAc)2 (0.15 equiv.), dppp (0.15 equiv.), MeOH (50 equiv.), DMSO, Hunig’s 
Base, CO (2 bar), 80C, 48 h. 85%; d) LiAlH4 (2 equiv.), Et2O, 99%. 
 
Lacour had effected the coupling of the octahydrobinaphthyl- motif to the amine 
species through its bis(benzaldehyde) 247, although in our experience it is much 
simpler, cleaner and higher yielding to achieve the ring formation through 
(bis)bromomethyl species 248 (Scheme 2.19). 
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Scheme 2.19: a) PCC (1 equiv.), CH2Cl2, RT, 2 h, 99%; b) PBr3 (3 equiv.), pyridine (0.1 
equiv.), toluene, 60 °C, 3 h, 90%. 
 
Oxidation of 243 with PCC was simple and furnished 247 in an excellent yield.1 The 
synthesis of 248 was more troublesome, however, and three routes were 
investigated: the first was an acidic displacement of the hydroxyl and required HBr 
(48% aq.), the reaction did proceed in a good yield, but it appeared that complete 
racemization had occurred, and we later discovered that a report published by 
Rawal observed the same result;17 secondly, we tried to apply the Appel reaction to 
243, this procedure also worked well, but the removal of the triphenylphosphine 
oxide by-product was time-consuming and difficult; finally, our third route utilized 
PBr3, and we were pleased that the isolated product did not require any further 
purification after work-up, 248 was isolated cleanly in a 90% yield.  
 
The formation of the azepine ring system with 168 was successful for both of the 
differently functionalized backbone motifs. The reductive amination procedure did 
run to full conversion, but the product 259 was impure and required purification by 
column chromatography; some of the product was lost on the column despite the 
eluent being buffered with TEA and the yield was compromised as a result, echoing 
our experiences with the 6,6’-dimethylbiphenyl-azepine species. Contrastingly, the 
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quantitative isolation of 249 in excellent purity was achieved using exactly the same 
reaction parameters used for the synthesis of the binaphthyl-azepines (Scheme 
2.20).  
 
 
Scheme 2.20: Comparison of the two methods to synthesize the azepine: a) 
NaCNBH3 (2.2 equiv.), AcOH, RT, 24 h, 67%; b) 168 (1 equiv.), 248 (1 equiv.), K2CO3 
(3. equiv.), MeCN, reflux, 16 h, 97%. 
We synthesized four octahydrobinaphthyl-azepines following route b), and their 
preparation is summarized below (Scheme 2.21). 
 
Scheme 2.21: The family of octahydrobinaphthyl-azepines prepared. 
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The octahydrobinaphthyl- azepinium salts were prepared by oxidation with NBS, 
and isolated as their –BPh4 salts following ion exchange, summarized below 
(Scheme 2.22). 
 
Scheme 2.22: The family of octahydrobinaphthyl-azepiniums prepared: a) NBS (1.1 
equiv.), CH2Cl2, RT, 30 min; then NaBPh4 (1.1 equiv.), EtOH / MeCN. 
We first assessed 253 for the epoxidation of 1-phenyl-3,4-dihydronaphthylene 
under a range of aqueous conditions, to determine under which it performed best 
(Table 2.10). We have recently reported the employment of H2O2 or NaOCl as the 
stoichiometric oxidant; it is desirable to be able to use such oxidants because they 
are extremely cheap and offer excellent atom efficiency. Oxone® by comparison is 
relatively expensive and atom inefficient. Unfortunately, we observed only catalyst 
degradation with 253, and no catalytic turnover for both the peroxide and 
hypochlorite systems. Surprisingly, under the two Oxone® systems, 253 
demonstrated poorer enantioselectivity than its analogous binaphthyl-azepinium 
salt 171 when the same 1:1 solvent system was used (Entry 2). We had expected 
253 to be slightly superior due to the greater dihedral angle within its backbone.1 
The enantioselectivity was improved when employing the 10:1 solvent system, but 
still did not match that of 171.  
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Entry Conditions Time (h) Conv. (%) ee (%) 
1 Oxone® (2 equiv.), NaHCO3 (5 equiv.),  
MeCN / H2O 10:1, 0 °C 
0.7 99 93,  
(+)-(1R,2S) 
2 Oxone® (2 equiv.), NaHCO3 (5 equiv.),  
MeCN / H2O 1:1, 0 °C 
1.3 99 86, 
(+)-(1R,2S) 
3 H2O2 (6 equiv., 50% aq.),  
NaHCO3 (0.2 equiv.), MeCN, 0 °C 
4 0 - 
4 NaOCl (3 equiv., 16% aq.),  
K2CO3 (0.25 equiv.), MeCN, 0 °C 
4 0 - 
Table 2.10: Assessment of 253 for the epoxidation of 1-phenyl-3,4-
dihydronaphthylene under a range of aqueous conditions. 
The substrate range was expanded for the two Oxone® condition sets, to include 
two other tri-substituted alkenes; it was clear that the 10:1 system’s superiority was 
general (Table 2.11).   
 MeCN / H2O 
Substrate 10:1 1:1 
 
0.6 h, 99, 90,  
(–)-(1S,2S) 
1 h, 99, 80,  
(–)-(1S,2S) 
 
0.7 h, 99, 93,  
(+)-(1R,2S) 
1.3 h, 99, 86,  
(+)-(1R,2S) 
 
1 h, 99, 60,  
(–)-(1S,2S) 
2 h, 99, 63,  
(–)-(1S,2S) 
Table 2.11: Extended substrate screen for 253, conditions as per Table 2.10: In each 
case (time, conversion (%), ee (%), config.) 
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An assessment of 256 under various epoxidation conditions, including several non-
aqueous systems, was also undertaken. It was evident that 256 was much less 
reactive under the non-aqueous conditions, while the ee of the isolated epoxide 
was similar for all the conditions, although we highlight the (+)-96% ee achieved 
under the non-aqueous MeCN system (Table 2.12). 
 
Entry Conditions Time (h) Conv. (%) ee (%) 
1 Oxone® (2 equiv.), NaHCO3 (5 equiv.),  
MeCN / H2O 10:1, 0 °C 
1.3 99 90,  
(+)-(1R,2S) 
2 Oxone® (1 equiv.), NaHCO3 (4 equiv.), 
18-crown-6 (2.5 mol%), CH2Cl2 / H2O 
3:2, 0 °C, 2 h. 
2 99 91, 
(+)-(1R,2S) 
3 CH2Cl2, TPPP (2 equiv.), –20 °C 48 68 90, 
(+)-(1R,2S) 
4 CHCl3, TPPP (2 equiv.), –20 °C 48 29 86, 
(+)-(1R,2S) 
5 MeCN, TPPP (2 equiv.), –20 °C 48 88* 96, 
(+)-(1R,2S) 
Table 2.12: Assessment of 256 for the epoxidation of 1-phenyl-3,4-
dihydronaphthylene under several solvent systems. *16% of which had ring-opened 
to the diol. 
Two other tri-substituted alkenes were oxidized with the conditions above (from 
Entries 1 and 2). The ees of the isolated epoxides were similar between the two sets 
of conditions, but 256 was more reactive under the MeCN-containing conditions 
(Table 2.13), due, most likely, to the more polar nature of the MeCN solvent 
system. One could make a case for 256 demonstrating improved stereocontrol over 
224, as indeed it was expected to, but that would be based on the result of the 
epoxidation of 1-phenylcyclohexene. 
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 Solvent System 
Substrate MeCN / H2O CH2Cl2 / H2O 
 
1 h, 99, 90,  
(–)-(1S,2S) 
2 h, 99, 92,  
(–)-(1S,2S) 
 
1.3 h, 99, 90,  
(+)-(1R,2S) 
2 h, 75, 91,  
(+)-(1R,2S) 
 
3.5 h, 99, 66,  
(–)-(1S,2S) 
2 h, < 3, - 
Table 2.13: Extended substrate screen for 256, conditions as per Table 2.12. In each 
case (time, conversion (%), ee (%), config.) 
The two catalysts derived from 3,3-dimethyl-2-butylamine, previously prepared by 
Lacour as the –SbF6 ion-pair, were tested under Lacour’s conditions (Table 2.14). 
The anion made little difference in this instance, as our results with the –BPh4 
species were almost identical to those reported by Lacour for the –SbF6 species.
13 
 Catalyst 
Substrate 254 255 
 
99, 92,  
(–)-(1S,2S) 
99, 89,  
(–)-(1S,2S) 
 
89, 93,  
(+)-(1R,2S) 
99, 87,  
(+)-(1R,2S) 
 
< 4, -  43, 61,  
(–)-(1S,2S) 
Table 2.14: Substrate screen for 254 and 255: Catalyst (5 mol%), Oxone® (1 equiv.), 
NaHCO3 (4 equiv.), 18-crown-6 (2.5 mol%), CH2Cl2 / H2O 3:2, 0 °C, 2 h. In each case: 
(conversion (%), ee (%), config.). 
Both catalysts 254 and 255 were superior to their respective binaphthyl-azepinium 
salts with regards to the stereocontrol they demonstrated over the epoxidation 
process. The epoxidation of trans-α-methylstilbene by 254 appears anomalous as its 
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reactivity is typically similar to the other tri-substituted alkenes, but the same result 
was achieved several times, and also for 256 under Lacour’s conditions. Lacour 
chose the CH2Cl2 / H2O conditions because he believed the TS would not be 
stabilized to the same extent in a solvent with a low ε and so would lead to higher 
epoxide ees. It is perhaps the case, in these instances, that this solvent system 
exacerbates a so-far unknown unfavourable interaction in any potential TS with the 
trans-α-methylstilbene. It would be expected that an ion-pair solvated by a solvent 
which possesses a low ε would be held more compactly. Likewise, so would any 
charged TS, thus any potential unfavourable interaction would be exacerbated. 
The investigation of the octahydrobinaphthyl motif continued with the introduction 
of the methyl group to the C-terminus of the iminium bond, generating the three 
methylazepines shown below (Scheme 2.23). We did not invest any further 
resources into the modification of 256, since we did not expect to elicit any 
improvement in enantiocontrol by the incorporation of the methyl group at the α-
position from our results with the analogous binaphthylazepinium salts.   
 
Scheme 2.23: Synthesis of the octahydrobinaphthyl-methylazepines: a) MeMgBr (10 
equiv.), THF, –78 °C  RT, 16 h. 
The insertion was achieved with MeMgBr and was entirely diastereoselective in all 
three instances when performed at –78 °C (Scheme 2.24). The assignment of the 
pseudo-axial configuration of the methyl substituent was again possible due to its 
observed up-field shift in the NMR spectra of the methylazepines.4  
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Scheme 2.24: Synthesis of the octahydrobinaphthyl-methylazepinium salts: a) NBS 
(1.1 equiv.), CH2Cl2, RT, 15 min. 
The formation of the iminium salts proceeded well; they were again each isolated as 
the expected regioisomer with the configuration of the methyl substituent 
maintained in all instances. However, the work-up of 261 was, problematic, the 
crude salt was macerated in hot EtOH and the resulting powdery solid which 
formed on cooling was filtered off and washed with Et2O. These salts usually show 
no solubility in Et2O, so it was somewhat unexpected when the solid congealed and 
formed a viscous yellow oil. The oil was dissolved in CH2Cl2 and filtered into a flask, 
removal of the solvent in vacuo eventually provided 261 as a stiff foam in good 
purity, albeit in low yield. The same occurred for 262, but the work-up was planned 
and executed with the expectation that it would show the same behaviour when 
washed with Et2O, so no complications arose. 
The three octahydrobinaphthyl-methylazepinium salts were tested for their 
reactivity and stereoselectivity in the epoxidation of a battery of alkene substrates. 
We were extremely pleased with the stereocontrol exhibited by 260 - we achieved 
the highest ees for the epoxidation of 1-phenylcyclohexene and 1-phenyl-3,4-
dihydronaphthylene that have been reported to date  for an iminium salt 
organocatalyst (Table 2.15). 
The reactivity of 260 did drop off somewhat in comparison to 253, but the drop was 
far larger for the substrates which contained the trans-stilbene motif, similar to the 
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reactivity pattern observed for 254 and 255. Presumably, in this instance, the more 
pronounced existence of the anti-rotamer caused the manifestation of a strong 
steric interaction with one of the phenyl substituents present on those substrates 
(Table 2.15). 
Substrate 260 
 
1.5 h, 99, 96, (–)-(1S,2S) 
 
3 h, 87, 97, (+)-(1R,2S) 
 
18 h, 80, 69, (–)-(1S,2S) 
 
 
 
 
 
 
 
18 h, 15, 34, (–)-(1S,2S) 
 
0.8 h, 99, 0, (+)-(1R,2S) 
 
18 h, < 4, - 
Table 2.15: Substrate screen for 260: Oxone® (2 equiv.), NaHCO3 (5 equiv.), MeCN / 
H2O 1:1, 0 °C. In each case: (time, conversion (%), ee (%), config.) 
 
Lacour has previously proposed a mnemonic to predict the facial selectivity that 
occurs with these catalysts with Ra chirality, explaining the observed 
enantioselectivity by splitting the interactions into four quadrants.15 A pendent 
phenyl group on the alkene has been shown to be crucial to observe high 
enantioselectivity for these systems, suggesting the existence and necessity of a π-
stacking interaction, an interaction which exists in the lower left quadrant 1 as 
drawn below (Figure 2.17).  
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Figure 2.17: Mnemonic proposed by Lacour, displaying the four quadrants and the 
key interactions in each. The quadrants have been arbitrarily numbered. 
It has been suggested that quadrant 2 is sterically encumbered from the 
stereochemical outcome of the epoxidations of (E) and (Z)-1-methyl-1-phenyl-1-
propene, and any substituent other than a proton is subject to a unfavourable steric 
interaction. Quadrant 3 has been suggested to exert some steric interaction; small 
R groups are accommodated in quadrant 3 and substrates which satisfy that 
requirement can led to high ees. This mnemonic suggests why the tri-substituted 
trans-α-methylstilbene is not oxidized with the same enantiocontrol as other tri-
substituted alkenes such as 1-phenyl-3,4-dihydronaphthylene and 1-
phenylcyclohexene – the relatively large phenyl group would sit in quadrant 3 and 
be subject to some unfavourable steric interactions, so causing an increase in the 
energy of the favoured TS, leading to the lower enantiocontrol observed. We 
suggest that the poor reactivity of the alkenes containing the trans-stilbene motif 
for 260 in this instance is because of an increased steric encumbrance in quadrant 3 
(Figure 2.18). Witnessing an improvement in the enantioselectivity for trans-α-
methylstilbene despite the large increase in steric hindrance suggested to us that 
the TS from which the minor epoxide is formed was affected by the extra steric 
encumbrance to an even greater extent.  
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Figure 2.18: Mnemonic to suggest why the substrates that contain the trans-
stilbene motif suffered a large drop in their reactivity with 260. 
Obviously, the factors that determine the stereochemical outcome of these 
epoxidations mediated by these iminium salts requires a more detailed analysis. The 
nuances of a 3-D chiral pocket will be lost in translation to a 2-D mnemonic, and to 
fully understand these observations, to take a full and balanced account of the 
many factors that contribute to reactivity and enantioselectivity, a detailed 
computer modelling study is required. 
  
Chapter 2 – Results and Discussion 
 
168 
 
 Catalyst 
Substrate 261 262 
 
13 h, 53, 85,  
(–)-(1S,2S) 
2 h, 99, 90,  
(–)-(1S,2S) 
 
13 h, 44, 90,  
(+)-(1R,2S) 
2 h, 99, 95,  
(+)-(1R,2S) 
 
13 h, 0, -  2 h, 33, 62,  
(–)-(1S,2S) 
Table 2.16: Substrate screen for 261 and 262: Catalyst (5 mol%), Oxone® (1 equiv.), 
NaHCO3 (4 equiv.), 18-crown-6 (2.5 mol%), CH2Cl2 / H2O 3:2, 0 °C, 2 h. In each case: 
(time, conversion (%), ee (%), config.) 
 
The results from the epoxidations using the catalysts derived from  3,3-dimethyl-2-
butylamine were also interesting and offered further insight into the action of the 
methyl substituent, and by extrapolation, the action of the iPr- and Ph- substituents 
in 226 and 227. So, for 262 we observe an increase in ees of the isolated epoxides 
and that is what we had expected. Also, the exacerbated reduction in reactivity 
toward trans-α-methylstilbene does concur with our observations with 260. For 
261, however, we not only see a reduction in the reactivity towards all substrates, 
but also a reduction in the imparted enantioselectivity. The only other time we had 
witnessed a drop in epoxide ees, on incorporation of a substituent at the α- 
position for a ‘matched’ azepinium system, was when we incorporated iPr-  and Ph- 
substituents into 222. Lacour has shown, and we know firsthand from our own 
measurements, that the (Ra)-(R)-3,3-dimethyl-2-butylamine species favour the anti-
periplanar rotamer more than the (Ra)-(S)-3,3-dimethyl-2-butylamine species vide 
supra.  We were not able to measure the rotameric situation for 226 or 227, but it 
is no leap of logic to suggest that the bulkier substituents caused an even greater 
increase in the existence of the anti-periplanar rotamer than did the methyl group. 
This led us to conclude that the relationship between the occupancy of the two 
rotamers and the enantioselectivity of the resulting catalyst is not linear. That is to 
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say, that beyond a certain point, an increase in the existence of the anti-periplanar 
rotamer may cause enantioselectivity to decrease (Figure 2.19). 
 
Figure 2.19: Graph to illustrate how the ratio of the rotamers appear to influence 
both rate and ee. (Arbitrary units). 
This can be crudely rationalized by considering an increasing steric bulk in sector 3; 
to the point at which even a small R group (RS) becomes subject to unfavourable 
steric interactions (Figure 2.20). That, for such tri-substituted substrates, leads to a 
decrease in both reactivity and enantioselectivity.  
 
Figure 2.20: Mnemonic to illustrate an increased unfavourable steric interaction in 
quadrant 3 present in catalysts 226, 227 and 261. 
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2.7 Investigation Into the Utility of 1,5-Oxazocines as Organocatalysts for the 
Asymmetric Epoxidation of Alkenes 
With the different families of iminium salt catalyst we have designed to date, we 
can epoxidize cis-di-substituted and tri-substituted alkenes that contain aromatic 
functionality with excellent enantiocontrol. To investigate whether we might be 
able to create a range of catalysts that might demonstrate excellent 
enantioselectivity for other structural classes of alkenes, we began a preliminary 
study into the synthesis and use of a new family of iminium salt catalysts based on a 
tropos 8-membered 1,5-oxazocinium ring system 263 (Figure 2.21).  
 
Figure 2.21: General target structure for the new iminium salt species. 
We initially planned to form the 1,5-oxazocine ring system using a reductive 
amination procedure. The required bis(benzaldehyde) 265 was prepared in one 
step by a di-ortho-formylation of diphenyl ether 264, which was achieved by an 
ortho-lithiation procedure employing nBuLi. The resulting dianion was quenched 
with DMF, and 265 was isolated in a 48% yield (Scheme 2.25). 
 
Scheme 2.25: Synthesis of (bis)aldehyde 265: a) nBuLi (3 equiv.), 78C  RT, 16 h, 
then DMF (3 equiv.), 48%. 
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The reductive amination was attempted using the conditions which had been 
successful for the formation of the azepine ring systems; in this instance, however, 
no ring closure with 265 was observed. The NMR spectrum of the crude mixture 
showed what appeared to be a mixture of 3 compounds: un-reacted 265, mono-
addition 266 of the amine and di-addition 267. Repeating the reaction at high 
dilution (1 mM) and slow addition of the amine (6 h) still did not result in the 
formation of the desired cyclised product (Scheme 2.26).  
 
Scheme 2.26: Attempted synthesis of a 1,5-oxazocine: a) NaCNBH3 (2.2 equiv.), 
AcOH, RT, 1 mM, 10 h. 
We considered that the required 8-exo-trig cyclisation might be unfavourable; to 
circumvent the problem, we envisaged that an 8-exo-tet cyclisation might be more 
facile. We therefore prepared the (bis)bromomethyl compound 269, via diol 268 
Scheme 2.27). 
 
Scheme 2.27: Synthesis of bis-bromomethylene 269: a) LiAlH4, Et2O, 0 °C, 98%; b) 
HBr (48%), reflux, 4 h., 85%. 
Much to our delight, the coupling of 269 and 216 to form the oxazocine 270 ring 
was successful when employing the same simple procedure used for the 
binaphthyl- and octahydrobinaphthyl- species, and we used the procedure to create 
chiral oxazocine 271 from 168. The amines were added over 6 h to a refluxing 
Chapter 2 – Results and Discussion 
 
172 
 
solution of 269 in MeCN, as a precaution to ensure ring closure was achieved. The 
yield of the cyclisation with the bulkier 168 was somewhat lower than for the 
smaller 216, though much of the disparity was due to the requirement for further 
purification of 271 (Scheme 2.28). 
 
Scheme 2.28: Synthesis of the oxazocines: a) K2CO3 (3 equiv.), MeCN, reflux, 16 h. 
We expected these species would not be conformationally well-defined, and 
indeed, the interchange between several conformations of the acetonamine-
containing oxazocine was slow on the NMR timescale at RT.  
We intended to synthesize the respective oxazocinium salts of the species prepared 
above to test their efficacy as organocatalysts for the epoxidation of alkenes. Much 
to our surprise, all attempts to isolate the salts failed - we observed decomposition 
of the SM in all instances. On addition of NBS to a stirring solution of the oxepines, 
the colour rapidly changed to an intense yellow, perhaps indicating that the 
iminium salt 272 did form. However, the colour rapidly dissipated during aqueous 
work-up. This observation led us to suspect that the oxazocinium was being 
hydrolysed. To investigate our suspicion, we performed the oxidation of 271 in an 
NMR tube in CD2Cl2; indeed, we observed the rapid colour change and emergence 
of a signal at 9.21 ppm – characteristic of the N=CH proton. To test its susceptibility 
to hydrolysis, we then introduced a few drops of D2O and mixed the biphasic 
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mixture by ultrasound at RT for several minutes. After that time, a second NMR 
spectrum was recorded; the iminium signal had disappeared while two signals at 
10.51 and 9.98 ppm appeared – one of which corresponded to the 
bis(benzaldehyde), and the other, presumably, corresponded to the partially 
hydrolysed product 273 (Scheme 2.29).   
Scheme 2.29: Decomposition of the oxazocine: a) NBS (1.1 equiv.), CD2Cl2, RT, 5 
min., then b) D2O, ultrasound, 5 min, RT. 
It has been shown that the synthetic precursors to azepinium salts also catalyse the 
epoxidation reaction, so in spite of the failure to synthesize the oxazocinium salts, 
we screened the oxazocines under several sets of conditions to ascertain whether 
or not this class of compound were capable of catalysing the epoxidation of alkenes 
(Table 2.17). 
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Entry Conditions Time (h) Conv. (%) ee (%) 
1 Oxone® (2 equiv.), NaHCO3 (5 equiv.),  
MeCN / H2O 10:1, 0 °C 
5 0 - 
2 Oxone® (2 equiv.), NaHCO3 (5 equiv.),  
MeCN / H2O 1:1, 0 °C 
5 50 35 
3 Oxone® (2 equiv.), NaHCO3 (4 equiv.),  
18-crown-6, CH2Cl2 / H2O 3:2, 0 °C 
8 0 - 
4 CHCl3, TPPP (2 equiv.), –20 °C 8 0 - 
5 CHCl3, TPPP (2 equiv.), 0 °C 8 0 - 
6 MeCN, TPPP (2 equiv.), 0 °C 8 0 - 
7 CH2Cl2, TPPP (2 equiv.), 0 °C 8 0 - 
 
Table 2.17: Assessment of oxazocine 271 in the epoxidation of 1-phenylcyclohexene 
under a range of conditions. 
When binaphthyl-azepines were used in the recent study by Lacour and Page, they 
noted that the azepines performed best in the most polar conditions with 
remarkable similarity - in terms of reactivity and enantioselectivity - to their 
respective iminium salt counterparts. The similarity did seem to indicate that the 
iminium salt was formed in situ, and the reaction then proceeded along the 
established pathway. Our results with the oxazocines did echo these results 
somewhat, i.e. we observed the best conversion with the most polar conditions, 
but differed in that we did not observe conversion under any other conditions. In 
this instance however, given that we have shown the oxazocinium species to be 
readily hydrolysed, the fact that the oxidation only proceeded under the conditions 
with the highest ratio of water was perplexing and counterintuitive. We concluded 
then, that these systems did not mediate the epoxidation through the iminium / 
oxaziridinium mechanism. 
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Aggarwal demonstrated, as described above in Chapter 1, that under similar 
conditions, secondary amines were capable of mediating the epoxidation of 
alkenes.19 The amines were believed to exist as their respective ammonium salts in 
situ, and were able to coordinate to Oxone® and augment its reactivity in doing so. 
A process similar to that Aggarwal described did fit our data; it was conceivable that 
the oxazocinium species was formed in situ and then rapidly hydrolysed to 273 and 
/ or 168, either of which could theoretically hydrogen bond as its ammonium salt to 
Oxone®, thus activating it to nucleophilic attack (Figure 2.22). 
 
Figure 2.22: Possible activation of Oxone® to nucleophilic attack by H-bonding 
interactions between 2° and 1° ammonium salts. 
That there was significant stereoinduction for the epoxidation of 1-
phenylcyclohexene more or less ruled out the idea that a dioxirane, formed by 
oxidation of the benzaldehyde on 273, was responsible for the epoxidation. The 
resultant dioxirane would probably be too far removed from the chiral information 
to impart a 35% ee. Further, a dioxirane-mediated epoxidation is unlikely to be 
feasible from a simple benzaldehyde. 
To investigate, an epoxidation of 1-phenylcyclohexene was attempted under the 
MeCN / H2O 1:1 conditions with 168 (5 mol%). After 4 h, the reaction was stopped 
and the conversion was assessed by NMR to be 32%, which was remarkably close to 
the conversion achieved with the oxazocine 271. This provided strong evidence in 
support of a mode of action similar to that proposed by Aggarwal. 
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It was clear that the oxazocines were a dead end, and while we were pleased to 
understand why they made poor catalysts, we did not take our investigation into 
the utility of 1,5-oxazocines as organocatalysts any further. 
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2.8 Application of the Page Asymmetric Epoxidation in the Synthesis of (+)- 
Scuteflorin A 
 
 The scutellaria genus, more commonly known as skullcaps, has been used in 
herbal remedies for many hundreds of years. To date, around 300 individual 
compounds have been isolated from the scutellaria and many of these have been 
shown to have pharmacological activities, including anti-bacterial; anti-
angiogenesis; anti-viral; anti-convulsant and anti-cancer activities.20 Scutellaria 
lateriflora L., or the American skullcap, has demonstrated particular utility as a 
therapy for anxiety in a recent study of healthy subjects.21 During an investigation 
to elucidate the origin of the therapeutic activity of the American skullcap, Khan 
reported the isolation and characterization of two new dihydropyranocoumarins – 
scuteflorins A 274 and B 275 (Figure 2.23).22  
 
Figure 2.23: The recently isolated novel dihydropyranocoumarins. 
 
We have previously reported the highly enantioselective epoxidation of the cis-
alkene seselin 180 as the key step in the synthesis of (–)-(3′S)-lomatin 182 and (+)-
(3′S,4′R)-trans-khellactone 181, using our non-aqueous epoxidation conditions.23 To 
our knowledge, only the racemic synthesis of 274 has so far been accomplished.24 
We envisaged that the synthesis of the scuteflorins could be effected by a similar 
epoxidation of xanthyletin 276 to install the stereocentre and functionality required 
for further manipulation. Owing to the similarity of the alkene motif in 180 and 276, 
we believed that we would be able to form the epoxide with excellent 
enantiocontrol (Figure 2.24). 
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Figure 2.24: The cis-di-substituted alkenes seselin 180 and xanthyletin 276. 
 
A disconnection which summarizes our retrosynthetic analysis to 276 is shown 
below (Figure 2.25). 
 
Figure 2.25: Retrosynthetic summary. 
 
The synthesis of 276 was straightforward, and originally followed the route starting 
from 7-hydroxycoumarin 277 outlined by Jun (Scheme 2.30).25 The hydrogenation 
of 277 proceeded as expected, and, after the complete consumption of the 
coumarin was observed by TLC, a solvent change was performed followed by an 
aqueous work-up. Subsequent filtration though celite then carbon black yielded 
chroman 278 in an essentially quantitative yield. The phenylboronic acid-catalysed 
cyclisation of 3-methyl-2-butenal with 278 was achieved applying Jun’s optimized 
conditions in a yield of 51%. This ortho- directing cyclisation on a phenol with an 
enal species was first outlined by Nagata in 1976, who proposed that the cyclisation 
proceeds through a [3,3]-sigmatropic rearrangement.26 
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Scheme 2.30: Synthesis of xanthyletin: a) Pd/C, AcOH, H2, 30 °C, 16 h, 99%; b) 3-
methyl-2-butenal, PhB(OH)2, toluene / AcOH, reflux, 40 h, 51%; c) DDQ, toluene, 
reflux, 10 h, 52%. 
 
The re-introduction of the enone moiety with DDQ proceeded well with full 
conversion, and the isolated yield was high on a small scale (>90%). There were 
complications with the work-up when the reaction was scaled-up and those 
complications did compromise the isolated yields (52%). The purification of the 
crude deep red oil was attempted by flash column chromatography. Unfortunately, 
276 isolated from this procedure was not pure and held a distinct red colour. 
Despite successive purification attempts and crystallizations, an unidentified 
residual impurity from the dehydrogenation step could not be removed - in some 
cases, a solution made from seemingly pure, colourless, crystalline xanthyletin 
turned red on addition of TPPP. The subsequent epoxidation under our non-
aqueous conditions was frustratingly and uncharacteristically irreproducible - the 
conversion would typically range from 0% to 42% (Scheme 2.31).  
 
 
Scheme 2.31: Epoxidation of xanthyletin prepared by Jun’s route: a) TPPP, CHCl3, –
30 °C, iminium salt 174 (10 mol%). 
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In an attempt to solve the issue, the possibility of using DDQ catalytically to achieve 
the dehydrogenation was investigated as well as several other methods including: a 
Pd mediated protocol described by Shvo;27 Nicolaou’s IBX methodology28 and also a 
selenoxide elimination procedure. Presented below are the results from the 
attempts to synthesize xanthyletin (Table 2.18). 
Entry Conditions Conv. Yield 
1 DDQ (5 mol%), NMO, CH2Cl2 / MeCN, reflux 20 h 0%  
2 IBX, DMSO, fluorobenzene, 72 h, 70 - 80 °C 33%  
3 Pd(OAc)2, ADP, NaHCO3, THF, reflux, 40 h   0%  
4 LDA, PhSeCl, THF, –78 °C then H2O2, THF, 0 °C, 1 h  4% 
Table 2.18: Attempted oxidations of 276. 
Disappointingly, the experiment with a catalytic loading of DDQ was completely 
unsuccessful, most likely because it was ill-conceived.29 Perhaps a more thorough 
investigation of potential stoichiometric re-oxidants and other parameters could 
have elicited a successful protocol, but this route was not pursued any further.  
 The oxidation with IBX, developed by Nicolaou, was initially promising and 
significant conversion was observed; however, we were unable to optimise the 
procedure significantly and acknowledged that a 33% yield was not acceptable. 
The formation of an enone from an α,β-unsaturated ketone with a 
palladium species is well known. The procedure chosen for the attempted oxidation 
employed Pd(OAc)2 and required a stoichiometric quantity of allyl diethyl 
phosphate (ADP) – which plays a critical role in the catalytic cycle. Unfortunately, in 
our hands, the procedure was unsuccessful. 
The selenoxide pathway was more taxing and less economical than the DDQ 
or IBX mediated procedures, but, if we were able to achieve a high yield, it would 
certainly have made a viable route. Formation of the selenyl species 282 via the 
intermediate lithium enolate 281 was straightforward, and 282 isolated in an 
acceptable yield.   
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Scheme 2.32: Formation of xanthyletin by a selenoxide elimination: a) LDA, –78 °C, 
THF; b) PhSeCl, THF, –78 °C to RT, 48%; c) 30% H2O2, THF, 0 °C, 7%. 
Many methods for the oxidation of selenide compounds are known, though the 
presence of an electron-rich double bond did rule out the use of O3, because the 
facile ozonolysis would be impossible to control. The chance for the epoxidation of 
the double bond, and also the potential Bayer-Villiger oxidation of the ester, ruled 
out the use of peracids. Aqueous hydrogen peroxide (30% w/v) presented the most 
promise, and we decided to attempt a protocol involving its use. The reaction was 
performed at 0 °C - a temperature at which the elimination is known to occur.30 
Indeed, the formation of 276 appeared to be complete by TLC, so we were then 
surprised to observe the presence of 282 by TLC after the work-up. A four-fold 
excess of peroxide was used and so the reaction was quenched with sat. aq. Na2SO3 
preceding extraction. It is conceivable, we believe, that some of the selenoxide 283 
had not undergone elimination and was reduced back to the selenide by the 
thiosulfate. Frustratingly, only a 7% yield of xanthyletin and 10% of 279 were 
obtained after flash column chromatography. The exhaustion of starting materials 
and time constraints caused us to cease our efforts with this method (Scheme 
2.32). 
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The unsuccessful attempts to isolate significant quantities of xanthyletin of suitable 
purity through the route outlined by Jun and variants thereof, led us to seek 
alternatives. The most promising in the literature was an apparently robust 
synthesis again beginning from 277.31 The procedure first requires the iodination of 
277 at the 8 position 284 followed by the attachment of 3-methyl-butyne at the 
phenolic hydroxyl 285, which was then cyclised at high temperature. Coumarin 277 
participates in electrophilic aromatic substitution principally through the 8 position, 
a propensity which was demonstrated in North’s synthesis of 180 from 277.32 So, 
the iodination was required to alter this preference, and causes the cyclisation to 
occur preferentially at the otherwise less favoured 6 position. NMR analysis of our 
crude cyclisation reaction mixture showed that 276 and 180 were both produced 
and in a ratio of 4:1. The iodine is concomitantly removed in the cyclisation 
process, perhaps explaining the formation of 180. This second route allowed us 
access to pure 276 on a gram scale in an overall yield of 30% (Scheme 2.33).  
  
Scheme 2.33: The second route used for the synthesis of xanthyletin: a) I2, KI, 
NH4OH, RT, 4 h, 65%; b) 3-chloro-3-methyl-butyne, K2CO3, CuI, Cu, acetone, reflux, 3 
h, 99%; c) N,N-dimethylaniline, 250 °C, μW, 276 45%, 180 12%. 
We wanted to assess the three main structural classes of catalyst developed by our 
group, for the epoxidation of 276, namely: biphenyl-azepinium;33 
dihydroisoquinolinium10,34 and octahydrobinaphthyl-azepinium salts (Figure 2.26). 
Catalysts 169 and 286 were prepared according to well-used procedures within our 
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group that are outlined in Chapter 3, while a sample of catalyst 174 was available to 
use from previous studies and was not synthesized during this work.   
 
Figure 2.26: The four catalysts assessed in the epoxidation of xanthyletin, covering 
the three main structural classes of catalyst used within our group. 
We screened the catalysts for the epoxidation of both 276 and 180. We were not 
surprised to observe that the 260 was poor for both alkenes; the backbones 
featuring atropisomerism only show good selectivity and reactivity for electron rich 
tri-substituted alkenes. However, we were slightly disappointed that catalyst 174, 
used previously for the enantioselective epoxidation of 180, gave only a 94% ee for 
the epoxidation of 276 as we suspected it would be the best catalyst for this motif. 
Somewhat surprisingly, and much to our delight, the biphenyl catalyst 169 was 
actually superior in terms of reactivity and enantioselectivity. Full conversion and 
an ee of 99% was achieved in <30 h. Because the sulfone group was present in 174, 
and because it had shown the best selectivity under non-aqueous conditions 
previously, we wanted to know whether we could improve upon the reactivity 169 
displayed, and thus prepared 286. Unfortunately it performed worse for unknown 
reasons, but the reactivity of 169 was more than acceptable, and accordingly we 
employed 169 in the epoxidation of 276. 
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Entry Catalyst Substrate Conditions Conv. (%) ee (%) Enantiomer 
1 169 276 TPPP (2 equiv.), CHCl3, –30 
°C, <30 h 
99 99 (–) 
2 287 276 TPPP (2 equiv.), CHCl3, –30 
°C, <30 h 
80 98 (–) 
3 174* 276 TPPP (2 equiv.), CHCl3, –30 
°C, 39 h 
82 94 (–) 
4 270 276 Oxone® (2 equiv.), NaHCO3, 
MeCN / H2O, 0 °C, 
2 - - 
5 169 180 TPPP (2 equiv.), CHCl3, –30 
°C, 18 h 
90 98 (+) 
6 287 180 TPPP (2 equiv.), CHCl3, –30 
°C, 39 h 
40 93 (+) 
7 174* 180 TPPP (2 equiv.), CHCl3, –30 
°C, 39 h 
98 96 (+) 
8 270 180 Oxone® (2 equiv.), NaHCO3, 
MeCN / H2O, 0 °C, 
3 -  
Table 2.19: Attempted epoxidations, run at 5 mol% loading. *10mol% loading. 
On smaller scales (<50 mg of 276), (+)-280 was isolated quantitatively in very good 
purity negating the need for column chromatography; the work-up required the 
addition of Et2O to precipitate any TPPP and its reduced by-products, followed by 
filtration through celite and the removal of solvents. However, when the 
epoxidation was performed on a larger scale (0.8 g) the epoxide was not obtained 
with the same purity (incomplete conversion) and purification by column 
chromatography was required. Despite buffering the eluent with TEA at 2%, a 
substantial amount of the epoxide was unrecovered, which dropped the isolated 
yield to 69%.  
The next step followed an acid-catalysed epoxide ring-opening procedure used by 
our group previously in the synthesis of 181. The epoxide (–)-280 was stirred in a 
mixture of acetone and 1M H2SO4, and this was expected to furnish (+)-trans-
decursinol 287 quantitatively in good purity (Scheme 2.34).  
 
Scheme 2.34: Acid catalysed ring opening of the epoxide: a) acetone / 1M H2SO4 
(2:1), RT, 10 min., 60%. 
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Interestingly, a significant by-product 288 was observed (8%), which we were 
unable to conclusively identify by NMR spectroscopy, though it seemed clear there 
were two extra methyl groups present. Results from high resolution mass 
spectrometry suggested the addition of a C3H6O fragment, and we concluded it was 
due, somehow, to the incorporation of acetone, which the NMR data also 
supported, but we were still unsure of the connectivity. Fortunately, we were able 
to obtain a single crystal for X-ray analysis, which gave us the structure. The 
structure seemed to suggest that acetone had participated in a variant of the Ritter 
reaction with the epoxide (Scheme 2.35).35  
 
Scheme 2.35: Acetone Ritter-type product from xanthyletin oxide: a) H2SO4, 
acetone, RT, 10 min, 8%. 
The stability of the benzylic cation 289 and the cis- configuration of the acetal in 
288 imply that acetone first interacts with the empty p orbital with a lone pair on its 
oxygen to give 290. Hydrogen bonding could explain the observed configuration, 
but also, if one considers the scenario in which acetone approaches the p orbital 
anti- to the hydroxyl 291, - the required 5-endo-trig cyclisation is prevented and 
292 was not observed because the reactive centres are held apart. Furthermore, 
the reverse 3-exo-tet reaction to expel acetone from the anti- configuration would 
presumably be be rapid (Scheme 2.36). 
Chapter 2 – Results and Discussion 
 
186 
 
 
Scheme 2.36: Ritter-type reaction pathway. 
The oxidation of the benzylic hydroxyl of (+)-trans-decursinol was first attempted 
with MnO2, since it is mild and was expected to leave the more hindered non-
benzylic hydroxyl completely untouched. At RT, in CH2Cl2 no conversion to the α-
hydroxy ketone 293 was observed with 10 equiv. of MnO2. When searching the 
literature for a method to augment the reactivity, we discovered that MnO2 readily 
cleaves cis-, and even trans- 1,2-diols.36 In light of this, we immediately abandoned 
using MnO2. Due to its excellent reactivity, and the mild conditions required, we 
next employed Dess-Martin periodinane to effect the oxidation of the benzylic 
hydroxyl. Pleasingly, it appeared that only one major product was formed and, this 
was confirmed by NMR spectoscopy. The crude reaction mixture was purified by 
flash column chromatography and 293 was isolated in excellent yield (Scheme 
2.37). 
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Scheme 2.37: Selective oxidation of the benzylic hydroxyl with DMP; a) DMP (1 
equiv.), CHCl3, RT, 95%. 
As described above, the side chain fragments of the scuteflorins were to be 
introduced as their acyl chlorides – 3,3-dimethylacryloyl chloride 295 for 274 and 
angeloyl chloride 299 for 275. The preparation of 295 was achieved by reacting 3,3-
dimethylacrylic acid 294 with a slight excess of oxalyl chloride in CH2Cl2 at RT 
(Scheme 2.38). Solvents were removed 1 h after the effervescence ceased. To 
ensure excess oxalyl chloride was removed, CHCl3 was added and removed in vacuo 
to constant weight three times. The acyl chloride 294 was isolated as a pungent 
pale-yellow oil and stored under an inert atmosphere to prevent re-formation of 
the acid 295.  
 
Scheme 2.38: Synthesis of acryloyl chloride; a) Oxalyl chloride (1.1 equiv.), CH2Cl2, 
RT, 99%. 
The same method could not be used for the angeloyl side chain as angelic acid 296 
is, reportedly, extremely sensitive to acid, light, heat and moisture; which cause it 
to isomerize to tiglic acid 297 (Scheme 2.39). 
 
Scheme 2.39: Isomerization of angeloyl chloride 
Direct exposure to oxalyl chloride causes it to isomerize due to the HCl produced as 
a by-product over the course of the reaction.37 This problem was circumvented by 
first isolating the potassium salt 298, and then treating that with oxalyl chloride. In 
our hands, the angeloyl chloride 299 was not produced cleanly, and purification by 
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preparative TLC was required to obtain a pure sample for the coupling, which, of 
course, significantly compromised the yield (Scheme 2.40). 
 
Scheme 2.40: Preparation of angeloyl chloride: a) KOH (1 equiv.), EtOH, 10 min.; b) 
Oxalyl chloride (1.1 equiv.), Et2O, 0 °C, 9 % over two steps. 
The attachment of the acryloyl side chain was straightforward, and 274 was isolated 
in good yield following purification. The optical rotation for the synthetic material 
matched that reported by Khan for the authentic sample (Scheme 2.41). 
 
Scheme 2.41: Coupling of the acryloyl side chain: a) 295 (5 equiv.), NaHCO3 (1.1 
equiv.), THF, RT, 5 h, 88%. 
The same reaction was attempted for the attachment of angeloyl side chain, but, 
unfortunately, after 24 h, there was no formation of 275 and both components 
were still intact. Couplings of this sort can usually be accelerated by the addition of 
catalytic amounts of DMAP or pyridine, which activate the acyl chloride, but, due to 
the capricious nature of the angeloyl species, isomerization to tigloyl has been 
observed with their use.35 We did try the addition of DMF (1 equiv.), but no 
reaction was seen under these conditions after 10 h, and again, the two coupling 
partners were still intact (Scheme 2.42).  
 
Scheme 2.42: Attempted coupling of the angeloyl side chain: a) 299 (5 equiv.), THF, 
RT, 24 h, 0%; b) 299 (5 equiv.), DMF (1 equiv.), THF, RT, 10 h, 0%. 
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It was frustrating and confusing not to observe any conversion at all, particularly 
when the coupling with 295 was so facile. We certainly did not exhaust the known 
methods to achieve the coupling, and work to this end is continuing within our 
group. 
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2.9 Conclusions and Future Work 
At the beginning of this work, we challenged ourselves to create a more 
enantioselective iminium-salt catalyst for organocatalytic epoxidation. We believe 
we achieved that goal with the development of catalyst 260, which arose from the 
combination of two modifications: a larger Φ angle, and α-substitution. Iminium-
salt 260 demonstrated the best facial selectivity across a range of tri-substituted 
alkene substrates bearing an aryl group that we had seen to date, ees of up to 97% 
being achieved with its use.  
 
The most interesting and important aspect of this project however, and those 
closely linked to it within the group, came from the investigation into how 
substitution at the α-position influenced enantioselectivity in the epoxidation 
process.   
 
This investigation gave us great insight to the structures and behaviour of these 
iminium salts, both in isolation and during the epoxidation process. This 
understanding will allow the directed design of future iminium-salt catalysts. That 
aspect of the work was important because, while the development of catalyst 260 
was an interesting intellectual exercise, in all likelihood, it will never be employed 
by any other academic group or in industry. This is because a large synthetic 
investment is required for its synthesis (11 steps in total) – an investment which 
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perhaps outweighs its proficient enantiocontrol. Taking into account its synthesis 
and its high mass of 826 Da, any process it could be used for would suffer from poor 
atom economy.38 Furthermore, these azepinium catalysts suffer from narrow 
substrate scope. Thus, any future work directed at developing catalysts which are 
capable of epoxidizing these and other substrate classes will require a paradigm 
shift in catalyst structure and synthetic strategy in particular.  
That said, work within the group has highlighted the particular utility of biphenyl 
catalyst 169 for the enantioselective epoxidation of cis-alkene substrates, especially 
chromenes. We employed 169 to install the required stereochemistry and epoxide 
functionality necessary for the subsequent manipulation to achieve the first 
enantioselective total synthesis of (+)-scuteflorin A. Our enantioselective 
epoxidation of xanthyletin also offers a route to the asymmetric synthesis of 
decursin,39 which inhibits the estrogen-stimulated and estrogen-independent 
growth and survival of breast cancer cells, and related analogues, such as 
dihydropyranocoumarin D2, which has been shown to be a microphthalmia-
associated transcription factor (MITF) degrading agent, acting by inhibiting the 
synthesis of melanin at the transcription level.40  
 
These syntheses should be achievable by the reductive ring opening of 280, 
followed by acyl chloride coupling of the side chains.  
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3.0 Experimental 
 
3.1 General Experimental 
 
3.1.1 Physical Characterisation and Spectroscopic Techniques 
 
1H- and 13C-NMR spectra were recorded in Fourier Transform mode either on a 
Varian Unity Plus 400 or a Varian Gemini 300 spectrometer operating at nominal 1H 
NMR frequencies of 400 MHz and 300 MHz respectively using the specified 
deuteriated solvent. All spectra were processed using MestRe-C Nova software. The 
chemical shifts for both 1H- and 13C-spectra were recorded in ppm and were 
referenced to the residual solvent peak or TMS peak. Multiplicities in the NMR 
spectra are described as: s = singlet, d = doublet, t = triplet, q = quartet, sept. = 
septet, m = multiplet, br = broad singlet; coupling constants (J) are reported in Hz. 
Low resolution mass spectra were recorded using a Shimadzu LCMS 2010EV 
instrument operated under electrospray ionization in positive (ES+) or negative  
(ES–) modes. Accurate Mass spectra were recorded by the EPSRC national mass 
spectrometry service at the University of Wales, using electron-impact (EI), fast 
atom bombardment (FAB) or electrospray (ES) techniques. Melting points were 
recorded using open capillary tubes on a Büchi B-545 melting point instrument; 
melting points quoted as a range were observed manually while those quoted as a 
specific value were recorded by the instrument and correspond to the temperature 
at which the sample reached 40% translucency in accordance with the British 
Pharmacopeia. Infrared spectra were recorded as neat samples using a Perkin-
Elmer Spectrum BX FT-IR Spectrophotometer, or as thin films on NaCl plates using a 
Perkin-Elmer Paragon 2000 FT-IR spectrophotometer. All IR data were analysed 
using Spectrum v5.0.1 software. Optical rotation measurements were obtained 
using a Bellingham and Stanley ADP-440 polarimeter operating at the sodium (D) 
line emission of 589 nm at a nominal 20 °C. 
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3.1.2 Enantiomeric Excess Determination 
 
Enantiomeric excesses were determined either by Chiral HPLC or 1H-NMR 
spectroscopy. Chiral HPLC traces were run on a Chiracel OD column eluting with 
HPLC grade Hexane/IPA. The 1H-NMR spectra were run on a Varian Gemini 300 
spectrometer operating at a nominal 300 MHz in the presence of [(+)-Eu(hfc)3] as 
the chiral shift reagent and TMS as the internal standard. 
 
3.1.3 Chromatographic Techniques 
 
Flash chromatography was carried out using glass columns packed with Davisil 45-
60 μm silica-gel. Thin layer chromatography was carried out on Merck aluminium-
backed plates coated with 0.2 mm Kieselgel 60 GF254. After elution, the TLC plates 
were visualized under UV light followed by staining with phosphomolybdic acid 
(10% solution in EtOH) or vanillin and developed by heating.  
 
3.1.4 Reagent, Solvent and Apparatus Preparation 
 
Commercially available reagents were used as supplied, without any further 
purification, and stored according to the manufacturer’s recommendations, unless 
stated otherwise. DMF, specified as dry, was bought as such. DMSO, toluene, 
Hünig’s base and CH2Cl2 were distilled over CaH2. Et2O and THF were dried using the 
Na / benzoquinone ketyl radical system prior to distillation, and MeOH was dried 
over activated Mg ribbon prior to distillation. Water and light petroleum (b.p. 40-60 
°C) were distilled prior to use. For procedures where the exclusion of water was 
necessary, apparatus was dried using a flame gun while the vessel was flushed with 
a stream of Ar or N2. 
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3.2 Individual Experimental Procedures 
 
3.2.1 Experimental Procedures Related to the Synthesis of Chiral Amines 
 
General procedure for the formation of the formate protected 5-amino-1,2-
dixoanes from commercially available amino diols 
 
Methyl formate (1.2 equiv.) and sodium methoxide (0.1 equiv.) were added to a 
solution of the aminodiol (1 equiv.) in dry MeOH (10 mL per g of aminodiol). The 
reaction was stirred until full conversion was observed by TLC analysis. At which 
point the solvents were removed under reduced pressure. Toluene (30 mL per g of 
aminodiol) was added to a flask containing the crude oily residue and heated under 
reflux. Any MeOH remaining in the oil was collected in the attached Dean-Stark 
apparatus. The mixture was allowed to cool to 50 C and CSA (0.1 equiv.) and 2,2-
DMP (5 equiv.) were added. The reaction mixture was again heated to reflux and 
the MeOH that evolved was collected in the Dean-Stark apparatus as the reaction 
proceeded. When the collection of MeOH in the Dean-Stark apparatus had ceased, 
the reaction was allowed to cool and the solvents removed under reduced 
pressure. The crude oil was re-dissolved in EtOAc and washed with saturated 
aqueous NaHCO3 (2 x 15 mL per g of aminodiol) followed by brine (2 x 15 mL per g 
of aminodiol). The organic fraction was dried over MgSO4 then filtered, solvents 
were then again removed under reduced pressure to yield the 5-amino-1,2-
dioxanes in good purity. 
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(5S,6S)-N-Formyl-5-amino-6-phenyl-2,2-dimethyl-1,3-dioxane1,2 (196) 
 
Prepared according to the general procedure from 195 (5.00 g, 29.9 mmol). The 
known product 196 was isolated as a yellow oil (6.64 g, 94%): max(neat)/cm
-1 2991, 
1668, 1507, 1380, 1199, 1087, 845, 701; H (400 MHz; CDCl3) 1.48 (3H, s, CMe2), 
1.52 (3H, s, CMe2), 3.79 (1H, dd, J = 10.5 Hz, 1.5 Hz, NCH-CH2-O, upfield portion of 
ABX system), 4.17 (1H, d, J = 10.5 Hz, NCH-CH2-O, downfield portion of ABX system), 
4.21 (1H, d, J = 1.6 Hz, -NCH-), 5.15 (1H, s, NCH-CHAr-O), 6.48 (1H, br, -NH-), 7.14-
7.27 (5H, m, 5 x CH arom.), 7.89 (1H, s, NCHO);C (75 MHz; CDCl3) 18.3 (1C, CMe2), 
29.5 (1C, CMe2), 44.9 (1C, -NCH), 64.5 (1C, NCH-CH2-O), 71.5 (1C, NCH-CHAr-O), 
100.0 (1C, CMe2, C quat.), 123.5 (2C, 2 x CH arom.), 126.5 (2C, 2 x CH arom.), 145.5 
(1C, C quat. arom), 147.5 (1C, quat. arom.), 160.3 (1C, s, NCHO). 
 
 
(5S,6S)-N-Formyl-5-amino-6-(4-methylthiophenylether)-2,2-dimethyl-1,3-dioxane3 
 
 
 
Prepared according to the general procedure from (S)-thiomicamine (5.00 g, 23.4 
mmol.). The crude compound was isolated as an orange oil which was purified by 
column chromatography eluting with 2:1 EtOAc / EtOH. The known compound was 
isolated as a colourless oil (3.10 g, 47%): []20D +1.5 (c = 1.05, CHCl3), lit.  []
20
D +1.6 
(c = 1.00, CHCl3); max(neat)/ cm
-1 3311, 2985, 2360, 1666, 1494, 1381, 1198, 1085, 
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946; H (300 MHz; CDCl3) 1.58 (3H, s, CMe2), 1.62 (3H, s, CMe2), 2.50 (3H, s, -SMe), 
3.92 (1H, dd, J = 7.5 Hz, 1.5 Hz, NCH-CH2-O, upfield portion of ABX system), 4.30 
(1H, dd, J = 7.5 Hz, 1.5 Hz, NCH-CH2-O, downfield portion of ABX system), 4.35 (1H, 
m, -NCH-), 5.22 (1H, s, NCH-CHAr-O), 6.18 (1H, d, J = 5.8 Hz, -NH-) 7.28 (4H, s, 4 x CH 
arom.), 8.04 (1H, s, NCHO). 
 
 
(5S,6S)-N-Formyl-amino-6-(4-methylsulfonylphenyl)-2,2-dimethyl-1,3-dioxane3 
 
(5S,6S)-N-Formyl-5-amino-6-(4-methylthiophenylether)-2,2-dimethyl-1,3-dioxane 
(2.50 g, 8.88 mmol) was dissolved in CHCl3 (80 mL) and the solution was allowed to 
cool to 0 °C. m-CPBA (3.37 g, 19.5 mmol) was dissolved in CH2Cl2 (40 mL) and dried 
over MgSO4 before being filtered into the allowed to cool solution of the sulfide. 
The reaction was allowed to reach ambient temperature, and stirred overnight. The 
reaction was quenched with saturated aqueous NaHCO3 (100 mL); the resulting 
biphasic mixture was transferred to a separating funnel. The organic layer was 
separated and washed with 1M NaOH (200 mL) and then dried over MgSO4, 
followed by the addition of carbon black. Solvents were then removed under 
reduced pressure to yield the known title compound as a colourless foam in good 
purity (2.47 g, 88%): []20D +11.4 (c = 0.98, CHCl3), lit.  []
20
D +11.3 (c = 1.00, CHCl3); 
max(neat)/cm
-1 3053, 2994, 1676, 1516, 1383, 1301, 1341, 1202, 1149, 1087, 
947;H (300 MHz; CDCl3) 1.54 (3H, s, CMe2), 1.56 (3H, s, CMe2), 3.00 (3H, s, -
SO2Me), 3.82 (1H, dd, J = 12.0 Hz, 1.8 Hz, NCH-CH2-O, upfield portion of ABX 
system), 4.28 (1H, dd, J = 12.0 Hz, 1.8 Hz, NCH-CH2-O, downfield portion of ABX 
system), 4.38 (1H, dd, J = 10.0 Hz, 1.6 Hz -NCH-), 5.24 (1H, s, NCH-CHAr-O), 6.38 
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(1H, d, J = 9.8 Hz, NH), 7.52 (2H, d, J = 8.1 Hz, 2 x CH arom.), 7.86 (2H, d, J = 8.0 Hz, 2 
x CH arom.), 7.90 (1H, s, NCHO). 
 
General procedure for the deprotection of formamides with hydrazine hydrate 
 
The formate-protected acetonide was dissolved in 50% aq. hydrazine hydrate (20 
mL per g of the dioxane) and the solution heated under reflux for up to 3 h. The 
solution was allowed to cool to room temperature and extracted with EtOAc (3 x 30 
mL per g of the dioxane). The organic layers were combined and washed with water 
(2 x 30 mL per g of the dioxane) followed by brine (2 x 20 mL per g OF the dioxane). 
The organic layer was dried over MgSO4, and the solvents were then removed 
under reduced pressure to furnish the unprotected amines in excellent purity. 
 
 
(5S,6S)-5-Amino-6-phenyl-2,2-dimethyl-1,3-dioxane2 (168) 
 
Prepared according to the general procedure from 196 (6.60 g, 28.0 mmol). The 
known title compound 168 was isolated as a pale yellow oil (4.21 g, 73%): []20D 
+61.5 (c = 0.98, CHCl3), lit. []
20
D +61.5 (c = 0.99, CHCl3); max(neat)/cm
-1 2991, 2940, 
2868, 1673, 1586, 1498, 1450, 1378, 1270, 1239, 1196, 1159, 1130, 1086, 1051, 
1030, 998, 942, 863, 844, 792; H (300 MHz; CDCl3) 1.54 (3H, s, CMe2), 1.55 (3H, s, 
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CMe2), 2.76 (1H, dd, J = 2.0 Hz, 4.1 Hz, -NCH-), 3.90 (1H, dd, J = 2.0 Hz, 12.1 Hz, NCH-
CH2-O, upfield portion of ABX system), 4.30 (1H, dd, J = 1.9 Hz, 12.2 Hz, NCH-CH2-O, 
downfield portion of ABX system), 5.11 (1H, s, NCH-CHAr-O), 7.25-7.41 (5H, m, 5 x 
CH arom.); C (75 MHz; CDCl3) 18.6 (1C, CMe2), 29.7 (1C, CMe2), 49.57 (1C, -NCH-), 
65.9 (1C, NCH-CH2-O), 73.7 (1C, NCH-CHAr-O), 95.0 (1C, CMe2, C. quat.), 125.7 (2C, 
2 x CH arom.), 127.4 (1C, CH arom.) 128.4 (2C, 2 x CH arom.) 139.8 (1C, C quat. 
arom.); m/z (HNES) 208.1331 - C12H17NO2 [M+H]
+ requires 208.1332. 
 
 
(5S,6S)- 5-Amino-6-(4-methylsulfonylphenyl)-2,2-dimethyl-1,3-dioxane3  
 
Prepared according to the general procedure from (5S,6S)-N-formyl-5-amino-6-(4-
methylsulfonylphenyl)-2,2-dimethyl-1,3-dioxane (2.40 g, 7.65 mmol). The known 
title compound was isolated as a clear pale yellow oil (2.05 g, 94%): []20D +48.5 (c = 
1.08, CHCl3), lit. []
20
D +47.5 (c = 0.99, CHCl3); max(neat)/cm
-1 3371, 2990, 1602, 
1380, 1197, 1076, 948;H (300 MHz; CDCl3) 1.48 (2H, br, -NH2) 1.55 (6H, s, 2 x 
CMe2), 2.86 (1H, s, -NCH-) 3.06 (3H, s, -SO2Me), 3.91 (1H, dd, J = 11.6 Hz, 2.1 Hz, 
upfield portion of ABX system, NCH-CH2-O), 4.35 (1H, dd, J = 11.7 Hz, 2.3 Hz, 
downfield portion of ABX system, NCH-CH2-O), 5.19 (1H, s, NCH-CHAr-O), 7.57 (2H, 
d, J = 8.0 Hz, 2 x CH arom.), 7.98 (2H, d, J = 8.0 Hz, 2 x CH arom.); C (75 MHz; CDCl3) 
18.8 (1C, CMe2), 29.9 (1C, CMe2), 44.8 (1C, SO2Me), 49.6 (1C, -NCH-), 66.5 (1C, NCH-
CH2-O), 73.6 (1C, NCH-CHAr-O) , 99.7 (1C, CMe2, C. quat.), 127.0 (2C, 2 x CH arom.), 
127.7 (2C, 2 x CH arom.), 139.6 (1C, C quat. arom.), 146.3 (1C, C quat. arom.). 
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3.2.2 Experimental Procedures Related to the 6,6’-Dimethylbiphenyl Systems 
 
6,6’-Dimethylbiphenyl-2,2’-bis(carboxylic acid)4 (191) 
 
NaNO2 (7.8 g, 0.11 mol) was added in one portion to an ice cold solution of 190 
(17.0 g, 0.11 mol) in 2.45 M NaOH (60 mL). The mixture was then stirred at 0 C 
until it became homogeneous. To this solution, a 4 M aqueous solution of HCl (240 
mL) that had been pre-cooled to 0 C, was added at a rate such that the 
temperature remained below 5 C. The resulting orange solution of the diazonium 
salt was stirred at 0 C for 20 min. Cu2SO45H2O (24.0 g, 96 mmol) and water (75 
mL) were added to a flask and the resulting solution was left to cool in a large ice-
bath.  When the solution had reached 5 C, 30% w/v NH4OH solution (47.5 mL) was 
added in one portion. A freshly prepared solution of NH2OH, prepared from 
treatment of (NH2OH)H2SO4 (8.8 g, 53.5 mmol) with a 3 M ice-cold aqueous 
solution of NaOH (38 mL, 0.11 mol), was added to the resulting deep-blue solution. 
The deep blue solution was stirred for 20 min. to cool to 0 C. The diazonium salt 
prepared above was added to the copper solution in three equal portions of 50 mL 
via a syringe with the needle below the liquid surface. The temperature was 
maintained below 7 C throughout the procedure. After the addition was 
complete, the resulting orange/red solution was heated under reflux for 30 min. 
The vessel was removed from the heat and allowed to cool. After the red solution 
had attained ambient temperature, conc. HCl (37.5 mL) was added slowly and the 
mixture was allowed to stand overnight to provide for the complete precipitation 
of the product. The yellow/brown precipitate was removed by filtration using a 
Büchner funnel, washed with water and air-dried. The crude material was stirred in 
boiling EtOH (200 mL); any remaining bright yellow solid was removed by filtration, 
leaving a clear brown filtrate. Crystallization of the known bis(carboxylic acid) 191 
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was induced by the addition of water to the filtrate to yield light brown crystals 
(8.4 g, 55%): m.p. 225.6-230.1 C (dec.);max(neat)/cm
-1 2982, 2907, 2667, 2579, 
1680, 1583, 1436, 1377, 1316, 1159, 962, 799, 768, 722; H (400 MHz; DMSO) 1.85 
(6H, s, 2 x Ar-Me), 7.35 (2H, t, J = 8.0 Hz, 2 x CH arom.), 7.48 (2H, d, J = 8.0 Hz, 2 x 
CH arom.), 7.75 (2H, d, J = 8.0 Hz, 2 x CH arom.), 12.27 (2H, br, -CO2H). 
 
 
6,6’-Dimethyl-2,2’-bis(hydroxymethyl)biphenyl4 (193) 
 
 191 (2.20 g, 8.2 mmol) was dissolved in Et2O (30 mL) under a nitrogen 
atmosphere. The resulting pale yellow solution was then allowed to cool to 0 °C, 
and LiAlH4 (0.93 g, 24.5 mmol) was added slowly at a rate that just maintained the 
effervescence. The resulting suspension was heated under reflux for 1 h, after 
which time the reaction mixture was removed from the heat and allowed to cool to 
RT. Solid Na2SO4 (6.0 g) was added to the suspension, which was then allowed to 
cool in an ice-bath and stirred for 5 min. Water (10 mL) was added dropwise to 
quench the excess LiAlH4. The mixture was then stirred for 30 min., filtered through 
a layered pad of Celite and Na2SO4, and the colourless filtrate was then 
concentrated under reduced pressure to yield known 193 as a colourless crystalline 
solid (1.91 g, 96%): max(neat)/cm
-1 3254, 3064, 3017, 2935, 2880, 1679, 1592, 
1458, 1378, 1239, 1211, 1163, 1028, 994, 902, 783, 760, 623; H (400 MHz; DMSO) 
1.85 (6H, s, 2 x Ar-Me), 3.99 (4H, s, 2 x -CH2OH), 5.03 (2H, s, 2 x -CH2OH), 7.24 (2H, 
s, J = 8.0 Hz, 2 x CH arom.), 7.32 (2H, t, J = 8.1 Hz, 2 x CH arom.), 7.45 (2H, d, J = 8.0 
Hz, 2 x CH arom.); m/z (HNES) 265.1200 - C16H18O2 [M+Na]
+ requires 265.1199. 
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6,6’-Dimethyl-1,1’-biphenyl-2,2’-bis(carboxaldehyde)4 (194) 
 
PCC (1.33 g, 62.0 mmol) was added in one portion to a solution of 193 (0.50 g, 20.7 
mmol) in CH2Cl2 (20 mL), producing a dark-orange solution. The solution was stirred 
vigorously for 3 h at RT. Et2O (20 mL) and a spatula of Celite was added to the 
resulting black mixture, which was stirred for a further 30 min. The reaction mixture 
was filtered through a layered pad of Celite and silica gel. Solvents were removed 
under reduced pressure to yield the known 194 as a colourless crystalline solid 
(0.43 g, 87%): m.p. 108.7 C; H (400 MHz; DMSO) 1.92 (6H, s, 2 x Ar-Me), 7.62 (2H, 
t, J = 8.0 Hz, 2 x CH arom.), 7.74 (2H, d, J = 8.0 Hz, 2 x CH arom.), 7.88 (2H, d, J = 8.0 
Hz, 2 x CH arom.), 9.48 (2H, s, 2 x -CHO) m/z (HNES) 256.1333 - C16H14O2 [M+NH4]
+ 
cation requires 256.1332. 
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(+)-(R)-6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,11-dimethyl-6,7-
dihydro-5H-dibenzo[c,e]azepine (197) and (+)-(S)-6-((4S,5S)-2,2-dimethyl-4-
phenyl-1,3-dioxan-5-yl)-1,11-dimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine (198) 
 
 168 (2.70 g, 12.9 mmol) was added to a solution of 194 (2.81 g, 11.8 mmol) in 
MeOH (160 mL). After being stirred for 5 min., NaBH3CN (1.62 g, 25.8 mmol) and 
glacial acetic acid (1 mL) were added. The solution was stirred for 24 h at RT. The 
reaction was quenched by the addition of a 1 M aqueous solution of NaOH (20 mL). 
Et2O (100 mL) was added and the resulting biphasic mixture was transferred to a 
separating funnel where the organic layer was collected. The aqueous layer was 
further extracted with Et2O (2 x 30 mL). The organic fractions were combined, 
washed with brine, and dried over Na2SO4. The solvents were removed under 
reduced pressure to yield a crude oil that was then subjected flash column 
chromatography to purify and separate the diastereomers, eluting with light 
petroleum / EtOAc (10:1), buffered with 2% TEA.  
 
First eluting amine 197 was obtained as a colourless crystalline solid (1.18 g, 49%): 
[]D +54.9 (c = 0.97, CDCl3); max(neat)/cm
-1 2990, 2934, 2860, 1452, 1378, 1308, 
1263, 1236, 1200, 1172, 1150, 1075, 1027 953, 852, 787, 749, 727, 698;H (400 
MHz; CDCl3) 1.58 (3H, s, CMe2), 1.64 (3H, s, CMe2), 2.11 (6H, s, Ar-Me), 2.65 (1H, d, J 
= 1.9 Hz, -NCH-), 3.16 (2H, d, J = 12.1 Hz, 2 x ArCH2N, upfield portion of AB system), 
3.67 (2H, d, J = 12.1 Hz, 2 x ArCH2N, downfield portion of AB system), 4.12-4.21 (2H, 
m, 2 x NCH-CH2-O), 5.10 (1H, d, J = 3.1 Hz, NCH-CHAr-O), 6.98-7.02 (2H, m, 2 x CH 
arom.), 7.14-7.18 (4H, m, 4 x CH arom.), 7.24-7.36 (5H, m, 5 x CH arom.); C (100 
MHz; CDCl3) 19.3 (1C, CMe2), 20.0 (2C, 2 x Ar-Me), 29.9 (1C, CMe2), 53.2 (2C, 2 x 
ArCH2N), 60.1 (1C, -NCH-), 61.9 (1C, NCH-CH2-O), 75.3 (1C, NCH-CHAr-O), 99.3 (1C, 
CMe2, C quat.), 126.4 (2C, 2 x CH arom.), 126.7 (2C, 2 x CH arom.), 126.9 (1C, CH 
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arom.), 127.5 (2C, 2 x CH arom.), 127.8 (2C, 2 x CH arom.), 129.0 (2C, 2 x CH arom.), 
135.4 (2C, 2 x C quat. arom.), 136.7 (2C, 2 x C quat. arom.), 138.6 (1C, C quat. 
arom.), 140.5 (1C, C quat. arom.), C quat. arom. not observed; m/z 414.2431 - 
C28H32NO2 (M+H)
+ requires 414.2428.  
 
The second eluting amine 198 was obtained as a colourless foam, (0.62 g, 26%): 
[]D +121.0 (c = 1.07, CDCl3); MAX(neat)/cm
-1 2990, 2939, 2859, 1497, 1452, 1378, 
1332, 1263, 1236, 1198, 1168, 1140, 1076 1024, 1001, 952, 853, 787, 750, 722, 697, 
665; H (400 MHz; CDCl3) 1.46 (3H, s, CMe2), 1.49 (3H, s, CMe2), 2.12 (6H, s, Ar-Me), 
3.01 (1H, br, -NCH-), 3.31 (2H, d, J = 12.5 Hz, 2 x ArCH2N, upfield portion of AB 
system), 3.46 (2H, d, J = 12.4 Hz, 2 x ArCH2N, downfield portion of AB system), 3.92 
(1H, d, J = 12.4 Hz, NCH-CH2-O, upfield portion of ABX system), 4.13 (1H, d, J = 12.4 
Hz, NCH-CH2-O, downfield portion of ABX system), 5.13 (1H, d, J = 3.0 Hz, NCH-
CHAr-O), 6.80-7.02 (2H, m, 2 x CH arom.), 7.16-7.27 (4H, m, 4 x CH arom.), 7.33 (2H, 
t, J = 7.6 Hz, 2 x CH arom.), 7.45 (2H, d, J = 7.6 Hz, 2 x CH arom.); m/z 414.2425 - 
C28H32NO2 (M+H)
+ requires 414.2428. 
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General procedure for the synthesis of 6,6’-dimethylbiphenyl iminium salts 
 
NBS (1.1 equiv.) was added to a flask containing a solution of the azepine substrate 
(1 equiv.) in CH2Cl2 in a flask equipped with a stirrer bar and allowed to cool in an 
ice-bath. The resulting yellow solution was removed from the ice-bath and allowed 
to attain ambient temperature. The reaction mixture was then heated under reflux 
for 2 h. After the vessel had been removed from the heat and allowed to cool, a 
solvent switch to EtOH was performed. NaBPh4 (1.1 equiv.) dissolved in the 
minimum amount of MeCN was added to the ethanolic solution. The resulting 
precipitate was isolated by filtration and washed with cold EtOH then Et2O. 
 
 
(–)-(Ra)-6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,11-dimethyl-5H-
dibenzo[c,e]azepin-6-ium tetraphenylborate (199) 
 
Prepared according to the general procedure from 197 (1.10 g, 2.66 mmol). Title 
compound 199 was isolated as a fine yellow powder (1.18 g, 61%): []20D –190.5 (c 
= 1.01, MeCN); max(neat)/cm
-1 3055, 3002, 2161, 2041, 1976, 1629, 1580, 1478, 
1450, 1426, 1382, 1350, 1263, 1238, 1202, 1164, 1107, 1031, 955, 847, 790, 730, 
664, 611; H (400 MHz; DMSO) 1.70 (3H, s, CMe2), 1.71 (3H, s, CMe2), 1.94 (3H, s, 
Ar-Me), 2.18 (3H, s, Ar-Me), 3.96 (1H, d, J = 12.7 Hz, ArCH2N, upfield portion of AB 
system), 4.17 (1H, d, J = 13.7 Hz, NCH-CH2-O, upfield portion of ABX system), 4.53 
(1H, s, -NCH-), 4.62 (1H, dd, J = 13.7 Hz, 2.9 Hz, NCH-CH2-O, downfield portion of 
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ABX system), 5.55 (1H, br, ArCH2N, downfield portion of AB system), 5.82 (1H, d, J = 
2.5 Hz, NCH-CHAr-O), 6.79 (4H, t, J = 7.1 Hz, 4 x CH arom., para- –BPh4), 6.92 (8H, t, 
J = 7.3 Hz, 8 x CH arom., meta- –BPh4), 7.10-7.29 (14H, m, 6 x CH arom. / 8 x CH 
arom., ortho- –BPh4), 7.36 (1H, d, J = 7.9 Hz, CH arom.), 7.41-7.48 (2H, m, 2 x CH 
arom.), 7.53 (1H, t, J = 7.8 Hz, CH arom.), 7.71 (1H, d, J = 7.6 Hz, CH arom.), 8.92 
(1H, s, -N=CH-); C (100 MHz; DMSO-d6) 19.3 (1C, CMe2), 20.2 (2C, 2 x Ar-Me), 29.9 
(1C, CMe2), 56.2 (1C, N-CH2-Ar), 61.2 (1C, NCH-CH2-O), 66.5 (1C, -NCH-), 71.3 (1C, 
NCH-CHAr-O), 100.8 (1C, CMe2, C quat.), 122.2 (4C, s, 4 x CH arom., para- 
–BPh4), 
125.5 (2C, 2 x CH arom.), 125.8 (1C, CH arom.), 125.9 (8C, 8 x CH arom., meta- –
BPh4), 128.4 (1C, C quat. arom.), 128.4 (2C, 2 x C quat. arom.), 128.4 (1C, CH 
arom.), 129.1 (2C, 2 x CH arom.), 129.7 (1C, CH arom.), 132.2 (1C, CH arom.), 136.2 
(8C, 8 x CH arom., ortho- –BPh4), 137.1 (1C, CH arom.), 138.3 (1C, C quat. arom.), 
139.0 (1C, C quat. arom.), 139.9 (1C, C quat. arom.), 164.0 (4C, q, J = 49 Hz, 4 x C 
quat. arom., ipso- –BPh4), C quat. arom. and -N=CH- not observed; m/z 412.2273 - 
C28H30NO2 [M–BPh4]
+ requires 412.2271. 
 
 
(+)-(Sa)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-[1,3]dioxan-5-yl)-1,11-dimethyl-5H-
dibenzo[c,e] azepinium tetraphenylborate (200) 
 
Prepared according to the general procedure from 198 (0.56 g, 1.35 mmol) The 
title compound 200 was isolated as a yellow solid (0.83 g, 83%): []20D +329.8 (c = 
0.98, MeCN); max(neat)/cm
-1 3059, 2989, 2161, 1977, 1623, 1578, 1559, 1427, 
1381, 1359, 1308, 1263, 1239, 1168, 1122, 1086, 1069, 1031, 1000, 969, 43, 783, 
728, 664, 608; H (400 MHz; DMSO-d6) 1.72 (3H, s, CMe2), 1.75 (3H, s, CMe2), 2.03 
(3H, s, Ar-Me), 2.23 (3H, s, Ar-Me), 3.83 (1H, d, J = 13.2 Hz, ArCH2N, upfield portion 
of AB system), 4.19 (1H, d, J = 13.7 Hz, ArCH2N, downfield portion of AB system), 
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4.70 (1H, dd, J = 13.8 Hz, 3.9 Hz, NCH-CH2-O, upfield portion of ABX system), 4.83 
(1H, s, -NCH-), 4.97 (1H, d, J = 13.5 Hz, NCH-CH2-O, downfield portion of ABX 
system), 5.85 (1H, d, J = 2.9 Hz, NCH-CHAr-O), 6.84 (4H, t, J = 7.2 Hz, 4 x CH arom., 
para- –BPh4), 6.98 (8H, t, J = 7.4 Hz, 8 x CH arom., meta- 
–BPh4), 7.10-7.19 (5H, m, 5 
x CH arom.), 7.21-7.29 (8H, m, 8 x CH arom., ortho- –BPh4), 7.42 (1H, d, J = 8.0 Hz, 
CH arom.), 7.49 (1H, t, J = 7.5 Hz, CH arom.), 7.55 (1H, d, J = 8.0 Hz, CH arom.), 7.64 
(1H, t, J = 7.7 Hz, CH arom.), 7.71-7.76 (2H, m, 2 x CH arom.), 9.17 (1H, s, -N=CH-); 
m/z 412.2268 - C28H30NO2 [M–BPh4]
+ requires 412.2271. 
 
 
(–)-(5R, 11bRa)-6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,5,11-trimethyl-
5H-dibenzo[c,e]azepin-6-ium tetraphenylborate (203) 
 
Prepared according to the general procedure from 201 (0.34 g, 0.81 mmol). The 
title compound 203 was isolated as a yellow powder, (0.18 g, 30%): []20D   167.2 (c 
= 1.00, MeCN); MAX(neat)/cm
-1 3053, 2986, 1632, 1579, 1559, 1540, 1478, 1425, 
1379, 1298, 1262, 1239, 1201, 1165, 1107, 1085, 1045, 1032; H (400 MHz; DMSO) 
0.78 (3H, br, N-CHMe-Ar), 1.68 (3H, s, CMe2), 1.70 (3H, s, CMe2), 1.90 (3H, s, Ar-
Me), 2.16 (3H, s, Ar-Me), 4.26 (1H, d, J = 13.2 Hz, NCH-CH2-O, upfield portion of 
ABX system), 4.63-4.68 (2H, m, NCH-CH2-O, downfield portion of ABX system / -
NCH-), 5.76 (1H, br, N-CHMe-Ar), 5.82 (1H, s, NCH-CHAr-O), 6.79 (4H, t, J = 7.2 Hz, 4 
x CH arom., para- –BPh4), 6.92 (8H, t, J = 7.4 Hz, 8 x CH arom., meta- 
–BPh4), 7.10-
7.25 (14H, m, 6 x CH arom. / 8 x CH arom. ortho- –BPh4), 7.32-7.40 (2H, m, 2 x CH 
arom.), 7.59 (1H, br, 2 x CH arom.), 7.71-7.74 (1H, m, CH arom.), 9.20 (1H, s, -
N=CH-); C (100 MHz; DMSO) 14.9 (1C, N-CHMe-Ar), 19.3 (1C, CMe2), 19.9 (1C, Ar-
Me), 20.0 (1C, Ar-Me), 29.9 (1C, CMe2), 62.0 (1C, NCH-CH2-O), 65.9 (1C, N-CHMe-
Ar), 67.4 (1C, -NCH-), 70.8 (1C, NCH-CHAr-O), 101.0 (1C, CMe2, C quat.), 122.2 (4C, 
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s, 4 x CH arom., para- –BPh4), 125.2 (2C, 2 x CH arom.), 125.9 (1C, CH arom.), 126.5 
(8C, s, 8 x CH arom., meta- –BPh4), 127.5 (1C, C arom.), 128.3 (1C, C arom.), 128.7 
(1C, CH arom.), 128.8 (2C, 2 x CH arom.), 129.7 (1C, C arom.), 131.1 (1C, CH arom.), 
132.0 (1C, CH arom.), 132.1 (1C, C arom.), 136.2 (8C, 8 x CH arom., ortho- –BPh4), 
136.4 (1C, C arom.), 137.7 (1C, CH arom.), 138.8 (1C, C arom.), 139.2 (1C, C arom.), 
140.2 (1C, C arom.), 164.0 (4C, q, J = 49 Hz, 4 x C quat. arom., ipso- –BPh4), -N=CH- 
not observed; m/z 428.2435 - C29H32NO2 [M–BPh4]
+ requires 428.2428. 
 
 
(+)-(5S, 11bSa)-6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,5,11-trimethyl-
5H-dibenzo[c,e]azepin-6-ium tetraphenylborate (204) 
 
Prepared according to the general procedure from 202 (0.25 g, 0.58 mmol). The 
title compound 204 was isolated as a pale yellow powder (0.14 g, 32%): []20D 
+310.0 (c = 1.00, MeCN); max(neat)/cm
-1 3055, 2999, 1625, 1580, 1562, 1478, 
1452, 1427, 1383, 1306, 1262, 1202, 1166, 1112, 1085, 1032, 952, 844, 789, 748, 
734, 666, 611; H (400 MHz; DMSO) 0.65 (3H, d, J = 7.2 Hz, N-CHMe-Ar), 1.67 (6H, s, 
2 x CMe2), 1.96 (3H, s, Ar-Me), 2.13 (3H, s, Ar-Me), 4.15 (1H, d, J = 14.3 Hz, NCH-
CH2-O, upfield portion of ABX system), 4.65-4.69 (2H, m, -NCH- / NCH-CH2-O, 
downfield portion of ABX system), 5.76 (1H, q, J = 7.3 Hz, N-CHMe-Ar), 5.85 (1H, s, 
NCH-CHAr-O), 6.79 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –BPh4), 6.92 (8H, t, J = 7.4 
Hz, 8 x CH arom., meta- –BPh4), 7.04-7.22 (13H, m, 5 x CH arom. / 8 x CH arom., 
ortho- –BPh4), 7.38 (1H, J = 7.4 Hz, CH arom.), 7.42-7.52 (2H, m, 2 x CH arom.), 7.59 
(1H, t, J = 7.7 Hz, CH arom.), 7.72 (2H, t, J = 7.7 Hz, CH arom.), 8.98 (1H, s, -N=CH-); 
C (100 MHz; DMSO) 14.4 (1C, N-CHMe-Ar), 19.3 (1C, CMe2), 19.9 (1C, Ar-Me), 20.0 
(1C, Ar-Me), 30.0 (1C, CMe2), 61.6 (1C, NCH-CH2-O), 68.1 (1C, N-CHMe-Ar), 68.4 
(1C, -NCH-), 71.8 (1C, NCH-CHAr-O), 101.0 (1C, CMe2, C quat.), 122.2 (4C, s, 4 x CH 
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arom., para- –BPh4), 125.9 (2C, 2 x CH arom.), 126.0 (8C, s, 8 x CH arom., meta- 
–
BPh4), 127.65 (1C, C arom.), 127.70 (1C, C arom.), 128.4 (1C, C arom.), 128.6 (1C, C 
arom.), 128.9 (2C, 2 x CH arom.), 129.5 (1C, C arom.), 132.1 (1C, C arom.), 132.3 
(1C, C arom.), 132.5 (1C, C arom.), 136.17 (8C, 8 x CH arom., ortho- –BPh4), 136.18 
(1C, C arom.), 136.5 (1C, C arom.), 137.9 (1C, C arom.), 139.0 (1C, C arom.), 139.3 
(1C, C arom.), 140.1 (1C, C arom.), 141.1 (1C, C arom.), 164.0 (4C, q, J = 49 Hz, 4 x C 
quat. arom., ipso- –BPh4), 170.7 (-N=CH-); m/z 426.2424 - C29H32NO2 [M–BPh4]
+ 
requires 426.2428. 
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General Procedure for the Grignard Addition to Iminium Salts 
 
The desired iminium salt (1 equiv.) and Et2O (50 mL per g of iminium salt) was 
added to a flame dried round-bottomed flask under an atmosphere of N2. The 
solution was then allowed to cool to –78 °C in a Dewar of dry ice/acetone. 3 M 
MeMgCl in THF (10 equiv.) was added drop wise over 10 min. After 1 h, the flask 
was removed from the Dewar and allowed to attain ambient temperature 
overnight. The reaction was then quenched with saturated aqueous NH4Cl solution 
(5 mL per g of iminium salt) and CH2Cl2 (30 mL per g of iminium salt) was then 
added to dilute the mixture. The resulting biphasic mixture was transferred to a 
separating funnel and brine (100 mL) was added. The organic layer was collected 
and the remaining aqueous layer was washed with CH2Cl2 (2 x 50 mL per g of 
iminium salt). The combined organics were washed with water (2 x 100 mL per g of 
iminium salt) and brine (2 x 100 mL per g of iminium salt). The organic fraction was 
dried over MgSO4, evaporated to dryness under reduced pressure to yield the 
desired methyl-azepines.  
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(5R, 11bRa)-6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,5,11-trimethyl-
6,7-dihydro-5H-dibenzo[c,e]azepine (201) 
 
Prepared according to the general procedure from 199 (0.60 g, 1.45 mmol). The 
title compound 201 was isolated as a colourless foam (0.34 g, 94%): max(neat)/cm
-
1 3059, 2991, 2921, 2859, 1593, 1497, 1452, 1378, 1342, 1265, 1239, 1201, 1156, 
1079, 1029, 955, 910, 885, 853, 787, 744, 700; H (400 MHz; CDCl3) 0.21 (3H, d, J = 
7.2 Hz, N-CHMe-Ar), 1.56 (3H, s, CMe2), 1.63 (3H, s, CMe2), 2.07 (3H, s, Ar-Me), 2.13 
(3H, s, Ar-Me), 2.91 (1H, dd, J = 6.0 Hz, 3.9 Hz, -NCH-), 3.35 (1H, d, J = 11.4 Hz, 
ArCH2N, upfield portion of AB system), 3.52 (1H, d, J = 11.4 Hz, ArCH2N, downfield 
portion of AB system), 4.08 (1H, dd, J = 12.3 Hz, 2.1 Hz, upfield portion of ABX 
system, NCH-CH2-O), 4.22 (1H, dd, J = 12.0 Hz, 4.0 Hz, downfield portion of ABX 
system, NCH-CH2-O), 4.33 (1H, q, J = 7.0 Hz, N-CHMe-Ar), 5.15 (1H, d, J = 3.5 Hz, 
NCH-CHAr-O), 6.81 (1H, t, J = 4.4 Hz, CH arom.), 6.86 (1H, dd, J = 6.7 Hz, 2.0 Hz, CH 
arom.), 7.09-7.15 (4H, m, 4 x CH arom.), 7.20-7.38 (5H, m, 5 x CH arom.); C (100 
MHz; CDCl3) 19.2 (1C, CMe2), 19.3 (1C, Ar-Me), 19.4 (1C, Ar-Me), 21.0 (1C, N-CHMe-
Ar), 29.1 (1C, CMe2), 54.0 (1C, ArCH2N), 59.7 (1C, N-CHMe-Ar), 60.0 (1C, -NCH-), 
63.2 (1C, NCH-CH2-O), 74.2 (1C, NCH-CHAr-O), 99.3 (1C, CMe2, C quat.), 126.0 (1C, 
CH arom.), 126.4 (2C, 2 x CH arom.), 126.6 (1C, CH arom.), 126.8 (1C, CH arom.), 
127.4 (2C, 2 x CH arom.), 127.6 (2C, 2 x CH arom.), 128.5 (1C, CH arom.), 128.7 (1C, 
CH arom.), 135.9 (2C, 2 x C quat. arom.), 136.9 (1C, C quat. arom.), 138.9 (1C, C 
quat. arom.), 139.2 (1C, C quat. arom.), 140.3 (1C, C quat. arom.), 141.3 (1C, C 
quat. arom.); m/z (HNES) 428.2582 - C29H33NO2 [M+H]
+ requires 428.2584. 
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(5S, 11bSa)-6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,5,11-trimethyl-
6,7-dihydro-5H-dibenzo[c,e]azepine (202) 
 
Prepared according to the general procedure from 200, (0.40 g, 0.97 mmol). The 
title compound 202 was isolated as a colourless foam, (0.23 g, 99%): max(neat)/cm
-
1 3059, 2991, 2921, 2859, 1593, 1497, 1452, 1378, 1342, 1265, 1239, 1201, 1156, 
1079, 1029, 955, 910, 885, 853, 787, 744, 700; H (400 MHz; CDCl3) 0.14 (3H, d, J = 
7.2 Hz, N-CHMe-Ar), 1.47 (3H, s, CMe2), 1.50 (3H, s, CMe2), 2.05 (3H, s, Ar-Me), 2.14 
(3H, s, Ar-Me), 3.02 (1H, dd, J = 6.5 Hz, 4.1 Hz, -NCH-), 3.31 (1H, d, J = 11.3 Hz, 
ArCH2N, upfield portion of AB system), 3.63 (1H, q, J = 7.1 Hz, N-CHMe-Ar), 3.90 
(1H, d, J = 11.3 Hz, ArCH2N, downfield portion of AB system), 4.01 (1H, dd, J = 12.3 
Hz, 2.4 Hz, NCH-CH2-O, upfield portion of ABX system), 4.15 (1H, dd, J = 12.3 Hz, 4.0 
Hz, NCH-CH2-O, downfield portion of ABX system), 5.20 (1H, d, J = 4.2 Hz, NCH-
CHAr-O), 6.65-6.71 (1H, m, CH arom.), 6.95 (1H, dd, J = 6.6 Hz, 2.1 Hz, CH arom.), 
7.02-7.07 (2H, m 2 x CH arom.), 7.15-7.24 (3H, m, 3 x CH arom.), 7.32 (2H, t, J = 7.7 
Hz, 2 x CH arom.), 7.46 (2H, t, J = 7.1 Hz, 2 x CH arom.); m/z (HNES) 428.2579 - 
C29H33NO2 [M+H]
+ requires 428.2584. 
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3.2.3 Experimental Procedures Related to the Binaphthyl- Systems 
 
(+)-(Sa)-[1,1’]-Binaphthalene-2,2’-diol-bis-trifluoromethanesulfonate
5 ((Sa)-212) 
 
(Sa)-211 (5.0 g, 17.5 mmol) was added to a flame dried flask and dissolved in CH2Cl2 
(100 mL) under and atmosphere of N2. The vessel was placed in a Dewar and 
allowed to cool to 30 °C with stirring. After the solution had reached the correct 
temperature, DMAP (0.85 g, 7.0 mmol), 2,6-lutidine (5.3 mL, 3 equiv., 45.0 mmol) 
and Tf2O (7.6 mL, 3 equiv., 45 mmol) were added to the solution. The resulting 
brown solution was removed from the Dewar and allowed to reach ambient 
temperature with stirring overnight. Silica gel was added to the dark brown solution 
and stirred for 20 min. Solvents were removed under reduced pressure to load the 
silica gel with the reaction mixture. The loaded silica gel was transferred to a 
sintered glass funnel containing a pad of silica gel, and washed with hexane until 
the product had eluted. The solvents were removed under reduced pressure to 
yield the known (Sa)-212 as a colourless crystalline solid (9.5 g, 99%): m.p. 76.3-78.2 
°C; []20D +150.3 (c = 1.03, CHCl3), , lit. []
20
D +154.2 (c = 1.00, CHCl3); max(neat)/cm
-
1 1624, 1584, 1509, 1471, 1407, 1325, 1208, 1173, 1133, 1065, 960, 938, 867, 856, 
826, 811, 773, 750, 701, 675, 615; H (300 MHz; CDCl3) 7.26 (2H, d, J = 8.5 Hz, 2 x CH 
arom.), 7.41 (2H, d, J = 7.2 Hz, 2 x CH arom.), 7.59 (2H, d, J = 7.7 Hz, 2 x CH arom.), 
7.63 (2H, d, J = 9.1 Hz, 2 x CH arom.), 8.02 (2H, d, J = 8.2 Hz, 2 x CH arom.), 8.14 (2H, 
d, J = 9.2 Hz, 2 x CH arom.). 
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(–)-(Ra)-[1,1’]-Binaphthalene-2,2’-diol-bis-trifluoromethanesulfonate
5 ((Ra)-212) 
 
Prepared in an identical manner to (Sa)-212 above, from (Ra)-211 (0.97 g, 3.39 
mmol). The known (Ra)-212 was Isolated as a colourless crystalline solid (1.85 g, 99 
%): m.p. 76.5-78.2 °C; []20D –150.9 (c = 1.01, CHCl3). All other data closely matched 
that of (Sa)-212. 
 
 
(+)-(Sa)-Dimethyl-[1,1’]-binaphthalene
5 ((Sa)-213) 
 
(Sa)-212 (9.0 g, 16.4 mmol) and 1,3-bis(diphenylphosphino)propane nickel (II) 
chloride (1.3 g, 2.45 mmol) were placed in a flame dried flask equipped with a 
stirrer bar, under an atmosphere of N2. Et2O (60 mL) was added to the vessel to 
dissolve the reaction components. The vessel was then allowed to cool to 30 °C 
prior to the the slow addition of 3 M MeMgBr in Et2O (21.8 mL, 65.6 mmol). After 
15 min., the vessel was removed from the Dewar and left to reach ambient 
temperature, with stirring, overnight. The reaction mixture was diluted with Et2O 
(60 mL) prior to the addition of Celite. The suspension was then stirred for 30 min. 
before it was filtered through a sintered glass funnel containing a pad of Celite. The 
filtrate was transferred to a separating funnel and washed consecutively with 2 M 
aqueous HCl (30 mL), water (100 mL) and brine (100 mL). Removal of the solvent 
under reduced pressure yielded the known (Sa)-213 as a colourless powder (4.12 g, 
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88%): m.p. 72.5-73.9 °C; []20D +41.1 (c = 0.99, CHCl3), lit. []
20
D +42.0 (c = 1.00, 
CHCl3); max(neat)/cm
-1 3045, 2918, 2857, 1618, 1594, 1509, 1421, 13779, 1352, 
1261, 1221, 1158, 1143 1028, 958, 947, 898, 864, 810, 775, 743, 720, 656; H (300 
MHz; CDCl3) 2.03 (6H, s, 2 x Ar-Me), 7.04 (2H, d, J = 8.0 Hz, 2 x CH arom.), 7.19 (2H, 
m, 2 x CH arom.), 7.39 (2H, m, 2 x CH arom.), 7.50 (2H, d, J = 8.4 Hz, 2 x CH arom.), 
7.86 (2H, d, J = 4.6 Hz, 2 x CH arom.), 7.89 (2H, d, J = 4.5 Hz, 2 x CH arom.);C (75 
MHz; CDCl3); 20.1 (2C, 2 x Ar-Me), 124.9 (2C, 2 x CH-arom.), 125.7 (2C, 2 x CH-
arom.), 126.1 (2C, 2 x CH-arom.), 127.3 (2C, 2 x CH-arom.), 127.8 (2C, 2 x CH-arom.), 
128.8 (2C, 2 x CH-arom.), 132.2 (2C, 2 x C quat. arom.), 132.8 (2C, 2 x C quat. 
arom.), 134.3 (2C, 2 x C quat. arom.), 135.2 (2C, 2 x C quat. arom.). 
 
 
(–)-(Ra)-Dimethyl-[1,1’]-binaphthalene
5 ((Ra)-213) 
 
Prepared in an identical manner to (Sa)-213 (0.58 g, 1.05 mmol). The known title 
compound (Ra)-213 was isolated as a colourless powder (0.23 g, 80%): m.p. 72.1-
73.9 °C; []20D   40.9 (c = 1.19, CHCl3). All other data closely matched that of (Sa)-
213. 
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(–)-(Sa)-Bis-bromomethyl-[1,1’]-binaphthylenyl
5 ((Sa)-214) 
 
(Sa)-213 (3.5 g, 12.4 mmol) was dissolved in cyclohexane (24.5 mL). N-
bromosuccinimide (4.85 g, 27.3 mmol) and AIBN (0.21 g, 1.24 mmol) were added 
and the reaction mixture was heated under reflux. The reaction was removed from 
the heat when the consumption of the starting material had been observed by TLC 
analysis. After the vessel was removed from the heat and allowed to cool to 
ambient temperature, water (52.5 mL) and EtOAc (7.75 mL) were added to dissolve 
by-products and excess NBS. The biphasic suspension was stirred for 1 h to allow 
the complete precipitation of (Sa)-214. The solid was isolated by filtration, washed 
with cold cyclohexane and then dried to yield the known (Sa)-214 as a colourless 
powder (3.17 g, 58%): m.p. 184.3-187.2 °C; []20D –162.2 (c = 1.09, CHCl3), lit. []
20
D  
-–161.5 (c = 1.00, CHCl3); max(neat)/cm
-1 3049, 2925, 1772, 1722, 1507, 1433, 1361, 
1329, 1211, 1025, 969, 928, 820, 752, 722, 686, 626; H (400 MHz; CDCl3) 4.25 (4H, 
s, 2 x -CH2Br), 7.07 (2H, dq, J = 0.8 Hz, 8.5 Hz, 2 x CH arom.), 7.27 (2H, m, 2 x CH 
arom.), 7.49 (2H, m, 2 x CH arom.), 7.74 (2H, d, J = 8.6 Hz, 2 x CH arom.), 7.92 (2H, d, 
J = 8.2 Hz, 2 x CH arom.), 8.02 (2H, d, J = 8.5 Hz, 2 x CH arom.). 
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(+)-(Ra)-Bis-bromomethyl-[1,1’]-binaphthylenyl
5 ((Ra)-214) 
 
Prepared in an identical manner to (Sa)-214 from (Ra)-213 (3.5 g, 12.4mmol). The 
known title compound (Ra)-214 was isolated as a colourless powder (3.02 g, 55%): 
m.p. 182.9-184.8 °C; []20D +162.2 (c = 1.07, CHCl3). All other data closely matched 
that of (Sa)-214. 
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General procedure for the synthesis of binaphthalene-derived azepines 
 
The primary amine (1 equiv.) was added to a solution of (Ra)- or (Sa)-214 (1 equiv.) 
and K2CO3 (3 equiv.) in dry MeCN (10 mL per g of 214) at RT. The reaction mixture 
was heated under reflux overnight under an atmosphere of N2. Solvents were 
removed under reduced pressure and the resulting residue was dissolved in CH2Cl2 
(40 mL per g of 214) and filtered into a separating funnel to remove excess 
K2CO3.The organic layer was washed with water (2 x 30 mL per g of 214) and brine 
(1 x 30 mL per g of 214). The organic phase was collected, dried over MgSO4 and 
evaporated to dryness under reduced pressure to furnish the desired azepines in 
excellent purity. 
 
 
(–)-(Ra)-4-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine6 (217) 
 
Prepared according to the general procedure from (Ra)-214 (0.48 g, 1.12 mmol) and 
168 (0.23 g, 1.12 mmol). The known 217 was isolated as a colourless foam (0.51 g, 
99 %): []20D –342.8 (c = 1.06, CHCl3), lit. []
20
D -–360.8 (c = 1.00, CHCl3); 
max(neat)/cm
-1 2989, 1710, 1507, 1450, 1380, 1237, 1197, 1146, 1079, 1060, 1018, 
953, 851, 818, 770, 750, 697;H (300 MHz; CDCl3) 1.62 (3H, s, CMe2), 1.71 (3H, s, 
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CMe2), 2.72 (1H, td, J = 1.4 Hz, 3.5 Hz, -NCH-), 3.35 (2H, d, J = 12.2 Hz, 2 x ArCH2N, 
upfield portion of an AB system), 3.92 (2H, d, J = 12.2 Hz, 2 x ArCH2N, downfield 
portion of an AB system), 4.11 (1H, dd, J = 12.6 Hz, 1.5 Hz, NCH-CH2-O, upfield 
portion of an ABX system), 4.24 (1H, dd, J = 12.6 Hz, 3.6 Hz, NCH-CH2-O, downfield 
portion of an ABX system), 5.18 (1H, d, J = 3.3 Hz, NCH-CHAr-O), 7.18-7.45 (13H, m, 
13 x CH arom.), 7.85 (2H, d, J = 8.3 Hz, 2 x CH arom.), 7.89 (2H, d, J = 8.1 Hz, 2 x CH 
arom.). 
 
 
(Sa)-4-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine6 (221) 
 
Prepared according to the general procedure from (Sa)-214 (0.48 g, 1.12 mmol) and 
168 (0.23 g, 1.12 mmol). The known 221 was isolated as a colourless foam (0.49 g, 
93 %): max(neat)/cm
-1 3049, 2989, 2857, 1708, 1594, 1507, 1449, 1378, 1237, 1195, 
1136, 1078, 1061, 1027, 1014, 953, 851, 838, 817, 770, 751, 736, 697;H (300 MHz; 
CDCl3) 1.46 (3H, s, CMe2), 1.51 (3H, s, CMe2), 2.72 (1H, dd, J = 3.8 Hz, 6.0 Hz, -NCH-), 
3.50 (2H, d, J = 12.5 Hz, 2 x ArCH2N, upfield portion of AB system), 3.70 (2H, d, J = 
12.5 Hz, 2 x ArCH2N, downfield portion of AB system), 3.96 (1H, dd, J = 12.6 Hz, 2.1 
Hz, NCH-CH2-O, upfield portion of ABX system), 4.20 (1H, dd, J = 12.6 Hz, 3.7 Hz, 
NCH-CH2-O, downfield portion of ABX system), 5.19 (1H, d, J = 3.7 Hz, NCH-CHAr-O), 
7.20-7.27 (3H, m, 3 x CH arom.), 7.34-7.42 (8H, m, 8 x CH arom.), 7.50-7.56 (2H, m, 
2 x CH arom.), 7.82-7.90 (4H, m, 4 x CH arom.); m/z (HNES) 486.2420 - C34H31NO2 
[M+H]+ requires 486.2428. 
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(–)-(Ra)-4-((R)-3,3-Dimethylbutan-2-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine7 (218) 
 
Prepared according to the general procedure from (Ra)-214 (1.50 g, 3.39 mmol) and 
(R)-215 (0.34 g, 3.39 mmol). The known 218 was isolated as a colourless foam (1.20 
g, 99%): []20D –256.5 (c = 1.77, CDCl3), lit. []
20
D -–254.8 (c = 1.00, CHCl3); 
max(neat)/cm
-1 2957, 1709, 1508, 1459, 1377, 1357, 1243, 1195, 1162, 1144, 1109, 
1028, 865, 821, 731;H (400 MHz; CDCl3) 0.82 (3H, d, J = 7.2 Hz, N-CHMe
tBu), 0.96 
(9H, s, N-CHMetBu), 2.80 (1H, q, J = 7.2 Hz, N-CHMetBu), 3.51 (2H, d, J = 12.1 Hz, 2 x 
ArCH2N, upfield portion of AB system), 3.55 (2H, d, J = 12.1 Hz, 2 x ArCH2N, 
downfield portion of AB system), 7.25 (2H, ddd, J = 1.3 Hz, 6.8 Hz, 8.3 Hz, 2 x CH 
arom.), 7.42 (2H, ddd, J = 1.2 Hz, 6.8 Hz, 8.1 Hz, 2 x CH arom.), 7.48 (2H, d, J = 8.5 
Hz, 2 x CH arom.), 7.53 (2H, d, J = 8.3 Hz, 2 x CH arom.), 7.93 (4H, d, J = 8.2 Hz, 4 x 
CH arom.). 
 
 
(–)-(Ra)-4-((S)-3,3-Dimethylbutan-2-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine7 (219) 
 
Prepared according to the general procedure from (Ra)-214 (0.34 g) and (S)-215 
(1.50 g). The known 219 was isolated as a colourless foam (1.18 g, 99%): []20D –
301.4 (c = 1.98, CHCl3), lit. []
20
D –285.3 (c = 1.00, CHCl3); MAX(neat)/cm
-1 3409, 
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2967, 1711, 1595, 1508, 1465, 1352, 1144, 1113, 1050, 864, 815, 783, 749;H (400 
MHz; CDCl3) 0.96 (9H, s, N-CHMe
tBu), 1.10 (3H, d, J = 7.2 Hz, N-CHMetBu), 2.48 (1H, 
q, J = 6.9 Hz, N-CHMetBu), 3.50 (2H, d, J = 12.2 Hz, 2 x ArCH2N, upfield portion of AB 
system), 3.71 (2H, d, J = 12.2 Hz, 2 x ArCH2N, downfield portion of AB system), 7.23 
(2H, ddd, J = 1.3 Hz, 6.8 Hz, 8.3 Hz, 2 x CH arom.), 7.35-7.46 (4H, m, 4 x CH arom.), 
7.56 (2H, d, J = 8.3 Hz, 2 x CH arom), 7.91 (2H, dd, J = 2.6 Hz, 8.0 Hz, 2 x CH arom.). 
 
 
(–)-(Ra)-4-Isopropyl-2,7-dihydrodinaphtho[2,1-c;1’,2’-e]azepine
8 (220) 
 
Prepared according to the general procedure from (Ra)-214 (1.20 g, 2.73 mmol) and 
226 (0.16 g, 2.73 mmol). The known 220 was isolated as a colourless powder, (0.91 
g, 98%): m.p. 158.5-160.2C; []20D –473.6 (c = 0.47, CHCl3), lit. []
20
D –474.2 (c = 
1.08, CHCl3); max(neat)/cm
-1 3043, 2966, 2923, 2802, 1709, 1591, 1506, 1459, 1388, 
1373, 1349, 1261, 1239, 1160, 1112, 1086, 1065, 1028, 957, 945, 869, 852, 840, 
819, 806, 772, 755, 732, 693, 667, 624; H (300 MHz; CDCl3) 1.14 (3H, d, J = 6.4 Hz, 
NCHMe2), 1.28 (3H, d, J = 6.3 Hz, NCHMe2), 2.77 (1H, sept., J = 6.4 Hz, NCHMe2), 
3.26 (2H, d, J = 12.4 Hz, ArCH2N, upfield portion of AB system), 3.93 (2H, d, J = 12.4 
Hz, ArCH2N, downfield portion of AB system), 7.26 (2H, m, 2 x CH arom.), 7.45 (4H, 
m, 4 x CH arom.), 7.60 (2H, d, J = 8.3 Hz, 2 x CH arom.), 7.95 (4H, d, J = 8.0 Hz, 4 x CH 
arom.); C (75 MHz; CDCl3) 21.1 (1C, NCHMe2), 22.0 (1C, NCHMe2), 52.2 (2C, 2 x 
ArCH2N), 52.9 (1C, NCHMe2), 125.4 (2C, 2 x CH arom.), 125.7 (2C, 2 x CH arom.), 
127.5 (2C, 2 x CH arom.), 128.0 (2C, 2 x CH arom.), 128.3 (2C, 2 x CH arom.), 128.4 
(2C, 2 x CH arom.), 131.4 (2C, 2 x C quat. arom.), 133.1 (2C, 2 x C quat. arom.), 134.2 
(2C, 2 x C quat. arom.), 135.1 (2C, 2 x C quat. arom.). 
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General procedure for the synthesis of binaphthalene-derived iminium salt 
catalysts 
 
NBS (1.1 equiv.) was added to a solution of the azepine substrate (1 equiv.) in 
CH2Cl2 (30 mL per g of azepine). The resulting yellow solution was stirred for 1 h, 
when the solvent was switched to EtOH (20 mL per g of azepine). NaBPh4 (1.1 
equiv.), which had previously been dissolved in the minimum amount of MeCN, 
was added to the ethanolic solution. Solvents were removed under reduced 
pressure to yield an intensely yellow foam. EtOH (20 mL per g of azepine) was 
added and heated until the solid had dissolved (a few drops of MeCN was 
sometimes required to completely solvate some of the iminium salts). The solution 
was then allowed to cool to RT and the precipitate was isolated by filtration. The 
precipitate was washed with cold EtOH followed by Et2O and hexane. The fine 
yellow crystalline solids were left to dry under reduced pressure in an oven at 60 °C 
overnight. 
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(–)-(Ra)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3H-dinaphtho[2,1-
c:1',2'-e]azepin-4-ium tetraphenylborate5 (171) 
 
Prepared according to the general procedure from 217 (0.41 g, 0.84 mmol). The 
known 171 was isolated as a bright yellow powder (0.43 g, 63%): m.p. 153.8-163.9 
°C (dec.); []20D –357.7 (c = 0.99, acetone), lit. []
20
D –357.8 (c = 1.00, acetone); 
max(neat)/cm
-1 3056, 2997, 1612, 1580, 1548, 1463, 1426, 1381, 1266, 1237, 1200, 
1165, 1112, 1084, 1031, 961, 850, 818, 750, 730, 701, 668, 624;H (400 MHz; 
acetone-d6) 1.80 (3H, s, CMe2), 1.85 (3H, s, CMe2), 4.41 (1H, d, J = 13.9 Hz, ArCH2N, 
upfield portion of AB system), 4.51 (1H, d, J = 13.8 Hz, NCH-CH2-O, upfield portion 
of an ABX system), 4.71 (1H, t, J=3 Hz, -NCH-), 4.81 (1H, dd, J = 13.8 Hz, 3.0 Hz, NCH-
CH2-O, downfield portion of ABX system), 5.94 (1H, s, ArCH2N, downfield portion of 
AB system), 5.96 (1H, d, J = 3.0 Hz, NCH-CHAr-O), 6.75 (4H, t, J = 7.3 Hz, 4 x CH 
arom., para- –BPh4), 6.92 (8H, t, J = 7.4 Hz, 8 x CH arom., meta- 
–BPh4), 6.85-7.00 
(1H, m, CH arom.), 6.95 (1H, d, J = 8.6 Hz, CH arom.), 7.05 (2H, m, 2 x CH arom.), 
7.27 (1H, ddd, J = 8.6 Hz, 6.9 Hz, 1.3 Hz, CH arom.), 7.28-7.38 (10H, m, 2 x CH arom. 
/ 8 x CH arom. ortho- –BPh4), 7.40-7.51 (3H, m, 3 x CH arom.), 7.57 (1H, ddd, J = 8.0 
Hz, 6.8 Hz, 1.2 Hz, CH arom.), 7.78 (1H, m, CH arom.), 7.86 (1H, d, J = 8.4 Hz, CH 
arom.), 8.10 (1H, d, J = 8.2 Hz, CH arom.), 8.17 (1H, d, J = 8.3 Hz, CH arom.), 8.21 
(1H, d, J = 8.6 Hz, CH arom.), 8.22 (1H, d, J = 8.3 Hz, CH arom.), 9.09 (1H, s, -N=CH-). 
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(+)-(Sa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3H-dinaphtho[2,1-
c:1',2'-e]azepin-4-ium tetraphenylborate5 (172) 
 
Prepared according to the general procedure from 221 (0.48 g, 0.99 mmol). The 
known 172 was isolated as a yellow powder (0.42 g, 46%): m.p. 217.3-224.9 °C 
(dec.); []20D +533.3 (c = 0.99, acetone), lit. []
20
D –534.2 (c = 1.00, acetone); 
max(neat)/cm
-1 3054, 2998, 1637, 1613, 1580, 1548, 1461, 1426, 1383, 1337, 1263, 
1201, 1160, 1110, 1059, 1031, 966, 838, 817, 733, 704;H (400 MHz; acetone-d6) 
1.75 (3H, s, CMe2), 1.79 (3H, s, CMe2), 4.20 (1H, d, J = 13.6 Hz, ArCH2N, upfield 
portion of AB system), 4.33 (1H, d, J = 13.9 Hz, 1 x NCH-CH2-O, upfield portion of 
ABX system), 4.84 (1H, dd, J = 3.0 Hz, 13.9 Hz, NCH-CH2-O, downfield portion of ABX 
system), 5.06 (1H, t, J = 2.6 Hz, -NCH-), 5.08 (1H, d, J = 13.5 Hz, ArCH2N, downfield 
portion of AB system), 6.02 (1H, d, J = 2.7 Hz, NCH-CHAr-O), 6.77 (4H, t, J = 7.2 Hz, 4 
x CH arom., para- –BPh4), 6.92 (8H, t, J = 7.4 Hz, 8 x CH arom., meta- 
–BPh4), 6.95-
7.10 (4H, m, 4 x CH arom.), 7.25 (2H, d, J = 6.8 Hz, 2 x CH arom.), 7.30 (1H, m, CH 
arom.), 7.32-7.35 (8H, m, 8 x CH arom., ortho- –BPh4), 7.40-7.47 (2H, m, 2 x CH 
arom.), 7.59 (1H, t, J = 7.5 Hz, CH arom.), 7.79 (1H, ddd, J = 8.2 Hz, 5.8 Hz, 2.4 Hz, CH 
arom.), 7.90 (1H, d, J = 8.5 Hz, CH arom.), 8.04 (1H, d, J = 8.5 Hz, CH arom.), 8.12 
(1H, d, J = 8.2 Hz, CH arom.), 8.21 (1H, d, J = 8.3 Hz, CH arom.), 8.28 (1H, d, J = 8.5 
Hz, CH arom.), 8.34 (1H, d, J = 8.6 Hz, CH arom.), 9.67 (1H, s, -N=CH-). 
 
  
Chapter 3 - Experimental 
 
227 
 
(–)-(Ra)-4-((R)-3,3-Dimethylbutan-2-yl)-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate  (222) 
 
Prepared according to the general procedure from 218 (0.82 g, 2.16 mmol). 222 
was isolated as a bright yellow powder (1.11 g, 74 %): m.p. 197.8-204.2 °C (dec.); 
[]20D –468.1 (c = 1.01, acetone); max(neat)/cm
-1 3055, 2982, 1740, 1614, 1580, 
1548, 1470, 1425, 1370, 1325, 1228, 1135, 1080, 1033, 957, 840, 816, 745, 733, 
702, 671, 623;H (400 MHz; acetone-d6) 1.21 (9H, s, N-CHMe
tBu), 1.54 (3H, d, J = 
7.0 Hz, N-CHMetBu), 4.77 (1H, q, J = 7.1 Hz, N-CHMetBu), 5.08 (1H, d, J = 13.3 Hz, 
ArCH2N, upfield portion of AB system), 5.47 (1H, d, J = 13.3 Hz, ArCH2N, downfield 
portion of AB system), 6.76 (4H, t, J = 7.17 Hz, 4 x CH arom., para- –BPh4), 6.92 (8H, 
t, J = 7.4Hz, 8 x CH arom., ortho- –BPh4), 7.11 (1H, d, J = 8.7 Hz, CH arom.), 7.32-7.35 
(8H, m, 8 x CH arom., meta- –BPh4), 7.48 (1H, m, CH arom.), 7.56 (1H, d, J = 8.5 Hz, 
CH arom.), 7.58 (1H, ddd, J = 8.1 Hz, 6.8 Hz, 1.1 Hz, CH arom.), 7.81 (1H, ddd, J = 8.1 
Hz, 6.7 Hz, 1.3 Hz, CH arom.), 8.02 (1H, t, J = 8.2 Hz, CH arom.), 8.12 (1H, d, J = 8.5 
Hz, CH arom.), 8.23 (1H, d, J = 7.8 Hz, CH arom.), 8.28 (1H, d, J = 8.5 Hz, CH arom.), 
8.35 (1H, d, J = 8.7 Hz, CH arom.), 9.62 (1H, s, -N=CH-). 
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(–)-(Ra)-4-((S)-3,3-Dimethylbutan-2-yl)-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (223) 
 
Prepared according to the general procedure from 219 (0.92 g, 2.53 mmol). 223 
was isolated as a bright yellow powder (1.53 g, 87%): m.p. 217.8-223.4 °C (dec.); 
[]20D –390.0 (c = 1.07, acetone); max(neat)/cm
-1 3055, 2981, 1738, 1613, 1590, 
1478, 1428, 1374, 1328, 1253, 1226, 1122, 1098, 1032, 960, 841, 817, 750, 734, 
664, 610;H (400 MHz; acetone-d6) 1.23 (9H, s, N-CHMe
tBu), 1.77 (3H, d, J = 7.0 Hz, 
N-CHMetBu), 4.47 (1H, q, J = 6.7 Hz, N-CHMetBu), 4.90 (1H, d, J = 13.6 Hz, ArCH2N, 
upfield portion of AB system), 5.43 (1H, d, J = 13.7 Hz, ArCH2N, downfield portion of 
AB system), 6.75 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –BPh4), 6.89 (8H, t, J = 7.4 Hz, 
8 x CH arom., meta- –BPh4), 7.09 (1H, d, J = 8.7 Hz, CH arom.), 7.28-7.37 (9H, m, 8 x 
CH arom. ortho- –BPh4 / CH arom.), 7.48 (1H, m, CH arom.), 7.53 (1H, t, J = 8.6 Hz, 
CH arom.), 7.58 (1H, ddd, J = 8.1 Hz, 6.8 Hz, 1.1 Hz, CH arom.), 7.81 (1H, ddd, J = 8.2 
Hz, 6.6 Hz, 1.4 Hz, CH arom.), 7.98 (1H, d, J = 8.5 Hz, CH arom.), 8.03 (1H, d, J = 8.6 
Hz, CH arom.), 8.10 (1H, d, J = 8.2 Hz, CH arom.), 8.25 (2H, t, J = 8.8 Hz, 2 x CH 
arom.), 8.34 (1H, d, J = 8.7 Hz, CH arom.), 9.51 (1H, s, -N=CH-). 
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(–)-(Ra)-4-Isopropyl-3H-dinaphtho-[2,1-c;1’,2’-e]azepin-4-ium tetraphenylborate
8 
(224) 
 
Prepared according to the general procedure from 220 (0.80 g, 2.37 mmol). The 
known 224 was isolated as a fine yellow powder (0.85 g, 55%): m.p. 174.0 °C (dec); 
[]20D –485.8 (c = 1.12, acetone), lit. []
20
D –481.4 (c = 1.01, acetone); 
max(neat)/cm
-1 3052, 2981, 1633, 1578, 1551, 1459, 1426, 1375, 1354, 1253, 1128, 
1031, 841, 820, 749, 738, 731, 699, 669, 624, 611; H (300 MHz; CDCl3) 1.58 (3H, d, J 
= 6.6 Hz, NCHMe2), 1.61 (3H, d, J = 6.6 Hz, NCHMe2), 4.67 (1H, dd, J = 1.9 Hz, 13.5 
Hz, ArCH2N, upfield portion of AB system), 4.68 (1H, sept., J = 6.7 Hz, NCHMe2), 5.40 
(1H, dd, J = 1.2 Hz, 13.7 Hz, ArCH2N, downfield portion of AB system), 6.66 (4H, t, J = 
7.1 Hz, 4 x CH arom., para- –BPh4), 6.82 (8H, t, J = 7.4 Hz, 8 x CH arom., meta- 
–
BPh4), 7.01 (1H, dd, J = 0.8 Hz, 8.7 Hz, CH arom.), 7.25 (9H, m, CH arom., 8 x CH 
arom., ortho- –BPh4), 7.41 (2H, m, 2 x CH arom.), 7.51 (1H, ddd, J = 1.1 Hz, 6.8 Hz, 
8.1 Hz, CH arom.), 7.73 (1H, ddd, J = 1.8 Hz, 6.2 Hz, 8.2 Hz, CH arom.), 7.93 (2H, t, J = 
8.5 Hz, 2 x CH arom.), 8.03 (1H, d, J = 8.0 Hz, CH arom.), 8.15 (1H, d, J = 8.3 Hz, CH 
arom.), 8.20 (1H, d, J = 8.4 Hz, CH arom.), 8.26 (1H, d, J = 8.6 Hz, CH arom.), 9.31 
(1H, s, -N=CH-); C (75 MHz; CDCl3) 20.8 (1C, NCHMe2), 21.1 (1C, NCHMe2), 54.0, 
66.8, 122.4, (4C, 4 x CH arom., para- –BPh4), 126.2 (8C, 8 x CH arom., meta- 
–BPh4), 
126.8 (1C, CH arom.), 127.9 (1C, CH arom.), 127.95 (1C, CH arom.), 127.99 (1C, C 
quat. arom.), 128.2 (1C, CH arom.), 128.3 (1C, CH arom.), 128.7 (1C, CH arom.), 
129.7 (1C, CH arom.), 129.8 (1C, CH arom.), 130.3 (1C, CH arom.), 130.4 (1C, CH 
arom.), 131.2 (1C, CH arom.), 132.3 (1C, CH arom.), 132.6 (1C, C quat. arom.), 133.0 
(1C, C quat. arom.), 134.9 (1C, C quat. arom.), 136.4 (1C, C quat. arom.), 137.19 (1C, 
C quat. arom.), 137.21 (8C, 8 x CH arom. ortho- –BPh4) 137.6 (1C, C quat. arom.), 
142.4 (1C, C quat. arom.), 165.2 (4C, q, J = 49.4 Hz, 4 x CH arom. ipso- –BPh4 gp), 
169.5 (1C, -N=CH-). 
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General Procedure for the Grignard Addition to Binpahthyl-iminium Salts 
 
A flame dried round-bottomed flask under an atmosphere of N2 was charged with 
the desired iminium salt (1 equiv.) and THF (50 mL per g of iminium salt). The 
resulting bright-yellow solution was then allowed to cool to –78 C in a Dewar 
containing dry ice / acetone slurry. While maintaining the nitrogen atmosphere and 
temperature, the desired Grignard reagent (10 equiv.) was added dropwise down 
the inside of the flask. After a period of 1 h, the flask was removed from the Dewar 
and allowed to attain ambient temperature overnight. The reaction was then 
quenched with saturated aqueous NH4Cl solution (5 mL per g of iminium salt) and 
the reaction mixture was concentrated to a viscous slurry under reduced pressure. 
The slurry was diluted with EtOAc and filtered into a separating funnel removing 
any undissolved solid. The organic layer was collected and washed sequentially with 
water (2 x 60 mL per g of iminium salt) and brine (50 mL per g of iminium salt). The 
organic layer was dried over MgSO4. Solvents removed under reduced pressure 
after filtration to yield the desired azepine. The crude azepines were purified using 
flash column chromatography, typically eluting with light petroleum / EtOAc (5:1), 
buffered with 2% TEA. 
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(–)-(3R,11cRa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3-methyl-4,5-
dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (228) 
 
Prepared according to the general procedure from 171 (1.20 g, 1.49 mmol). 228 
was isolated as a colourless solid (0.51 g, 68%): m.p. 200.4 C (dec.); []20D 152.35 
(c = 0.68, CHCl3); max(neat)/cm
-1 3044, 2987, 2857, 1496, 1448, 1378, 1196, 1144, 
1101, 1078, 1016, 952, 907, 850, 818, 767, 749, 727, 697; H (400 MHz; CDCl3) 0.12 
(3H, d, J = 6.9 Hz, N-CHMe-Ar), 1.50 (3H, s, CMe2), 1.59 (3H, s, CMe2), 2.87 (1H, s, -
NCH-), 3.52 (1H, d, J = 11.5 Hz, ArCH2N, upfield portion of AB system), 3.72 (1H, d, J 
= 11.4 Hz, ArCH2N, downfield portion of AB system), 3.97 (1H, d, J = 12.4 Hz, NCH-
CH2-O, upfield portion of ABX system), 4.19 (1H, dd, J = 12.4 Hz, 3.6 Hz, NCH-CH2-O, 
downfield portion of ABX system), 4.44 (1H, q, J = 6.8 Hz, N-CHMe-Ar), 5.12 (1H, s, 
NCH-CHAr-O), 7.06-7.33 (13H, m, 13 x CH arom.), 7.72-7.80 (4H, m, 4 x CH arom.); 
C (75 MHz; CDCl3) 19.2 (1C, CMe2), 21.1 (1C, N-CHMe-Ar), 29.3 (1C, CMe2), 54.1 
(1C, ArCH2N), 59.9 (1C, s, -NCH-, C5), 60.1 (1C, N-CHMe-Ar), 63.9 (1C, NCH-CH2-O), 
72.3 (1C, NCH-CHAr-O), 99.4 (1C, s, CMe2, C quat.), 125.1 (1C, CH arom.), 125.1 (1C, 
CH arom.), 125.4 (1C, CH arom.), 125.6 (1C, CH arom.), 126.3 (2C, 2 x CH arom.), 
126.7 (1C, CH arom.), 127.4 (1C, CH arom.), 127.5 (1C, CH arom.), 127.6 (1C, CH 
arom.), 127.8 (2C, 2 x CH arom.), 128.0 (1C, CH arom.), 128.2 (1C, CH arom.), 128.4 
(2C, 2 x CH arom.), 128.6 (1C, CH arom.), 128. 9 (1C, CH arom.), 131.9 (1C, C quat. 
arom.), 132.0 (1C, C quat. arom.), 132.3 (1C, C quat. arom.), 132.6 (1C, C quat. 
arom.), 133.0 (1C, C quat. arom.), 135.0 (1C, C quat. arom.), 136.5 (1C, C quat. 
arom.), 140.0 (1C, C quat. arom.), 140.3 (1C, C quat. arom.); m/z (HNES) 500.2576 - 
C35H33NO2 [M+H]
+ requires 500.2584.  
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(+)-(3S,11cSa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3-methyl-4,5-
dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (231) 
 
Prepared according to the general procedure from 172 (0.39 g, 0.49 mmol). 231 
was isolated as a colourless foam (0.21 g, 78%): []20D +227.1 (c = 0.93, acetone); 
max(neat)/cm
-1 2991, 2920, 1714, 1596, 1498, 1449, 1378, 1221, 1197, 1079, 1014, 
854, 819, 768, 752, 698; H (400 MHz; acetone-d6) 0.15 (3H, d, J = 7.1 Hz, N-CHMe-
Ar), 1.38 (3H, s, CMe2), 1.51 (3H, s, CMe2), 3.28 (1H, m, -NCH-), 3.55 (1H, d, J = 11.4 
Hz, ArCH2N, upfield portion of AB system), 4.00-4.19 (2H, m, NCH-CH2-O, upfield 
portion of ABX system / N-CHMe-Ar), 4.26 (1H, d, J = 11.4 Hz, ArCH2N, downfield 
portion of AB system), 4.37 (1H, dd, 1H, d, J = 3.5 Hz, 12.4 Hz, NCH-CH2-O, 
downfield portion of ABX system), 5.38 (1H, d, J = 4.0 Hz, NCH-CHAr-O), 7.09 (1H, d, 
J = 8.3 Hz, CH arom.), 7.17-7.29 (4H, m, 4 x CH arom.), 7.33-7.41 (4H, m, 4 x CH 
arom.), 7.45 (1H, ddt, J = 1.1 Hz, 6.7 Hz, 8.7 Hz, CH arom.), 7.57-7.61 (3H, m, 3 x CH 
arom.), 7.78 (1H, d, J = 8.3 Hz, CH arom.), 7.90 (1H, d, J = 8.3 Hz, CH arom.), 8.00 
(1H, d, J = 8.2 Hz, CH arom.), 8.04 (1H, d, J = 8.3 Hz, CH arom.); C (75 MHz; acetone-
d6) 19.3 (1C, CMe2), 22.8 (1C, N-CHMe-Ar.), 28.8 (1C, CMe2), 52.1 (1C, ArCH2N), 62.9 
(1C, -NCH-), 63.9 (1C, NCH-CH2-O), 66.8 (1C, N-CHMe-Ar.), 74.3 (1C, NCH-CHAr-O), 
99.6 (1C, CMe2, C quat.), 126.0 (1C, CH arom.), 126.4 (1C, CH arom.), 126.5 (1C, CH 
arom.), 126.6 (1C, CH arom.), 126.9 (2C, 2 x CH arom.), 127.2 (1C, CH arom.), 127.8 
(1C, CH arom.), 128.0 (1C, CH arom.), 128.3 (2C, 2 x CH arom.), 129.1 (1C, CH 
arom.), 129.2 (1C, CH arom.), 129.3 (2C, 2 x CH arom.), 129.9 (2C, 2 x CH arom.), 
132.7 (1C, C quat. arom.), 133.0 (1C, C quat. arom.), 133.8 (1C, C quat. arom.), 
133.9 (1C, C quat. arom.), 134.0 (1C, C quat. arom.), 135.7 (1C, C quat. arom.), 
137.5 (1C, C quat. arom.), 140.8 (1C, C quat. arom.), 141.7 (1C, C quat. arom.); m/z 
(HNES) 500.2577 - C35H33NO2 [M+H]
+ requires 500.2584. 
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(3R,11cRa)-4-((R)-3,3-Dimethylbutan-2-yl)-3-methyl-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine 
 
Prepared according to the general procedure from 222 (0.50 g, 0.72 mmol). The 
title compound was isolated as a colourless foam (0.29 g, 99%): []21D   291.3 (c = 
1.03, CHCl3); max(neat)/cm
-1 3046, 2953, 2912, 2860, 1739, 1505, 1469, 1455, 1377, 
1364, 1325, 1313, 1248, 1218, 1199, 1166, 1147, 1110, 1071, 997, 815; (400 MHz; 
acetone-d6) 0.51 (3H, d, J = 7.1 Hz, N-CHMe-Ar), 0.98 (1H, d, J = 7.1 Hz, N-
CHMetBu), 1.04 (9H, s, N-CHMetBu), 2.73 (1H, q, J = 6.9 Hz, N-CHMetBu), 3.29 (1H, 
d, J = 10.8 Hz, ArCH2N, upfield portion of AB system), 3.70 (1H, d, J = 10.8 Hz, 
ArCH2N, downfield portion of AB system), 4.11 (1H, q, J = 7.0 Hz, N-CHMe-Ar), 7.25-
7.32 (2H, m, 2 x CH arom.), 7.35 (1H, d, J = 8.4 Hz, CH arom.), 7.41-7.51 (3H, m, 3 x 
CH arom.), 7.59 (1H, d, J = 8.3 Hz, CH arom.), 7.64 (1H, d, J = 8.3 Hz, CH arom.), 7.98-
8.08 (4H, m, 4 x CH arom.); C (100 MHz; acetone-d6) 10.5 (1C, N-CHMe
tBu), 22.5 
(1C, N-CHMe-Ar), 27.7 (3C, N-CHMetBu), 35.8 (1C, N-CHMetBu, C quat.), 49.4 (1C, 
ArCH2N), 70.1 (1C, N-CHMe-Ar), 73.0 (1C, N-CHMe
tBu), 125.4 (1C, CH arom.), 125.5 
(1C, CH arom.), 125.8 (1C, CH arom.), 125.9 (1C, CH arom.), 127.0 (1C, CH arom.), 
127.1 (1C, CH arom.), 127.9 (1C, CH arom.), 128.4 (1C, CH arom.), 128.6 (1C, CH 
arom.), 128.9 (1C, CH arom.), 129.0 (1C, CH arom.), 129.2 (1C, CH arom.), 132.0 (1C, 
C quat. arom.), 132.1 (1C, C quat. arom.), 132.3 (1C, C quat. arom.), 133.1 (1C, C 
quat. arom.), 133.2 (1C, C quat. arom.), 135.3 (1C, C quat. arom.), 136.8 (1C, C quat. 
arom.), 140.3 (1C, C quat. arom.); m/z (HNES) 324.2531 - C29H32N [M+H]
+ requires 
394.2529. 
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(3R,11cRa)-4-((S)-3,3-dimethylbutan-2-yl)-3-methyl-4,5-dihydro-3H-dinaphtho[2,1-
c:1',2'-e]azepine (229) 
 
Prepared according to the general procedure from 222 (0.50 g, 0.72 mmol). 229 
was isolated in good purity as a yellow foam (0.29 g, 99%): []20D   185.6 (c = 0.97, 
CHCl3); max(neat)/cm
-1 2950, 2920, 1688, 1505, 1458, 1431, 1388, 1364, 1321, 
1245, 1226, 1217, 1206, 1173, 1158, 1137, 1080, 1006, 863, 817; (400 MHz; 
acetone-d6) 0.52 (3H, d, J = 7.1 Hz, N-CHMe-Ar), 1.00 (9H, s, N-CHMetBu), 1.10 (1H, 
d, J = 7.0 Hz, N-CHMetBu) 2.63 (1H, q, J = 7.0 Hz, N-CHMetBu), 3.65 (1H, d, J = 10.9 
Hz, ArCH2N, upfield portion of AB system), 3.68 (1H, d, J = 11.0 Hz, ArCH2N, 
downfield portion of AB system), 4.26 (1H, q, J = 7.1 Hz, N-CHMe-Ar), 7.25-7.31 (3H, 
m, 3 x CH arom.), 7.40 (1H, d, J = 8.6 Hz, CH arom.), 7.44-7.51 (2H, m, 2 x CH arom.), 
7.57 (1H, d, J = 8.4 Hz, CH arom.), 7.67 (1H, d, J = 8.3 Hz, CH arom.), 7.99-8.05 (4H, 
m, 4 x CH arom.); C (100 MHz; acetone-d6) 11.6 (1C, N-CHMe
tBu), 22.6 (1C, N-
CHMe-Ar), 27.1 (3C, N-CHMetBu), 36.8 (1C, N-CHMetBu, C quat.), 57.5 (1C, ArCH2N), 
59.9 (1C, N-CHMe-Ar), 69.7 (1C, N-CHMetBu), 126.3 (1C, CH arom.), 126.4 (1C, CH 
arom.), 126.6 (1C, CH arom.), 126.7 (1C, CH arom.), 127.9 (1C, CH arom.), 128.0 (1C, 
CH arom.), 129.2 (1C, CH arom.), 129.3 (1C, CH arom.), 129.5 (1C, CH arom.), 129.6 
(1C, CH arom.), 129.9 (1C, CH arom.), 130.5 (1C, CH arom.), 132.9 (1C, C quat. 
arom.), 133.0 (1C, C quat. arom.), 133.8 (1C, C quat. arom.), 134.0 (1C, C quat. 
arom.), 134.2 (1C, C quat. arom.), 136.1 (1C, C quat. arom.), 137.2 (1C, C quat. 
arom.), 140.8 (1C, C quat. arom.); m/z (HNES) 324.2530 - C29H32N (M+H)
+ requires 
394.2529. 
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(–)-(3R,11cRa)-4-Isopropyl-3-methyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine (230) 
 
Prepared according to the general procedure from 224 (0.70 g, 1.07 mmol). 230 
was isolated as a colourless foam (0.32 g, 85%): []20D –375.3 (c = 1.02, CHCl3); 
max(neat)/cm
-1 3044, 2958, 2802, 1594, 1505, 1458, 1363, 1317, 1243, 1164, 1101, 
1057, 979, 948, 862, 810, 767, 749, 699, 674, 628; H (300 MHz; CDCl3) 0.50 (3H, d, J 
= 7.2 Hz, N-CHMe-Ar), 1.05 (3H, d, J = 6.5 Hz, NCHMe2), 1.13 (3H, d, J = 6.7 Hz, 
NCHMe2), 3.12 (1H, sept., J = 6.6 Hz, NCHMe2), 3.44 (1H, d, J = 10.5 Hz, ArCH2N, 
upfield portion of AB system), 3.64 (1H, d, J = 10.5 Hz, ArCH2N, downfield portion of 
AB system), 4.23 (1H, q, J = 7.2, N-CHMe-Ar), 7.26 (3H, m, 3 x CH arom.), 7.38 (1H, 
dd, J = 0.9 Hz, 8.6 Hz, CH arom.), 7.46 (2H, m, 2 x CH arom.), 7.61 (1H, d, J = 8.4 Hz, 
CH arom.), 7.66 (1H, d, J = 8.3 Hz, CH arom.), 8.01 (4H, m, 4 x CH arom.); C (75 
MHz; CDCl3) 18.9 (1C, N-CHMe-Ar), 21.2 (1C, NCHMe2), 24.5 (1C, NCHMe2), 53.1 
(1C, NCHMe2), 57.0 (1C, ArCH2N), 60.0 (1C, ArCHMe), 126.3 (1C, CH arom.), 126.4 
(1C, CH arom.), 126.6 (1C, CH arom.), 126.7 (1C, CH arom.), 128.0 (1C, CH arom.), 
129.0 (1C, CH arom.), 129.2 (1C, CH arom.), 129.3 (1C, CH arom.), 129.4 (1C, CH 
arom.), 129.7 (1C, CH arom.), 129.7 (1C, CH arom.), 130.4 (1C, CH arom.), 132.9 (1C, 
C quat. arom.), 133.0 (1C, C quat. arom.), 133.87 (1C, C quat. arom.), 133.93 (1C, C 
quat. arom.), 134.1 (1C, C quat. arom.), 135.9 (1C, C quat. arom.), 137.2 (1C, C quat. 
arom.), 141.0 (1C, C quat. arom.); m/z (HNES) 352.2064 - C26H26N [M+H]
+ requires 
352.2060. 
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(–)-(3R,11cRa)-4-((R)-3,3-Dimethylbutan-2-yl)-3-isopropyl-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine 
 
Prepared according to the general procedure from 222 (0.55 g, 0.80 mmol) and 3 M 
solution of iPrMgCl in Et2O (4.00 mL, 7.96 mmol). The crude product isolated as a 
yellow foam (0.32 g, 95%). A sample was purified by preparative TLC, eluting with 
light petroleum / EtOAc (5:1), which yielded a colourless residue for spectral 
analysis: []20D 225.0 (c = 0.88, CHCl3); max(neat)/cm
-1 3051, 2955, 2864, 1507, 
1462, 1428, 1366, 1319, 1227, 1138, 1086, 996, 952, 865, 814, 803, 744; H (300 
MHz; CDCl3) 0.18 (3H, d, J = 6.4 Hz, Ar-CH(CHMe2)-N), 0.30 (1H, m, Ar-CH(CHMe2)-
N), 0.78 (3H, d, J = 6.3 Hz, Ar-CH(CHMe2)-N), 0.91 (1H, d, J = 6.8, N-CHMe
tBu), 1.09 
(9H, s, N-CHMetBu), 2.62 (1H, q, J = 6.8 Hz, N-CHMetBu), 3.23 (1H, d, J = 10.2 Hz, Ar-
CH(CHMe2)-N), 3.32 (1H, d, J = 10.5 Hz, ArCH2N, upfield portion of AB system), 3.67 
(1H, d, J = 10.4 Hz, ArCH2N, downfield portion of AB system), 7.16-7.22 (2H, 2 x CH 
arom.), 7.33 (1H, J = 7.4 Hz, CH arom.), 7.35-7.47 (4H, m, 4 x CH arom.), 7.56 (1H, d, 
J = 7.1 Hz, CH arom.), 7.86-7.93 (4H, m, 4 x CH arom.); C (75 MHz; CDCl3) 9.6, 21.1, 
21.3, (1C, Ar-CH(CHMe2)-N), 29.2 (3C, N-CHMe
tBu), 33.6, 36.1, 48.2 (1C, ArCH2N), 
72.60, 81.12, 125.1 (1C, CH arom.), 125.2 (1C, CH arom.), 125.50 (1C, CH arom.), 
125.52 (1C, CH arom.), 127.3 (1C, CH arom.), 127.5 (1C, CH arom.), 127.9 (1C, CH 
arom.), 128.00 (1C, CH arom.), 128.02 (1C, CH arom.), 128.3 (1C, CH arom.), 128.5 
(1C, CH arom.), 131.1 (1C, CH arom.), 131.6 (1C, C quat. arom.), 131.8 (1C, C quat. 
arom.), 132.55 (1C, C quat. arom.), 132.57 (1C, C quat. arom.), 132.9 (1C, C quat. 
arom.), 135.4 (1C, C quat. arom.), 136.1 (1C, C quat. arom.), 139.2 (1C, C quat. 
arom.); m/z (HNES) 422.2836 - C31H35N [M+H]
+ requires 422.2842. 
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(3R,11cRa)-4-((R)-3,3-Dimethylbutan-2-yl)-3-phenyl-4,5-dihydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine 
 
Prepared according to the general procedure from 222 (0.56 g, 0.81 mmol) and 3 M 
solution of PhMgCl in Et2O (4.02 mL, 8.1 mmol). The crude product was isolated as 
yellow foam (0.30 g, 82%). Purification was attempted by preparative TLC, after 
various crystallization attemps failed. An unidentified impurity could not be 
removed. H (300 MHz; CDCl3) 1.03 (3H, d, J = 7.2 Hz, N-CHMe
tBu), 1.11 (9H, s, N-
CHMetBu), 2.86 (1H, q, J = 7.2 Hz, N-CHMetBu), 3.43 (1H, d, J = 10.5 Hz, ArCH2N, 
upfield portion of AB system), 3.78 (1H, d, J = 10.5 Hz, ArCH2N, downfield portion of 
AB system), 5.16 (1H, s, N-CHPh-Ar), 6.33 (1H, t, J = 7.5 Hz, CH arom.), 6.45 (2H, t, J 
= 7.5 Hz, 2 x CH arom.), 6.81 (1H, d, J = 8.2 Hz, CH arom.), 6.87-6.95 (2H, m, 2 x CH 
arom.), 7.16-7.24 (2H, m, 2 x CH arom.), 7.28-7.53 (6H, m, 6 x CH arom.), 7.59 (2H, 
m, 2 x CH arom.), 7.66 (1H, d, J = 8.3 Hz, CH arom.), 7.72 (1H, d, J = 8.3 Hz, CH 
arom.), 7.96 (1H, d, J = 8.1 Hz, CH arom.), 8.03 (1H, d, J = 8.2 Hz, CH arom.); m/z 
(HNES) 456.2677 - C34H34N [M+H]
+ requires 456.2686  
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General Procedure for the Synthesis of Substituted Binaphthyl Azepiniums 
 
NBS (1.1 equiv.) was added in one portion to a solution of the azepine substrate (1 
equiv.) in CH2Cl2 (30 mL per g of azepine) in a flask equipped with a stirrer bar. The 
resulting yellow solution was stirred for 10 min. The reaction was transferred to a 
separating funnel and the organic layer was washed with water (2 x 60 mL per g of 
azepine) and brine (30 mL per g of azepine), then dried over MgSO4. A solvent 
switch to EtOH was then performed. NaBPh4 (1.1 equiv.) in the minimum amount of 
MeCN was added to the ethanolic solution, resulting in the formation of a 
precipitate. Solvents were removed under reduced pressure to yield a almost solid 
residue. EtOH (40 mL per g of azepine) was added to the residue and heated until it 
had dissolved; a few drops of MeCN were added in the instances where the residue 
was not completely solvated. The solution was allowed to cool to ambient 
temperature and the precipitate was filtered off. The precipitate was washed with 
cold EtOH followed by hexane and Et2O. The fine powders were left to dry under 
reduced pressure in an oven at 60 °C overnight. 
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(–)-(3R,11cRa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3-methyl-3H-
dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate (232) 
 
Prepared according to the general procedure from 228 (0.48 g, 0.96 mmol), 232 
was isolated as orange-yellow powder (0.54 g, 69 %): m.p. 126.5-128.4 C (dec.); 
[]20D 302.48 (c = 1.05, acetone); max(neat)/cm
-1 3055, 2983, 2358, 2335, 1633, 
1612, 1580, 1551, 1464, 1426, 1380, 1262, 1238, 1201, 1164, 1111, 1031, 958, 857, 
816, 749, 733, 702, 668, 631, 611;H (300 MHz; MeCN-d3) 1.00 (3H, d, J = 7.1 Hz, N-
CHMe-Ar), 1.69 (3H, s, CMe2), 1.76 (3H, s, CMe2), 4.35 (1H, dd, J = 1.1 Hz, 13.8 Hz, 
NCH-CH2-O, upfield portion of ABX system), 4.44 (1H, td, J = 1.0 Hz, 3.0 Hz, -N-CH-), 
4.73 (1H, dd, J = 3.0 Hz, 13.8 Hz, NCH-CH2-O, downfield portion of ABX system), 5.61 
(1H, q, J = 6.9 Hz, N-CHMe-Ar), 5.67 (1H, d, J = 2.9 Hz, NCH-CHAr-O), 6.47 (1H, t, J = 
7.5 Hz, CH arom.), 6.67 (2H, t, J = 7.8 Hz, CH arom.), 6.81-6.89 (5H, m, CH arom. / 4 
x CH arom., para- –BPh4), 6.95-7.06 (10H, m, 2 x CH arom. / 8 x CH arom., meta- 
–
BPh4), 7.16-7.24 (1H, m, CH arom.), 7.25-7.37 (11H, m, 3 x CH arom. / 8 x CH arom. 
ortho in –BPh4), 7.55 (1H, ddd, J = 1.1 Hz, 6.8 Hz, 8.1 Hz, CH arom.), 7.73 (2H, ddd, J 
= 1.7 Hz, 4.9 Hz, 7.9 Hz, 2 x CH arom.), 8.01 (1H, d, J = 8.2 Hz, CH arom.), 8.02 (1H, d, 
J = 8.3 Hz, CH arom.), 8.12 (1H, d, J = 8.3 Hz, CH arom.), 8.21 (1H, d, J = 8.5 Hz, CH 
arom.), 9.31 (1H, s, -N=CH-); C (75 MHz; MeCN-d3) 13.8 (1C, s, N-CHMe-Ar), 18.0 
(1C, CMe2), 28.9 (1C, CMe2) 62.0 (1C, NCH-CH2-O), 68.4 (1C, -NCH-), 69.7 (1C, N-
CHMe-Ar) 71.2 (1C, NCH-CHAr-O), 101.2 (1C, CMe2, C quat.), 122.0 (4C, 4 x CH 
arom., para- –BPh4), 124.8 (2C, 2 x CH arom.), 124.9 (1C, C quat. arom.), 125.8-125.9 
(8C, 8 x CH arom., meta- –BPh4), 126.2 (1C, CH arom.), 126.4 (1C, CH arom.), 127.1 
(2C, 2 x CH arom.), 127.2 (1C, CH arom.), 127.9 (1C, CH arom.), 128.1 (1C, CH 
arom.), 128.5 (2C, 2 x CH arom.), 128.7 (1C, CH arom.), 129.0 (1C, CH arom.), 129.49 
(1C, CH arom.), 129.50 (1C, CH arom.), 131.0 (1C, CH arom.), 131.9 (1C, C quat. 
arom.), 132.0 (1C, CH arom.), 133.0 (1C, C quat. arom.), 134.0 (1C, C quat. arom.), 
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135.8 (1C, C quat. arom.), 135.9 (1C, C quat. arom.), 136.0 (8C, 8 x CH arom., ortho- 
–BPh4), 138.9 (1C, C quat. arom.), 142.1 (1C, C quat. arom.), 164.2 (4C, q, J = 49.0 Hz, 
4 x C quat. arom., ipso- –BPh4), 169.2 (1C, -N=CH-), C quat. arom. not observed; m/z 
(HNES) 498.2415 - C35H32NO2 [MBPh4]
+ requires 498.2428.  
 
 
(+)-(3S,11cSa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3-methyl-3H-
dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate (235) 
 
Prepared according to the general procedure from 231 (0.17 g, 0.34 mmol). 235 
was isolated as bright yellow powder (0.20 g, 72%): m.p. 203.1 - 204.5 C (dec.); 
[]20D +421.4 (c = 0.99, acetone); max(neat)/cm
-1 3054, 2986, 1631, 1611, 1586, 
1554, 1464, 1426, 1379, 1240, 1198, 1120, 1086, 1048, 1030, 952, 834, 821, 753, 
733, 701, 672;H (400 MHz; acetone-d6) 0.75 (1H, d, J = 7.1 Hz, N-CHMe-Ar), 1.73 
(3H, s, CMe2), 1.74 (3H, s, CMe2), 4.29 (1H, d, J = 13.9 Hz, NCH-CH2-O, upfield 
portion of ABX system), 4.88 (1H, dd, J = 2.9 Hz, 13.9 Hz, NCH-CH2-O, downfield 
portion of ABX system), 5.01 (1H, t, J = 2.7 Hz, -NCH-), 6.02 (1H, d, J = 2.9 Hz, NCH-
CHAr-O), 6.05 (1H, q, J = 7.1 Hz, N-CHMe-Ar), 6.78 (4H, t, J = 7.2 Hz, 4 x CH arom., 
para- –BPh4), 6.93-7.04 (12H, 8 x CH arom., ortho- 
–BPh4 / 4 x CH arom.), 7.24-7.46 
(13H, m, 8 x CH arom. meta- –BPh4 / 5 x CH arom.), 7.59 (1H, t, J = 7.2 Hz, CH arom.), 
7.75-7.81 (2H, m, CH arom.), 7.95 (1H, d, J = 8.6 Hz, CH arom.), 8.12 (1H, d, J = 8.2 
Hz, CH arom.), 8.17 (1H, d, J = 8.2 Hz, CH arom.), 8.28 (1H, d, J = 8.6 Hz, CH arom.), 
8.29 (1H, d, J = 8.3 Hz, CH arom.), 9.47 (1H, s, N=CH); C (75 MHz; acetone-d6) 12.4 
(1C, N-CHMe-Ar), 17.9 (1C, CMe2), 28.6 (1C, CMe2), 61.8 (1C, NCH-CH2-O), 68.8 (1C, 
NCH-CHAr-O), 69.2 (1C, -NCH-), 71.8 (1C, N-CHMe-Ar), 101.1 (1C, CMe2, C quat.), 
121.6 (4C, 4 x CH arom., para- –BPh4), 125.3 (8C, 8 x CH arom., meta- 
–BPh4), 125.5 
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(2C, 2 x CH arom.), 126.6 (1C, CH arom.), 127.1 (1C, CH arom.), 127.2 (1C, CH 
arom.), 127.25 (1C, CH arom.), 127.29 (1C, CH arom.), 128.2 (1C, CH arom.), 128.3 
(1C, CH arom.), 128.7 (1C, CH arom.), 128.8 (2C, 2 x CH arom.), 129.0 (1C, CH 
arom.), 129.3 (1C, CH arom.), 129.5 (1C, C quat. arom.), 129.6 (1C, CH arom.), 131.0 
(1C, CH arom.), 131.7 (1C, CH arom.), 131.8 (1C, C quat. arom.), 132.9 (1C, C quat. 
arom.), 134.0 (1C, C quat. arom.), 135.9 (1C, C quat. arom.), 139.6 (1C, C quat. 
arom.), 141.8 (1C, C quat. arom.), 164.3 (4C, q, J = 49.0 Hz, 4 x CH arom., ipso- –
BPh4), 176.2 (1C, -N=CH-), 2 x C quat. arom. not observed; m/z (HNESP) 498.2413 - 
C35H32NO2 [MBPh4]
+ requires 498.2428. 
 
 
(–)-(3R,11cRa)-4-((R)-3,3-Dimethylbutan-2-yl)-3-methyl-3H-dinaphtho[2,1-c:1',2'-
e]azepin-4-ium tetraphenylborate (225) 
 
Prepared according to the general procedure from (3R, 11cR)-4-((R)-3,3-
dimethylbutan-2-yl)-3-methyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (0.25 
g, 0.64 mmol). The title compound 225 was isolated as a fine yellow powder (0.33 g, 
72%): m.p. 108.3 C (dec.); []20D 324.00 (c = 1.00, acetone); max(neat)/cm
-1 3054, 
2981, 1610, 1585, 1557, 1464, 1425, 1373, 1120, 1089, 1032, 817, 731, 702, 666, 
611;H (400 MHz; acetone-d6) 0.97 (9H, s, N-CHMe
tBu), 1.29 (3H, d, J = 7.1 Hz, 
NCHMeAr), 1.80 (3H, br, N-CHMetBu), 4.59 (1H, q, J = 6.9 Hz, N-CHMetBu), 5.88 (1H, 
q, J = 7.1 Hz, NCHMeAr), 6.74 (4H, t, J = 7.1 Hz, 4 x CH arom., para- –BPh4), 6.89 (8H, 
t, J = 7.4 Hz, CH arom., ortho- –BPh4), 7.06 (1H, d, J = 8.6 Hz, CH arom.), 7.25-7.35 
(11H, m, 3 x CH arom. / 8 x CH arom., meta- –BPh4), 7.42 (1H, m, CH arom.), 7.56 
(1H, ddd, J = 1.1 Hz, 6.8 Hz, 8.1 Hz, CH arom.), 7.77 (1H, ddd, J = 1.2 Hz, 6.8 Hz, 8.1 
Hz, CH arom.), 7.82 (1H, d, J = 8.5 Hz, CH arom.), 8.04 (1H, d, J = 8.6 Hz, CH arom.), 
8.07 (1H, d, J = 8.2 Hz, CH arom.), 8.19 (1H, d, J = 8.3 Hz, CH arom.), 8.26 (1H, d, J = 
Chapter 3 - Experimental 
 
242 
 
8.4 Hz, CH arom.), 8.33 (1H, d, J = 8.5 Hz, CH arom.), 9.67 (1H, s, -N=CH-); C (75 
MHz; acetone-d6); 12.2 (1C, N-CHMe
tBu), 14.7 (1C, N-CHMe-Ar), 26.5 (3C, N-
CHMetBu), 35.8 (1C, N-CHMetBu, C quat.), 62.1 (1C, N-CHMe-Ar), 81.8 (1C, N-
CHMetBu), 122.3 (4C, 4 x CH arom., para- –BPh4), 126.1 (8C, 8 x CH arom., meta- 
–
BPh4), 126.6 (1C, arom.), 128.05 (1C, CH arom.), 128.13 (1C, CH arom.), 128.2 (1C, 
CH arom.), 128.3 (1C, C arom.), 128.9 (1C, CH arom.), 129.5 (1C, CH arom.), 129.8 
(1C, CH arom.), 130.1 (1C, CH arom.), 130.4 (1C, CH arom.), 131.0 (1C, C arom.), 
131.7 (1C, CH arom.), 132.1 (1C, C quat. arom.), 132.8 (1C, C quat. arom.), 133.3 
(1C, C quat. arom.), 134.6 (1C, C quat. arom.), 136.9 (1C, C quat. arom.), 137.2 (8C, 
8 x CH arom., ortho- –BPh4), 140.7 (1C, C arom.), 142.7 (1C, C quat. arom.), 165.3 
(4C, q, J = 49.0 Hz, 4 x C quat. arom., ipso- –BPh4) 171.7 (1C, -N=CH-), C arom. not 
observed; m/z (HNESP) 392.2370 - C29H30N [M–BPh4]
+ requires 392.2373. 
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(–)-(3R,11cRa)-4-((S)-3,3-Dimethylbutan-2-yl)-3-methyl-3H-dinaphtho[2,1-c:1',2'-
e]azepin-4-ium tetraphenylborate (233) 
 
Prepared according to the general procedure from 229 (0.27 g, 0.69 mmol). 233 
was isolated as a fine orange-yellow powder (0.31 g, 64%): m.p. 131.2 C (dec.); 
[]20D 259.56 (c = 0.90, acetone); max(neat)/cm
-1 3056, 2986, 1612, 1587, 1552, 
1478, 1426, 1381, 1261, 1119, 1088, 1032, 960, 817, 732, 702, 670, 632, 611;H 
(400 MHz; acetone-D6) 1.18 (9H, br, N-CHMe
tBu), 1.33 (3H, d, J = 6.9 Hz, N-CHMe-
Ar), 1.74 (3H, br, N-CHMetBu), 4.55 (1H, br, N-CHMetBu), 5.89 (1H, q, J = 7.0 Hz, N-
CHMe-Ar), 6.73 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –BPh4), 6.88 (8H, t, J = 7.4 Hz, 
CH arom., meta- –BPh4), 7.07 (1H, d, J = 8.6 Hz, CH arom.), 7.29 (9H, m, CH arom. / 8 
x CH arom., ortho- –BPh4), 7.45 (2H, m, 2 x CH arom.), 7.55 (1H, ddd, J = 1.1 Hz, 6.8 
Hz, 8.0 Hz, CH arom.), 7.79 (1H, m, CH arom.), 7.85 (1H, br, CH arom.), 8.06 (1H, d, J 
= 8.2 Hz, CH arom.), 8.10 (1H, br, CH arom.), 8.21 (1H, d, J = 8.3 Hz, CH arom.), 8.22 
(1H, d, J = 8.5 Hz, CH arom.), 8.34 (1H, d, J = 8.6 Hz, CH arom.), 9.52 (1H, br, -N=CH-
); C (75 MHz; MeCN-d3) 13.6 (1C, 1 N-CHMe-Ar), 26.1 (3C, N-CHMe
tBu), 35.8 (1C, N-
CHMetBu, C quat.), 80.6 (1C, N-CHMetBu), 121.5 (4C, 4 x CH arom., para- –BPh4), 
125.3 (8C, 8 x CH arom., meta- –BPh4), 125.7 (1C, C arom.), 127.2 (1C, CH arom.), 
127.3 (2C, 2 x CH arom.), 128.2 (1C, CH arom.), 128.7 (1C, CH arom.), 129.0 (1C, CH 
arom.), 129.3 (1C, CH arom.), 129.8 (1C, CH arom.), 129.8 (1C, C quat. arom.), 130.8 
(1C, CH arom.), 131.5 (1C, CH arom.), 132.0 (1C, C quat. arom.), 132.7 (1C, C quat. 
arom.), 133.9 (1C, C quat. arom.), 135.9 (1C, C quat. arom.), 136.4 (8C, 8 x CH 
arom., ortho- –BPh4), 141.6 (1C, C quat. arom.), 164.3 (4C, q, J = 49.0 Hz, 4 x CH 
arom., ipso- –BPh4), N-CHMe
tBu, NCHMeAr, 3 x C arom. and -N=CH- not observed; 
m/z (HNESP) 392.2372 - C29H30N [M–BPh4]
+ requires 392.2373. 
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(–)-(3R,11cRa)-4-isopropyl-3-methyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (234) 
 
Prepared according to the general procedure from 230 (0.32 g, 0.92 mmol). The 
title compound 234 was isolated as a bright yellow powder (0.43 g, 71%): m.p. 
209.0-218.3 C (dec.); []20D 358.38 (c = 0.99, acetone); max (neat)/cm
-1 2053, 
1652, 1591, 1578, 1552, 1474, 1461, 1524, 1376, 1359, 1262, 1211, 1134, 1109, 
1045, 1030, 969, 867, 823, 796, 746, 735, 702; H (300 MHz; DMSO) 1.05 (3H, d, J = 
7.1 Hz, N-CHMe-Ar), 1.44 (3H, d, J = 6.5 Hz, NCHMe2), 1.57 (3H, d, J = 6.5 Hz, 
NCHMe2), 4.57 (1H, sept., J = 6.5 Hz, NCHMe2), 5.90 (1H, q, J = 7.1 Hz, N-CHMe-Ar), 
6.76 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –BPh4), 6.90 (8H, t, J = 7.3 Hz, 8 x CH 
arom., meta- –BPh4), 6.97 (1H, d, J = 8.5 Hz, CH arom.), 7.17 (8H, m, 8 x CH arom., 
ortho- –BPh4), 7.26 (1H, ddd, J = 1.3 Hz, 6.8 Hz, 8.2 Hz, CH arom.), 7.34 (1H, d, J = 8.6 
Hz, CH arom.), 7.45 (1H, ddd, J = 1.2 Hz, 6.8 Hz, 8.0 Hz, CH arom.), 7.53 (1H, ddd, J = 
1.0 Hz, 6.8 Hz, 8.0 Hz, CH arom.), 7.76 (1H, ddd, J = 1.0 Hz, 6.8 Hz, 8.0 Hz, CH arom.), 
7.90 (1H, d, J = 8.5 Hz, CH arom.), 8.07 (2H, m, 2 x CH arom.), 8.23 (2H, t, J = 8.6 Hz, 
2 x CH arom.), 8.36 (1H, d, J = 8.6 Hz, CH arom.), 9.52 (1H, s, -N=CH-); C (75 MHz; 
DMSO) 14.3, 19.4, 20.0, 60.2, 66.7, 121.7 (4C, 4 x CH arom., para- –BPh4), 125.5 (8C, 
8 x CH arom., meta- –BPh4), 125.8 (1C, CH arom.), 126.6 (1C, CH arom.), 126.7 (1C, 
CH arom.), 126.9 (1C, CH arom.), 127.0 (1C, CH arom.), 127.1 (1C, CH arom.), 128.0 
(1C, CH arom.), 128.7 (1C, CH arom.), 129.0 (1C, CH arom.), 129.25 (1C, CH arom.), 
129.34 (1C, CH arom.), 130.3 (1C, CH arom.), 131.3 (1C, CH arom.), 131.4 (1C, CH 
arom.), 132.0 (1C, CH arom.), 133.3 (1C, CH arom.), 134.7 (1C, CH arom.), 135.0 (1C, 
CH arom.), 135.8 (8C, 4 x CH arom., ortho- –BPh4), 140.2 (1C, C arom.), 140.4 (1C, C 
arom.), 163.6 (4C, q, J = 49.0 Hz, 4 x C quat. arom., ipso- –BPh4), 167.6 (1C, -N=CH-); 
m/z (HNESP) 350.1904 - C26H25N [MBPh4]
+ requires 350.1903. 
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(–)-(3R,11cRa)-4-((R)-3,3-Dimethylbutan-2-yl)-3-isopropyl-3H-dinaphtho[2,1-
c:1',2'-e]azepin-4-ium tetraphenylborate (226) 
 
Prepared according to the general procedure from (–)-(3R,11cRa)-4-((R)-3,3-
dimethylbutan-2-yl)-3-isopropyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 
(0.32 g, 0.69 mmol) and NBS (0.14 g, 0.76 mmol). Title compound 226 was isolated 
as a dark yellow powder (0.20 g, 38%): m.p. 113.6 C (dec.); []20D 373.5 (1.04, 
acetone); max(neat)/cm
-1 3049, 2969, 1587, 1549, 1465, 1426, 1372, 1120, 1086, 
1032, 842, 815, 732, 666, 621, 612; H (400 MHz; CDCl3) 0.85 (12H, m, N-
CH(CHMe2)-Ar / N-CHMe
tBu), 0.92 (3H, d, J = 6.8 Hz, N-CHMetBu), 1.85 (3H, d, J = 
6.9 Hz, N-CH(CHMe2)-Ar), 4.63 (1H, q, J = 7.0 Hz, N-CHMe
tBu), 5.34 (1H, d, J = 10.7 
Hz, N-CH(CHMe2)-Ar), 6.77 (4H, t, J = 7.3 Hz, 4 x CH arom., para- 
–BPh4), 6.92 (8H, t, 
J = 7.4 Hz, 8 x CH arom., meta- –BPh4), 7.13 (1H, d, J = 8.7 Hz, CH arom.), 7.31-7.43 
(10H, m, 2 x CH arom. / 8 x CH arom., ortho- –BPh4), 7.44 (1H, ddd, J = 8.1 Hz, 6.8 Hz, 
1.1 Hz, CH arom.), 7.60 (1H, ddd, J = 8.1 Hz, 6.8 Hz, 1.1 Hz, CH arom.), 7.80 (1H, ddd, 
J = 8.1 Hz, 6.7 Hz, 1.2 Hz, CH arom.), 7.95 (1H, d, J = 8.5 Hz, CH arom.), 8.12 (1H, d, J 
= 8.4 Hz, CH arom.), 8.13 (1H, d, J = 8.4 Hz, CH arom.), 8.22 (1H, d, J = 8.6 Hz, CH 
arom.), 8.33 (1H, d, J = 8.4 Hz, CH arom.), 8.34 (1H, d, J = 8.5 Hz, CH arom.), 9.79 
(1H, s, -N=CH-); C (75 MHz; CDCl3) 13.4, 19.5, 19.9, 25.8, 26.5 (3C, N-CHMe
tBu), 
35.9, 72.9, 81.8, 121.5 (4C, 4 x CH arom., para- –BPh4), 125.3 (8C, 8 x CH arom., 
meta- –BPh4), 125.4 (1C, C quat. arom.), 126.7 (1C, CH arom.), 127.4 (1C, CH arom.), 
127.5 (2C, 2 x CH arom.), 128.2 (1C, CH arom.), 128.7 (1C, CH arom.), 129.1 (1C, CH 
arom.), 129.2 (1C, CH arom.), 129.3 (1C, CH arom.), 129.7 (1C, C quat. arom.), 129.9 
(1C, CH arom.), 130.9 (1C, CH arom.), 131.0 (1C, CH arom.), 131.8 (1C, C quat. 
arom.), 133.1 (1C, C quat. arom.), 133.7 (1C, C quat. arom.), 136.2 (1C, C quat. 
arom.), 136.4 (8C, 8 x CH arom., ortho- –BPh4), 140.2 (1C, C quat. arom.), 141.9 (1C, 
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C quat. arom.), 163.8 (4C, q, J = 49.0 Hz, 4 x C quat. arom., ipso- –BPh4), 170.9 (1C, -
N=CH-); m/z (HNES) 420.2684 - C31H34N (M+H)
+ requires 420.2686. 
 
 
(3R,11cRa)-4-((R)-3,3-Dimethylbutan-2-yl)-3-phenyl-3H-dinaphtho[2,1-c:1',2'-
e]azepin-4-ium tetraphenylborate (227) 
 
Prepared according to the general procedure from crude (3R,11cRa)-4-((R)-3,3-
dimethylbutan-2-yl)-3-phenyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (0.25 
g, 0.55 mmol) and NBS (0.11 g, 0.61 mmol). The title compound 227 was isolated as 
a yellow powder (0.21 g, 48%): m.p. 113.6C (dec.) max(neat)/cm
-1 3056, 2966, 
1945, 1686, 1594, 1552, 1494, 1448, 1427, 1372, 1259, 1151, 1120, 1094, 1030, 
1001, 869, 816, 797, 731; H (400 MHz; acetone-d6) 1.04 (9H, s, N-CHMe
tBu), 1.89 
(3H, d, J = 6.8 Hz, N-CHMetBu), 5.07 (1H, q, J = 6.8 Hz, N-CHMetBu), 6.78 (6H, m, 2 x 
CH arom. / 4 x CH arom., para- –BPh4), 6.93 (8H, t, J = 7.4 Hz, 8 x CH arom., meta- 
–
BPh4), 6.98-7.04 (3H, m, 3 x CH arom.), 7.07 (1H, s, CH arom.), 7.12 (1H, d, J = 8.6 
Hz, CH arom.), 7.22-7.28 (2H, m, 2 x CH arom.), 7.34-7.39 (8H, m, 8 x CH arom., 
ortho- –BPh4), 7.57-7.67 (2H, m, 2 x CH arom.), 7.92 (1H, d, J = 8.2 Hz, CH arom.), 
8.06 (2H, s, 2 x CH arom.), 8.17 (1H, d, J = 8.2 Hz, CH arom.), 8.28 (1H, d, J = 8.5 Hz, 
CH arom.), 8.42 (1H, d, J = 8.5 Hz, CH arom.), 10.24 (1H, s, -N=CH-); C (75 MHz; 
acetone-d6) 26.1, 26.6, 36.0, 80.7, 121.6 (4C, 4 x CH arom., para- –BPh4), 125.3 (8C, 
8 x CH arom., meta- –BPh4), 125.6 (2C, 2 x CH arom.), 126.4 (1C, CH arom.), 127.0 
(1C, CH arom.), 127.3 (1C, CH arom.), 127.4 (1C, CH arom.), 127.46 (1C, CH arom.), 
127.49 (1C, CH arom.), 127.6 (1C, CH arom.), 128.0 (2C, 2 x CH arom.), 128.3 (1C, C 
quat. arom.), 128.5 (1C, CH arom.), 128.8 (2C, 2 x CH arom.), 129.0 (1C, CH arom.), 
129.1 (1C, CH arom.), 129.4 (1C, CH arom.), 129.5 (1C, C quat. arom.), 130.5 (1C, C 
quat. arom.), 131.0 (1C, C quat. arom.), 131.1 (1C, C quat. arom.), 133.2 (1C, C quat. 
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arom.), 133.4 (1C, C quat. arom.), 134.0 (1C, C quat. arom.), 135.4 (1C, C quat. 
arom.), 136.4 (8C, 8 x CH arom., ortho- –BPh4), 164.3 (4C, q, J = 49.0 Hz, 4 x C quat. 
arom., ipso- –BPh4), 172.45 (1C, -N=CH-); m/z (HNES) 454.2524 - C34H32N (M+H)
+ 
requires 454.2529. 
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3.2.4 Experimental Procedures Related to the Octahydrobinaphthyl- Systems 
 
(–)-(Ra)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diol
9 (243) 
 
(Ra)-214 (3.00 g, 11.5 mmol) was divided equally between 3 test tubes each 
containing Pd/C 10% w/w (0.20 g). Glacial acetic acid (4.0 mL) was added to each of 
the test tubes and mixed. The tubes were then placed in hydrogenation apparatus, 
and were charged and evacuated with H2 two times. The pressure was then 
increased to 50 atm while the reactions stirred at ambient temperature. The 
reactions were monitored over 10 days and full conversion was not achieved. The 
vials were removed from the apparatus and filtered through celite with CHCl3. The 
organic filtrate was washed with saturated aqueous NaHCO3 (1 x 50 mL), water (2 x 
50 mL) and brine (1 x 50 mL). The organic layer was dried over MgSO4 and solvents 
were then removed under reduced pressure to yield a colourless solid. Column 
chromatography was performed, eluting with light petroleum ether / EtOAc (4:1) to 
yield known 243 as a colourless solid which was crystallised from hexane to give 
fine colourless needles (1.63 g, 52%): []20D 42.6 (c = 1.06, CHCl3), lit. []
20
D –42.5 
(c = 1.00, CHCl3); max(neat)/cm
-1 3475, 3381, 2929, 2856, 1587, 1472, 1333, 1287, 
1248, 1195, 1152, 936, 828, 812, 726;H (300 MHz; CDCl3) 1.63-1.78 (8H, m, 8 x -
CH2-), 2.16 (2H, dt, J = 17.0 Hz, 6.0 Hz, 2 x -CH2-), 2.29 (2H, dt, J = 17.0 Hz, 6.1 Hz, 2 x 
-CH2-), 2.75 (4H, t, J = 6.2 Hz, 4 x -CH2-), 4.56 (2H, br, 2 x Ar-OH), 6.83 (2H, d, J = 8.4 
Hz, 2 x CH arom.), 7.07 (2H, d, J = 8.3 Hz, 2 x CH arom.); C (75 MHz; CDCl3) 22.8 (2C, 
2 x -CH2-), 22.9 (2C, 2 x -CH2-), 27.0 (2C, 2 x -CH2-), 29.1 (2C, 2 x -CH2-), 113.0 (2C, 2 x 
CH arom.), 118.8 (2C, 2 x C quat. arom.), 130.2 (2C, 2 x C quat. arom.), 131.1 (2C, 2 x 
CH arom.), 137.2 (2C, 2 x C quat. arom.), 151.5 (2C, 2 x C quat. arom.). 
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(–)-(Ra)-2,2’-Trifluoromethanesulfonyloxy-5,5’6,6’7,7’,8,8’-octahydro-1,1’-
binaphthyl10 (244) 
 
243 (10.0 g, 34 mmol) was dissolved in CH2Cl2 (250 mL) in a flame-dried flask under 
an atmosphere of N2. The vessel was placed in a Dewar to cool to 30 °C. After the 
solution had allowed to cool, DMAP (1.66 g, 13.6 mmol), 2,6-lutidine (11.9 mL, 102 
mmol) and Tf2O (17.2 mL, 102 mmol) were added to the solution and stirred for 10 
min. The solution was then removed from the Dewar and stirred at RT overnight. 
Silica gel was added to the dark brown solution and stirred for 20 min., after which 
time solvents were removed under reduced pressure. The loaded silica gel was 
transferred to a sintered glass funnel containing a layer of silica gel topped with 
filter paper and washed with hexane until the product had eluted. The solvent was 
removed under reduced pressure to yield known 244 as a colourless crystalline 
solid (28.01 g, 99%): m.p. 120.0 C; []20D 259.6 (c = 1.03, CHCl3), lit. []
20
D –260.3 
(c = 1.00, CHCl3); max(neat)/cm
-1; 2947, 2870, 2836, 1476, 1464, 1451, 1410, 1249, 
1202, 1182, 1138, 1048, 926, 872, 926, 872, 853, 834, 806, 763, 699, 644;H (300 
MHz; CDCl3) 1.75 (8H, m, 8 x -CH2-), 2.28 (2H, dt, J = 6.0 Hz, 17.4 Hz, 2 x -CH2-), 2.43 
(2H, dt, J = 6.0, 17.7 Hz, 2 x -CH2-), 2.86 (4H, t, J = 6.0 Hz, 4 x -CH2-), 7.16 (2H, d, J = 
8.6 Hz, 2 x CH arom.), 7.23 (2H, d, J = 8.6 Hz, 2 x CH arom.); C (75 MHz; CDCl3) 22.2 
(2C, 2 x -CH2-), 22.3 (2C, 2 x -CH2-), 27.4 (2C, 2 x -CH2-), 29.3 (2C, 2 x -CH2-), 118.1 
(2C, 2 x CH arom.), 118.2 (2C, q, J = 1274 Hz, 2 x -CF3), 127.1 (2C, 2 x C quat. arom.), 
130.9 (2C, 2 x CH arom.), 138.3 (2C, 2 x C quat. arom.), 139.3 (2C, 2 x C quat. arom.), 
144.8 (2C, 2 x C quat. arom.). 
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(–)-(Ra)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-bis(carboxylate)
10 (245) 
 
To a thick-walled glass vessel under an atmosphere of Ar containing 244 (1.50 g, 
17.9 mmol), Pd(OAc)2 (0.61 g, 4.7 mmol) and dppp (1.11 g, 4.70 mmol) were added: 
DMSO (90 mL), MeOH (36.0 mL, 1.56 mol) and Hünig’s base (13.4 mL, 137 mmol). 
The vessel was sealed with a gas-manifold and pressurised with CO (g) at 2 bar 
followed by evacuation of the atmosphere until the orange solution just begins to 
boil and that cycle was repeated five times. During the cycles, the solution turned 
to opaque black. The vessel was heated to 80 °C and maintained at at a pressure of 
2.4 atm. of CO for 48 h. The reaction mixture was then transferred to a round-
bottomed flask and solvents were removed under reduced pressure to yield an oily 
residue. This crude residue was purified by column chromatography eluting with 
light petroleum / EtOAc (5:1). The known title compound 245 was obtained as a 
colourless crystalline solid (5.9 g, 88%): m.p. = 99.0-105.1 C; []20D 2.1 (c = 0.96, 
CHCl3), lit. []
20
D –1.9 (c = 1.00, CHCl3); max(neat)/cm
-1 2926, 2853, 1718, 1588, 
1430, 1400, 1289, 1251, 1186, 1164, 1124, 1066, 1050, 878, 861, 832, 771, 749;H 
(300 MHz; CDCl3) 1.69 (8H, m, 8 x -CH2-), 1.99 (2H, dt, J = 5.9 Hz, 17.0 Hz, 2 x -CH2-), 
2.18 (2H, dt, J = 6.4 Hz, 17.2 Hz, 2 x -CH2-), 2.86 (4H, m, 4 x -CH2-), 3.57 (6H, s, 2 x Ar-
CO2Me), 7.13 (2H, d, J = 8.1 Hz, 2 x CH arom.), 7.76 (2H, d, J = 8.1 Hz, 2 x CH arom.); 
C (75 MHz; CDCl3) 22.4 (2C, 2 x -CH2-), 23.0 (2C, 2 x -CH2-), 27.2 (2C, 2 x -CH2-), 30.2 
(2C, 2 x -CH2-), 51.5 (2C, 2 x Ar-CO2Me), 126.6 (2C, C quat. arom.), 127.1 (2C, 2 x CH 
arom.), 128.0 (2C, 2 x CH arom.), 135.4 (2C, C quat. arom.), 141.7 (2C, 2 x C quat. 
arom.), 141.9 (2C, 2 x C quat. arom.), 167.6 (2C, 2 x Ar-CO2Me). 
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(–)-(Ra)-5,5',6,6',7,7',8,8'-Octahydro-1,1'-binaphthyl-2,2'-dimethanol
11 (246) 
 
LiAlH4 (0.30 g, 7.94 mmol) was suspended in Et2O (50 mL). The suspension was then 
placed under N2 and allowed to cool to 0 °C. 245 (1.50 g, 3.97 mmol) was added 
slowly, which caused a slight effervescence. After the effervescence had ceased, the 
reaction mixture was heated under reflux for a further 30 min. The solution was 
then removed from the heat and placed in an ice bath. Na2SO4 (1.50 g) and Celite 
were added in one portion and stirred for 10 min. followed by the dropwise 
addition of water (2.0 mL). After 30 min. of stirring, the reaction was filtered 
through a pad of celite and Na2SO4, washing though with Et2O. The solvents were 
removed under reduced pressure to yield the known title compound 246 as a 
colourless foam in quantitative yield (1.24 g, 99%): []20D –39.1 (c = 0.96, MeOH), 
lit. []20D –39.0 (c = 1.01, MeOH); MAX(neat)/cm
-1 3257, 2923, 2853, 1594, 1433, 
1231, 1061, 1005, 899, 815, 740;H (300 MHz; CDCl3) 1.69 (8H, m, 8 x -CH2-), 2.02 
(4H, m, 4 x -CH2-), 2.82 (4H, t, J = 8.8 Hz, 4 x -CH2-), 2.92 (2H, s, 2 x Ar-CH2OH), 4.02 
(2H, d, J = 12.0 Hz, 2 x Ar-CH2OH), 4.21 (2H, d J = 12.0 Hz, 2 x Ar-CH2OH), 7.11 (2H, d, 
J = 8.8 Hz, 2 x CH arom.), 7.24 (2H, d, J = 8.8 Hz, 2 x CH arom.); C (75 MHz; CDCl3) 
22.7 (2C, 2 x -CH2-), 23.2 (2C, 2 x -CH2-), 27.6 (2C, 2 x -CH2-), 29.8 (2C, 2 x -CH2-), 62.9 
(2C, 2 x Ar-CH2OH), 127.2 (2C, 2 x CH arom.), 128.9 (2C, 2 x CH arom.), 134.8 (2C, 2 x 
C quat. arom.), 135.7 (2C, 2 x C quat. arom.), 137.6 (2C, 2 x C quat. arom.), 138.3 
(2C, 2 x C quat. arom.). 
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(+)-(Ra)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-bis(carbaldehyde)
11 247 
 
To a solution of 246 (0.11 g, 0.34 mmol) in CH2Cl2 (20 mL) was added PCC (0.22 g, 
1.02 mmol) in one portion. The resulting dark orange solution was stirred for 2 h, 
after which time celite was added followed by the addition of Et2O (20 mL). The 
mixture was stirred for an additional 30 min. and then filtered through a layered 
pad of silica and Celite. The desired compound was eluted with Et2O. Solvents were 
then removed to furnish the known title compound 247 as colourless crystals (0.11 
g, 99 %): m.p. 129.4-131.2 C; []20D +110.4 (c = 0.83, CHCl3), lit. []
20
D +108.5 (c = 
1.00, CHCl3); max(neat)/cm
-1 2931, 2851, 2747, 1688, 1672, 1582, 1441, 1383, 1315, 
1292, 1268, 1246, 1230, 1162, 1125, 996, 968, 943, 913, 897, 836, 811, 760; H (300 
MHz; CDCl3) 1.73 (8H, m, 8 x -CH2-), 2.15 (4H, m, 4 x -CH2-), 2.91 (4H, t, J = 6.1 Hz, 4 
x -CH2-), 7.29 (2H, d, J = 8.1 Hz, 2 x CH arom.), 7.82 (2H, d, J = 8.1 Hz, 2 x CH arom.), 
9.51 (2H, s, 2 x Ar-CHO); C (75 MHz; CDCl3) 22.2 (2C, 2 x -CH2-), 22.7 (2C, 2 x -CH2-), 
27.4 (2C, 2 x -CH2-), 30.4 (2C, 2 x -CH2-), 125.1 (2C, 2 x CH arom.), 129.8 (2C, 2 x CH 
arom.), 132.4 (2C, 2 x C quat. arom.), 136.2 (2C, 2 x C quat. arom.), 140.7 (2C, 2 x C 
quat. arom.), 145.2 (2C, 2 x C quat. arom.), 191.5 (2H, 2 x Ar-CHO). 
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(Ra)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-bis(bromomethyl)
11 (248) 
 
246 (2.03 g, 6.3 mmol) was dissolved in toluene (60 mL) and pyridine (0.05 mL, 0.7 
mmol) in a flask under an atmosphere of N2. Tribromophosphine (1.78 mL, 18.9 
mmol) was added dropwise to the solution. After the addition was complete, the 
reaction was heated at 60 °C for 3 h. The reaction was quenched by the slow 
addition of water (50 mL), the resulting biphasic mixture was transferred to a 
separating funnel and the organic layer was isolated and washed with NaHCO3 (20 
mL, saturated aqueous). The organic layers were dried over MgSO4 and decoloured 
with a spatula of carbon black. Solvents were then removed under reduced 
pressure to yield 248 as a colourless powder (2.79 g, 99%): []20D 0.0 (c = 2.05, 
CHCl3), lit. []
20
D +36.5 (c = 1.00, CH2Cl2); max(neat)/cm
-1 2920, 2851, 1592, 1457, 
1376, 1235, 1204, 928, 862, 831, 814, 759, 723, 623; H (300 MHz; CDCl3) 1.71 (8H, 
m, 8 x -CH2-), 2.07 (2H, dt, J = 6.4 Hz, 17.6 Hz, 2 x -CH2-), 2.34 (2H, dt, J = 5.5 Hz, 17.0 
Hz, 2 x -CH2-), 2.83 (4H, t, J = 5.9 Hz, 4 x -CH2-), 4.10 (2H, d, J = 9.9 Hz, 2 x Ar-CH2Br), 
4.15 (2H, d, J = 10.0 Hz, 2 x Ar-CH2Br), 7.14 (2H, d, J = 7.9 Hz, 2 x CH arom.), 7.33 
(2H, d, J = 7.9 Hz, 2 x CH arom.); C (75 MHz; CDCl3) 22.6 (2C, 2 x -CH2-), 22.9 (2C, 2 x 
-CH2-), 27.5 (2C, 2 x -CH2-), 29.9 (2C, 2 x -CH2-), 32.9 (2C, 2 x Ar-CH2Br), 128.1 (2C, 2 
x CH arom.), 129.6 (2C, 2 x CH arom.), 132.3 (2C, 2 x C quat. arom.), 135.6 (2C, 2 x C 
quat. arom.), 137.9 (2C, 2 x C quat. arom.), 138.6 (2C, 2 x C quat. arom.). 
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(–)-(Ra)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-
4,5,8,9,10,11,12,13,14,15-decahydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (249) 
 
Method 1 
To a solution of 248 (0.17 g, 0.38 mmol) in MeCN (10 mL) in oven dried flask under 
an atmosphere of N2, was added K2CO3 (0.15 g, 1.11 mmol) and 168 (79 mg, 0.38 
mmol) pre-dissolved in MeCN (2 mL). The reaction was stirred at RT for 1 h before 
being heated under reflux overnight. The flask was then removed from the heat and 
allowed to cool, after which time CH2Cl2 (30 mL) and water (30 mL) were added. The 
organic layer was separated and the aqueous layer was washed further with CH2Cl2 
(2 x 20 mL). The organic layers were combined and dried over MgSO4, solvents were 
then removed under reduced pressure to yield 249 in excellent purity as colourless 
crystals (0.18 g, 97%): []20D –27.7 (c = 0.72, CHCl3); max(neat)/cm
-1 2928, 2832, 
1451, 1377, 1291, 1267, 1237, 1194, 1172, 1147, 1074, 1053, 1017, 939, 898, 852, 
829, 810, 753, 723, 700, 654, 640, 628; H (300 MHz; CDCl3) 1.46-1.57 (2H, m, 2 x -
CH2-), 1.57 (3H, s, CMe2), 1.62 (3H, s, CMe2), 1.67-1.82 (6H, m, 6 x -CH2-), 2.13 (2H, 
dt, J = 5.9 Hz, 11.5 Hz, 2 x -CH2-), 2.58-2.65 (3H, m, 2 x -CH2- / -NCH-), 2.75-2.86 (4H, 
m, 4 x -CH2-), 3.09 (2H, d, J = 12.1 Hz, 2 x ArCH2N, upfield portion of AB system), 
3.57 (2H, d, J = 12.2 Hz, 2 x ArCH2N, downfield portion of AB system), 4.17 (2H, m, 
NCH-CH2-O), 5.07 (1H, d, J = 3.1 Hz, NCH-CHAr-O), 6.89 (2H, d, J = 7.6 Hz, 2 x CH 
arom.), 6.98 (2H, d, J = 7.6 Hz, 2 x CH arom.), 7.30 (5H, m, 5 x CH arom.); C (75 
MHz; CDCl3) 19.1 (2C, CMe2), 22.7 (2C, 2 x -CH2-), 22.9 (2C, 2 x -CH2-), 27.6 (2C, 2 x -
CH2-), 29.4 (2C, 2 x -CH2-), 29.6 (2C, CMe2), 52.7 (2C, 2 x ArCH2N), 59.8 (1C, NCH-
CH2-O), 61.8 (1C, -NCH-), 75.0 (1C, NCH-CHAr-O), 99.1 (1C, CMe2, C quat.), 126.0 
(2C, 2 x CH arom.), 126.7 (2C, 2 x CH arom.), 127.6 (2C, 2 x CH arom.), 128.2 (2C, 2 x 
CH arom.), 133.6 (2C, 2 x C quat. arom.), 135.0 (2C, 2 x C quat. arom.), 136.0 (2C, 2 x 
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C quat. arom.), 138.2 (2C, 2 x C quat. arom.), 140.4 (1C, C quat. arom.), CH arom. 
not observed; m/z (HNES) 494.3039 - C34H40NO2 [M+H]
+ requires 494.3039.  
 
 
Method 212 
To an oven dried flask under an atmosphere of N2, containing a suspension of 247 
(0.11 g, 0.35 mmol) in MeOH (4 mL), was added 168 (79 mg, 1.1 equiv., 0.38 mmol) 
as a solution in MeOH (1 mL) followed by NaCNBH3 (44 mg, 2 equiv., 0.70 mmol) 
and glacial acetic acid (0.2 mL). The reaction was stirred for 24 h at ambient 
temperature, then quenched with a 1 M aq. solution of NaOH (25 mL). The title 
compound was extracted from the aqueous layer with Et2O (3 x 20 mL). The 
combined organic layers were washed with brine (30 mL) and dried over MgSO4. 
Solvents were removed under reduced pressure to yield a faint yellow foam that 
was purified by column chromatography eluting with light petroleum ether / EtOAc 
(5:1), 249 was isolated as colourless crystals (116 mg, 67 %):  []20D –28.2 (c = 0.89, 
CHCl3); max(neat)/cm
-1 2928, 2832, 1451, 1377, 1291, 1267, 1237, 1194, 1172, 
1147, 1074, 1053, 1017, 939, 898, 852, 829, 810, 753, 723, 700, 654, 640, 628; H 
(300 MHz; CDCl3) 1.46-1.57 (2H, m, 2 x -CH2-), 1.57 (3H, s, CMe2), 1.62 (3H, s, CMe2), 
1.67-1.82 (6H, m, 6 x -CH2-), 2.13 (2H, dt, J = 5.9 Hz, 11.5 Hz, 2 x -CH2-), 2.58-2.65 
(3H, m, 2 x -CH2- / -NCH-), 2.75-2.86 (4H, m, 4 x -CH2-), 3.09 (2H, d, J = 12.1 Hz, 2 x 
ArCH2N, upfield portion of AB system), 3.57 (2H, d, J = 12.2 Hz, 2 x ArCH2N, 
downfield portion of AB system), 4.17 (2H, m, NCH-CH2-O), 5.07 (1H, d, J = 3.1 Hz, 
NCH-CHAr-O), 6.89 (2H, d, J = 7.6 Hz, 2 x CH arom.), 6.98 (2H, d, J = 7.6 Hz, 2 x CH 
arom.), 7.30 (5H, m, 5 x CH arom.) 
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(–)-(Ra)-4-((R)-3,3-Dimethylbutan-2-yl)-4,5,8,9,10,11,12,13,14,15-decahydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine12 (250) 
 
Prepared according to the general procedure described in method 1 from (R)-215 
(0.40 mL, 2.98 mmol) and 248 (1.00 g, 2.23 mmol). The known title compound 250 
was isolated as a colourless crystalline solid in good purity (0.80 g, 94%): m.p. 
151.6-158.5 C (dec.); []20D 78.8 (c = 1.03, CHCl3); max(neat)/cm
-1 2928, 2863, 
1454, 1356, 1109, 1065, 922, 816, 735, 628, 620, 614; H (400 MHz; CDCl3) 0.80 
(3H, d, J = 7.2 Hz, N-CHMetBu), 0.91 (9H, s, N-CHMetBu), 1.50-1.59 (2H, m, 2 x -CH2-
), 1.74-1.86 (6H, m, 6 x -CH2-), 2.24 (2H, dt, J =10.6 Hz, 6.1 Hz, 2 x -CH2-), 2.64-2.75 
(3H, m, 2 x -CH2- / N-CHMe
tBu), 2.75-2.85 (4H, m, 4 x -CH2-), 3.28 (4H, 2 x ArCH2N), 
7.05 (4H, m, 4 x CH arom.); C (75 MHz; CDCl3) 11.4, 22.7, 22.8, 27.0, 27.7, 29.4, 
37.0, 55.2, 69.1, 125.4, 128.2, 134.3, 135.2, 136.1, 138.1; m/z (HNES) 388.2991 - 
C28H38N [M+H]
+ requires 388.2999. 
 
 
(–)-(Ra)-4-((S)-3,3-Dimethylbutan-2-yl)-4,5,8,9,10,11,12,13,14,15-decahydro-3H-
dinaphtho[2,1-c:1',2'-e]azepine12 (251) 
 
Prepared according to the general procedure described in method 1 from (S)-215 
(0.30 mL, 2.23 mmol) and 248 (1.00 g, 2.23 mmol). The known title compound 251 
was isolated as a colourless foam in good purity (0.79 g, 92%): []20D 64.1 (c = 
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0.98, CHCl3); max(neat)/cm
-1 2932, 2858, 1436, 1348, 1113, 1070, 907, 830, 810, 
732, 632, 614; H (400 MHz; CDCl3) 0.89 (9H, s, N-CHMe
tBu), 1.03 (3H, d, J = 7.1 Hz, 
N-CHMetBu), 1.50-1.60 (2H, m, 2 x -CH2-), 1.73-1.84 (6H, m, 6 x -CH2-), 2.19 (2H, dt, 
J = 10.3 Hz, 6.1 Hz, 2 x -CH2-), 2.39 (1H, q, J = 7.1 Hz, N-CHMe
tBu), 2.68 (3H, ddd, J = 
16.2 Hz, 7.9 Hz, 4.5 Hz, 2 x -CH2-), 2.76-2.87 (4H, m, 4 x -CH2-), 3.29 (2H, d, J = 12.2 
Hz, 2 x ArCH2N, upfield portion of AB system), 3.44 (2H, d, J = 12.3 Hz, 2 x ArCH2N, 
downfield portion of AB system), 7.07 (4H, m, 4 x CH arom.); C (75 MHz; CDCl3) 
11.5, 22.7, 22.9, 26.8, 27.6, 29.4, 36.8, 53.6, 67.8, 126.6 (2C, s, CH arom.), 128.2 (2C, 
s, CH arom.), 134.1 (2C, s, C quat. arom.), 135.1 (2C, s, C quat. arom.), 135.9 (2C, s, 
C quat. arom.), 138.2 (2C, s, C quat. arom.); m/z (HNES) 388.2991 - C28H38N [M+H]
+ 
requires 388.2999. 
 
 
(–)-(Ra)-4-Isopropyl-4,5,8,9,10,11,12,13,14,15-decahydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine (252) 
 
Prepared according to the general procedure described in method 1 from 216 (0.30 
mL, 2.23 mmol) and 248 (1.00 g, 2.23 mmol). The title compound 252 was isolated 
as a colourless foam in good purity (0.79 g, 92%): []20D –136.70 (c = 1.03, CHCl3); 
max(neat)/cm
-1 2927, 2858, 1449, 1378, 1325, 1212, 1162, 1125, 1064, 1024, 908, 
869, 829, 811, 731, 638; H (400 MHz; CDCl3) 1.08 (3H, d, J = 6.4 Hz, NCHMe2), 1.21 
(3H, d, J = 6.4 Hz, NCHMe2), 1.51-1.61 (2H, m, 2 x -CH2-), 1.74-1.85 (6H, m, 6 x -CH2-
), 2.23 (2H, dt, J = 10.5 Hz, 6.0 Hz, 2 x -CH2-), 2.53 (1H, sept., J = 6.5 Hz, NCHMe2), 
2.66-2.72 (2H, m, 2 x -CH2-), 2.84 (4H, J = 11.0 Hz, 6.5 Hz, 4 x -CH2-), 2.92 (2H, d, J = 
12.4 Hz, 2 x ArCH2N, upfield portion of AB system), 3.65 (2H, d, J = 12.4 Hz, 2 x 
ArCH2N, downfield portion of AB system), 7.04 (2H, d, J = 7.7 Hz, 2 x CH arom.), 7.08 
(2H, d, J = 7.7 Hz, 2 x CH arom.); C (75 MHz; CDCl3) 21.2 (1C, NCHMe2), 22.0 (1C, 
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NCHMe2), 22.7 (2C, 2 x -CH2-), 22.8 (2C, 2 x -CH2-), 27.6 (2C, 2 x -CH2-), 29.4 (2C, 2 x -
CH2-), 51.8 (2C, 2 x ArCH2N), 51.8 (1C, NCHMe2), 126.3 (2C, 2 x CH arom.), 128.0 (2C, 
2 x CH arom.), 132.4 (2C, 2 x C quat. arom.), 135.5 (2C, 2 x C quat. arom.), 136.7 (2C, 
2 x C quat. arom.), 138.3 (2C, 2 x C quat. arom.); m/z (HNES) 346.2533 (M+H)+ - 
C25H31N (M+H)
+ requires 346.2529. 
 
 
Synthesis of Octahydro-binaphthyl derived iminium salts 
 
To a solution of the azepine substrate (1 equiv.) in CH2Cl2 (30 mL per g of azepine) 
in a flask equipped with a stirrer bar, was added NBS (1.1 equiv.). The resulting 
bright yellow solution was stirred for 30 min. at RT, after which time the solvent 
was switched for EtOH. To the ethanolic solution was added NaBPh4 (1.1 equiv.) in 
the minimum amount of MeCN, which caused the iminium salt to precipitate. The 
solvent was switched to CH2Cl2 and transferred to a separating funnel. The organic 
layer was washed with water (2 x 60 mL per g of azepine) and brine (30 mL per g of 
azepine) and transferred straight in to a round bottomed flask. The crude product 
isolated after the removal of solvents, was recrystallized from hot EtOH. The 
crystalline product was filtered off and washed with cold EtOH followed by Et2O 
and hexane. The isolated iminium salts were left to dry under reduced pressure in 
an oven at 60 °C overnight.  
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(–)-(Ra)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-8,9,10,11,12,13,14,15-
octahydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate (253) 
 
Prepared according to the general procedure from 249 (1.47 g, 2.98 mmol) and NBS 
(0.58 g, 3.28 mmol). Ion exchange was performed with NaBPh4 (1.12 g, 3.28 mmol). 
Title compound 253 was isolated as a fine, pale-yellow crystalline solid (1.51 g, 
63%): m.p. 195.2-199.3 C; []20D –331.9 (c = 1.01, acetone); max(neat)/cm
-1 3053, 
2982, 2936, 2864, 1615, 1577, 1479, 1450, 1424, 1380, 1304, 1263, 1235, 1198, 
1107, 1083, 1010, 954, 941, 904, 835, 763, 746, 731, 701, 660, 623, 609; H (400 
MHz; acetone-d6, 50 °C) 1.35-1.41 (1H, m, -CH2-), 1.45-1.56 (1H, m, -CH2-), 1.67 (3H, 
s, CMe2), 1.70 (3H, s, CMe2), 1.67-1.85 (6H, m, 6 x -CH2-), 2.01-2.06 (1H, m, -CH2-), 
2.24 (1H, J = 7.5 Hz, -CH2-), 2.53-2.62 (1H, m, -CH2-), 2.70-3.01 (5H, m, 5 x -CH2-), 
4.12 (1H, d, J = 13.2 Hz, ArCH2N, upfield portion of AB system), 4.21 (2H, d, J = 13.7 
Hz, NCH-CH2-O, upfield portion of ABX system), 4.41 (1H, t, J = 2.6 Hz, -NCH-), 4.63 
(1H, dd, J = 13.7 Hz, 3.0 Hz, NCH-CH2-O, downfield portion of ABX system), 5.18 (1H, 
d, J = 13.7 Hz, ArCH2N, downfield portion of AB system), 5.74 (1H, d, J = 3.0 Hz, 
NCH-CHAr-O), 6.75 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –BPh4), 6.89 (8H, t, J = 7.4 
Hz, 8 x CH arom., ortho- –BPh4), 7.06-7.21 (6H, m, 6 x CH arom.), 7.23-7.40 (11H, m, 
8 x CH arom. meta- –BPh4 / 3 x CH arom.), 8.73 (1H, s, -N=CH-); C (75 MHz; acetone-
d6) 18.0 (1C, -CH2-), 21.6 (1C, -CH2-), 21.9 (1C, -CH2-), 22.0 (1C, -CH2-), 22.1 (1C, -
CH2-), 27.4 (1C, -CH2-), 27.5 (1C, -CH2-), 28.9 (1C, CMe2), 29.2 (1C, CMe2), 29.8 (1C, -
CH2-), 57.6 (1C, ArCH2N), 60.1 (1C, NCH-CHAr-O), 66.0 (1C, -NCH-), 71.3 (1C, NCH-
CHAr-O), 100.8 (1C, CMe2, C quat.), 121.6 (4C, s, 4 x CH arom., para- 
–BPh4), 124.9 
(1C, CH arom.), 125.0 (2C, 2 x CH arom.), 125.3 (8C, 8 x CH arom., meta- –BPh4), 
125.8 (1C, C quat. arom.), 128.1 (1C, CH arom.), 128.8 (2C, 2 x CH arom.), 129.1 (1C, 
CH arom.), 129.4 (1C, C quat. arom.), 130.4 (1C, CH arom.), 133.5 (1C, C quat. 
arom.), 134.5 (1C, C quat. arom.), 136.3 (1C, C quat. arom.), 136.3 (8C, 8 x CH 
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arom., ortho- –BPh4), 137.7 (1C, C quat. arom.), 139.1 (1C, C quat. arom.), 139.9 (1C, 
C quat. arom.), 140.9 (1C, C quat. arom.), 145.0 (1C, C quat. arom.), 164.3 (4C, q, J = 
49 Hz, 4 x C quat. arom., ipso- –BPh4), 169.7 (1C, -N=CH-); m/z (HNES) 492.2895 - 
C34H38NO2 [M–BPh4]
+ requires 492.2897. 
 
 
(–)-(Ra)-4-((R)-3,3-Dimethylbutan-2-yl)-8,9,10,11,12,13,14,15-octahydro-3H-
dinaphtho[2,1-c:1',2'-e]azepin-4-ium (254) 
 
Prepared according to the general procedure from 250 (0.79 g, 2.03 mmol) and NBS 
(0.40 g, 2.23 mmol). Ion exchange was performed with NaBPh4 (0.77 g, 2.23 mmol). 
Title compound 254 was isolated as pale yellow crystalline solid (0.99 g, 70%): m.p. 
126.3 C (dec.); []20D 478.8 (c = 1.03, acetone); max(neat)/cm
-1 2942, 1622, 1574, 
1478, 1429, 1370, 1320, 1149, 1085, 1030, 973, 836, 812, 732, 704, 662; H (400 
MHz; acetone-d6) 1.08 (9H, s, N-CHMetBu), 1.32-1.42 (1H, m, -CH2-), 1.39 (3H, d, J = 
6.9 Hz, N-CHMetBu), 1.50-1.61 (1H, m, -CH2-), 1.63-2.01 (7H, m, 7 x -CH2-), 2.35 (1H, 
dt, J = 16.4 Hz, 5.5 Hz, -CH2-), 2.63-3.12 (6H, m, 6 x -CH2-), 4.48 (1H, sept., J = 7.1 Hz, 
N-CHMetBu), 4.61 (1H, d, J = 13.1 Hz, ArCH2N, upfield portion of AB system), 4.98 
(1H, d, J = 13.2 Hz, ArCH2N, downfield portion of AB system), 6.73 (4H, t, J = 7.2 Hz, 
4 x CH arom., para- –BPh4), 6.88 (8H, t, J = 7.4 Hz, 8 x CH arom., ortho- 
–BPh4), 7.26 
(1H, d, J = 7.9 Hz, CH arom.), 7.28-7.35 (8H, m, 8 x CH arom., meta- –BPh4), 7.45 (1H, 
d, J = 8.0 Hz, CH arom.), 7.48 (1H, d, J = 8.0 Hz, CH arom.), 7.73 (2H, J = 8.0 Hz, 2 x 
CH arom.), 9.14 (1H, s, -N=CH-); C (75 MHz; CDCl3) 15.80 (1C, N-CHMe
tBu), 21.7 
(1C, -CH2-), 21.97 (1C, -CH2-), 22.01 (1C, -CH2-), 22.2 (1C, -CH2-), 25.9 (3C, N-
CHMetBu), 27.5 (1C, -CH2-), 27.6 (1C, -CH2-), 29.1 (1C, -CH2-), 29.8 (1C, -CH2-), 36.0 
(1C, N-CHMetBu, C quat.), 60.3 (1C, ArCH2N), 76.5 (1C, N-CHMe
tBu), 121.5 (4C, 4 x 
CH arom., para- –BPh4), 125.27 (8C, 8 x CH arom., meta- 
–BPh4), 125.32 (1C, CH 
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arom.), 127.0 (1C, C quat. arom.), 129.2 (1C, CH arom.), 129.6 (1C, CH arom.), 130.2 
(1C, CH arom.), 134.0 (1C, C quat. arom.), 135.3 (1C, C quat. arom.), 136.4 (8C, 8 x 
CH arom., ortho- –BPh4), 138.1 (1C, C quat. arom.), 139.3 (1C, C quat. arom.), 140.2 
(1C, C quat. arom.), 141.0 (1C, C quat. arom.), 146.7 (1C, C quat. arom.), 163.3 (4C, 
q, J = 49 Hz, 4 x C quat. arom., ipso- –BPh4), 168.7 (1C, -N=CH-); m/z (HNES) 
386.2845 - C28H36N [M–BPh4]
+ requires 386.2842. 
 
 
(–)-(Ra)-4-((S)-3,3-Dimethylbutan-2-yl)-8,9,10,11,12,13,14,15-octahydro-3H-
dinaphtho[2,1-c:1',2'-e]azepin-4-ium (255) 
 
Prepared according to the general procedure from 251 (0.75 g, 1.92 mmol) and 
NBS (0.38 g, 2.14 mmol). Ion exchange was performed with NaBPh4 (0.72 g, 2.14 
mmol). Title compound 255 was isolated as cream powder (0.81 g, 60 %): m.p. 
111.5-115.7 C (dec.); []20D 344.08 (c = 1.03, acetone); max(neat)/cm
-1 3056, 
2935, 2863, 1718, 1621, 1578, 1478, 1426, 1382, 1309, 1244, 1221, 1122, 1099, 
1032, 972, 848, 810, 732, 702, 611; H (400 MHz; acetone-d6) 1.10 (9H, s, N-
CHMetBu), 1.38-1.50 (1H, m, -CH2-), 1.51-1.63 (1H, m, -CH2-) 1.61 (3H, d, J = 6.9 Hz, 
N-CHMetBu), 1.64-1.92 (6H, m, 6 x -CH2-), 1.95-2.03 (1H, -CH2-), 2.36 (1H, dt, J = 
10.6 Hz, 3.7 Hz, -CH2-), 2.65-3.12 (6H, m, 6 x -CH2-), 4.23 (1H, sept., J = 6.9 Hz, N-
CHMetBu), 4.43 (1H, d, J = 13.8 Hz, ArCH2N, upfield portion of AB system), 4.98 (1H, 
d, J = 13.7 Hz, ArCH2N, downfield portion of AB system), 6.76 (4H, t, J = 7.2 Hz, 4 x 
CH arom., para- –BPh4), 6.89 (8H, t, J = 7.4 Hz, 8 x CH arom., ortho- 
–BPh4), 7.28 (1H, 
d, J = 7.8 Hz, CH arom.), 7.29-7.37 (8H, m, 8 x CH arom., meta- –BPh4), 7.45 (1H, d, J 
= 8.3 Hz, CH arom.), 7.48 (1H, d, J = 8.2 Hz, CH arom.), 7.64 (1H, J = 7.9 Hz, CH 
arom.), 9.03 (1H, s, -N=CH-); C (75 MHz; CDCl3) 13.2 (1C, N-CHMe
tBu), 21.7 (1C, -
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CH2-), 22.0 (2C, 2 x -CH2-), 22.2 (1C, -CH2-), 26.2 (3C, N-CHMe
tBu), 27.57 (1C, -CH2-), 
27.59 (1C, -CH2-), 29.1 (1C, -CH2-), 29.8 (1C, -CH2-), 35.9 (1C, N-CHMe
tBu, C quat.), 
53.5 (1C, ArCH2N), 77.9 (1C, N-CHMe
tBu), 121.6 (4C, 4 x CH arom., para- –BPh4), 
125.3 (8C, 8 x CH arom., meta- –BPh4), 126.1 (1C, CH arom.), 126.5 (1C, C quat. 
arom.), 129.3 (1C, CH arom.), 129.6 (1C, CH arom.), 130.1 (1C, CH arom.), 134.7 
(1C, C quat. arom.), 135.5 (1C, C quat. arom.), 136.4 (8C, 8 x CH arom., ortho- –
BPh4), 137.7 (1C, C quat. arom.), 139.4 (1C, C quat. arom.), 139.9 (1C, C quat. 
arom.), 140.9 (1C, C quat. arom.), 146.6 (1C, C quat. arom.), 164.3 (4C, q, J = 49 Hz, 
4 x C quat. arom., ipso- –BPh4), 170.2 (1C, -N=CH-); m/z (HNES) 386.2839 - C28H36N 
[M–BPh4]
+ requires 386.2842.  
 
 
(–)-(Ra)-4-Isopropyl-8,9,10,11,12,13,14,15-octahydro-3H-dinaphtho[2,1-c:1',2'-
e]azepin-4-ium tetraphenylborate (256) 
 
Prepared according to the general procedure from 252 (1.47 g, 2.98 mmol) and NBS 
(0.58 g, 3.28 mmol). Ion exchange was performed with NaBPh4 (1.12 g, 3.28 mmol). 
Title compound 256 was isolated as pale yellow fine crystalline solid (1.51 g, 63%): 
m.p. 167.4 C; []20D –443.1 (c = 1.04, acetone); max(neat)/cm
-1 3054, 2929, 1628, 
1577, 1426, 1306, 1311, 1030, 968, 843, 733, 703, 611; H (400 MHz; acetone-d6) 
1.31-1.42 (1H, m, -CH2-), 1.50-1.62 (1H, m, -CH2-), 1.51 (3H, d, J = 6.5 Hz, NCHMe2), 
1.56 (3H, d, J = 6.7 Hz, NCHMe2), 1.67-1.90 (6H, m, 6 x -CH2-), 1.91-2.05 (1H, m, -
CH2-), 2.30-2.41 (1H, m, -CH2-), 2.67-3.08 (6H, m, 6 x -CH2-), 4.29 (1H, d, J = 13.4 Hz, 
ArCH2N, upfield portion of AB system), 4.49 (1H, sept., J = 6.6 Hz, NCHMe2), 5.02 
(1H, d, J = 13.6 Hz, ArCH2N, downfield portion of AB system), 6.72 (4H, t, J = 7.2 Hz, 
4 x CH arom., para- –BPh4), 6.87 (8H, t, J = 7.4 Hz, 8 x CH arom., ortho- 
–BPh4), 7.25 
(1H, d, J = 7.8 Hz, CH arom.), 7.28-7.39 (8H, m, 8 x CH arom., meta- –BPh4), 7.44 (1H, 
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d, J = 8.4 Hz, CH arom.), 7.48 (1H, d, J = 8.4 Hz, CH arom.), 7.73 (1H, d, J = 8.0 Hz, CH 
arom.), 8.93 (1H, s, -N=CH-); C (75 MHz; CDCl3) 19.98 (1C, -CH2-), 20.03 (1C, -CH2-), 
21.6 (1C, -CH2-), 22.0 (2C, 2 x NCHMe2), 22.24 (1C, -CH2-), 27.54 (1C, -CH2-), 27.58 
(1C, -CH2-), 29.1 (1C, -CH2-), 29.8 (1C, -CH2-), 52.9 (1C, ArCH2N), 64.5 (1C, N-CHMe2), 
121.5 (4C, 4 x CH arom., para- –BPh4), 125.3 (8C, 8 x CH arom., meta- 
–BPh4), 125.6 
(1C, CH arom.), 126.7 (1C, C quat. arom.), 129.1 (1C, CH arom.), 129.7 (1C, CH 
arom.), 130.2 (1C, CH arom.), 134.4 (1C, C quat. arom.), 135.7 (1C, C quat. arom.), 
136.3 (8C, 8 x CH arom., ortho- –BPh4), 137.7 (1C, C quat. arom.), 139.2 (1C, C quat. 
arom.), 139.8 (1C, C quat. arom.), 141.0 (1C, C quat. arom.), 146.4 (1C, C quat. 
arom.), 164.4 (4C, q, J = 49 Hz, 4 x C quat. arom., ipso- –BPh4), 167.1 (1C, -N=CH-); 
m/z (HNES) 344.2378 - C25H30N [M–BPh4]
+ requires 344.2373. 
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General Procedure for the Grignard Addition to Octahydro-binpahthyl Iminium 
Salts 
 
A flame dried round-bottomed flask under nitrogen atmosphere was charged with 
the desired iminium salt (1 equiv.) and THF (50 mL per g of iminium salt), the yellow 
solution was then allowed to cool to –78 C in a Dewar containing dry ice / acetone. 
While maintaining the N2 atmosphere and temperature, 3 M MeMgBr in Et2O (10 
equiv.) was added drop-wise down the inside of the flask. After complete addition, 
the reaction was allowed to slowly attain ambient temperature overnight. Excess 
Grignard was then quenched with saturated aqueous NH4Cl solution (5 mL per g of 
iminium salt) and the organic solvents were then removed under reduced pressure. 
The aqueous emulsion was diluted with EtOAc to dissolve the organic component, 
and filtered into a separating funnel to remove any undissolved solid. The organic 
layer was separated and washed with water (2 x 60 mL per g of iminium salt) and 
brine (40 mL per g of iminium salt). The organic layer was then dried over MgSO4, 
and solvents were then removed under reduced pressure to yield the desired 
azepine. The crude azepines were purified by column chromatography, typically 
eluting with light petroleum / EtOAc and buffered with 2% TEA. 
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(–)-(3R,11cRa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3-methyl-
4,5,8,9,10,11,12,13,14,15-decahydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (257) 
 
Prepared according to the general procedure from 253 (1.28 g, 1.57 mmol) and 3 
M MeMgBr (5.26 mL, 15.7 mmol). The crude mixture was purified by column 
chromatography eluting with light petroleum / EtOAc (5:1), buffered with 2% TEA. 
The title compound 257 was isolated as a colourless oil (0.63 g, 79%): []20D 8.4 (c 
= 2.04, CHCl3); H (300 MHz; CDCl3) 0.18 (3H, d, J = 7.1 Hz, N-CHMe-Ar), 1.42-1.63 
(2H, m, 2 x -CH2-), 1.55 (3H, s, CMe2), 1.63 (3H, s, CMe2), 1.68-1.81 (6H, m, 6 x -CH2-
), 2.09-2.19 (2H, m, 2 x -CH2-), 2.54-2.69 (2H, m, 2 x -CH2-), 2.77-2.82 (4H, m, 4 x -
CH2-), 2.91 (1H, td, J = 4.2 Hz, 2.5 Hz, -NCH-), 3.31 (1H, d, J = 11.2 Hz, ArCH2N, 
upfield portion of AB system), 3.35 (1H, d, J = 11.2 Hz, ArCH2N, downfield portion 
of AB system), 4.09 (1H, dd, J = 12.3 Hz, 2.4 Hz, NCH-CH2-O, upfield portion of ABX 
system), 4.21 (1H, dd, J = 12.3 Hz, 4.3 Hz, NCH-CH2-O, downfield portion of ABX 
system), 4.34 (1H, q, J = 7.0 Hz, N-CHMe-Ar), 5.13 (1H, d, J = 3.5 Hz, NCH-CHAr-O), 
6.81 (1H, d, J = 7.6 Hz, CH arom.), 6.81 (1H, d, J = 7.7 Hz, CH arom.), 6.94 (1H, d, J = 
7.6 Hz, CH arom.), 6.97 (1H, d, J = 7.7 Hz, CH arom.), 7.22-7.38 (1H, m, 5 x CH 
arom.); C (75 MHz; CDCl3) 19.4 (1C, CMe2), 21.0 (1C, N-CHMe-Ar), 22.7 (1C, -CH2-), 
22.8 (2C, 2 x -CH2-), 22.9 (1C, -CH2-), 27.3 (2C, 2 x -CH2-), 29.0 (1C, -CH2-), 29.3 (1C, 
CMe2), 29.4 (1C, -CH2-), 54.3 (1C, N-CH2-Ar), 59.0 (1C, N-CHMe-Ar), 60.1 (1C, -NCH-
), 62.9 (1C, NCH-CH2-O), 74.1 (1C, NCH-CHAr-O), 99.3 (1C, CMe2, C quat.), 125.9 
(1C, CH arom.), 126.4 (2C, 2 x CH arom.), 126.5 (1C, CH arom.), 126.6 (1C, CH 
arom.), 127.6 (2C, 2 x CH arom.), 128.1 (1C, CH arom.), 128.2 (1C, CH arom.), 135.2 
(1C, C quat. arom.), 135.5 (1C, C quat. arom.), 135.6 (1C, C quat. arom.), 135.7 (1C, 
C quat. arom.), 136.1 (1C, C quat. arom.), 136.6 (1C, C quat. arom.), 138.4 (1C, C 
quat. arom.), 138.8 (1C, C quat. arom.), 140.3 (1C, C quat. arom.); m/z (HNES) 
508.3204 - C34H40NO2 [M+H]
+ requires 508.3210 
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(–)-(3R,11cRa)-4-((R)-3,3-Dimethylbutan-2-yl)-3-methyl-4,5,8,9,10,11,12,13,14,15-
decahydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (258) 
 
Prepared according to the general procedure from 254 (0.80 g, 1.13 mmol) and 3 
M MeMgBr in Et2O (3.77 mL, 11.3 mmol). The crude mixture was purified by 
column chromatography eluting with light petroleum / EtOAc (17.5:1), buffered 
with 2% TEA. The title compound 258 was isolated as a colourless foam (0.31 g, 
68%): []20D 60.0 (c = 1.0, CHCl3); max(neat)/cm
-1 2933, 2862, 1448, 1363, 1316, 
1248, 1151, 1105, 1068, 998, 923, 828, 812, 783, 754; H (400 MHz; CDCl3) 0.51 
(3H, d, J = 7.2 Hz, N-CHMe-Ar), 0.92 (3H, d, J = 7.0 Hz, N-CHMetBu), 0.96 (9H, s, N-
CHMetBu), 1.45-1.60 (2H, m, 2 x -CH2-), 1.72-1.83 (6H, m, 6 x -CH2-), 2.23 (2H, dt, J 
= 16.9 Hz, 5.8 Hz, 2 x -CH2-), 2.48 (1H, q, J = 7.1 Hz, N-CHMe
tBu), 2.62-2.77 (2H, m, 
2 x -CH2-), 2.78-2.90 (4H, m, 4 x -CH2-), 3.01 (1H, d, J = 10.7 Hz, ArCH2N, upfield 
portion of AB system), 3.33 (1H, d, J = 10.7 Hz, ArCH2N, downfield portion of AB 
system), 3.65 (1H, q, J = 7.2 Hz, N-CHMe-Ar), 6.92 (1H, d, J = 7.6 Hz, CH arom.), 7.02 
(1H, d, J = 7.7 Hz, CH arom.), 7.05 (1H, d, J = 7.8 Hz, CH arom.), 7.08 (1H, d, J = 7.8 
Hz, CH arom.); C (75 MHz; CDCl3) 11.1 (1C, N-CHMe
tBu), 22.9 (1C, -CH2-), 22.97 
(1C, N-CHMe-Ar), 23.04 (1C, -CH2-), 23.2 (1C, -CH2-), 27.6 (1C, -CH2-), 27.7 (1C, -CH2-
), 28.3 (3C, N-CHMetBu), 29.0 (1C, -CH2-), 29.4 (1C, -CH2-), 36.3 (1C, -CH2-), 49.3 (1C, 
ArCH2N), 70.7 (1C, N-CHMe-Ar), 73.4 (1C, N-CHMe
tBu), 126.2 (1C, CH arom.), 126.9 
(1C, CH arom.), 128.5 (1C, CH arom.), 128.6 (1C, CH arom.), 136.0 (1C, C quat. 
arom.), 136.1 (1C, C quat. arom.), 136.17 (1C, C quat. arom.), 136.22 (1C, C quat. 
arom.), 136.27 (1C, C quat. arom.), 136.29 (1C, C quat. arom.), 139.0 (1C, C quat. 
arom.), 139.2 (1C, C quat. arom.), N-CHMetBu, C quat. not observed; m/z (HNES) 
402.3149 - C29H40N [M+H]
+ requires 402.3155. 
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(–)-(3R,11cRa)-4-((S)-3,3-Dimethylbutan-2-yl)-3-methyl-4,5,8,9,10,11,12,13,14,15-
decahydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (259) 
 
Prepared according to the general procedure from 255 (0.60 g, 0.85 mmol) and 3 
M MeMgBr in Et2O (2.83 mL, 8.5 mmol). The crude mixture was purified by column 
chromatography eluting with light petroleum / EtOAc (30:1), buffered with 2% TEA. 
The title compound 259 was isolated as a colourless foam (0.23g, 68%): []20D 
346.0 (c = 0.98, CHCl3); max(neat)/cm
-1 2931, 2861, 1437, 1388, 1359, 1249, 1172, 
1121, 1079, 1000, 926, 829, 812, 784, 752; H (400 MHz; CDCl3) 0.50 (3H, d, J = 7.1 
Hz, N-CHMe-Ar), 0.91 (9H, s, N-CHMetBu), 0.99 (3H, d, J = 7.0 Hz, N-CHMetBu), 
1.44-1.66 (2H, m, 2 x -CH2-), 1.71-1.84 (6H, m, 6 x -CH2-), 2.15-2.35 (2H, m, 2 x -CH2-
), 2.46 (1H, q, J = 6.9 Hz, N-CHMetBu), 2.58-2.77 (2H, m, 2 x -CH2-), 2.77-2.90 (4H, 
m, 4 x -CH2-), 3.29 (1H, d, J = 11.1 Hz, ArCH2N, upfield portion of AB system), 3.41 
(1H, d, J = 11.0 Hz, ArCH2N, downfield portion of AB system), 3.87 (1H, q, J = 6.9 Hz, 
N-CHMe-Ar), 6.91 (1H, d, J = 7.7 Hz, CH arom.), 7.02 (1H, d, J = 7.8 Hz, CH arom.), 
7.05 (1H, d, J = 7.5 Hz, CH arom.), 7.09 (1H, d, J = 7.5 Hz, CH arom.); C (75 MHz; 
CDCl3) 11.0 (1C, N-CHMe
tBu), 21.7, 22.7, 22.8, 23.0, 27.1 (3C, N-CHMetBu), 27.3, 
27.4, 29.3, 36.2, 56.1, 59.0, 68.4 (1C, N-CHMetBu), 126.4 (1C, CH arom.), 127.3 (1C, 
CH arom.), 128.1 (1C, CH arom.), 128.3 (1C, CH arom.), 135.5 (1C, C quat. arom.), 
135.5 (1C, C quat. arom.), 135.7 (1C, C quat. arom.), 135.9 (1C, C quat. arom.), 
136.3 (1C, C quat. arom.), 136.8 (1C, C quat. arom.), 138.83 (1C, C quat. arom.), 
138.87 (1C, C quat. arom.); m/z (HNES) 402.3154 - C29H40N [M+H]
+ requires 
402.3155. 
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General Procedure for the Synthesis of Methyl Substituted Octahydro-binaphthyl 
Azepinium Salts 
 
NBS (1.1 equiv.) was added to a solution of the azepine substrate (1 equiv.) in 
CH2Cl2 (20 mL per g of azepine) in a flask equipped with a stirrer bar. The resulting 
bright yellow solution was stirred for 15 min. at RT, after which time the solvents 
were removed under reduced pressure. The resulting crude yellow foam was 
dissolved in EtOH. To the ethanolic solution was added NaBPh4 (1.1 equiv.) in the 
minimum amount of MeCN which caused the iminium salt to precipitate out. 
Solvents were then switched to CH2Cl2, and the organic solution was washed with 
water (2 x 45 mL per g of azepine) and brine (30 mL per g of azepine), then 
transferred into a round bottomed flask and evaporated to dryness under reduced 
pressure. The resulting foam was then recrystallized from EtOH. The crystalline 
product was filtered off and washed with EtOH and hexane. The isolated iminium 
salts were left to dry under reduced pressure in an oven at 60 °C overnight.  
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(–)-(3R,11cRa)-4-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-3-methyl-
8,9,10,11,12,13,14,15-octahydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 
tetraphenylborate (260) 
 
Prepared according to the general procedure from 257 (0.62 g, 1.22 mmol) and NBS 
(0.24 g, 1.34 mmol). Ion exchange was performed using NaBPh4 (0.46 g, 1.34 
mmol). The title compound 260 was isolated as pale yellow crystals (0.71 g, 71%): 
m.p. 121.6 C; []20D 232.8 (c = 1.00, acetone); max(neat)/cm
-1 3055, 2986, 2936, 
2864, 1623, 1575, 1479, 1449, 1426, 1381, 1308, 1265, 1236, 1201, 1165, 1107, 
1080, 1031, 1000, 956, 910, 835, 731; H (400 MHz; acetone-d6) 1.05 (3H, d, J = 7.1 
Hz, N-CHMe-Ar), 1.35-1.58 (2H, m, 2 x -CH2-), 1.66-1.90 (6H, m, 6 x -CH2-), 1.69 (3H, 
s, CMe2), 1.74 (3H, s, CMe2), 2.25 (1H, dt, J = 10.4 Hz, 5.7 Hz, -CH2-), 2.47-2.60 (1H, 
m, -CH2-), 2.72-2.88 (4H, m, -CH2-), 2.98 (2H, dd, J = 11.7 Hz, 6.5 Hz, 2 x -CH2-), 4.39 
(1H, dd, J = 0.8 Hz, 13.6 Hz, NCH-CH2-O, upfield portion of ABX system), 4.74 (1H, t, J 
= 2.5 Hz, -NCH-), 4.81 (1H, dd, J = 13.7 Hz, 2.9 Hz, NCH-CH2-O, downfield portion of 
ABX system), 5.49 (1H, q, J = 6.5 Hz, N-CHMe-Ar), 5.83 (1H, d, J = 2.8 Hz, NCH-CHAr-
O), 6.78 (4H, t, J = 7.1 Hz, 4 x CH arom., para- –BPh4), 6.92 (8H, t, J = 7.4 Hz, 8 x CH 
arom., ortho- –BPh4), 7.02-7.23 (7H, m, 7 x CH arom.), 7.28-7.37 (8H, m, 8 x CH 
arom., meta- –BPh4), 7.44 (1H, d, J = 8.0 Hz, CH arom.), 7.60 (1H, d, J = 8.0 Hz, CH 
arom.), 9.25 (1H, s, -N=CH-); C (100 MHz; acetone-d6) 14.9 (1C, N-CHMe-Ar), 18.1 
(1C, CMe2), 21.6 (1C, CMe2), 22.1 (1C, -CH2-), 22.2 (1C, -CH2-), 22.4 (1C, -CH2-), 27.3 
(1C, -CH2-), 27.6 (1C, -CH2-), 29.1 (1C, -CH2-), 29.3 (1C, -CH2-), 30.0 (1C, -CH2-), 61.9 
(1C, NCH-CH2-O), 67.5 (1C, -NCH-), 69.8 (1C, N-CHMe-Ar), 71.1 (1C, NCH-CHAr-O), 
101.0 (1C, CMe2, C quat.), 121.6 (4C, 4 x CH arom., para- 
–BPh4), 124.8 (1C, C quat. 
arom.), 124.9 (2C, 2 x CH arom.), 125.3 (8C, 8 x CH arom., meta- –BPh4), 125.8 (1C, 
CH arom.), 128.0 (1C, CH arom.), 128.6 (2C, 2 x CH arom.), 129.2 (1C, CH arom.), 
130.2 (1C, CH arom.), 130.5 (1C, CH arom.), 131.3 (1C, C quat. arom.), 136.0 (1C, C 
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quat. arom.), 136.4 (8C, 8 x CH arom., ortho- –BPh4), 138.1 (1C, C quat. arom.), 
139.5 (1C, C quat. arom.), 139.7 (1C, C quat. arom.), 141.2 (1C, C quat. arom.), 
147.7 (1C, C quat. arom.), 164.3 (4C, q, J = 49.0 Hz, 4 x C quat. arom., ipso- –BPh4), 
168.6 (1C, -N=CH-); m/z (HNES) 506.3054 - C35H40NO2 [M–BPh4]
+ requires 506.3043 
 
 
(–)-(3R,11cRa)-4-((R)-3,3-dimethylbutan-2-yl)-3-methyl-8,9,10,11,12,13,14,15-
octahydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium (261) 
 
Prepared according to the general procedure from 258 (0.30 g, 0.75 mmol) and 
NBS (0.15 g, 0.82 mmol). Ion exchange was performed using NaBPh4 (0.28 g, 0.82 
mmol). The product isolated according to the general procedure above was not of 
satisfactory purity, accordingly the yellow powder was washed with Et2O, which 
caused the solid to coalesce. The residual thick yellow oil was dissolved in CH2Cl2 
and the solvents were then removed under reduced pressure to yield 261 as a 
yellow foam in good purity (0.19 g, 36%): []20D 346.9 (c = 0.98 acetone); 
max(neat)/cm
-1 3056, 2938, 1621, 1575, 1478, 1448, 1427, 1385, 1370, 1310, 1248, 
1180, 1121, 1102, 1032, 970, 896, 833, 732, 702, 610; H (400 MHz; acetone-d6) 
0.98 (9H, s, N-CHMetBu), 1.24 (3H, d, J = 7.1 Hz, N-CHMe-Ar), 1.38-1.52 (1H, m, -
CH2-), 1.53-1.63 (1H, m, -CH2-), 1.65-2.00 (9H, m, 6 x -CH2- / N-CHMe
tBu), 2.12-2.19 
(1H, m, -CH2-), 2.35 (1H, dt, J = 15.8 Hz, 4.7 Hz, -CH2-), 2.68-2.99 (4H, m, 4 x -CH2-), 
3.00-3.12 (2H, m, 2 x -CH2-), 4.44 (1H, q, J = 6.9 Hz, N-CHMe
tBu), 5.47 (1H, q, J = 7.0 
Hz, N-CHMe-Ar), 6.79 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –BPh4), 6.94 (8H, t, J = 
7.4 Hz, 8 x CH arom., ortho- –BPh4), 7.31 (1H, d, J = 7.8 Hz, CH arom.), 7.33-7.45 
(9H, m, 8 x CH arom., meta- –BPh4 / CH arom.), 7.50 (1H, d, J = 8.0 Hz, CH arom.), 
7.77 (1H, d, J = 8.0 Hz, CH arom.), 9.36 (1H, s, -N=CH-); C (75 MHz; CDCl3) 15.5 (1C, 
Me), 21.5 (1C, -CH2-), 21.95 (1C, -CH2-), 22.00 (1C, -CH2-), 22.3 (1C, -CH2-), 26.4 (3C, 
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N-CHMetBu), 27.3 (1C, -CH2-), 27.4 (1C, -CH2-), 29.9 (1C, -CH2-), 35.4 (1C, N-
CHMetBu, C quat.), 80.7 (1C, N-CHMetBu), 121.5 (4C, 4 x CH arom., para- –BPh4), 
125.3 (8C, 8 x CH arom., meta- –BPh4), 125.6 (1C, C arom.), 127.0 (1C, CH arom.), 
129.3 (1C, CH arom.), 129.8 (1C, CH arom.), 131.2 (1C, C arom.), 132.6 (1C, C 
arom.), 136.4 (8C, 8 x CH arom., ortho- –BPh4), 138.8 (1C, C quat. arom.), 139.8 (1C, 
C quat. arom.), 139.9 (1C, C quat. arom.), 141.3 (1C, C quat. arom.), 148.0 (1C, C 
quat. arom.), 164.3 (4C, q, J = 49 Hz, 4 x C quat. arom., ipso- –BPh4), 169.8 (1C, -
N=CH-); -CH2- / Me / C arom. not observed; m/z (HNES) 400.2993 - C29H38N [M–
BPh4]
+ requires 400.2999 
 
 
(–)-(3R,11cRa)-4-((S)-3,3-dimethylbutan-2-yl)-3-methyl-8,9,10,11,12,13,14,15-
octahydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium (262) 
 
Prepared according to the general procedure from 259 (0.21 g, 0.52 mmol) and 
NBS (0.10 g, 0.58 mmol). Ion exchange was performed using NaBPh4 (0.20 g, 0.858 
mmol). The initially isolated product was not of satisfactory purity, accordingly the 
yellow powder was washed with Et2O causing the solid to coalesce. The residual 
thick yellow oil was dissolved in CH2Cl2 and the solvents were then removed under 
reduced pressure to yield 262 as a yellow foam in good purity (0.23 g, 60%): []20D 
279.6 (c = 0.94, acetone); max(neat)/cm
-1 3049, 2937, 1624, 1572, 1477, 1425, 
1308, 1117, 1031, 894, 842, 731, 704, 644, 631, 611; H (400 MHz; acetone-d6) 
1.11 (9H, br, N-CHMetBu), 1.28 (3H, d, J = 7.1 Hz, N-CHMe-Ar), 1.32-1.56 (1H, m, -
CH2-), 1.57-1.74 (4H, m, -CH2- / N-CHMe
tBu), 1.77-2.04 (6H, m, 6 x -CH2-), 2.08-2.15 
(1H, m, -CH2-), 2.41 (1H, dt, J = 16.6 Hz, 5.6 Hz, -CH2-), 2.20-2.66 (4H, m, 4 x -CH2-), 
3.07 (2H, q, J = 6.1, 2 x -CH2-), 4.36 (1H, br, N-CHMe
tBu), 5.47 (1H, q, J = 7.0 Hz, N-
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CHMe-Ar), 6.82 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –BPh4), 6.95 (8H, t, J = 7.4 Hz, 
8 x CH arom., ortho- –BPh4), 6.76 (1H, d, J = 8.0 Hz, CH arom.), 7.31-7.44 (9H, m, 8 x 
CH arom., meta- –BPh4 / CH arom.), 7.52 (1H, d, J = 7.9 Hz, CH arom.), 7.81 (1H, br, 
CH arom.), 9.10 (1H, s, -N=CH-); C (75 MHz; CDCl3) 14.3 (1C, Me), 21.5 (1C, -CH2-), 
21.98 (1C, -CH2-), 22.01 (1C, -CH2-), 22.3 (1C, -CH2-), 26.1 (3C, N-CHMe
tBu), 27.3 
(1C, -CH2-), 27.5 (1C, -CH2-), 29.0 (1C, -CH2-), 29.8 (1C, -CH2-), 35.6 (1C, N-CHMe
tBu, 
C quat.), 79.9 (1C, N-CHMetBu), 121.5 (4C, 4 x CH arom., para- –BPh4), 125.3 (8C, 8 
x CH arom., meta- –BPh4), 125.6 (1C, C arom.), 129.3 (1C, CH arom.), 130.1 (1C, CH 
arom.), 132.5 (1C, C auat. arom.), 136.3 (8C, 8 x CH arom., ortho- –BPh4), 138.4 (1C, 
C auat. arom.), 139.8 (1C, C auat. arom.), 139.9 (1C, C auat. arom.), 141.2 (1C, C 
auat. arom.), 164.3 (4C, q, J = 49.0 Hz, 4 x C quat. arom., ipso- –BPh4); Me / 
ArCHMeN / 4 x C arom. / -N=CH- not observed; m/z (HNES) 400.2993 - C29H38N [M–
BPh4]
+ requires 400.2999 
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3.2.5 Experimental Procedures Related to the 1,5-Oxazocine Systems 
 
2,2'-Oxydibenzaldehyde (265) 
 
THF (80 mL) was added to a flame dried flask under N2, containing 264 (7.32 g, 42.3 
mmol) and a magnetic stirrer flea. This solution was allowed to cool to 78 °C with 
a Dewar flask containing cardice and acetone. nBuLi 2.5 M in hexanes (35.26 mL, 
127 mmol) was added to the allowed to cool solution slowly over 5 min. After 1 h, 
the Dewar was removed and the reaction was left to attain RT with stirring 
overnight, during which time, the solution had turned bright yellow. DMF (6.80 mL, 
127 mmol) was added to the reaction slowly, which caused the solution to lose its 
yellow hue. The solvents were then switched for CH2Cl2 (50 mL), washed with water 
(3 x 50 mL) and then brine (1 x 50 mL) and dried over MgSO4. Solvents were 
removed under reduced pressure to give a colourless foam. The crude foam was 
subjected to column chromatography, eluting with light petroleum / EtOAc (3:1). 
The title compound 265 was isolated as colourless crystals (4.60 g, 48%): m.p. 89.9-
92.1 C; max(neat)/cm
-1 2858, 1678, 1642, 1595, 1574, 1470, 1452, 1391, 1270, 
1222, 1204, 1186, 1159, 1151, 1097, 878, 827, 754, 630, 613;H (400 MHz; CDCl3) 
6.96 (2H, d, J = 8.3 Hz, 2 x CH arom.), 7.31 (2H, t, J = 7.0 Hz, 2 x CH arom.), 7.60 (2H, 
t, J = 8.3 Hz, 2 x CH arom.), 8.00 (2H, d, J = 7.7 Hz, 2 x CH arom.), 10.51 (2H, s, 2 x Ar-
CHO); C (100 MHz; CDCl3) 119.3 (2C, 2 x CH arom.), 124.8 (2C, 2 x CH arom.), 127.4 
(2C, 2 x C quat. arom.), 129.4 (2C, 2 x CH arom.), 136.3 (2C, 2 x CH arom.), 159.1 
(2C, 2 x C quat. arom.), 188.8 (2C, 2 x Ar-CHO); m/z (HNES) 227.0703 - C14H10O3 
[M+H]+ requires 227.0703.  
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2,2'-Oxybis(2,1-phenylene)dimethanol (268) 
 
To a flame dried round-bottomed flask under N2, containing 265 (3.40 g, 15.0 
mmol), was added Et2O (100 mL). The colourless solution was then allowed to cool 
to 0 °C. LiAlH4 (1.17 g, 30.0 mmol) was then added slowly, to a slight effervescence. 
The resulting suspension was stirred at RT for 1h. The suspension was then re-
allowed to cool in an ice bath and Na2SO4 (4 g) was added to the suspension, which 
was then stirred for 5 min., after which time water (4.6 mL) was added dropwise to 
quench excess hydrides. The mixture was then allowed to stir for 30 min. The 
quenched mixture was then filtered through a layered pad of Celite and Na2SO4. 
The filtrate was concentrated under reduced pressure to yield 268 as a colourless 
crystalline solid (3.42 g, 99%): m.p. 97.3-100.0 C; max(neat)/cm
-1 3253, 2886, 1579, 
1479, 1445, 1371, 1334, 1301, 1225, 1099, 995, 934, 879, 811, 755, 715;H (400 
MHz; CDCl3) 3.39 (2H, t, J = 5.6 Hz, 2 x Ar-CH2OH), 4.62 (4H, d, J = 5.6 Hz, 2 x Ar-
CH2OH), 6.81 (2H, dd, J = 8.0 Hz, 0.8 Hz, CH arom.), 7.09 (2H, dt, J = 1.2 Hz, 7.6 Hz, 
CH arom.), 7.24 (2H, td, J = 8.0 Hz, 1.8 Hz, CH arom.), 7.35 (2H, dd, J = 1.6 Hz, 7.6 Hz, 
CH arom.); C (100 MHz; CDCl3) 62.0 (2C, Ar-CH2OH), 118.2 (2C, 2 x CH arom.), 124.0 
(2C, 2 x CH arom.), 129.9 (2C, 2 x CH arom.), 131.3 (2C, 2 x CH arom.), 132.5 (2C, 2 x 
C quat. arom.), 155.2 (2C, 2 x C quat. arom.); m/z (HNES) 253.0837 - C14H14O3 
[M+Na]+ requires 253.0835. 
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2,2'-Oxybis((bromomethyl)benzene) (269) 
 
To a flask containing 268 (2.50 g, 10.8 mmol) and a stirrer bar was added 48% HBr 
(aq., 100 mL). The solution was heated under reflux for 4 h, after which time the 
reaction was allowed to cool to RT, transferred to a separating funnel, and 
extracted with Et2O (3 x 100 mL), washed with water (2 x 50 mL) and then brine (1 x 
50 mL). The organic layer was dried over MgSO4, and filtered into a flask containing 
silica, solvents were then removed under reduced pressure. The resulting loaded 
silica gel was placed into a sintered funnel containing a layer of silica gel. The silica 
was washed through with Et2O, until the product had eluted, solvents were 
removed to yield 269 a colourless solid (3.34 g, 85%): m.p. 82.1-83.4 C; 
max(neat)/cm
-1 3059, 2981, 2925, 2852, 1918, 1579, 1486, 1449, 1430, 1239, 1220, 
1184, 1086, 1039, 899, 853, 793, 738;H (400 MHz; CDCl3) 4.65 (4H, s, 2 x Ar-
CH2Br), 6.84 (2H, d, J = 8.1 Hz, 2 x CH arom.), 7.12 (2H, t, J = 7.5 Hz, 2 x CH arom.), 
7.24-7.30 (2H, m, 2 x CH arom.), 7.47 (2H, dd, J = 7.5 Hz, 1.5 Hz, 2 x CH arom.); C 
(100 MHz; CDCl3) 28.1 (2C, 2 x Ar-CH2Br), 118.7 (2C, 2 x CH arom.), 124.7 (2C, 2 x CH 
arom.), 129.1 (2C, 2 x C quat. arom.), 130.5 (2C, 2 x CH arom.), 131.6 (2C, 2 x CH 
arom.), 155.1 (2C, 2 x C quat. arom.); m/z (HNES) 373.9572 - C14H12Br2O [M+NH4]
+ 
requires 373.9573.  
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General procedure for the synthesis of 1,5-oxazocines 
 
The primary amine (1 equiv.), dissolved in dry MeCN (20 mL per g of amine), was 
added to a suspension of 269 (1 equiv.) and K2CO3 (3 equiv.) in MeCN (100 mL per g 
of amine) at RT over a period of 6 h. The reaction mixture was heated under reflux 
overnight. Solvents were then switched for CH2Cl2 (40 mL per g of amine) and 
filtered into a separating funnel to remove excess K2CO3. The organic phase was 
washed with water (2 x 30 mL per g of amine) and brine (1 x 30 mL per g of amine). 
The organic phase was collected, dried over MgSO4 and evaporated to dryness 
under reduced pressure to yield the desired 1,5-oxazocines. 
 
 
6-isopropyl-6,7-dihydro-5H-dibenzo[b,g][1,5]oxazocine (270) 
 
Prepared according to the general procedure from 269 (0.40 g, 0.11 mmol) and 216 
(0.13 g, 0.22 mmol). The title compound 270 was isolated in good purity as a 
colourless solid (0.25 g, 89%): m.p. 83.5 C; max(neat)/cm
-1 3021, 2997, 2962, 2921, 
2867, 1601, 1578, 1478, 1447, 1377, 1347, 1330, 1260, 1213, 1173, 1104, 1084, 
1048, 1037, 950, 930, 892, 877, 794, 774, 758, 714; H (400 MHz; CDCl3) 1.10 (6H, 
br., NCHMe2), 2.67 (1H, sept., J = 6.0 Hz, NCHMe2), 3.84 (4H, br, 2 x ArCH2N), 7.04 
(2H, d, J = 8.0 Hz, 2 x CH arom.), 7.14-7.50 (2H, br, 2 x CH arom.) 7.15 (2H, d, J = 7.2 
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Hz, 2 x CH arom.), 7.23 (2H, m, 2 x CH arom.); m/z (HNES) 254.1542 - C17H20NO 
[M+H]+ requires 254.1539. No signals seen in the 13C spectra taken at ambient 
temperature. 
 
 
(+)-6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-6,7-dihydro-5H-
dibenzo[b,g][1,5]oxazocine (271) 
 
Prepared according to the general procedure from 269 (0.68 g, 1.93 mmol) and 168 
(0.40 g, 1.93 mmol). The crude product was columned with light petroleum / EtOAc 
(5:1) to yield the title compound 271 as colourless foam (0.37 g, 48%); []20D +108.4 
(c = 0.85, EtOH); max(neat)/cm
-1 3070, 2991 2904, 2882, 1601, 1578, 1479, 1449, 
1421, 1380, 1360, 1311, 1265, 1197, 1022, 969, 880, 835;H (400 MHz; DMSO, 85 
°C) 1.42 (3H, s, CMe2), 1.45 (3H, s, CMe2), 3.01 (1H, s, -NCH-, underneath the 
residual water peak), 3.39 (1H, d, J = 12.4 Hz, NCH-CH2-O, upfield portion of ABX 
system), 3.55 (2H, d, J = 13.8 Hz, 2 x ArCH2N, upfield portion of AB system), 3.90 
(1H, dd, J = 12.2 Hz, 4.2 Hz, NCH-CH2-O, downfield portion of ABX system), 4.01 (2H, 
d, J = 14.3 Hz, 2 x ArCH2N downfield portion of AB system), 5.15 (1H, d, J = 2.9 Hz, 
NCH-CHAr-O), 6.97 (4H, d, J = 3.9 Hz, 4 x CH arom.), 7.19 (5H, m, 5 x CH arom.), 7.36 
(2H, t, J = 7.6 Hz, 2 x CH arom.), 7.43 (2H, d, J = 7.2 Hz, 2 x CH arom.); C (100 MHz; 
DMSO, 85 C) 18.5 (1C, CMe2), 19.1 (1C, CMe2), 53.7 (2C, 2 x ArCH2N), 57.8 (1C, -
NCH-), 61.8 (1C, NCH-CH2-O), 73.9 (1C, NCH-CHAr-O), 98.2 (1C, CMe2, C quat.), 
121.0, (1C, CH arom.), 123.7 (1C, CH arom.), 125.8 (1C, CH arom.), 126.1 (1C, CH 
arom.), 127.0 (1C, CH arom.), 128.2 (1C, CH arom.), 130.2 (1C, CH arom.), no C quat. 
arom. signals observed; m/z (HNES) 402.2064 - C26H27NO3 [M+H]
+ requires 
402.2064 
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3.2.6 Experimental Procedures Related to the Biphenyl- Systems 
 
2,2’-Bis(bromomethyl)-1,1’-biphenyl13 
 
2,2-biphenyl dimethanol (2.0 g, 9.33 mmol) was dissolved in 48% aq. HBr (50 mL), 
and heated under reflux for 2h. The reaction was allowed to cool and the acid 
solution was transferred to a separating funnel and extracted with CH2Cl2 (2 x 60 
mL). The organic layers were combined and washed with saturated aqueous 
NaHCO3 (2 x 50 mL) followed by brine (50 mL). The organic fraction was dried over 
MgSO4, and a spatula of carbon black was added to remove any residual impurities. 
Solvents were removed after filtration to yield the title compound as a colourless 
crystalline solid (2.95 g, 93%); m.p. 91.3 C; max(neat)/cm
-1 2993, 1736, 1652, 
1598, 1567, 1474, 1451, 1435, 1370, 1270, 1217, 1197, 1156, 1136, 1085, 1048, 
1006, 989, 956, 809, 755;H (300 MHz; CDCl3) 4.20 (2H, d, J = 10.1 Hz, 2 x -CH2Br, 
upfield portion of AB system), 4.36 (2H, d, J = 10.0 Hz, 2 x -CH2Br, downfield portion 
of AB system), 7.28 (2H, m, 2 x CH arom), 7.40 (4H, m, 4 x CH arom), 7.56 (2H, dd, J 
= 7.4 Hz, 1.5 Hz, 2 x CH arom.); C (75 MHz; CDCl3) 27.7 (2C, 2 x -CH2Br), 124.3 (2C, 
2 x CH arom.), 124.6 (2C, 2 x CH arom.), 126.1 (2C, 2 x CH arom.), 126.7 (2C, 2 x CH 
arom.), 131.9 (2C, 2 x C quat. arom.), 135.4 (2C, 2 x C quat. arom.).  
 
 
  
Chapter 3 - Experimental 
 
279 
 
5,7-Dihydro[c,e]oxepine14 
 
A suspension of 2,2-biphenyl dimethanol (4.20 g, 19.5 mmol) in HBr (60 mL, 24% 
aq.) was heated under reflux for 45 min. The slightly green solution was removed 
from the heat and allowed to cool, transferred to a separating funnel and extracted 
with CH2Cl2 (2 x 40 mL). The organic layers were combined and washed with 
NaHCO3 solution (40 mL, saturated aqueous) and then dried over MgSO4 and 
decoloured with carbon black (1 spatula). Solvents were removed under reduced 
pressure to furnish the known title compound as a colourless solid (3.04 g, 80%): 
m.p. 72.0 C; max(neat)/cm
-1 2852, 1651, 1556, 1447, 1377, 1199, 1071, 1046, 997, 
902, 893, 753, 668;H (300 MHz; CDCl3) 4.20 (4H, s, 2 x Ar-CH2O-), 7.22-7.47 (8H, 
m, 8 x CH arom.); C (75 MHz; CDCl3) 67.8 (2C, 2 x Ar-CH2O-), 127.6 (2C, 2 x CH 
arom.), 128.5 (2C, 2 x CH arom.), 129.0 (2C, 2 x CH arom.), 129.9 (2C, 2 x CH arom.), 
135.2 (2C, 2 x C quat. arom.), 141.4 (2C, 2 x C quat. arom.). 
 
 
2-Bromomethyl-2’-formyl-1,1’-biphenyl14 
 
5,7-Dihydro[c,e]oxepine (3.00 g, 15.3 mmol) was dissolved in CCl4 (30 mL) in a flask 
equipped with a reflux condenser. The solution was first allowed to cool in an ice 
bath prior to the dropwise addition of Br2 (0.86 mL, 6.6 mmol). After stirring for 5 
min, the vessel was heated under reflux for 2 h. After which time, the solvents 
were removed and the residue was dissolved with Et2O (50 mL). The organic phase 
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was washed with Na2CO3 solution saturated aqueous (2 x 30 mL) and brine (30 mL) 
and dried over MgSO4 and decoloured with carbon black. The crude product was 
recrystallized from EtOAc / light petroleum to yield the known title compound as a 
colourless crystalline solid (2.45 g, 58%): m.p. 56.8 C; max(neat)/cm
-1 3188, 1667, 
1589, 1391, 1248, 1198, 774, 722, 630;H (400 MHz; CDCl3) 4.25 (2H, d, J = 10.4 Hz, 
2 x Ar-CH2Br, upfield portion of AB system), 4.35 (2H, d, J = 10.4 Hz, Ar-CH2Br, 
downfield portion of AB system), 7.22 (1H, dd, J = 7.5 Hz, 1.2 Hz, CH arom.), 7.38 
(1H, ddd, J = 7.4 Hz, 7.3 Hz, 1.3 Hz, CH arom.), 7.39-7.48 (2H, m, 2 x CH arom.), 
7.49-7.54 (2H, m, 2 x CH arom.), 7.68 (1H, ddd, J = 7.4 Hz, 7.4 Hz, 1.3 Hz, CH arom.), 
8.08 (1H, ddd, J = 7.7 Hz, 1.4 Hz, 0.6 Hz, CH arom.), 9.75 (1H, d, J = 0.7 Hz, Ar-CHO); 
C (100 MHz; CDCl3) 31.5 (2C, 2 x Ar-CH2Br), 127.6 (1C, CH arom.), 128.4 (1C, CH 
arom.), 128.6 (1C, CH arom.), 129.0 (1C, CH arom.), 130.67 (1C, CH arom.), 130.71 
(1C, CH arom.), 131.1 (1C, CH arom.), 133.6 (1C, CH arom.), 134.8 (2C, 2 x C quat. 
arom.), 143.3 (2C, 2 x C quat. arom.). 
 
 
(+)-6-[(4S,5S)-2,2-Dimethyl-4-(4-(methylsulfonyl)phenyl)-1,3-dioxan-5-yl]6,7-
dihydro-5H-dibezo[c,e]azepine 
 
The (4S,5S)-5-amino-6-(4-methylsulfone)-2,2-dimethyl-1,3-dioxane (0.88 g, 3.08 
mmol) was added to a nitrogen purged stirred solution of 2,2’-bis(bromomethyl)-
1,1’-biphenyl (1.04 g, 3.08 mmol) and CsCO3 (2.0 g, 5.68 mmol) in MeCN (30 mL) at 
RT. The reaction mixture was heated at reflux overnight under an atmosphere of 
N2. Solvents were switched to CH2Cl2 (30 mL) and the resulting suspension was 
filtered into a separating funnel to remove excess CsCO3.The mixture was washed 
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with water (2 x 30 mL) and brine (1 x 30 mL). The organic phase was separated, 
dried over MgSO4 and solvents were then removed under reduced pressure to give 
the title compound as a yellow foam in excellent purity (0.86 g, 60%): []20D +124.6 
(c = 1.22, CHCl3), lit. []
20
D +123.5 (c = 1.15, CHCl3); max(neat)/cm
-1 3060, 2991, 
1735, 1670, 1602, 1480, 1449, 1376, 1309, 1298, 1267, 1238, 1200, 1171, 1143, 
1108, 1078, 1011, 951, 912, 851; H (400 MHz; CDCl3) 1.58 (3H, s, CMe2), 1.60 (3H, 
s, CMe2), 3.04 (1H, s, -NCH-), 3.05 (3H, s, -SO2Me), 3.45 (2H, d, J = 12.6 Hz, 2 x 
ArCH2N, upfield portion of AB system), 3.68 (2H, d, J = 12.6 Hz, 2 x ArCH2N, 
downfield portion of AB system), 4.24 (2H, m, NCH-CH2-O), 5.31 (1H, s, NCH-CHAr-
O), 7.19 (2H, d, 2 x CH arom.), 7.25-7.45 (6H, m, 6 x CH arom.), 7.66 (2H, d, J = 8.4 
Hz, 2 x CH arom.), 7.93 (2H, d, J = 8.4 Hz, 2 x CH arom.); C (100 MHz; CDCl3) 19.3 
(1C, s, CMe2), 29.6 (1C, s, CMe2), 44.9 (1C, s, -SO2Me), 54.2 (2C, s, 2 x ArCH2N), 60.6 
(1C, -NCH-), 61.8 (1C, s, NCH-CH2-O), 74.4 (1C, s, NCH-CHAr-O), 99.5 (1C, CMe2, C 
quat.), 126.9 (2C, 2 x CH arom.), 127.3 (2C, 2 x CH arom.), 127.6 (2C, 2 x CH arom.), 
127.9 (2C, 2 x CH arom.), 128.1 (2C, 2 x CH arom.), 129.4 (2C, 2 x CH arom.), 136.4 
(2C, 2 x C quat. arom.), 138.8 (2C, 2 x C quat. arom.), 141.0 (2C, 2 x C quat. arom.), 
127.2 (2C, 2 x C quat. arom.); m/z (HNES) 462.1721 - C27H28O4N1S1 [M–2H]
+ 
requires 462.1734. 
 
 
(–)-6-[(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl]-5H-dibezo[c,e]azepinium 
tetraphenylborate14 (169) 
 
A solution of 168 (0.86 g, 4.18 mmol) dissolved in EtOH (10 mL), was added to an 
ice-allowed to cool solution of 2-[2-(bromomethyl)-phenyl]benzene carbaldehyde 
(1.28 g, 4.60 mmol) in EtOH (20 mL). The solution was allowed to attain ambient 
temperature overnight. NaBPh4 (1.57 g, 4.60 mmol) was dissolved in the minimum 
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amount of MeCN and added in one portion to the reaction, which caused the 
formation of a precipitate. Solvents were removed under reduced pressure and the 
remaining residue was macerated in hot EtOH and allowed to cool to ambient 
temperature. The crystalline product was filtered off and washed with cold EtOH 
followed by Et2O. The iminium salt was left to dry in an oven under reduced 
pressure at 60 C overnight for 4 h (1.83 g, 63%): m.p. 186.3-188.1 C (dec.); []20D 
44.4 (c = 1.25, MeCN), lit. []20D –42.5 (c = 1.00, MeCN); max(neat)/cm
-1 3050, 
2967, 1630, 1479, 1447, 1382, 1341, 1264, 1205, 1113, 733, 705; H (400 MHz; 
DMSO, 80 °C) 1.65 (3H, s, CMe2), 1.72 (3H, s, CMe2), 4.29 (1H, d, J = 13.5 Hz, NCH-
CH2-O, upfield portion of ABX system), 4.52 (1H, d, J = 11.5 Hz, ArCH2N, upfield 
portion of AB system), 4.65-4.72 (2H, m, -NCH- / NCH-CH2-O, downfield portion of 
ABX system), 5.18 (1H, d, J = 12.1 Hz, ArCH2N, downfield portion of AB system), 
5.83 (1H, d, J = 2.1 Hz, NCH-CHAr-O), 6.77 (4H, t, J = 7.2 Hz, 4 x CH arom., para- –
BPh4), 6.88 (8H, t, J = 7.2 Hz, 8 x CH arom., meta- 
–BPh4), 7.09-7.22 (13H, m, 5 x CH 
arom. / 8 x CH arom. ortho- –BPh4), 7.57-7.68 (6H, m, 6 x CH arom.), 7.90-7.95 (2H, 
m, 2 x CH arom.), 9.05 (1H, s, -N=CH-); C (100 MHz; DMSO 80 °C) 18.2 (1C, CMe2), 
28.7 (1C, CMe2), 54.1 (1C, ArCH2N), 60.8 (1C, NCH-CH2-O), 66.1 (1C, s, -NCH-), 70.6 
(1C, NCH-CHAr-O), 99.9 (1C, quat., CMe2), 120.8 (4C, 4 x CH arom., para- 
–BPh4), 
124.46 (8C, 8 x CH arom., meta- –BPh4), 124.47 (2C, 2 x CH arom.), 124.55 (1C, CH 
arom.), 124.57 (2C, 2 x CH arom.), 125.4 (2C, 2 x C quat. arom.), 127.4 (1C, CH 
arom.), 127.9 (1C, CH arom.), 128.0 (1C, CH arom.), 128.4 (1C, CH arom.), 129.3 
(1C, CH arom.), 129.6 (1C, CH arom.), 129.6 (1C, CH arom.), 132.9 (2C, 2 x C quat. 
arom.), 133.8 (1C, CH arom.), 135.1 (8C, 8 x CH arom., ortho- –BPh4), 136.1 (2C, 2 x 
C quat. arom.), 140.5 (2C, 2 x C quat. arom.), 163.3 (4C, q, J = 49.0 Hz, 4 x C quat. 
arom., ipso- –BPh4), 170.4 (1C, -N=CH-). 
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(–)-6-[(4S,5S)-2,2-Dimethyl-4-(4-(methylsulfonyl)phenyl)-1,3-dioxan-5-yl]-5H-
dibezo[c,e]azepin-6-ium tetraphenylborate (286) 
 
To a solution of (+)-6-[(4S,5S)-2,2-dimethyl-4-(4-(methylsulfonyl)phenyl)-1,3-
dioxan-5-yl]6,7-dihydro-5H-dibezo[c,e]azepine (0.82 g, 1.76 mmol) in CH2Cl2 (20 
mL) in a flask equipped with a stirrer bar, was added NBS (0.35 g, 1.94 mmol). The 
resulting bright yellow solution was stirred for 15 min. at RT, after which time the 
solvent was switched for EtOH. To this solution was added NaBPh4 (0.66 g, 1.94 
mmol) pre-dissolved in the minimum amount of MeCN. The solvent was then 
switched for CH2Cl2 and transferred to a separating funnel. The organic layer was 
washed with water (2 x 45 mL) and brine (30 mL) and transferred straight in to a 
round bottomed flask and solvents were removed. The resulting foam was then 
recrystallized from EtOH. The crystalline product was filtered off and washed with 
cold EtOH followed by hexane, and dried under reduced pressure in an oven at 60 
°C overnight (0.82 g, 60%): m.p. 153.6-156.8 C (dec.); []20D 52.7 (c = 1.07, 
acetone); max(neat)/cm
-1 3054, 2995, 1639, 1600, 1580, 1554, 1480, 1454, 1427, 
1404, 1382, 1351, 1304, 1237, 1199, 1147, 1128, 1109, 1086, 1054, 1030, 973, 948, 
871, 841, 827, 782, 767, 704; H (400 MHz; acetone-d6, 50 °C) 1.80 (3H, s, CMe2), 
1.83 (3H, s, CMe2), 2.98 (3H, s, -SO2Me), 4.48 (1H, br, ArCH2N, upfield portion of AB 
system), 4.50 (1H, d, J = 13.2 Hz, NCH-CH2-O, upfield portion of ABX system), 4.87 
(1H, dd, J = 13.8 Hz, 2.9 Hz, NCH-CH2-O, downfield portion of ABX system), 4.91 
(1H, br, -NCH-), 5.61 (1H, br, ArCH2N, upfield portion of AB system), 6.09 (1H, d, J = 
2.1 Hz, NCH-CHAr-O), 6.77 (4H, tt, J = 7.3 Hz, 1.4 Hz, 4 x CH arom., para- –BPh4), 
6.92 (8H, t, J = 7.4 Hz, 8 x CH arom., meta- –BPh4), 7.32-7.39 (8H, m, 8 x CH arom. 
ortho- –BPh4), 7.60-7.64 (5H, m, 5 x CH arom.), 7.72-7.77 (5H, m, 5 x CH arom.), 
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7.94-7.80 (2H, m, 2 x CH arom.), 9.24 (1H, s, -N=CH-); C (100 MHz; acetone-d6, 50 
°C) Only the counter-ion’s 13C signals were observed. 
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3.2.7 Experimental Procedures for the Total Synthesis of Scuteflorins A and B 
  
8-Iodo-7-hydroxy-2H-benzopyran-2-one15 (284) 
 
7-hydroxycoumarin 277 (1.00 g, 6.2 mmol) was dissolved in 20% NH4OH solution 
(40 mL). In a separate flask, KI (4.91 g, 29.6 mmol) and I2 (1.88 g, 7.5 mmol) were 
dissolved in water (67 mL). The resulting triiodide solution was transferred 
dropwise via cannula to the stirring alkaline solution of 7-hydroxycoumarin at RT, 
during which time the reaction was observed to change from pale yellow to 
orange. After the complete consumption of 7-hydroxycoumarin was observed by 
TLC ( 4 h), the ammonia was removed under reduced pressure at RT until the 
solution was pH 7-8. The aqueous solution was transferred to a separatory funnel 
and extracted with CH2Cl2 (3 x 60 mL), the combined organic extracts were dried 
over MgSO4 and evaporated to dryness under reduced pressure to yield a brown 
solid. The crude solid was recrystallized from hot EtOAc to yield the known title 
compound 284 as light brown crystals (0.75 g, 65%): m.p. 215.8 C; max(neat)/cm
-1 
3334, 1769, 1603, 1547, 1498, 1406, 1311, 1234, 1168, 1144, 1106, 1031, 928, 840, 
738; H (300 MHz; CDCl3) 6.19 (1H, d, J = 9.5 Hz, -CH=CH-CO2-), 6.95 (1H, d, J = 8.5 
Hz, CH arom.), 7.52 (1H, d, J = 8.5 Hz, CH arom.), 7.83 (1H, d, J = 9.5 Hz, -CH=CH-
CO2-), 10.00 (1H, br, -OH); C (75 MHz; acetone-d6) 111.8 (1C, -CH), 112.7 (1C, -CH), 
129.7 (1C, -CH), 144.0 (1C, -CH=CH–CO2-), no quaternary carbons were observed. 
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3-Chloro-3-methylbut-1-yne16  
 
 
 
To a flask charged with CaCl2 (23.0 g, 209 mmol), CuCl (20.0 g, 204 mmol) and Cu 
powder (0.4 g, 6.67 mmol), was added ice-cold conc. HCl (250 mL). The dark green 
solution was placed under an atmosphere of Ar and stirred at 0 °C for 5 min. While 
maintaining the reaction at 0 - 5 °C, 2-methyl-3-butyn-2-ol (65.0 mL, 667 mmol) 
was added slowly to the acidic solution. After complete addition of the alcohol, the 
reaction was stirred at 0 °C for 1 h. The biphasic reaction mixture was transferred 
to a separating funnel and the aqueous layer was removed. The remaining organic 
layer was then washed with cold HCl (3 x 150 mL), cold water (2 x 150 mL) and 
saturated aqueous NaHCO3 (150 mL). The remaining cloudy organic fraction was 
dried over MgSO4 and filtered to yield the known title compound as a clear 
colourless liquid (40.1 g, 59%): max(neat)/cm
-1 3300, 2988, 1368, 1227, 1119, 787, 
652, 595;H (400 MHz; CDCl3) 1.81 (6H, s, 2 x Me), 2.59 (1H, s, -C≡C-H); c (100 
MHz; CDCl3) 34.70 (2C, 2 x Me), 57.42 (1C, -CClMe2, C quat.), 72.08 (1C, -C≡C-H), 
86.78 (1C, -C≡C-H, C quat.). 
 
 
8-Iodo-7-((2-methylbut-3-yn-2-yl)oxy)-2H-chromen-2-one17 (285) 
 
8-iodo-7-hydroxy-2H-1-benzopyran-2-one 284 (0.78 g, 2.70 mmol), K2CO3 (1.12 g, 
8.11 mmol), KI (1.12 g, 6.76 mmol) and CuI (15 mg, 0.079 mmol) were added to a 
flame dried flask equipped with a reflux condenser under an inert atmosphere of 
Ar. Dried acetone (30 mL) was added via cannula through the bung on top of the 
condenser. The suspension was stirred for 5 min. prior to the addition of 3-chloro-
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3-methyl-1-butyne (0.47 mL, 4.06 mmol). The reaction mixture was heated under 
reflux for 3 h over which time the reaction turned bright yellow. The reaction was 
allowed to cool and a solvent switch to EtOAc (40 mL) was performed. The organic 
solution was washed with water (40 mL), and the aqueous phase was extracted 
further with EtOAc (2 x 40 mL), the combined organic extracts were washed with 
brine (50 mL) and dried over MgSO4. The solvent was boiled off until crystals began 
to form and the crystallising solution was allowed to cool to RT before being placed 
in the freezer. The colourless crystals of the known title compound were collected 
by filtration (0.95 g, 99%): m.p. 185.6 C;H (300 MHz; CDCl3) 1.77 (6H, s, 2 x Me), 
2.68 (1H, s, -C≡C-H), 6.27 (1H, d, J = 9.5 Hz, -CH=CH-CO2-), 7.38 (1H, d, J = 8.6 Hz, CH 
arom.), 7.56 (1H, d, J = 8.6 Hz, CH arom.), 7.59 (1H, d, J = 9.5 Hz, -CH=CH-CO2-); C 
(75 MHz; CDCl3) 29.5 (2C, 2 x Me), 74.6 (1C, CMe2, C quat.), 75.1 (1C, -C≡C-H), 81.2 
(1C, C-I), 85.0 (1C, -C≡C-H), 114.48 (1C, -CH), 114.54 (1C, -CH), 128.1 (1C, -CH), 
143.1 (1C, -CH=CH–CO2-), 155.1 (1C, C quat.), 159.3 (1C, C quat.), 160.5 (1C, C 
quat.).  
 
 
7-Hydroxychroman-2-one18 (278) 
 
277 (5.00 g, 30.7 mmol) and Pd/C (0.50 g, 10% wt/wt), were suspended in AcOH 
(150 mL). The flask was sealed with a bung and flushed with H2 and subsequently 
maintained under an atmosphere of H2 for 20 h. The solvent was switched for 
EtOAc (120 mL), and the organic solution was then washed with 50% saturated 
aqueous, NaHCO3 (60 mL) and water (2 x 60 mL) to remove any residual AcOH. The 
organic layer was dried over MgSO4 and filtered through celite to remove the Pd/C. 
Solvents were removed under reduced pressure to furnish the known title 
compound 278 as a colourless powder (5.01 g, 99%): m.p. 133.8 C; max(neat)/cm
-1 
3291, 1725, 1630, 1603, 1512, 1463, 1350, 1285, 1251, 1153, 1110, 976, 902, 841, 
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815, 768;H (300 MHz; CDCl3) 2.73 (2H, m, 2 x -CH2-), 2.92 (2H, m, 2 x -CH2-), 6.48 
(1H, d, J = 2.4 Hz, CH arom.), 6.60 (1H, dd, J = 8.2 Hz, 2.4 Hz, CH arom.), 7.07 (1H, d, 
J = 8.2 Hz, CH arom.), 8.58 (1H, br, -OH); C (75 MHz; CDCl3) 22.6 (1C, -CH2-), 29.1 
(1C, -CH2-), 103.6 (1C, CH arom.), 111.3 (1C, CH arom.), 114.1 (1C, C quat. arom.), 
128.9 (1C, CH arom.), 153.1 (1C, C quat. arom.), 157.5 (1C, C quat. arom.), 168.1 
(1C, C quat.). 
 
 
8,8-Dimethyl-3,4-dihydropyrano[3,2-g]chromen-2(8H)-one19 (279) 
 
Chroman 278 (0.50 g, 3.05 mmol) and PhB(OH)2 (0.74 g, 6.10 mmol) were placed in 
a flame dried flask, under N2, equipped with a condenser to which toluene (45 mL) 
and AcOH (14 mL) were added. The mixture was stirred until the solids had 
completely dissolved. 3-methyl-2-butenal (0.43 mL, 4.57 mmol) was added in one 
portion and the clear colourless solution was wrapped in foil and heated under 
reflux until the starting material was judged to have been consumed by TLC 
analysis (24 h). The solvents were switched for Et2O (50 mL) and water (50 mL). 
The ethereal layer was separated and washed with 50% saturated aqueous 
NaHCO3 (2 x 30 mL) and brine (50 mL). The organic layer was dried over MgSO4 and 
evaporated to dryness under reduced pressure to yield an orange oil. The oil was 
purified by column chromatography, eluting with light petroleum / EtOAc (9:1) to 
furnish 279 as a colourless powder (0.41 g, 51%): max(neat)/cm
-1 3006, 2989, 2948, 
2907, 1764, 1635, 1620, 1579, 1489, 1446, 1425, 1385, 1373, 1362, 1334, 1303, 
1282, 1258, 1230, 1218, 1174, 1143, 1117, 1026, 987, 949, 932, 919, 860, 789, 761, 
741, 709, 702;H (300 MHz; CDCl3) 1.39 (6H, s, 2 x Me), 2.71 (2H, m, 2 x -CH2-), 2.86 
(2H, m, 2 x -CH2-), 5.55 (1H, d, J = 9.8 Hz, -CH=CH-CMe2O-), 6.22 (1H, d, J = 9.8 Hz, -
CH=CH-CMe2O-), 6.47 (1H, s, CH arom.), 6.74 (1H, s, CH arom.); C (75 MHz; CDCl3) 
23.2 (1C, -CH2-), 28.1 (2C, 2 x Me), 29.7 (1C, -CH2-), 76.8 (1C, CMe2, C quat.), 105.5 
(1C, CH arom.), 114.6 (1C, C quat. arom.), 118.1 (1C, C quat. arom.), 121.5 (1C, -
Chapter 3 - Experimental 
 
289 
 
CH=CH-CMe2O-), 125.3 (1C, CH arom.), 130.5 (1C, -CH=CH-CMe2O-), 152.3 (1C, C 
quat. arom.), 153.1 (1C, C quat. arom.), 168.8 (1C, C=O, C quat.). 
 
 
8,8-Dimethyl-3-(phenylselanyl)-3,4-dihydropyrano[3,2-g]chromen-2(8H)-one 
(282) 
 
A solution of nBuLi (1.63 mL, 1.6 M in hexanes, 2.61 mmol) in THF (5 mL) was 
allowed to cool to –78 °C in a round bottomed flask under Ar. Diisopropylamine 
(0.34 mL, 2.39 mmol) was added to the allowed to cool solution and stirred for 5 
min. to allow the formation of LDA. In a separate flask, also under Ar, 279 (0.50 g, 
2.17 mmol) was dissolved in THF (15 mL) and allowed to cool to –78 °C. The 
solution of LDA was transferred dropwise via cannula to the flask containing the 
dihydroxanthyletin and the vessel was stirred for a further 10 min. Phenylselenyl 
chloride (0.46 g, 2.39 mmol) was dissolved in THF (6 mL) and syringed into the 
yellow solution of the lithium enolate over a period of 2 min. The resulting light-
orange solution was left to attain ambient temperature over a period of 1 h, then, 
saturated aqueous NH4Cl (10 mL) was added to the flask to quench the reaction. 
The resulting biphasic mixture was transferred to a separating funnel. The organic 
phase was collected and the aqueous phase was washed with Et2O (2 x 10 mL). The 
organic layers were combined and washed with brine (20 mL) and dried over 
MgSO4. Solvents were then removed under reduced pressure to yield a dark-yellow 
tar which was purified by column chromatography, eluting with light petroleum / 
EtOAc (8:1). The title compound 282 was isolated as a light-yellow oil (0.40 g, 48%). 
max(neat)/cm
-1 3051, 2973, 2930, 1748, 1639, 1621, 1581, 1485, 1438, 1364, 1369, 
1362, 1332, 1312, 1284, 1261, 1243, 1221, 1162, 1106, 1045, 952, 904, 738;H (300 
MHz; CDCl3) 1.41 (3H, s, Me), 1.45 (3H, s, Me), 3.04 (1H, dd, J = 16.7 Hz, 3.2 Hz, -
CH2-), 3.43 (1H, dd, J = 16.5 Hz, 5.0 Hz, -CH2-), 4.12 (1H, m, -CHSePh), 5.59 (1H, d, J = 
9.8 Hz, -CH=CH-CMe2O-), 6.25 (1H, d, J = 9.9 Hz, -CH=CH-CMe2O-), 6.47 (1H, s, CH 
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arom.), 6.72 (1H, s, CH arom.), 7.25 (3H, m, 3 x CH arom.), 7.59 (2H, m, 2 x CH 
arom.); C (75 MHz; CDCl3) 27.8 (1C, Me), 28.1 (1C, Me), 30.6 (1C, -CH2-), 37.9 (1C, -
CHSePh), 105.0 (1C, CH arom.), 111.9 (1C, C quat. arom.), 118.0 (1C, C quat. arom.), 
121.3 (1C, -CH=CH-CMe2O-), 125.6 (1C, CH arom.), 127.3 (1C, C quat. arom.), 129.0, 
(1C, CH arom.), 129.4 (2C, 2 x CH arom.), 130.6 (1C, -CH=CH-CMe2O-), 135.6 (2C, 2 x 
CH arom.), 151.8 (1C, C quat. arom.), 153.5 (1C, C quat. arom.), 167.2 (1C, C=O, C 
quat.), CMe2, C quat. – was not observed; m/z (HNESP) 398.0823 - C20H22O3SeN 
[M+NH4]
+ requires 398.0819 . 
 
Xanthyletin (276) / Seselin (180) 
Route A 
 
The alkyne 285 (0.30 g, 0.84 mmol) was placed in a microwave vessel and N,N-
dimethylaniline (4 mL) was added The flask was sealed and flushed with Ar and 
gently warmed until the alkyne had completely dissolved. The reaction mixture was 
heated to 200 °C by μW irradiation for 10 min., turning dark blue. The mixture was 
resubmitted to a total of 90 min. at 240 °C, after which time the reaction had 
turned dark red and judged to have run to completion by TLC. The N,N-
dimethylaniline was removed under reduced pressure, the crude residue was 
purified by column chromatography eluting with light petroleum / EtOAc (8.5:1.5) 
to yield xanthyletin 276 (0.095 g, 45%) and seselin 180 (0.027g, 12.5%) as 
colourless solids. 
 
180:20 m.p. 119.6 C; max(neat)/cm
-1 2976, 2361, 1734, 1597, 1485, 1152;H (300 
MHz; CDCl3) 1.45 (6H, s, 2 x Me), 5.72 (1H, d, J = 10.0 Hz, -CH=CH-CMe2O-), 6.21 
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(1H, d, J = 9.5 Hz, CH=CH-CO2-), 6.70 (1H, d, J = 10.0 Hz, -CH=CH-CMe2O-), 6.86 (1H, 
d, J = 8.0 Hz, CH arom.), 7.03 (1H, s, CH arom.), 7.56 (1H, d, J = 9.5 Hz, –CH=CH-
CO2–). 
 
Route B18 
 
DDQ (2.50 g, 11.0 mmol) was added in one portion to a solution of chroman 279 
(2.40 g, 10.5 mmol) in toluene (200 mL). The reaction was heated under reflux for 
14 h after which time DDQ (0.24 g, 1.05 mmol) was added every two hours until 
the reaction was judged to have run to completion by TLC, (0.96 g in total). 
Solvents were removed under reduced pressure and the residue was re-dissolved 
in EtOAc (300 mL). Any residual solid was filtered off on transferral to the 
separating funnel. The organic solution was washed with water (4 x 300 mL) 
followed by 50% saturated aqueous NaHCO3 (2 x 200 mL) and brine (200 mL). The 
organic layer was dried over MgSO4 and evaporated to dryness under reduced 
pressure. The crude orange oil was purified by column chromatography, eluting 
with light petroleum / EtOAc (4:1) to yield an orange solid (1.32 g). This orange 
solid was then sequentially re-crystallised three times from CH2Cl2 / light 
petroleum, and twice from hot EtOH to yield 276 as colourless crystals (1.23 g, 
52%): m.p. 130.2  C; max(neat)/cm
-1 3275, 2983, 1731, 1596, 1535, 1479, 1451, 
1429, 1397, 1389, 1371, 1289, 1232, 1186, 1169, 1132, 1098, 1050, 974, 952, 924, 
897, 828, 810, 785, 752, 731, 703;H (300 MHz; CDCl3) 1.44 (6H, s, 2 x Me), 5.67 
(1H, d, J = 10.0 Hz, -CH=CH-CMe2O-), 6.19 (1H, d, J = 9.5 Hz, -CH=CH-CO2), 6.32 (1H, 
d, J = 10.0 Hz, -CH=CH-CMe2O-), 6.69 (1H, s, CH arom.), 7.03 (1H, s, CH arom.), 7.56 
(1H, d, J = 9.5 Hz, -CH=CH-CO2-); C (75 MHz; CDCl3) 28.2 (2C, 2 x Me), 77.7 (1C, 
CMe2, C quat.) 104.1 (1C, CH arom.), 112.7 (1C, C quat. arom.), 113.0 (1C, CH), 
118.5 (1C, C quat. arom.), 121.1 (1C, CH), 124.8 (1C, CH arom.), 131.3 (1C, CH) 
143.4 (1C, -CH=CH-CO2-), 155.5 (1C, C quat.), 156.9 (1C, C quat.), 161.3 (1C, C 
quat.). 
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(+)-Xanthyletin oxide21 (280) 
 
 
Xanthyletin 276 (24 mg, 0.11 mmol) was dissolved in CHCl3 (2.5 mL) and allowed to 
cool to –30 °C. TPPP (96 mg, 0.22 mmol) was added in one portion followed by 
catalyst 169 (3.7 mg, 0.0053 mmol). The reaction was stirred vigorously at –30 °C 
until the xanthyletin had been consumed ( 20 h) at which time Et2O (20 mL), pre-
allowed to cool to the reaction temperature, was added to precipitate the TPPP 
and by-products. The suspension was then filtered through celite and solvents 
were then removed under reduced pressure. The epoxide 280 was isolated in good 
purity and no further purification was required (26 mg, 97%): m.p. 157.6C; []18D 
+280.1 (c = 1.23, CHCl3), lit. []
20
D +281.3 (c = 1.00, CHCl3); max(neat)/cm
-1 2984, 
2961, 2928, 1730, 1627, 1562, 1496, 1459, 1435, 1390, 1367, 1348, 1333, 1282, 
1271, 1235, 1207, 1189, 1144, 1103, 1035, 1001, 981, 948, 915, 894, 852, 834, 819, 
755, 717;H (300 MHz; CDCl3) 1.29 (3H, s, Me) 1.59 (3H, s, Me), 3.53 (1H, d, J = 4.4 
Hz, -CHO-), 3.96 (1H, d, J = 4.4 Hz, -CHO-), 6.26 (1H, d, J = 9.5 Hz, -CH=CH-CO2-), 
6.75 (1H, s, CH arom.), 7.45 (1H, d, J = 9.5 Hz, -CH=CH-CO2), 7.62 (1H, s, CH arom.); 
C (75 MHz; CDCl3) 22.9 (1C, Me), 25.3 (1C, Me), 50.1 (1C, -CHO-), 61.9 (1C, -CHO-), 
74.6 (1C, CMe2, C quat.), 106.1 (1C, CH arom.), 113.01 (1C, C quat. arom.), 113.9 
(1C, -CH=CH-CO2-), 117.3 (1C, C quat. arom.), 128.9 (1C, CH arom.), 142.9 (1C, -
CH=CH-CO2-), 156.2 (1C, C quat.), 160.9 (1C, C quat.), C quat. not observed. HPLC 
conditions - hexane/2-propanol (90:10), oven temp 20 °C, column Chiracel OD-H 01 
250 × 4.6 mm, 5 μm particle size, flow rate 1 mL/min,  254 nm: : tr – 34.89 min (+), 
37.00 min (–). 
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(+)-Seselin oxide20 
 
Seselin 180 (20 mg, 0.088 mmol) was dissolved in CHCl3 (2.0 mL) and allowed to 
cool to –30 °C. TPPP (80 mg, 0.18 mmol) was added in one portion followed by 
catalyst 169 (3.0 mg, 0.0044 mmol). The reaction was stirred at –30 °C for 39 h at 
which time Et2O (20 mL), pre-allowed to cool to the reaction temperature, was 
added to precipitate the TPPP and by-products. The suspension was then filtered 
through celite and the solvents were then removed under reduced pressure. The 
known epoxide was isolated as a colourless solid after preparative TLC eluting with 
light petroleum / EtOAc (4:1) (8.8 mg, 41%): m.p. 147.8 C (dec.); []20D +7.3 (c = 
0.98, CDCl3), lit. []
20
D +7.5 (c = 1.02, CHCl3); max(neat)/cm
-1 3422, 3057, 2983, 
2918, 1694, 1289, 1263, 1074, 1063, 1024, 976, 862, 762, 743;H (300 MHz; CDCl3) 
1.16 (3H, s, Me), 1.43 (3H, s, Me), 3.58 (1H, d, J = 9.02 Hz, -CHO-), 3.87 (1H, br, –
CHO–), 4.17 (1H, br, –CHOH–), 4.52 (1H, d, J = 8.6 Hz, –CHOH–), 6.05 (1H, d, J = 9.5 
Hz, –CH=CH-CO2–), 6.53 (1H, s, CH arom.), 7.46 (1H, d, J = 9.5 Hz, –CH=CH-CO2–), 
7.47 (1H, s, CH arom.); C (75 MHz; acetone-d6) 19.0 (1C, CH3), 26.2 (1C, CH3), 68.2 
(1C, -CHOH-), 75.2 (1C, -CHOH-), 80.19 (1C, CMe2, C quat.) 103.2 (1C, CH arom.), 
112.9 (1C, –CH=CH–CO2–), 123.0 (1C, C quat. arom.), 128.5 (1C, CH arom.), 143.9 
(1C, –CH=CH–CO2–), 155.1 (1C, C quat.), 156.2 (1C, C quat.), 160.3 (1C, C quat.), C 
quat. not observed. HPLC conditions - hexane/2-propanol (90:10), oven temp 20 
°C, column Chiracel OD-H 01 250 × 4.6 mm, 5 μm particle size, flow rate 1 mL/min,  
254 nm. 
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(+)-Trans-decursinol21 (287) 
 
Xanthyletin oxide 280 (0.20 g, 8.92 mmol) was dissolved in acetone (10 mL) and 1 
M aq. solution of HCl (5 mL) was added in one portion. The reaction was stirred 
until it was judged by TLC that the starting material had been completely 
consumed, (5 min). The solution was diluted with CH2Cl2 (30 mL) and water (30 
mL), the organic layer was collected and the aqueous was extracted further with 
CH2Cl2 (2 x 30mL). The combined organic extracts were washed with brine (50 mL), 
and dried over MgSO4. The solvents were removed under reduced pressure to 
leave a colourless oily residue which was purified by column chromatography 
eluting with 1:1 light petroleum / EtOAc to yield the title compound 287 as a 
colourless foam (140 mg, 60%): m.p. 147.8 °C (dec.); []20D +146.1 (c = 0.33, 
MeOH), lit. []20D –148.2 (c = 1.00, MeOH); max(neat)/cm
-1 3422, 3057, 2983, 2918, 
1694, 1289, 1263, 1074, 1063, 1024, 976, 862, 762, 743;H (300 MHz; CDCl3) 1.16 
(3H, s, Me) 1.43 (3H, s, Me), 3.58 (1H, d, J = 9.0 Hz, -CHOH-), 3.87 (1H, br, -CHOH-), 
4.17 (1H, br, -CHOH-), 4.52 (1H, d, J = 8.6 Hz, -CHOH-), 6.05 (1H, d, J = 9.5 Hz, -
CH=CH-CO2-), 6.53 (1H, s, CH arom.), 7.46 (1H, d, J = 9.5 Hz, -CH=CH-CO2-), 7.47 
(1H, s, CH arom.); C (75 MHz; acetone-d6) 19.0 (1C, Me), 26.2 (1C, Me), 68.2 (1C, -
CHOH-), 75.2 (1C, -CHOH-), 80.2 (1C, CMe2, C quat.), 103.2 (1C, CH arom.), 112.9 
(1C, -CH=CH-CO2-), 123.0 (1C, C quat. arom.), 128.5 (1C, CH arom.), 143.9 (1C, -
CH=CH-CO2-), 155.1 (1C, C quat.), 156.2 (1C, C quat.), 160.3 (1C, C quat.), C quat. 
not observed; m/z (ASAP) 263.0911 - C14H14O5 [M+H]
+ requires 263.0914. 
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(3aS, 11bS)-2,2,4,4-tetramethyl-3a,4-dihydro-[1,3]dioxolo[4,5-c]pyrano[3,2-
g]chromen-8(11bH)-one (288) 
 
This Ritter-type product 288 was isolated as a colourless solid during purification of 
the acid-catalysed ring-opening reaction above (19 mg, 8%): max(neat)/cm
-1 2984, 
2931, 1725, 1622, 1564, 1494, 1461, 1391, 1371, 1334, 1298, 1263, 1221, 1161, 
1134, 1081, 1022, 967, 946, 922, 899, 865, 850, 821, 785, 751, 731;H (300 MHz; 
CDCl3) 1.16 (3H, s, Me), 1.25 (3H, s, Me), 1.42 (3H, s, Me), 1.52 (3H, s, Me), 3.71 
(1H, d, J = 2.4 Hz, -OH), 4.45 (1H, d, J = 6.0 Hz, -CHO-), 5.16 (1H, d, J = 6.0 Hz, -CHO-
), 6.25 (1H, d, J = 9.5 Hz, -CH=CH-CO2-), 6.78 (1H, s, CH arom.), 7.48 (1H, s, CH 
arom.), 7.62 (1H, d, J = 9.3 Hz, -CH=CH-CO2-); m/z (ASAP) HNESP 303.1226 - 
C14H12O5 [M+H]
+ requires 303.1227 
 
 
(+)-(R)-7-Hydroxy-8,8-dimethyl-7,8-dihydropyrano[3,2-g]chromene-2,6-dione 
(293) 
 
 
(+)-Trans-decursinol 287 (0.055 g, 0.21 mmol) was dissolved in CHCl3 (4 mL) in a 
round-bottomed flask equipped with a stirrer bar. DMP (0.89 g, 0.21 mmol) was 
added in two equal portions and the reaction was stirred for an hour between 
additions. After the reaction was judged to have run to completion by TLC, the 
reaction was transferred to a separating funnel and washed with 50% saturated 
aqueous NaHCO3 (15 mL). The aqueous phase was extracted with CHCl3 (3 x 10 mL) 
and the combined organic extracts were dried over MgSO4 and evaporated to 
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dryness under reduced pressure. The crude yellow oil was purified by column 
chromatography, eluting with light petroleum / EtOAc (8:5). The title compound 
293 was isolated as a colourless oil (0.52 g, 95%): []20D +31.37 (c = 0.51, CHCl3); 
max(neat)/cm
-1 3289, 3062, 2984, 1736, 1698, 1610, 1560, 1483, 1445, 1389, 1372, 
1336, 1284, 1201, 1140, 1101, 1018, 978, 905, 843, 826, 801, 764, 740, 657;H 
(300 MHz; CDCl3) 1.25 (3H, s, Me) 1.68 (3H, s, Me), 3.71 (1H, d, J = 2.4 Hz, -OH), 
4.45 (1H, d, J = 2.3 Hz, -CHOH-), 6.33 (1H, d, J = 9.3 Hz, -CH=CH-CO2-), 6.85 (1H, s, 
CH arom.), 7.67 (1H, d, J = 9.6 Hz, -CH=CH-CO2-), 7.99 (1H, s, CH arom.); C (75 MHz; 
CDCl3) 17.6 (1C, Me), 26.6 (1C, Me), 76.9 (1C, -CHOH-), 84.7 (1C, CMe2, C quat.) 
105.9 (1C, CH arom.), 113.7 (1C, C quat. arom.), 115.0 (1C, -CH=CH-CO2-), 116.2 
(1C, C quat. arom.), 127.4 (1C, CH arom.), 143.0 (1C, -CH=CH-CO2-), 159.7 (1C, C 
quat.), 159.8 (1C, C quat.), 162.2 (1C, C quat.), 193.0 (1C, C=O, C quat.); m/z (ASAP) 
261.0759 [M+H]+ - C14H12O5 [M+H]
+ requires 261.0757. 
 
 
3,3-Dimethyl-acryloyl chloride22 (295) 
 
To a flame-dried flask under an atmosphere of Ar, containing a solution of 3,3-
dimethyl-acrylic acid 294 (3.0 g, 30 mmol) in CH2Cl2 (25 mL), oxalyl chloride (2.83 
mL, 3.3 mmol) was added dropwise over a period of 5 min. The reaction was stirred 
at RT for 1 h after the evolution of gas had ceased. Solvents were then removed 
under reduced pressure without the use of a heated water bath. The excess oxalyl 
chloride was removed by three cycles of redissolving the product in CHCl3 and 
subsequent concentration under reduced pressure. The known title compound 295 
was isolated as an odorous pale yellow oil (3.57 g, 99 %): max(neat)/cm
-1 2254, 
1753, 1617, 1444, 1377, 1205, 1091, 1011, 904, 831, 764, 723, 650;H (400 MHz; 
CHCl3); 1.92 (3H, s, Me), 2.11 (3H, s, Me), 5.71 (1H, s, Me2C=CH-); C (75 MHz; 
CHCl3) 21.5 (1C, Me), 27.2 (1C, Me), 122.6 (1H, s, Me2C=CH-), 163.7 (1C, C quat.), 
164.3 (1C, C quat.). 
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(+)-Scuteflorin A23 (274) 
 
The α-hydroxy ketone 293 (0.041 g, 0.15 mmol) and NaHCO3 (0.014 g, 0.17 mmol) 
were placed in a oven-dried flask, equipped with a stirrer bar under an atmosphere 
of Ar. THF (2.0 mL) was added and the suspension was stirred for 2 min. preceding 
the addition of 3,3-dimethyl acryloyl chloride (0.087 mL, 0.75 mmol). The reaction 
was stirred for 4 h when the complete consumption of 293 had been observed by 
TLC. The reaction mixture was then filtered and concentrated under reduced 
pressure, the crude oil was purified by column chromatography, eluting with 
petroleum ether / EtOAc (3.5:1). (+)-Scuteflorin A was isolated as a colourless solid 
(0.045 g, 88%): []22D +27.0 (c 0.38, MeOH), lit. []
20
D +27.0 (c = 1.00, MeOH): 
max(neat)/cm
-1 2985, 2906, 1749, 1728, 1699, 1647, 1626, 1611, 1562, 1486, 1443, 
1389, 1354, 1342, 1287, 1260, 1221, 1201, 1168, 1128, 1095, 1084, 1070, 1029, 
913, 840, 823, 752, 740, 701, 655, 620, 600;H (400 MHz; CD3OD); 1.35 (3H, s, -
OCMe2-), 1.53 (3H, s, -OCMe2-), 1.96 (3H, s, Me2C=), 2.18 (3H, s, Me2C=), 5.69 (1H, s, 
-CH-), 5.82 (1H, s, Me2C=CH-), 6.31 (1H, d, J = 9.6 Hz, -CH=CH-CO2-), 6.89 (1H, s, CH 
arom.,) 7.91 (1H, d, J = 9.4 Hz, -CH=CH-CO2-), 8.06 (1H, s, CH arom.); C (75 MHz; 
CD3OD) 20.0 (1C, -OCMe2-), 20.7 (1C, -OCMe2-), 26.4 (1C, Me2C=), 27.7 (1C, Me2C=), 
77.3 (1C, -CHO-), 84.16 (1C, -OCMe2-), 106.6 (1C, CH arom.), 115.76 (1C, Me2C=CH-), 
115.80 (1C, -CH=CH-CO2-), 118.9 (1C, C quat. arom.), 129.3 (1C, CH arom.), 145.4 
(1C, –CH=CH–CO2–), 161.2 (1C, –CH=CH–CO2–), 161.7 (1C, Me2C=), 161.8 (1C, C 
quat. arom.), 163.1 (1C, C quat. arom.), 166.5 (1C, Me2CH=CH-CO2-), 189.3 (1C, 
C=O, C quat.), C quat. arom. not observed; m/z (HNESP) 343.1180 - C19H19O6 [M+H]
+ 
requires 343.1176. 
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3.2.6 Procedures regarding the epoxidation of alkenes 
 
General procedure for the formation of racemic epoxides 
 
The desired alkene was dissolved in CH2Cl2 (10 mL per g of alkene) and allowed to 
cool to 0 °C. A solution of m-CPBA (2 equiv.) in CH2Cl2 (10 mL per g of alkene), dried 
over MgSO4, was filtered into the solution of alkene. The reaction was allowed to 
achieve ambient temperature and stirred until complete conversion of the alkene 
was observed by TLC. The reaction was quenched with the addition of saturated 
aqueous NaHCO3 (10 mL per g of alkene) and the mixture transferred to a 
separating funnel. The organic layer was collected and washed with 1M NaOH (10 
mL per g of alkene) and dried over MgSO4. Solvents were removed under reduced 
pressure. Analytically pure samples of the epoxides were obtained by means of 
flash column chromatography, typically eluting with light petroleum / EtOAc (99:1), 
buffered with 2% TEA.  
 
General procedure for catalytic asymmetric epoxidation of alkenes with Oxone® 
mediated by iminium salts under aqueous conditions 
 
Method A 
Oxone® (2 equiv.) and NaHCO3 (5 equiv) were added to a solution of the catalyst (5 
mol%) in MeCN (1 mL) and water (0.1 mL) at 0 C. After 5 min. of stirring, the 
alkene (1 equiv., 3 mmol) dissolved in MeCN (1 mL), was added. The mixture was 
stirred at 0 C until either complete conversion of the alkene was observed by TLC 
or 6 h had past. The reaction mixture was then diluted with Et2O (10 mL) and the 
resulting suspension filtered through a mixed pad of Na2SO3 and MgSO4. Solvents 
were removed under reduced pressure and analytically pure samples of the 
epoxide were obtained by means of flash column chromatography or preparative 
TLC, typically eluting with light petroleum / EtOAc (99:1), containing 2% TEA. The 
major enantiomer was determined by []20D measurements and comparison to the 
literature, enantioselectivities were determined by either chiral HPLC, or by the use 
of the a resolving agent in 1H NMR. 
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Method B 
Water (1 ml), MeCN (1 mL) and NaHCO3 (100 mg, 1.2 mmol) were added to a test-
tube immersed in an ice-bath at 0 °C, followed, after 1 min, by Oxone® (370 mg, 
0.6 mmol). After the effervescence had subsided, the catalyst (5 mol%) was added 
followed, after 1 min, by the alkene (0.3 mmol). The mixture was stirred at 0 C 
until either complete conversion of the alkene was observed by TLC or 6 h had 
past. The reaction mixture was then diluted with Et2O (10 mL per 0.10 g of 
substrate), the resulting suspension was filtered through a mixed pad of Na2SO3 
and MgSO4. Solvents were then removed under reduced pressure and analytically 
pure samples of the epoxide were obtained by either flash column 
chromatography or preparative TLC, eluting with light petroleum / EtOAc (99:1), 
containing 2% TEA. The major enantiomer was determined by []20D 
measurements and comparison with the literature, enantioselectivities were 
determined by either chiral HPLC, or by the use of the a resolving agent in 1H NMR. 
 
 
Method C  
Water (0.8 mL) and NaHCO3 (67 mg, 0.80 mmol) were added to a test-tube 
immersed in an ice-bath at 0 °C, equipped with a magnetic stirring bar. Oxone® 
(132.0 mg, 0.21 mmol) was added and the solution stirred until the effervescence 
had ceased. The alkene (0.20 mmol) was dissolved in in CH2Cl2 (0.5 mL) and added 
to the aqueous solution. The catalyst (5 mol%) and 18-crown-6 (1 mg, 2.5 mol%) 
were dissolved in CH2Cl2 (0.7 mL) and allowed to cool to 0 °C, and added to the 
stirring biphasic mixture. The reaction mixture was then vigorously stirred, typically 
for 2 h at that temperature. To isolate the epoxides, CH2Cl2 (10mL) and water 
(10mL), both previously cooled to around 0 °C, were added. The organic layer was 
collected and dried over MgSO4. Solvents were removed under reduced pressure 
and analytically pure samples of the epoxide were obtained by either column 
chromatography or preparative TLC, eluting with light petroleum / EtOAc (99:1), 
containing 2% TEA. The major enantiomer was determined by []20D 
measurements, enantioselectivities were determined by either chiral HPLC, or by 
the use of the a resolving agent in 1H NMR. 
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Tetraphenylphosphonium monoperoxysulfate24 
 
Tetraphenylphosphonium chloride (15.0 g, 40 mmol) was dissolved in CH2Cl2 (200 
mL) and allowed to cool to 10 °C in a round bottomed flask equipped with a stirrer 
bar. Oxone® (15.0 g, 48 mmol), previously dissolved in deionised water (300 mL) 
and allowed to cool to 10 °C, was added over a period of 5 min. The resulting 
biphasic mixture was stirred vigorously for 1 h. The organic layer was separated 
and solvents were removed under reduced pressure at RT. The crude colourless 
solid was transferred to a sintered glass funnel and washed with deionised water (3 
x 80 mL). The solid was re-dissolved in CH2Cl2 (150 mL) and dried over MgSO4, 
hexane was added to this solution until a solid precipitate just started to form, the 
flask was then placed in the freezer overnight. The resulting colourless crystalline 
solid was filtered and measured to be 94% pure in peroxide, (12.87 g, 71%): 
max(neat)/cm
-1 3210, 3060, 1586, 1484, 1435, 1262, 1226, 1162, 1106, 1058, 1041, 
996, 721;H (400 MHz; CDCl3) 7.58-7.69 (8H, 8 x CH arom.), 7.71-7.80 (8H, 8 x CH 
arom.), 7.82-7.86 (4H, 4 x CH arom.), 9.18 (1H, s, -OH). The oxygen content was 
measured by comparing the integrals of the aromatic signals with with hydroxyl 
portion. 
 
General procedure for catalytic asymmetric epoxidation of alkenes with TPPP 
mediated by iminium salts under non-aqueous conditions 
 
The alkene (1 equiv.) and the desired solvent was added to a flask. The solution 
was allowed to cool down to the required temperature and TPPP was added in one 
portion and stirred for 2 min. The catalyst was then added as a solid in small 
portions over 1 min. The reaction was stirred until complete consumption of the 
starting alkene had been observed, or, until it was judged that no further 
conversion was occurring by TLC. Et2O, allowed to cool to 0 °C was added to 
prepcipitate out TPPP and its reduced by-products. The suspension was filtered 
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through a thin pad of celite and silica to yield the desired epoxide. If column 
chromatography was required, it was performed typically eluting with light 
petroleum / EtOAc (99:1), containing 2% TEA. The major enantiomer was 
determined by []20D measurements and comparison to the literature, 
enantioselectivities were determined by either chiral HPLC, or by the use of the a 
resolving agent in 1H NMR. 
 
 
2-Methyl-(E)-2,3-diphenyloxirane25 
 
Isolated as a colourless crystalline solid: max(neat)/cm
-1 3061, 1601, 1495, 1449, 
1370, 1278, 1156, 1117, 1065, 1026, 980;H (300 MHz; CDCl3) 1.46 (3H, s, Me), 3.95 
(1H, s, =CHAr), 7.30-7.45 (10H, m, CH arom.). HPLC conditions - hexane/2-propanol 
(80:20), oven temp 20 °C, column Chiracel OD-H 01 250 × 4.6 mm, 5 μm particle 
size, flow rate 1 mL/min,  254 nm: tr - 4.00 min (–)-(1S,2S), 6.92 min (+)-(1R,2R). 
 
 
1-Phenyl-7-oxa-bicyclo[4.1.0]heptane25 
 
Isolated as a colourless oil: max(neat)/cm
-1 3083, 1602, 1495, 1445, 1359, 1248, 
1174, 1133, 1078, 1030, 993, 974; H (300 MHz; CDCl3) 1.20-1.33 (1H, m, -CH2-), 
1.51-1.62 (3H, m, 3 x -CH2-), 1.97-2.05 (2H, m, 2 x -CH2-), 2.16-2.18 (1H, m, -CH2-), 
2.24-2.31 (1H, m, -CH2-), 3.10 (1H, t, J = 2.0 Hz, -CHO-), 7.26-7.41 (5H, m, 5 x CH 
arom.). 
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7b-Phenyl-1a,2,3,7b-tetrahydro-1oxa-cyclopropa[a]naphthalene25 
 
Isolated as a colourless crystalline solid: max(neat)/cm
-1 3087, 1601, 1493, 1284, 
1176, 1158, 1094, 1072, 1028; H (300 MHz; CDCl3) 2.10 (1H, td, J = 15.5 Hz, 5.6 Hz, 
-CH2-) 2.48-2.59 (1H, m, -CH2-), 2.76 (1H, dd, J = 15.5 Hz, 5.5 Hz, -CH2-) 2.96-3.07 
(1H, m, -CH2-), 3.70 (1H, d, J = 3.0 Hz, -CHO-), 7.09-3.29 (4H, m, CH arom.), 7.45-
7.60 (5H, m, CH arom.). HPLC conditions - hexane/2-propanol (90:10), oven temp 
20 °C, column Chiracel OD-H 01 250 × 4.6 mm, 5 μm particle size, flow rate 1 
mL/min,  254 nm: tr - 4.51 min (–)-(1S,2R), 5.94 min (+)-(1R,2S). 
 
 
(E)-2,3-diphenyloxirane25 
 
Isolated as a colourless crystalline solid: max(neat)/cm
-1 3081, 1776, 1602, 1485, 
1336, 1155, 1074, 1042, 953;H (400 MHz; CDCl3) 3.87 (2H, s, 2 x -CHO-), 7.29-7.39 
(10H, m, 10 x CH arom.); C (75 MHz; CDCl3) 63.3 (2C, 2 x -CHO-), 126.0 (4C, 4 x CH 
arom.), 128.6 (2C, 2 x CH arom.), 129.3 (4C, 4 x CH arom.), 137.6 (2C, 2 x C quat. 
arom.). HPLC conditions - hexane/2-propanol (80:20), oven temp 20 °C, column 
Chiracel OD-H 01 250 × 4.6 mm, 5 μm particle size, flow rate 1 mL/min,  254 nm: tr - 
4.98 min (–)-(1S,2S), 6.54 min (+)-(1R,2R). 
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1a,2,3,7b-Tetrahydro-1-oxa-cyclopropa[a]naphthalene26 
 
Isolated as a colourless oil: max(neat)/cm
-1 3058, 3028, 2931, 2850, 1602, 1492, 
1314, 1129, 1088, 1031, 965; H (400 MHz; CDCl3) 1.65-1.84 (1H, m, -CH2-), 2.33-
2.42 (1H, m, -CH2-), 2.52 (1H, dd, J = 15.5 Hz, 5.5 Hz, -CH2-), 2.67-2.85 (1H, m, -CH2-
), 3.71-3.80 (1H, m, -CHO-), 3.81-3.89 (1H, m, -CHO-), 7.05 (1H, d, J = 7.2 Hz, CH 
arom.), 7.18-7.35 (2H, m, 2 x CH arom.), 7.40 (1H, d, J = 7.1 Hz, CH arom.). 
 
 
2,2,3-Triphenyloxirane26 
 
Isolated as a colourless crystalline solid: max(neat)/cm
-1 3061, 3031, 2956, 2924, 
2857, 1604, 1595, 1498, 1471, 1448, 1262, 1220, 741, 699; H (400 MHz; CDCl3) 4.42 
(1H, s, -CHO-), 7.13- 5.50 (15H, m, 15 x CH arom.). HPLC conditions - hexane/2-
propanol (90:10), oven temp 20 °C, column Chiracel OD-H 01 250 × 4.6 mm, 5 μm 
particle size, flow rate 1 mL/min, 254 nm: tr – 4.26 min (+)-(S), 7.47 min (–)-(R). 
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3.3 Supporting Chiral Separation Data 
 
Area % report of racemic 1-phenyl-3,4-dihydronaphthalene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\DHPNOx.Racemic.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\90.10 30min.met  
 
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
4.507 1467968 50.36 201731 56.82 
5.933 1446888 49.64 153330 43.18 
     
Totals     
 2914856 100.00 355061 100.00 
 
 
 
Area % Report of enantioenriched 1-phenyl-3,4-dihydronaphthalene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\CJB281.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\lactoneacidBn.met  
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
4.520 8323 2.99 1336 4.37 
5.967 270063 97.01 29254 95.63 
     
Totals     
 278386 100.00 30590 100.00 
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Area % Report of racemic trans-α-methylstilbene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\taMSOx.Racemic.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\Trans-Stilbene2.met  
 
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
4.007 10514211 51.43 680756 65.88 
6.917 9928030 48.57 352506 34.12 
     
Totals     
 20442241 100.00 1033262 100.00 
 
 
 
 
Area % Report of enantioenriched trans-α-methylstilbene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\CJB298B.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\lactoneacidBn.met  
 
UV Results     
Retention Time Area Area % Height Height % 
4.153 3766399 83.23 555041 88.93 
6.883 759085 16.77 69085 11.07 
     
Totals     
 4525484 100.00 624126 100.00 
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Area % report of racemic triphenylethylene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\TPEOx.racemic.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\90.10 30min.met  
  
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
4.260 822126 50.04 115909 64.36 
7.470 820825 49.96 64180 35.64 
     
Totals     
 1642951 100.00 180089 100.00 
 
 
 
 
Area % report of enantioenriched triphenylethylene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\CJB420TPE.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\90.10 30min.met 
 
 
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
4.310 6759060 64.20 933684 76.40 
7.803 3769479 35.80 288474 23.60 
     
Totals     
 10528539 100.00 1222158 100.00 
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Area % Report of racemic trans-stilbene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\tSOx.Racemic.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\Trans-Stilbene2.met  
 
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
4.983 18312411 49.91 2394160 57.45 
6.543 18381757 50.09 1773413 42.55 
     
Totals     
 36694168 100.00 4167573 100.00 
 
 
 
 
Area % Report of enantioenriched trans-stilbene oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\CJB256A.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\yohan\Method\lactoneacidBn.met  
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
4.950 1946063 68.11 249137 74.51 
6.837 911091 31.89 85225 25.49 
     
Totals     
 2857154 100.00 334362 100.00 
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Area % Report of (±)-Xanthlyetin Oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\Xanthoxideracemic.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\ben\Method\90.10.1h.met  
 
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
34.890 5984246 51.88 97467 53.54 
37.003 5550421 48.12 84580 46.46 
     
Totals     
 11534667 100.00 182047 100.00 
 
 
 
 
Area % Report of (+)-Xanthlyetin Oxide 
Data File: C:\EZChrom Elite\Enterprise\Projects\Chris\CJB49490.10repo.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\ben\Method\90.10.1h.met  
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
35.313 3913986 100.00 61307 100.00 
     
Totals     
 3913986 100.00 61307 100.00 
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NMR spectrum of racemic 1,2-dihydonaphthalene oxide 
 
 
 
 
 
NMR spectrum of enantioenriched 1,2-dihydronaphthalene oxide 
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NMR of racemic 1-phenyl-3,4-cyclohexene oxide 
 
 
NMR sample of enantioenriched 1-phenylcyclohexene oxide 
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3.4 Supplementary NMR Data 
NOESY NMR Spectra for 169 @ -80C 
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NOESY NMR Spectra for 170 @ -80C 
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NOESY NMR Spectra for 224 @ -80C 
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NOESY NMR Spectra for 234 @ -80C 
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NOESY NMR Spectra for 222 @ -80C 
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NOESY NMR Spectra for 225 @ -80C 
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NOESY NMR Spectra for 171 @ -80C 
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NOESY NMR Spectra 232 @-80C 
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3.5 X-Ray Data Reports 
 Crystal Data and Structure Refinement for 228 
 
Identification code  page12 
Empirical formula  C35 H33 N O2 
Formula weight  499.62 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 11.198(3) Å α= 90°. 
 b = 12.171(3) Å β= 90°. 
 c = 19.804(5) Å γ = 90°. 
Volume 2699.0(11) Å3 
Z 4 
Density (calculated) 1.230 Mg/m3 
Absorption coefficient 0.075 mm-1 
F(000) 1064 
Crystal size 0.2000 x 0.2000 x 0.2000 mm3 
Theta range for data collection 1.96 to 25.33°. 
Index ranges -13<=h<=13, -11<=k<=14, -22<=l<=23 
Reflections collected 17103 
Independent reflections 4914 [R(int) = 0.0687] 
Completeness to theta = 25.00° 99.8 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.7911 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4914 / 0 / 343 
Goodness-of-fit on F2 0.978 
Final R indices [I>2sigma(I)] R1 = 0.0526, wR2 = 0.1188 
R indices (all data) R1 = 0.0669, wR2 = 0.1277 
Absolute structure parameter 0.7(17) 
Largest diff. peak and hole 0.243 and -0.226 e.Å-3 
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Crystal Data and Structure Refinement for 278 
 
Identification code  page20 
Empirical formula  C17 H18 O5 
Formula weight  302.31 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2 
Unit cell dimensions a = 23.18(3) Å α= 90°. 
 b = 5.353(6) Å β= 90.93(3)°. 
 c = 12.036(13) Å γ = 90°. 
Volume 1493(3) Å3 
Z 4 
Density (calculated) 1.345 Mg/m3 
Absorption coefficient 0.099 mm-1 
F(000) 640 
Crystal size 0.20 x 0.08 x 0.08 mm3 
Theta range for data collection 2.42 to 25.35°. 
Index ranges -26<=h<=26, -6<=k<=5, -14<=l<=12 
Reflections collected 4642 
Independent reflections 2175 [R(int) = 0.2869] 
Completeness to theta = 25.00° 98.0 %  
Absorption correction Multiscan 
Max. and min. transmission 1.000 and 0.9031 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2175 / 1 / 200 
Goodness-of-fit on F2 1.187 
Final R indices [I>2sigma(I)] R1 = 0.1817, wR2 = 0.4014 
R indices (all data) R1 = 0.2189, wR2 = 0.4379 
Absolute structure parameter 3(5) 
Extinction coefficient 0.031(10) 
Largest diff. peak and hole 0.600 and -0.427 e.Å-3 
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